Publications

Publications published since 2010 from OUS - Department of Oncology

2853 publications found (only first 1000 shown)

Publications 2026

Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV (2026)
CD38^hiCD19^dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade
Front Oncol, 16, 1815008
DOI 10.3389/fonc.2026.1815008, PubMed 42158424
Alnes SR, Laerum-Onsager E, Bye A, Vistven A, Franzén E, Holst M, Brovold T (2026)
Post-rehabilitation self-management support on physical activity and nutrition, including mHealth, improves physical capacity, physical activity, and health related quality of life in people with Parkinson's- results from a randomised controlled trial
Int J Behav Nutr Phys Act, 23 (1)
DOI 10.1186/s12966-026-01888-y, PubMed 41703544
Arffman M, Meriranta L, Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Pedersen M, Drott K, Fluge Ø, Jyrkkiö S, Brown P, Holte H, Leppä S (2026)
A targeted circulating tumor DNA landscape of copy number aberrations in large B-cell lymphomas
Leukemia (in press)
DOI 10.1038/s41375-026-02955-w, PubMed 42020781
Banys-Paluchowski M, Hartmann S, de Boniface J, Gentilini OD, Ditsch N, Stickeler E, Karadeniz Cakmak G, Hauptmann M, Schroth J, Thill M, di Micco R, Hahn M, Murawa D, Rubio IT, Pinto D, Kontos M, Niinikoski L, Gasparri ML, Nina H, Rebaza LP, Fröhlich S, Schmidt E, Wihlfahrt K, Berger T, Basali T et al. (2026)
Marking Techniques for Target Lymph Nodes in Node-Positive Breast Cancer Treated With Neoadjuvant Therapy in the AXSANA/EUBREAST-03/AGO-B-053 Study
J Clin Oncol, 44 (7), 575-585
DOI 10.1200/JCO-25-01921, PubMed 41564379
Berkovska O, Schliemann I, Mermelekas G, Özkan NE, Nikpour M, Haakensen VD, Helland Å, Lehtiö J, Orre LM (2026)
Mass spectrometry-based proteomics delivers in-depth proteome profiling of FFPE lung cancer biopsies from single glass slides
NPJ Precis Oncol, 10 (1)
DOI 10.1038/s41698-026-01517-8, PubMed 42215608
Bjørgo E, Ånensen N, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å (2026)
Merging clinical research and standard healthcare - Nordic Precision Cancer Medicine Symposium 2025
Acta Oncol, 65, 181-185
DOI 10.2340/1651-226X.2026.45168, PubMed 41778669
Brandal SHB, Mo T, Fangberget A, Nilsen LB, Geier OM, Bjørndal H, Holmen MM, Engebråten O, Garred Ø, Hole KH, Seierstad T (2026)
MRI for Predicting Response and 10-Year Outcome of Neoadjuvant Chemotherapy with or Without Additional Bevacizumab Treatment in HER2-Negative Breast Cancer
Cancers (Basel), 18 (3)
DOI 10.3390/cancers18030393, PubMed 41681863
Butt BP, Sorbye H, Ladekarl M, Stokmo HL, Lothe IMB, Fawad H, Tabaksblat EM, Revheim ME, Dybdahl B, Couvelard A, Perren A, Hjortland GO (2026)
Efficacy of FOLFIRINOX in digestive neuroendocrine carcinoma
J Neuroendocrinol, 38 (4), e70168
DOI 10.1111/jne.70168, PubMed 41911950
Bye A, Balstad TR, Ervik Raaness I, Solheim TS, Habberstad R, Klepstad P, Løhre ET, Dajani OF, Kaasa S, Aass N, Vagnildhaug OM (2026)
Linking Inflammation to Reduced Food Intake in Advanced Cancer: A Prospective Observational Study
Curr Oncol, 33 (4)
DOI 10.3390/curroncol33040209, PubMed 42041728
Carlsen IH, Dyvik VR, Johannessen TB, Fjellanger K, Sandvik IM, Hjørnevik JV, Sulen TH, Nybø T, Hundvin JA, Pilskog SMC, Fløtten Ø, Haakensen VD, Hysing LB (2026)
Prospective evaluation and clinical outcomes of adaptive radiotherapy for locally advanced non-small cell lung cancer (LA-NSCLC)
Acta Oncol, 65, 476-484
DOI 10.2340/1651-226X.2026.45745, PubMed 42200217
Chang L, Cameron A, Murphy BM, Muenter MW, Magelssen H, Wolden SL, Chisholm J, Merks JHM, Morris CD, De Corti F, Seitz G, Ebinger M, Sparber-Sauer M, Hawkins DS, Terezakis S (2026)
Recommendations for Radiation Treatment in Pediatric Patients With Metastatic Rhabdomyosarcoma: Expert Consensus From the International Soft Tissue SaRcoma ConsorTium (INSTRuCT)
Pract Radiat Oncol (in press)
DOI 10.1016/j.prro.2026.04.016, PubMed 42103103
Cheng J, Centeno I, Laird BJA, Lõhmus M, Chlebopaševienė G, Foss L, Kaasa S, Centeno C (2026)
Educational interventions for training oncology residents in palliative medicine: a rapid review of the available evidence to inform training standards in cancer care
Support Care Cancer, 34 (6)
DOI 10.1007/s00520-026-10830-8, PubMed 42234193
Donia M, Jespersen H, Jalving M, Lee R, Eriksson H, Hoeller C, Hernberg M, Gavrilova I, Kandolf L, Liszkay G, Helgadottir H, Zhukavets A, Pjanova D, Marquez-Rodas I, Neyns B, Westgeest H, Pourmir I, Sobczuk P, Ellebaek E, Amaral T (2026)
Corrigendum to "Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028": [ESMO Open 10 (2025) 104295]
ESMO Open, 11 (1), 105492
DOI 10.1016/j.esmoop.2025.105492, PubMed 41483632
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote VKJ, Shpilberg O, da Silva MG, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Heß G, Meerten TV, Wirths S, Herhaus P, Novak U, Dierlamm J, Hänel M, Hanoun C et al. (2026)
Addition of autologous stem-cell transplantation to an ibrutinib-containing first-line treatment in patients aged 18-65 years with mantle cell lymphoma (TRIANGLE): 4·5-year follow-up of a three-arm, randomised, open-label, phase 3 superiority trial of the European MCL Network
Lancet, 407 (10542), 1953-1967
DOI 10.1016/S0140-6736(26)00362-4, PubMed 42134356
Eide HA, Grut H, Jebsen P, Kyte JA, Bratland Å (2026)
Hyperfractionated reirradiation and PD-1 blockade in recurrent squamous cell head and neck carcinomas with poor prognosis, results from the REPORT-trial
Radiother Oncol, 219, 111514
DOI 10.1016/j.radonc.2026.111514, PubMed 41916446
Ejder P, Jespersen H, Hernberg M, Ny L, Carneiro A, Ellegård S, Mattila K, Bagge RO, Fountoukidis G, Brandberg Y, Mandala M, O Carrigan B, Schilling B, Aranche A, Hamid O, Berglund A, Helgadottir H, Ullenhag G (2026)
Grand SLAM study protocol: a prospective randomised multicentre study of shortened versus standard duration adjuvant immune checkpoint inhibition for stage IIB-C, III and IV cutaneous melanoma
BMC Cancer, 26 (1)
DOI 10.1186/s12885-026-15924-4, PubMed 41896823
Embring A, Skyttä T, Engellau J, Kerna I, Sendiuliene D, Blomstrand M, Indelicato DJ, Timmermann B, Lassen-Ramshad Y, Magelssen H (2026)
Nordic Society of Paediatric Haematology and Oncology (NOPHO) Radiotherapy Working Group consensus guidelines on radiotherapy for paediatric low-grade gliomas
Acta Oncol, 65, 101-108
DOI 10.2340/1651-226X.2026.44815, PubMed 41693214
Engelaar M, van der Heide I, Bos N, Schäfer W, Dantas C, Pinnavaia L, Apolone G, Brunelli C, Caraceni A, Couespel N, Garin O, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Rademakers J (2026)
Exploring health system factors related to the quality of life of people with (a history of) cancer: a rapid review
Health Qual Life Outcomes (in press)
DOI 10.1186/s12955-026-02545-5, PubMed 42129865
Fauske L, Bruland ØS, Holtermann A, Larsen SG (2026)
Experiences and Hopes Among Patients with Colorectal Carcinoma and Peritoneal Metastases Who Are Participating in an Early-Phase Clinical Trial
Cancers (Basel), 18 (2)
DOI 10.3390/cancers18020244, PubMed 41595164
Filippi AR, Bar J, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Van Den Heuvel MM, Vercauter P, Smit HJM, Solomon B, Chander P, Qiao Y, Faria J, Girard N (2026)
Radiotherapy patterns and factors associated with pneumonitis in PACIFIC-R, a real-world study of patients with unresectable stage III non-small-cell lung cancer treated with durvalumab after chemoradiotherapy
Clin Transl Radiat Oncol, 58, 101138
DOI 10.1016/j.ctro.2026.101138, PubMed 41809542
Foss L, Caraceni A, Centeno C, Chlebopaševienė G, Clemmensen SN, Fraterman I, González-Barboteo J, Groenvold M, Laird BJA, Lõhmus M, Mateu-Sanz M, Reyners A, Schildmann E, Hjermstad MJ, Kaasa S, WP6 Consortium (2026)
EU Joint Action: Integrating Palliative Care in the EU Cancer Agenda: Insights From JANE-2
J Pain Symptom Manage, 71 (5), e624-e634
DOI 10.1016/j.jpainsymman.2026.02.009, PubMed 41692079
Fosså SD, Myklebust TÅ, Brydøy M, Negaard HFS, Klepp OH, Dahl AA, Stangenes KM, Kleveland CR, Seljeflot EB, Haugnes HS (2026)
Post-treatment paternity in testicular cancer survivors: Do demographic variables matter?
Cancer Epidemiol, 102, 103074
DOI 10.1016/j.canep.2026.103074, PubMed 42033883
Frostegård E, Bobrova T, Leinebø A, Leray T, Ghosh S, García-Hevia L, Puccinelli C, Riccio L, Sorani J, Bonifazi D, Caumartin J, Donnadieu E, Gazeau F, Hischier R, Inderberg EM, Fanarraga ML, Loustau M, Nowack B, Wälchli S, Ménard-Moyon C (2026)
Nanomedicine Meets Immunotherapy: Advancing Adoptive Cell Therapy with Nanoparticles in the Treatment of Cancer with Sustainability Perspectives
Adv Sci (Weinh), e22864 (in press)
DOI 10.1002/advs.202522864, PubMed 41793185
Girard N, Bar J, Baas P, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido Lopez P, Gregorc V, Haakensen VD, Hiltermann TJN, Kao S, McDonald F, Mornex F, Moskovitz M, Peters S, Siva S, Solomon B, Qiao Y, Anand S, Chander P, Shcherbakova T, Diaz Perez I, Filippi AR (2026)
Real-world 5-year outcomes with durvalumab after chemoradiotherapy in unresectable stage III NSCLC
ESMO Open, 11 (2), 106070
DOI 10.1016/j.esmoop.2026.106070, PubMed 41643268
Gjerde CH, Kleinmanns K, Langer A, Ruiz de Garibay Ponce G, Rozmus E, Stangeland GN, Leitch C, Elnour R, Dongre HN, Berger C, Gultekin O, Forcados C, Stensland M, Nyman TA, Lehti K, Davidson B, Wälchli S, Gelebart P, Costea DE, Kotopoulis S, Bjørge L, McCormack E (2026)
A 3D ovarian cancer metastasis model using a decellularised peritoneal matrix to study therapy response
EBioMedicine, 124, 106135
DOI 10.1016/j.ebiom.2026.106135, PubMed 41633102
Hanekamp BA, Viktil E, Dormagen JB, Kløw NE, Brunborg C, Malinen E, Guren MG, Schulz A (2026)
Optimal time for MRI response evaluation in squamous cell carcinoma of the anus
BJR Open, 8 (1), tzag004
DOI 10.1093/bjro/tzag004, PubMed 41768146
Heggebø LC, Fjæra LF, Garrote FLB, Borgen IMH, Blakstad H, Hellebust TP, Saxhaug C, Knutstad K, Rylander H, Henry T, Gustafsson M, Werlenius K, Blomstrand M, Brandal P (2026)
Case Report: Proton beam therapy - friend or foe for patients with IDH-mutated WHO grade 2 and 3 gliomas?
Front Oncol, 16, 1803943
DOI 10.3389/fonc.2026.1803943, PubMed 42180039
Heggebø LC, Johannessen TA, Magelssen H, Sprauten M, Blakstad H, Brekke J, Goplen D, Marienhagen K, Solheim TS, Bjorland L, Brandal P (2026)
Norwegian consensus guidelines for selection of neuro-oncology patients to proton therapy
Clin Transl Radiat Oncol, 58, 101140
DOI 10.1016/j.ctro.2026.101140, PubMed 41798870
Hjorth S, Vandraas KF, Trewin-Nybråten CB, Botteri E, Ursin G, Andreassen BK, Støer NC (2026)
Anti-HER2 treatment in everyday practice: how we treat older women with breast cancer differently
Breast Cancer Res Treat, 215 (2), 54
DOI 10.1007/s10549-025-07888-z, PubMed 41498846
Holmén A, Murad F, Nilsson K, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, von Döbeln GA, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M, Klevebro F, Sunde B (2026)
Health-related quality of life comparing standard and prolonged time-to-surgery after neoadjuvant chemoradiotherapy for esophageal cancer: results from the multicenter, randomized, controlled NeoRes II trial
Dis Esophagus, 39 (3)
DOI 10.1093/dote/doag047, PubMed 42132923
Husby M, Frydenberg H, Myklebust TÅ, Skei NV, Solligård E, Thune I, Gustad LT, Furberg AS (2026)
Cancer Patients with Sepsis: Prognostic Insights from a Population-Based Cohort Study in Norway
Cancer Epidemiol Biomarkers Prev, 35 (2), 264-275
DOI 10.1158/1055-9965.EPI-25-1018, PubMed 41324403
Huynh BN, Futsaether CM, Tomic O, Liland KH, Kakar M, Hellebust TP, Malinen E, Dale E, Rydén-Eilertsen K (2026)
Direct integration of deep learning-based GTV auto-segmentation into a clinical radiotherapy planning system
Phys Imaging Radiat Oncol, 38, 100962
DOI 10.1016/j.phro.2026.100962, PubMed 42016352
Ivanova A, Amdal CD, Kvalem IL, Reme SE (2026)
Multidomain predictors of long-term work disability in late survivorship after head and neck cancer
Support Care Cancer, 34 (3)
DOI 10.1007/s00520-026-10524-1, PubMed 41772198
Karlsson K, Rancati T, Lindbäck E, Lindberg S, Grozman V, Al-Jirf K, Lax I, Hoffmann L, Møller DS, Khalil A, Knap MM, Nielsen TB, Land LH, Kristiansen C, Ramberg C, Rogg LV, Hagen RK, Frøland AS, Drugge N, Nyman J, Josipovic M, Persson GF, Olofsson J, Bergström P, Rosenbrand HO et al. (2026)
Dose-Volume Predictors of Fatal Bronchopulmonary Bleeding After Stereotactic Body Radiation Therapy of Centrally Located Lung Tumors: An Analysis of the Expanded HILUS Cohort
Int J Radiat Oncol Biol Phys, 124 (5), 1298-1308
DOI 10.1016/j.ijrobp.2025.12.007, PubMed 41532892
Klepaker IV, Fauske L, Uhlen-Strand MM (2026)
Exploring dental professionals' experiences of interprofessional collaboration with home care services
Acta Odontol Scand, 85, 200-208
DOI 10.2340/aos.v85.45934, PubMed 42027111
Kristiansen SK, Dernjani N, Bruland ØS, Edin NFJ, Juzeniene A (2026)
A 3D co-culture model with fibroblast-restricted FAP expression for cancer therapy using [²¹²Pb]Pb-FAPI-46
EJNMMI Radiopharm Chem, 11 (1)
DOI 10.1186/s41181-026-00444-0, PubMed 41998481
Kristiansen SK, Shubin K, Zubrienė A, Matulis D, Dernjani N, Juzenas P, Bruland ØS, Juzeniene A (2026)
Radiobiological investigations of a [²¹²Pb]Pb-carbonic anhydrase IX-targeting small-molecule ligand in renal cell carcinoma and colorectal cancer models
Int J Radiat Biol, 102 (2), 127-137
DOI 10.1080/09553002.2025.2595630, PubMed 41481374
Kryeziu K, Klokkerud SK, Totland MZ, Moosavi SH, Reims HM, Bergsland CH, Eilertsen IA, Smeby J, Lassen K, Lundesgaard KK, Syversveen T, Brændengen M, Nesbakken A, Guren TK, Yaqub S, Sveen A, Lothe RA (2026)
Patient-derived organoids from metastatic colorectal cancer mirror tumor heterogeneity and predict patient survival and drug sensitivity
Cell Rep Med, 102840 (in press)
DOI 10.1016/j.xcrm.2026.102840, PubMed 42208542
Kuhlen M, Roganivic J, Naviglio S, Baecklund F, Bello R, Ben-Ami T, Bergamaschi L, Bilic E, Bien E, Brito MJ, Castañeda A, Cesen Mazic M, Dos Reis Farinha NJ, Jovanovska A, de Krijger R, Debora de Pasquale M, Elisei R, Grau Bolado G, Guillén G, Haissaguerre M, Hartl D, Huerta-Aragonés J, Krawczyk MA, Lamartina L, Leite F et al. (2026)
Who leads, who treats, what dose? European paediatric differentiated thyroid carcinoma practice-an European Cooperative Study Group for Paediatric Rare Tumours survey
Eur J Endocrinol, 194 (6), 756-768
DOI 10.1093/ejendo/lvag091, PubMed 42139545
König M, Holmøy T, Nygaard GO, Riise J, Midtvedt K, Goll GL, Jørgensen KK, Munthe LA, Fevang B, Myhre AE, Trøseid M (2026)
Vaccination of immunosuppressed patients
Tidsskr Nor Laegeforen, 146 (5)
DOI 10.4045/tidsskr.25.0555, PubMed 42012114
Lansu J, Bovée JVMG, Braam PM, Miah AB, Bruland ØS, Baldini EH, Scholten AN, Hamming-Vrieze O, Heukelom J, Wiltink LM, Foppele F, Ubbels JF, van der Noort V, Haas RL (2026)
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: The Phase 2 DOREMY Nonrandomized Clinical Trial
JAMA Oncol (in press)
DOI 10.1001/jamaoncol.2026.1577, PubMed 42141895
Larsen RH, Kolstad A, Fosså A, Repetto-Llamazares A, Smerud KT, Illidge T, Bruland ØS (2026)
A Phase II Study of ¹⁷⁷Lu-Lilotomab Satetraxetan, a CD37 Antibody-Radionuclide Conjugate, as Third- or Later-Line Treatment of Rituximab-Refractory Follicular B-Cell Lymphoma Patients
Pharmaceuticals (Basel), 19 (2)
DOI 10.3390/ph19020250, PubMed 41754790
Leitzinger N, Falk RS, Jespersen H, Eide NA, Green AC, Robsahm TE, Veierød MB (2026)
Trends in incidence and survival for uveal melanoma in Norway, 1993-2021
Br J Ophthalmol (in press)
DOI 10.1136/bjo-2025-327605, PubMed 41991253
Lia K, Galleberg RB, Rostoft S, Jørgensen RRK, Smeland KB, Hjermstad MJ, Sørland K, Fagerli UM, Bø IB, Johansen J, Bhargava S, Kiserud CE, Fosså A (2026)
Self-reported late effects, daily functioning, and health-related quality of life in older Hodgkin lymphoma survivors - a national population-based cross-sectional survey
Leuk Lymphoma, 67 (5), 1125-1135
DOI 10.1080/10428194.2026.2633180, PubMed 41761714
Lien TG, Ohnstad HO, Lingjærde OC, Vallon-Christersson J, Aaserud M, Sveli MAT, Borg Å, On Behalf Of Osbreac, Garred Ø, Borgen E, Naume B, Russnes H, Sørlie T (2026)
Correction: Lien et al. Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer. Cancers 2021, 13, 6118
Cancers (Basel), 18 (9)
DOI 10.3390/cancers18091337, PubMed 42122291
Lizano-Barrantes C, Amat-Fernandez C, Garin O, Luer-Aguila R, Pardo Y, Rojas-Concha L, Thong MSY, Apolone G, Brunelli C, Caraceni A, Couespel N, Bos N, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Velikova G, Ferrer M, EUonQoL Working Group (2026)
Needs and health-related quality of life domains relevant to people in Europe with advanced cancer in need of palliative care: a systematic review of qualitative research
Qual Life Res, 35 (3), 74
DOI 10.1007/s11136-025-04129-0, PubMed 41706236
Lizano-Barrantes C, Amat-Fernandez C, Garin O, Pardo Y, Périz-Colón Ó, Saint-Jean PN, Rojas-Concha L, Thong M, Apolone G, Brunelli C, Caraceni A, Couespel N, Bos N, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Velikova G, Ferrer M, EUonQoL Working Group (2026)
Health-related quality of life domains relevant to people in Europe undergoing cancer treatment: a systematic review of qualitative research
Qual Life Res, 35 (6)
DOI 10.1007/s11136-026-04201-3, PubMed 42132971
Lo Greco MC, Kelly SM, Corning C, Fajardo RD, Magelssen H, Cameron AL, Albiac MR, Gaze MN, Safwat A, Scarzello G, Helfre S, Burke A, Chisholm JC, Boterberg T, Mandeville HC, European Soft Tissue Sarcoma Study Group (EpSSG) Radiotherapy Committee (2026)
Highly conformal whole abdominopelvic radiotherapy: Consensus delineation guidelines from EpSSG and QUARTET
Radiother Oncol, 221, 111577 (in press)
DOI 10.1016/j.radonc.2026.111577, PubMed 42119643
Lundereng ED, Brkic A, Absolom K, Andvik E, Beernaert K, Cresswell K, Dajani OF, De Glas N, Fallon M, Freitas-Durks V, Guldhav KV, Hjermstad MJ, Kaasa S, Kurita GP, Lund JÅ, Mitrea N, Damink SO, Paulsen Ø, Pedersen GM, Skåre TS, Lundeby T, The MyPath consortium (2026)
Balancing ideals and realities: health care professionals' perspectives of and attitudes toward digital patient-centered cancer care
Qual Life Res, 35 (3), 76
DOI 10.1007/s11136-025-04103-w, PubMed 41709015
Lundereng ED, Brkic A, Fallon M, Cresswell K, Deliens L, Pardon K, Beernaert K, Scherrens AL, Ausen D, Andresen M, Pedersen GM, Lykke C, Caraceni A, Cervantes A, Mitrea N, Olde Damink S, Hjermstad MJ, Kaasa S, Lundeby T, MyPath consortium (2026)
Opportunities and challenges in implementing digital patient-centred cancer care in Europe-a qualitative study of several ESMO Designated Centres
ESMO Real World Data Digit Oncol, 12, 100696
DOI 10.1016/j.esmorw.2026.100696, PubMed 41940183
Lysvik EK, Tulipan AJ, Haakensen VD, Revheim MR, Emblem KE, Hjørnevik T (2026)
Quantitative [¹⁸F]PSMA-1007 PET in Treatment Response Monitoring of Brain Metastases from Non-small Cell Lung Cancer
Mol Imaging Biol (in press)
DOI 10.1007/s11307-026-02104-w, PubMed 42026421
Meltzer S, Landmark SS, Šaltytė Benth J, Negård A, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH (2026)
Carcinoembryonic Antigen Flare Under Oxaliplatin-Based Chemotherapy Predicts Benefit from Nivolumab in Metastatic Microsatellite-Stable Colorectal Cancer - A Post Hoc Analysis of METIMMOX Trial Data
Immunotargets Ther, 15, 594176
DOI 10.2147/ITT.S594176, PubMed 42158080
Mendoza Mireles EE, Blakstad H, Server A, Leske H, Skaga E, Aarhus M, Brandal P, Helseth E, Nayak L, Rønning PA, Vik-Mo EO (2026)
Extent of resection and perioperative neurological status as prognostic markers in glioblastoma: a population-based study
J Neurooncol, 177 (1)
DOI 10.1007/s11060-026-05481-y, PubMed 41733819
Montagna G, Alvarado M, Myers S, Mrdutt MM, Sun SX, Sevilimedu V, Barrio AV, van den Bruele AB, Boughey JC, Boyle MK, Crown A, Kesmodel SB, King TA, Kuerer HM, Leisha EC, Moo TA, Weiss A, Williams AD, Parmar P, Diskin B, Hlavin C, Diego EJ, Polidorio N, Abdelwahab K, Banys-Paluchowski M et al. (2026)
Oncological outcomes with and without axillary lymph node dissection in patients with residual micrometastases after neoadjuvant chemotherapy (OPBC-07/microNAC): an international, retrospective cohort study
Lancet Oncol, 27 (1), 57-67
DOI 10.1016/S1470-2045(25)00598-4, PubMed 41449148
Moreno-Sanchez PM, Rezaeipour M, Inderberg EM, Platten M, Golebiewska A (2026)
Immunosuppressive mechanisms and therapeutic interventions shaping glioblastoma immunity
Nat Cancer, 7 (1), 29-42
DOI 10.1038/s43018-025-01097-9, PubMed 41507535
Morgan E, Bardot A, Langselius O, Rutherford MJ, Elkader HA, Bennett D, Brennan A, Bucher O, Butler J, Cameron DA, Canfell K, Chiam K, Chiarelli A, Creighton N, De P, Evans S, Fitzpatrick D, Guren MG, Hannah J, Huws DW, Jackson CGCA, Kønig SM, Kumar E, Larønningen S, Lawler M et al. (2026)
International disruptions to cancer diagnosis and stage at presentation during the COVID-19 pandemic in 2020: an International Cancer Benchmarking Partnership (ICBP) population-based study
Lancet Oncol, 27 (6), 738-750
DOI 10.1016/S1470-2045(26)00089-6, PubMed 42225103
Morken S, Langer SW, Hjortland GO, Sundlöv A, Hofsli E, Ladekarl M, Tabaksblat E, Vestermark LW, Svensson J, Knigge U, Nunes L, Glimelius B, Pfeiffer P, Aasebø K, Assmus J, Vassella E, Lothe IMB, Couvelard A, Perren A, Knappskog S, Sorbye H (2026)
Molecular-clinical characteristics and treatment outcomes in 163 metastatic colorectal neuroendocrine carcinomas with a comparison to colorectal adenocarcinomas
Int J Cancer, 158 (12), 3217-3231
DOI 10.1002/ijc.70367, PubMed 41642024
Myhre PL, Helland Å, Myhr KM, Skogås JG, Langø T, Goll R, Vikse J, Fretland SØ (2026)
NorTrials drives growth in Norwegian clinical trials
Tidsskr Nor Laegeforen, 146 (1)
DOI 10.4045/tidsskr.25.0685, PubMed 41556676
Napolitano A, Joensuu H, Rothschild S, Evans D, Heinrich MC, Sutton TL, Mayo SC, Boye K, Falkenhorst J, Le Cesne A, Hohenberger P, Rutkowski P, van Houdt WJ, Steeghs N, Gelderblom H, Desar IME, Pantaleo MA, Nishida T, Reichardt P, Blay JY, Somaiah N, Haddad EFN, Grignani G, Baldi GG, Steigen SE et al. (2026)
Adjuvant Imatinib or Observation in Patients With Gastrointestinal Stromal Tumors With KIT Exon 9 Mutations
JAMA Oncol, 12 (4), 407-412
DOI 10.1001/jamaoncol.2026.0007, PubMed 41746633
Negaard HFS, Haugnes HS, Fosså SD, Gjerset GM, Edvardsen E, Larsen KO, Tandstad T, Raastad T, Wisløff T, Thorsen L (2026)
Deterioration in Physical Fitness and Changes in Body Composition After Cisplatin-Based Chemotherapy for Metastatic Testicular Cancer
Clin Genitourin Cancer, 24 (2), 102507
DOI 10.1016/j.clgc.2026.102507, PubMed 41651700
Nicklin E, Bedding C, Alfieri S, Apolone G, Arndt V, Bos N, Bredart A, Brunelli C, Caselli L, Ciliberto G, Rojas-Concha L, Couespel N, Doege D, Ferrer M, Franzoi MA, Gangeri L, Garin O, Gillanders E, Groenvold M, Higgins C, de Jongh ECE, Kalmi T, Kaasa S, Lombardo C, Martin E et al. (2026)
The development of the European Toolkit for the self-assessment of quality of life across the cancer care continuum (EUonQoL-Kit)
Eur J Cancer, 238, 116677
DOI 10.1016/j.ejca.2026.116677, PubMed 41855780
Ottestad I, Løvstad AT, Gjevestad GO, Hamarsland H, Šaltytė Benth J, Andersen LF, Bye A, Biong AS, Retterstøl K, Iversen PO, Raastad T, Ulven SM, Holven KB (2026)
Corrigendum to "Intake of a protein-enriched milk and effects on muscle mass and strength. A 12-week randomized placebo controlled trial among community-dwelling older adults" [J Nutr Health Aging, 21 (2017) 1160-69]
J Nutr Health Aging, 30 (6), 100875
DOI 10.1016/j.jnha.2026.100875, PubMed 42140071
Ottestad I, Ulven SM, Øyri LKL, Sandvei KS, Gjevestad GO, Bye A, Sheikh NA, Biong AS, Andersen LF, Holven KB (2026)
Reduced plasma concentration of branched-chain amino acids in sarcopenic older subjects: a cross-sectional study - CORRIGENDUM
Br J Nutr, 1-2 (in press)
DOI 10.1017/S0007114526107363, PubMed 42168831
Pagani O, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Warner E, Amant F, Mailliez A, Moore HCF, Ruiz-Borrego M, Walshe JM, Borges VF, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Saunders C, Bjelic-Radisic V et al. (2026)
Updated Results of the POSITIVE (Pregnancy Outcome and Safety of Interrupting Therapy for Women with Endocrine Responsive Breast Cancer) Trial
Ann Oncol (in press)
DOI 10.1016/j.annonc.2026.05.699, PubMed 42214557
Ree AH, Bousquet PA, Visnovska T, Lüders T, Geisler BP, Wang S, Bordin DL, Nilsen HL, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Berg JP, Flatmark K, Meltzer S (2026)
Exploratory biomarkers for oxaliplatin-induced nivolumab responsiveness in metastatic microsatellite-stable colorectal cancer
Br J Cancer, 134 (8), 1176-1182
DOI 10.1038/s41416-026-03357-6, PubMed 41731117
Ross E, Bouissou O, Helland Å, Faxvaag A (2026)
From documentation to discovery: clinicians' perspectives on the generation, usability and standardization of real-world data
Int J Med Inform, 217, 106501
DOI 10.1016/j.ijmedinf.2026.106501, PubMed 42176598
Ryzhenkov A, Rachidi S, Nieminen V, Niemi M, Andersen MA, Niklander J, Paajanen J, Bhatnagar P, Bjerrum A, Kauppi P, Theophanous S, Deng WH, Van Schoor Z, Verbiest A, Helland Å, Sanoja J, Janssens A, Knuuttila A, Ilonen I, Fey E, Porkka K (2026)
Association Between Obesity and Sex-Related Survival Difference in Lung Cancer
JCO Clin Cancer Inform, 10 (2), e2500263
DOI 10.1200/CCI-25-00263, PubMed 41926719
Schou LK, Kristensen AW, Steffensen JH, Guren MG, Poulsen LØ, Spindler KG, Skovhus Kronborg CJ (2026)
Shared decision-making in radiotherapy for rectal cancer - A systematic review
Tech Innov Patient Support Radiat Oncol, 37, 100384
DOI 10.1016/j.tipsro.2026.100384, PubMed 41732547
Simonsen MR, Jerm MB, Johannesen TB, Enerstvedt L, El-Galaly T, Fosså A, Smeland K (2026)
Population-based survival after mantle cell lymphoma in Norway and Denmark: Limited impact of earlier BTKi access
Br J Haematol (in press)
DOI 10.1111/bjh.70538, PubMed 42117309
Slørdahl KS, Balto A, Guren MG, Wibe A, Kørner H, Norderval S, Gjelsvik YM, Myklebust TÅ, Larsen IK (2026)
Patient reported outcomes after treatment for colon cancer - A nationwide study
Eur J Surg Oncol, 52 (4), 111481
DOI 10.1016/j.ejso.2026.111481, PubMed 41722357
Slørdahl KS, Puco K, Falk RS, Dyvik I, Brabrand S, Niehusmann P, Steinskog ESS, Blix ES, Flobak Å, Oppedal IA, Meltzer S, Torkildsen CF, Blakstad H, Lindemann K, Smeland S, Amundsen A, Taskén K, Helland Å, InPred Consortium (2026)
Clinical outcomes of genomically guided trametinib monotherapy across cancer types: results from the IMPRESS-Norway trial
Acta Oncol, 65, 90-96
DOI 10.2340/1651-226X.2026.45086, PubMed 41664938
Smedman TM, Line PD, Dueland S (2026)
Pushing to resect colorectal liver metastases: rethinking surgical strategy in colorectal liver metastases with extrahepatic spread
Hepatobiliary Surg Nutr, 15 (3), 79
DOI 10.21037/hbsn-2025-aw-842, PubMed 42273562
Sommervoll FÅ, Horndalsveen H, Sommervoll DE, Koivonen J, Halvorsen TO, Grønberg BH, Aanerud M, Cicenas S, Helbekkmo N, Ahvonen J, Silvoniemi M, Barrera G, Bjaanæs MM, Haakensen V, Öjlert Å, Oselin K, Helland Å, Madebo T (2026)
How does pulmonary function impact QoL in patients with locally advanced NSCLC treated with chemoradiotherapy and durvalumab?
Acta Oncol, 65, 232-240
DOI 10.2340/1651-226X.2026.45040, PubMed 41854264
Spasojevic M, Mariathasan AB, Stoldt S, Larsen SG, Hompland I, Boye K (2026)
Tumour localization and oncological outcomes in nonuterine leiomyosarcoma of the abdomen and pelvis
Eur J Surg Oncol, 52 (5), 111737
DOI 10.1016/j.ejso.2026.111737, PubMed 41797032
Stensland EM, Stensgaard S, Eide IJZ, Nilssen Y, Horndalsveen H, Cicenas S, Grønberg BH, Ekman S, Hansen KH, Sorensen BS, Brustugun OT (2026)
Upfront treatment with osimertinib in lung cancer patients with and without active brain metastases, and the role of ctDNA as a biomarker; a phase II clinical trial (the FIOL study)
Lung Cancer, 214, 109338
DOI 10.1016/j.lungcan.2026.109338, PubMed 41723914
Strach M, Brkic A, Kaczor M, Wójcik R, Kuszmiersz P, Birkenes T, Krzanowski M, Topór-Mądry R, Haugeberg G, Korkosz M (2026)
Direct medical costs in inflammatory arthritis: a single center real-world analysis of cost drivers and impact of a national drug reimbursement program
Pol Arch Intern Med (in press)
DOI 10.20452/pamw.17298, PubMed 42138457
Støyten M, Knutsen T, Thune I, Stikbakke E, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Schirmer H, Haugnes HS (2026)
Cardiac Function and Prostate Cancer Risk and Prognosis: The PROCA-Life Study
Clin Genitourin Cancer, 24 (3), 102508
DOI 10.1016/j.clgc.2026.102508, PubMed 41688223
Svalheim KG, Andresen NK, Bjerre C, Gilje B, Jakobsen EH, Falk RS, Naume B, Kaasa S, Kyte JA (2026)
Patient-reported outcomes from the randomized ALICE trial evaluating the addition of atezolizumab to anthracycline-based chemotherapy in metastatic triple-negative breast cancer
Breast, 86, 104704
DOI 10.1016/j.breast.2026.104704, PubMed 41581361
Sveen A, Bergsland CH, Niederdorfer B, Berstad AE, Bjerkehagen B, Boye K, Guren TK, Lothe RA (2026)
Pembrolizumab in advanced malignant peripheral nerve sheath tumors: a single-arm phase 2 trial
NPJ Precis Oncol, 10 (1)
DOI 10.1038/s41698-026-01303-6, PubMed 41760889
Theophanous S, Lønne PI, Choudhury A, Berbee M, Deijen C, Dekker A, Field M, Gambacorta MA, Gilbert A, Grønlie Guren M, Jadon R, Kochhar R, Martin D, Mohamed AA, Muirhead R, Parés O, Raszewski Ł, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Vassiliou V, Malinen E, Wee L, Appelt A et al. (2026)
An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer
Nat Commun, 17 (1)
DOI 10.1038/s41467-026-70297-3, PubMed 41832163
Trent PB, Blaker Y, Nakken E, Bruheim K, Wang Y, Eriksson AGZ (2026)
Avoidance of adjuvant radiotherapy in inter mediate-risk endometrial carcinoma
Int J Gynecol Cancer, 102854 (in press)
DOI 10.1016/j.ijgc.2025.102854, PubMed 41775570
Valstad H, Fauske L, Wang YY, Eyjólfsdóttir B, Kristensen GB, Skeie-Jensen T, Areklett EW, Lindemann K (2026)
Pelvic exenteration for cervical cancer - Oncologic outcome and long-term health-related quality of life, a mixed methods study
Gynecol Oncol, 210, 183-192 (in press)
DOI 10.1016/j.ygyno.2026.06.001, PubMed 42263503
van Landschoot F, Scherrens AL, Jacobs A, Deliens L, Pardon K, Kaasa S, Fallon M, Cresswell K, Lundeby T, Hjermstad MJ, Warrington L, Olde Damink S, Mitrea N, Ausen D, Kurita GP, Cervantes A, Caraceni A, Beernaert K, MyPath Consortium (2026)
IT Barriers and Enablers for Implementing Electronic Patient Reported Outcome Measures: A Multi-Site Qualitative Study in Nine European Oncology Clinics
Stud Health Technol Inform, 336, 2475-2476
DOI 10.3233/SHTI260715, PubMed 42175382
Wei Q, Hajjar E, Cornillot-Clément S, Solli E, García-Díaz N, Landskron J, Gade A, Ahmad R, Taskén K (2026)
High-Throughput Phenotypic Screen to Identify FoxP3 Regulators in Primary T Cells
ACS Chem Biol, 21 (4), 764-778
DOI 10.1021/acschembio.5c01019, PubMed 41930720
Werlenius K, Parcaoglu F, Zupancic M, Jakobsson F, Flejmer A, Kinhult S, Bergström P, Gubanski M, Witt-Nyström P, Dahl L, Modin K, Heggebo LC, Brandal P, Jakola AS, Gustafsson M, Blomstrand M (2026)
Unexpected frequency of radiation induced contrast enhancement after proton radiotherapy in glioma patients treated within the Swedish PRO-CNS study
Radiother Oncol, 221, 111569 (in press)
DOI 10.1016/j.radonc.2026.111569, PubMed 42114602
Widder J, Bol GM, Simek IM, Ehret F, Abdel-Aty H, Basic S, Chuter D, Daly J, Fairbrother P, Zeqa D, Aboubakar Nana F, Achard V, Corradini S, Correia D, De Ruysscher D, Dingemans AC, Faivre-Finn C, Gillessen S, Guren MG, Hendriks L, Kunz WG, Lecouvet FE, Levy A, Lievens Y, McDonald F et al. (2026)
Clinical trial endpoints for metastases-directed therapy in oligometastatic cancer: a review and Delphi consensus on behalf of the EORTC-ESTRO OligoCare consortium
Lancet Oncol, 27 (5), e238-e247
DOI 10.1016/S1470-2045(26)00075-6, PubMed 42061381
Willumsen LH, Smeland KB, Eikeland S, Fosså A, Bersvendsen HS, Fagerli UM, Falk RS, Lie HC, Skaali T, Kiserud CE (2026)
Self-reported late effects and chronic fatigue, information needs and follow-up in long-term survivors of Hodgkin lymphoma-a cross-sectional study
Support Care Cancer, 34 (5)
DOI 10.1007/s00520-026-10625-x, PubMed 41951854
Zaidi W, Benterud T, Neukamm A, Mentzoni HK, Bratland Å (2026)
Radiology should play a more prominent role in tracheobronchomalacia evaluation
Tidsskr Nor Laegeforen, 146 (4)
DOI 10.4045/tidsskr.26.0801, PubMed 41891479
Zilli T, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, Campos FL, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Iturre AV, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C et al. (2026)
Health-related Quality of Life Outcomes of Salvage Metastasis-directed Treatment Versus Elective Nodal Treatment for Oligorecurrent Nodal Prostate Cancer: A Secondary Analysis of the Phase 2, Open-label PEACE V-STORM Randomized Trial
Eur Urol Oncol (in press)
DOI 10.1016/j.euo.2026.01.001, PubMed 41565552
Övergaard N, Lia K, Collin J, Asdahl PH, Wikman P, Glimelius I, Lagerlof I, Johansson AS, Hansson L, Enblad G, Linderoth J, Goldkuhl C, Jerlström U, Fosså A, Kamper P, Molin D (2026)
AVD is an effective chemotherapy backbone in first-line treatment of older patients with classical Hodgkin lymphoma
Blood Adv (in press)
DOI 10.1182/bloodadvances.2025018954, PubMed 41921203

Publications 2025

Abrantes R, Forcados C, Warren DJ, Santos-Ferreira L, Fleten KG, Senra E, Costa AF, Krpina K, Henrique R, Liberg AM, Rawat P, Gelebart P, McCormack E, Bjørge L, Davidson B, Greiff V, Costea DE, Pinto F, Flatmark K, Gomes C, Inderberg EM, Reis CA, Wälchli S (2025)
Pan-carcinoma sialyl-Tn-targeting expands CAR therapy to solid tumors
Cell Rep Med, 6 (9), 102350
DOI 10.1016/j.xcrm.2025.102350, PubMed 40925376
Al Haidari G, Solbakken AM, Åsli LM, Skovlund E, Undseth C, Guren MG (2025)
Treatment and outcomes for locally recurrent rectal cancer in Norway
Acta Oncol, 64, 784-792
DOI 10.2340/1651-226X.2025.42991, PubMed 40500960
Almhagen E, Alkhiat A, Sorcini B, Alpsten F, Kronborg CJS, Rønde HS, Guren MG, Pilskog S, Valdman A (2025)
An In Silico Feasibility Study of Dose-Escalated Hypofractionated Proton Therapy for Rectal Cancer
Cancers (Basel), 17 (16)
DOI 10.3390/cancers17162627, PubMed 40867256
Amat-Fernandez C, Garin O, Luer-Aguila R, Pardo Y, Briseño R, Lizano-Barrantes C, Rojas-Concha L, S Y Thong M, Apolone G, Brunelli C, Caraceni A, Couespel N, Bos N, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Velikova G, Ferrer M, EUonQoL Working Group (2025)
Systematic review of the needs and health-related quality of life domains relevant to people surviving cancer in Europe
Qual Life Res, 34 (4), 913-936
DOI 10.1007/s11136-024-03884-w, PubMed 39847267
Amdal CD, Falk RS, Alanya A, Schlichting M, Roychoudhury S, Bhatnagar V, Wintner LM, Regnault A, Ingelgård A, Coens C, le Cessie S, Holzner B, Chang J, Taphoorn M, Cislo P, Giesinger JM, Cappelleri JC, Pawar V, Ten Seldam S, Papadopoulos EJ, Calvert MJ, Joseph KL, Bottomley A, Griebsch I, Arraras JI et al. (2025)
SISAQOL-IMI consensus-based guidelines to design, analyse, interpret, and present patient-reported outcomes in cancer clinical trials
Lancet Oncol, 26 (12), e683-e693
DOI 10.1016/S1470-2045(25)00520-0, PubMed 41308689
Arends J, Dajani O, Philips I, Skipworth RJE, Solheim TS, Laird BJA (2025)
Comment on 'Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoint Series' by Dajani et al.-The Authors' Reply
J Cachexia Sarcopenia Muscle, 16 (5), e70069
DOI 10.1002/jcsm.70069, PubMed 40993884
Ascierto PA, Tang H, Dolfi S, Nyakas M, Marie Svane I, Muñoz-Couselo E, Grob JJ, Gomez-Roca CA, Chiarion-Sileni V, Peltola K, Larkin J, Melero I, Callahan M, Dummer R, Djidel P, Warad D, Reusser-Wolf D, Lipson EJ, Garnett-Benson C (2025)
Effect of prior and first-line immunotherapy on baseline immune biomarkers and modulation of the tumor microenvironment in response to nivolumab and relatlimab combination therapy in patients with melanoma from RELATIVITY-020
J Immunother Cancer, 13 (2)
DOI 10.1136/jitc-2024-009773, PubMed 40010775
Asphaug L, Akslen LA, Blix ES, Boge B, Borgen EF, Brekke MB, Falk RS, Geitvik GA, Gilje B, Gravdehaug B, Heie A, Janssen E, Kiserud CE, Kursetgjerde T, Langerød A, Lømo J, Mannsåker B, Mortensen E, Olsson P, Porojnicu AC, Raj SX, Roe OD, Russnes HEG, Skjerven HK, Songe-Møller S et al. (2025)
Cost-effectiveness of Prosigna for Adjuvant Treatment Decisions in Early Breast Cancer: Healthcare Sector and Societal Perspectives
Clin Breast Cancer, 25 (6), e721-e730
DOI 10.1016/j.clbc.2025.04.011, PubMed 40348620
Astrup GL, Siksjø MK, Aass N, Alves G, Brønnick KK, Hjermstad MJ, Kaasa S, Karlsson AT, Landrø NI, Tysnes OB, Seierstad T, Yri OE (2025)
Cognitive function in long-term survivors after treatment for brain metastases compared with normative samples
Neurooncol Pract, 13 (1), 178-188
DOI 10.1093/nop/npaf083, PubMed 41798131
Banys-Paluchowski M, Hartmann S, Basali T, Gasparri ML, de Boniface J, Gentilini OD, Cakmak GK, Ditsch N, Stickeler E, Schlichting E, Rubio I, Peintinger F, Untch M, Mau C, Federspiel FK, Bucher S, Ramaker K, Paluchowski P, Bauer L, Riemer S, Langanke D, Leuf TD, Schnabel J, von Abel E, Solbach C et al. (2025)
Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
Breast Cancer Res Treat, 211 (1), 203-211
DOI 10.1007/s10549-025-07635-4, PubMed 39976867
Belak B, Palfi E, Molnar A, Blasszauer C, Reibl D, Lövey J (2025)
Long-term nutrition therapy leads to survival benefit in head and neck cancer patients receiving targeted or immunotherapy. A retrospective cohort study with real-world data
Front Oncol, 15, 1667150
DOI 10.3389/fonc.2025.1667150, PubMed 41256317
Berner K, Hernes E, Kvassheim M, Revheim ME, Bastiansen J, Selboe S, Bakken CL, Grønningsæter SR, Bruland ØS, Larsen RH, Bouzelmat L, Jardine VL, Stokke C (2025)
First-in-Human Phase 0 Study of AB001, a Prostate-Specific Membrane Antigen-Targeted ²¹²Pb Radioligand, in Patients with Metastatic Castration-Resistant Prostate Cancer
J Nucl Med, 66 (5), 732-738
DOI 10.2967/jnumed.124.269299, PubMed 40081958
Bjelic-Radisic V, Cardoso F, Weis J, Pogoda K, Arraras JI, Greimel E, Bottomley A, Cameron D, Brain E, Hartup S, da Costa Vieira RA, Hoefnagels N, Huang CC, Shamieh O, Pinto M, Belay YB, Serpentini S, Bleiker E, Nookala Krishnamurthy M, Shimomura A, Sturm-Inwald EC, Getu MA, Bliem B, Astrup G, Morag O et al. (2025)
An international Phase IV field study - psychometric properties of the updated module on assessing quality of life of patients with breast cancer EORTC QLQ-BR42
Breast, 80, 103890
DOI 10.1016/j.breast.2025.103890, PubMed 39947087
Bouska A, Zhang W, Sharma S, Holte H, Shah RA, Lone WG, Soma MA, Yang R, Liu X, Mehmood S, Chawla RS, Cappelli LV, Fiore D, Gong Q, Heavican-Foral TB, Cannatella JJ, Amador C, Arif A, Smith LM, Lim ST, Ong CK, Feldman AL, Du MQ, Perry AM, de Leval L et al. (2025)
Integrative Genomic and Transcriptomic Analysis Reveals Targetable Vulnerabilities in Angioimmunoblastic T-Cell Lymphoma
Am J Hematol, 100 (9), 1486-1501
DOI 10.1002/ajh.27736, PubMed 40510016
Bregni G, Adams R, Bale R, Bali MA, Bargellini I, Blomqvist L, Brown G, Cremolini C, Demetter P, Denecke T, Dohan A, Dopazo C, Elez E, Evrard S, Feakins R, Guckenberger M, Guren MG, Hawkins M, Hoorens A, Huguet E, Intven M, Koessler T, Kunz WG, Lordick F, Lucidi V et al. (2025)
EORTC consensus recommendations on the optimal management of colorectal cancer liver metastases
Cancer Treat Rev, 136, 102926
DOI 10.1016/j.ctrv.2025.102926, PubMed 40179590
Bröckelmann PJ, Böll B, Molin D, Schneider G, Leppä S, Meissner J, Kamper P, Hutchings M, Christensen JH, Schnetzke U, Fuchs M, Jablonski J, Eichenauer DA, von Tresckow B, Klapper W, Kobe C, Borchmann P, Fosså A (2025)
Brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone for advanced-stage Hodgkin lymphoma in older patients
Hemasphere, 9 (8), e70190
DOI 10.1002/hem3.70190, PubMed 40832013
Bøhn SH, Reinertsen KV, Kiserud CE, Loge JH, Fosså A, Skaali T, Blomhoff R, Oldervoll LM, Courneya KS, Raastad T, Nilsen TS, Wisløff T, Lie HC, Berge T, Edvardsen E, Fagerli UM, Fjerstad E, Gjerset GM, Haavik I, Henriksen HB, Rutkovskiy A, Sandberg G, Seland M, Slott M, Tjessem KH et al. (2025)
Effects of a Multidisciplinary Intervention on Fatigue in Lymphoma Survivors With Chronic Fatigue: Protocol for a Randomized Controlled Trial (REFUEL)
JMIR Res Protoc, 14, e69336
DOI 10.2196/69336, PubMed 40882189
Carlsson PO, Hu X, Scholz H, Ingvast S, Lundgren T, Scholz T, Eriksson O, Liss P, Yu D, Deuse T, Korsgren O, Schrepfer S (2025)
Survival of Transplanted Allogeneic Beta Cells with No Immunosuppression
N Engl J Med, 393 (9), 887-894
DOI 10.1056/NEJMoa2503822, PubMed 40757665
Casali PG, Antoine-Poirel H, Berrocoso S, Blay JY, Dubois T, Ferrari A, Fullaondo A, Hovig E, Jagodzińska-Mucha P, Ługowska I, Kaasa S, Nicoară D, Pletsa V, Provenzano S, Santoro M, Šekerija M, Van Hoof W, Vyas M, Trama A, JANE Consortium (2025)
Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)
ESMO Open, 10 (2), 104126
DOI 10.1016/j.esmoop.2024.104126, PubMed 39874899
Chen IM, Johansen JS, Theile S, Silverman LM, Pelz KR, Madsen K, Dajani O, Lim KZM, Lorentzen T, Gaafer O, Koniaris LG, Ferreira AC, Neelon B, Guttridge DC, Ostrowski MC, Zimmers TA, Nielsen D (2025)
Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia
J Clin Oncol, 43 (18), 2107-2118
DOI 10.1200/JCO.23.01965, PubMed 40354592
Chen IM, Johansen JS, Theile S, Silverman LM, Pelz KR, Madsen K, Dajani O, Lim KZM, Lorentzen T, Gaafer O, Koniaris LG, Ferreira AC, Neelon B, Guttridge DC, Ostrowski MC, Zimmers TA, Nielsen D (2025)
Erratum: Randomized Phase II Study of Nab-Paclitaxel and Gemcitabine With or Without Tocilizumab as First-Line Treatment in Advanced Pancreatic Cancer: Survival and Cachexia
J Clin Oncol, 43 (25), 2840
DOI 10.1200/JCO-25-01631, PubMed 40700669
Christiansen GG, Farnes I, Hjermstad MJ, Labori KJ (2025)
Association between baseline quality of life and survival in patients with non-metastatic, advanced pancreatic cancer
Scand J Gastroenterol, 61 (1), 53-60
DOI 10.1080/00365521.2025.2585113, PubMed 41236811
Cilla S, Rossi R, Donati CM, Habberstad R, Klepstad P, Dall'Agata M, Valenti V, Kaasa S, Medici F, Morganti AG, Maltoni M (2025)
Pain Management Adequacy in Patients With Bone Metastases: A Secondary Analysis From the Palliative Radiotherapy and Inflammation Study Trial
Clin Med Insights Oncol, 19, 11795549241297054
DOI 10.1177/11795549241297054, PubMed 40144780
Collinge B, Hilton LK, Wong J, Alduaij W, Ben-Neriah S, Slack GW, Farinha P, Boyle M, Meissner B, Cook JR, Ott G, Rosenwald A, Campo E, Amador C, Greiner TC, Raess PW, Song JY, Inghirami G, Ondrejka SL, Jaffe ES, Weisenburger DD, Chan WC, Holte H, Beiske K, Fu K et al. (2025)
High-grade B-cell lymphoma, not otherwise specified: an LLMPP study
Blood Adv, 9 (21), 5409-5422
DOI 10.1182/bloodadvances.2025016651, PubMed 40674706
Connolly EA, Boye K, Bonvalot S, Kratz CP, Leithner A, Malkin D, Messiou C, Miah AB, Pantziarka P, Timmermann B, van der Graaf WTA, Thomas DM, Stacchiotti S (2025)
Genetic predisposition in sarcomas: clinical implications and management
EClinicalMedicine, 83, 103203
DOI 10.1016/j.eclinm.2025.103203, PubMed 40291347
Dahl AA, Fosså SD (2025)
A study of subjective memory impairment in long-term testicular cancer survivors
Br J Cancer, 133 (5), 648-654
DOI 10.1038/s41416-025-03108-z, PubMed 40640494
Dahl AA, Smedsland SK, Bøhn SK, Falk RS, Horn J, Kiserud CE, Skaali T, Vandraas KF, Reinertsen KV (2025)
Subjective memory impairment in long-term breast cancer survivors-associated factors and comparisons to controls from the HUNT study
J Cancer Surviv (in press)
DOI 10.1007/s11764-025-01957-4, PubMed 41454094
Dajani O, Philips I, Størkson EK, Balstad TR, Brown LR, Bye A, Dolan R, Greil C, Hjermstad M, Jakobsen G, Kaasa S, McDonald J, Ottestad I, Sayers J, Simpson M, Sousa MS, Vagnildhaug OM, Yule MS, Laird BJA, Skipworth RJE, Solheim TS, Stares M, Arends J, Cancer Cachexia Endpoints Working Group (2025)
Oncological and Survival Endpoints in Cancer Cachexia Clinical Trials: Systematic Review 6 of the Cachexia Endpoints Series
J Cachexia Sarcopenia Muscle, 16 (2), e13756
DOI 10.1002/jcsm.13756, PubMed 40065459
Dávila Fajardo R, Magelssen H, Cameron AL, Boterberg T, Mandeville HC (2025)
Current and Future Developments in Radiation Oncology Approach for Rhabdomyosarcoma
Cancers (Basel), 17 (10)
DOI 10.3390/cancers17101618, PubMed 40427117
Daw S, Claviez A, Kurch L, Stoevesandt D, Attarbaschi A, Balwierz W, Beishuizen A, Cepelova M, Ceppi F, Fernandez-Teijeiro A, Fosså A, Georgi TW, Hjalgrim LL, Hraskova A, Leblanc T, Mascarin M, Pears J, Landman-Parker J, Prelog T, Klapper W, Ramsay A, Kluge R, Dieckmann K, Pelz T, Vordermark D et al. (2025)
Transplant and Nontransplant Salvage Therapy in Pediatric Relapsed or Refractory Hodgkin Lymphoma: The EuroNet-PHL-R1 Phase 3 Nonrandomized Clinical Trial
JAMA Oncol, 11 (3), 258-267
DOI 10.1001/jamaoncol.2024.5636, PubMed 39745682
Demeestere I, Niman SM, Partridge AH, Diego DS, Kammler R, Ruggeri M, Colleoni M, Shimizu C, Saura C, Gelmon KA, Saetersdal AB, Kroep JR, Mailliez A, Amant F, Ruız-Borrego M, Lee JE, Kataoka A, Walshe JM, Takei J, Borstnar S, Borges VF, Saunders C, Susnjar S, Bjelic-Radisic V, Cardoso F et al. (2025)
Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial
Breast, 83, 104547
DOI 10.1016/j.breast.2025.104547, PubMed 40743662
Demeestere I, Niman SM, Partridge AH, Diego DS, Kammler R, Ruggeri M, Colleoni M, Shimizu C, Saura C, Gelmon KA, Saetersdal AB, Kroep JR, Mailliez A, Amant F, Ruız-Borrego M, Lee JE, Kataoka A, Walshe JM, Takei J, Borstnar S, Borges VF, Saunders C, Susnjar S, Bjelic-Radisic V, Cardoso F et al. (2025)
Corrigendum to "Hormonal factors predictive of fertility in patients with breast cancer interrupting adjuvant endocrine therapy to attempt pregnancy in POSITIVE trial" [The Breast 83 (2025) 104547]
Breast, 84, 104570
DOI 10.1016/j.breast.2025.104570, PubMed 40987054
Di Micco R, Hartmann S, Banys-Paluchowski M, de Boniface J, Schmidt E, Ditsch N, Stickeler E, Schroth J, Karadeniz Cakmak G, Hahn M, Thill M, Lux MP, Kolberg HC, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D, Pinto D, Peintinger F, Schlichting E, Nina H, Valiyeva Qanimat H, Vanhoeij M et al. (2025)
Diagnostic performance of axillary ultrasound after neoadjuvant chemotherapy in initially node-positive breast cancer patients - Results from the prospective AXSANA registry trial
Eur J Cancer, 226, 115607
DOI 10.1016/j.ejca.2025.115607, PubMed 40645031
Ding M, Maspero M, Harrabi S, Jouglar E, Vennarini S, Spencer T, Weber B, Magelssen H, Van Beek K, Stoica R, Saldi S, Boterberg T, Melchior P, van den Heuvel-Eibrink MM, Janssens GO (2025)
Impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in paediatric renal tumours: a SIOP-RTSG radiotherapy committee study
Clin Transl Radiat Oncol, 56, 101051
DOI 10.1016/j.ctro.2025.101051, PubMed 41141653
Ding M, Maspero M, Harrabi S, Jouglar E, Vennarini S, Spencer T, Weber B, Magelssen H, Van Beek K, Stoica R, Saldi S, Boterberg T, Melchior P, van den Heuvel-Eibrink MM, Janssens GO (2025)
Reply to comment on impact of deep learning on CT-based organ-at-risk delineation for flank irradiation in paediatric renal tumours: A SIOP-RTSG radiotherapy committee
Clin Transl Radiat Oncol, 57, 101087
DOI 10.1016/j.ctro.2025.101087, PubMed 41487396
Donia M, Jespersen H, Jalving M, Lee R, Eriksson H, Hoeller C, Hernberg M, Gavrilova I, Kandolf L, Liszkay G, Helgadottir H, Zhukavets A, Pianova D, Marquez-Rodas I, Neyns B, Westgeest H, Pourmir I, Sobczuk P, Ellebaek E, Amaral T (2025)
Adjuvant immunotherapy in the modern management of resectable melanoma: current status and outlook to 2028
ESMO Open, 10 (3), 104295
DOI 10.1016/j.esmoop.2025.104295, PubMed 39954389
Emblem KE, Ringstad G, Svensson SF, Vatnehol SAS, Storås TH, Vik-Mo EO, Heggebø LC, Brandal P, Eide PK (2025)
Intrathecal contrast-enhanced MRI reveals an alternative route for drug delivery and brain tumor visualization
Cancer Lett, 638, 218152
DOI 10.1016/j.canlet.2025.218152, PubMed 41276108
Engelaar M, van Schelven F, Bos N, L'Hote M, Rialland C, Couespel N, Dantas C, Higgins C, Kalmi T, Minnée-van Braak I, Pinnavaia L, Apolone G, Brunelli C, Caraceni A, Ferrer M, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Velikova G, Rademakers J (2025)
Evaluating the Involvement of People With Cancer and Informal Caregivers in the Development Process of a New Set of Quality of Life Questionnaires
Health Expect, 28 (3), e70267
DOI 10.1111/hex.70267, PubMed 40297991
Engh A, Rueegg CS, Bjerre Trent PK, Opheim LØ, Engeskaug I, Nordskar NJ, Bakken A, Steene-Johannessen J, Eriksson AGZ, Thorsen L (2025)
Physical activity and lower extremity lymphedema among endometrial cancer survivors: A population-based cross-sectional study
Gynecol Oncol, 195, 82-88
DOI 10.1016/j.ygyno.2025.03.009, PubMed 40086214
Erichsen M, Solheim TS, Ottestad I, Paur I, Sande RF, Nygaard A, Markhus EH, Thoresen L, Thronæs M, Tangvik RJ, Sygnestveit K, Hansson P, Vestnor C, Jakobsen G, Paulsen Ø, Løhre ET, Balstad TR (2025)
Parenteral Nutrition in Patients with Incurable Cancer: Exploring the Heterogenous and Non-Randomised Clinical Landscape
Curr Oncol, 32 (11)
DOI 10.3390/curroncol32110644, PubMed 41294706
Ericson J, Klevebro F, Sunde B, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Hjortland GO, Lorentzen SS, Slott M, Schröder W, Rouvelas I, Nilsson M (2025)
Nutritional outcomes and impact of malnutrition in a randomised comparison between standard and prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer
Eur J Surg Oncol, 51 (9), 110228
DOI 10.1016/j.ejso.2025.110228, PubMed 40550184
Eriksen JG, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Alsner J, Overgaard J, DAHANCA (2025)
DAHANCA19: A randomized phase III study of primary curative (chemo)-radiotherapy and the EGFR-inhibitor zalutumumab for squamous cell carcinoma of the head and neck
Radiother Oncol, 208, 110899
DOI 10.1016/j.radonc.2025.110899, PubMed 40258418
Fager A, Samuelsson M, Olofsson Bagge R, Pivodic A, Bjursten S, Levin M, Jespersen H, Ny L (2025)
Immune checkpoint inhibitor therapy is associated with a decreased risk of developing melanoma brain metastases
BJC Rep, 3 (1), 22
DOI 10.1038/s44276-025-00137-2, PubMed 40217072
Falchi L, Sureda A, Leppä S, Vermaat JSP, Nijland M, Christensen JH, de Vos S, Holte H, Merryman RW, Lugtenburg PJ, Abrisqueta P, Linton KM, Sunkersett G, Hoehn D, Rana A, Abbas A, Marek J, Hao Y, Steele AJ, Morehouse C, Hutchings M, Belada D (2025)
Fixed-duration epcoritamab plus R2 drives favorable outcomes in relapsed or refractory follicular lymphoma
Blood, 146 (22), 2629-2640
DOI 10.1182/blood.2025029909, PubMed 40920572
Fauske L, Bruland Ø, Hompland I (2025)
Addressing and supporting the unmet needs of sarcoma survivors: a qualitative study
Int J Qual Stud Health Well-being, 20 (1), 2597584
DOI 10.1080/17482631.2025.2597584, PubMed 41382317
Ferdinandus J, Kaul H, Fosså A, Hüttmann A, Keil F, Ko YD, Hitz F, Schwarz M, Trenker C, Kerkhoff A, Staib P, Wille K, Dresel I, Hahn D, Hertenstein B, Moosmann P, Mey U, Balabanov S, Armytage T, Roncolato F, Hellmuth JC, Hertzberg M, Kobe C, Klapper W, Baues C et al. (2025)
Positron Emission Tomography-Guided Brentuximab Vedotin, Etoposide, Cyclophosphamide, Doxorubicin, Dacarbazine, and Dexamethasone in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma: A Prospective, Multicenter, Single-Arm, Phase II Cohort of the German Hodgkin Study Group HD21 Trial
J Clin Oncol, 43 (27), 2974-2985
DOI 10.1200/JCO-25-00439, PubMed 40674676
Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, Hüttmann A, Keil F, Dierlamm J, Hänel M, Novak U, Meissner J, Hellmuth JC, Mathas S, Zijlstra JM, Fosså A, Viardot A, Hertenstein B, Martin S, Giri P, Kamper P, Molin D, Jablonski J, Damaschin C, Robertz AS et al. (2025)
Fertility in patients with advanced-stage classic Hodgkin lymphoma treated with BrECADD versus eBEACOPP: a secondary analysis of the multicentre, randomised, parallel, open-label, phase 3 HD21 trial
Lancet Oncol, 26 (8), 1081-1090
DOI 10.1016/S1470-2045(25)00262-1, PubMed 40652943
Festvåg LE, Sverre BL, Paulsen Ø, Eilertsen G (2025)
The value of home-based advance care planning in addressing existential concerns among older Norwegian patients with cancer and their relatives: A narrative ethnographic study
Palliat Care Soc Pract, 19, 26323524251330658
DOI 10.1177/26323524251330658, PubMed 40291547
Fletcher EAK, Cordfunke RA, Nasi A, Törnqvist G, Valentijn RRPM, Bergqvist A, Westhrin M, Rasch W, Lindqvist F, Dillmann I, Lord M, Bouwman N, Neefjes JJ, Franken KLMC, McArdle S, Ahmad M, Johansson S, Ossendorp F, Haggman M, Lampinen M, Ullenhag G, Ladjevardi S, Leja-Jarblad J, Lilleby W, Drijfhout JW et al. (2025)
Preclinical development and clinical safety assessment of a synthetic peptide conjugate enabling endogenous antibody binding to promote innate receptor engagement
Mol Ther Oncol, 33 (2), 200954
DOI 10.1016/j.omton.2025.200954, PubMed 40520577
Flølo TN, Tørris C, Riiser K, Almendingen K, Chew HSJ, Fosså A, Albertini Früh E, Hennessy E, Leung MM, Misvær N, Pavel N, Sundar TKB, Sæterstrand TM, Torbjørnsen A, Løyland B, Holmen H (2025)
Digital health interventions to treat overweight and obesity in children and adolescents: An umbrella review
Obes Rev, 26 (6), e13905
DOI 10.1111/obr.13905, PubMed 39972996
Forsgren E, Jørgensen RRK, Bentzen H, Riise J, Haaber J, Pasanen A, Kuitunen H, Wader KF, El-Galaly TC, Hutchings M, Glimelius I, Jerkeman M (2025)
Ibrutinib, lenalidomide, and rituximab in relapsed mantle cell lymphoma: Long-term follow-up of the Nordic Lymphoma Group MCL6 Philemon trial
Hemasphere, 9 (3), e70101
DOI 10.1002/hem3.70101, PubMed 40104044
Fosså A, Molin D, Bröckelmann PJ, Schneider G, Schnetzke U, Linderoth J, Kamper PMH, Leppä SM, Meissner J, Schaub V, Lia K, Fuchs M, Borchmann P, Böll B (2025)
Brentuximab vedotin monotherapy is a feasible and effective treatment for older patients with classical Hodgkin lymphoma unsuitable for curative chemotherapy: Results from the prospective GHSG-NLG phase II BVB trial
Hemasphere, 9 (3), e70099
DOI 10.1002/hem3.70099, PubMed 40124718
Fosså SD, Bjerner LJ, Tandstad T, Brydøy M, Dahl AA, Nome RV, Negaard H, Myklebust TÅ, Haugnes HS (2025)
Biochemical Hypogonadism in Aging Testicular Cancer Survivors: A Clinical Challenge
Eur Urol Open Sci, 72, 10-16
DOI 10.1016/j.euros.2024.12.010, PubMed 39897186
Fracchiolla F, Meijers A, Orlandi E, Korevaar E, Whitfield G, Jensen K, Hoogeman M, Wijsman R, Jouglar E, Weerd EV, Pérez JM, Rinaldi I, Garbacz-Stryszewska M, Cianchetti M, Feijoo MM, Molinelli S, Elstrøm UV, Pica A, Gosling A, Koczur B, Dahlgren CV, Alterio D, Dale E, Farid G, Compter I et al. (2025)
An ESTRO-EPTN Delphi consensus on robustness evaluation in proton therapy
Phys Imaging Radiat Oncol, 37, 100900
DOI 10.1016/j.phro.2025.100900, PubMed 41550258
Frich PS, Sigstad E, Berstad AE, Opsahl EM, Fagerlid KH, Grøholt KK, Bjøro T, Hole KH, Flinder LI (2025)
Ethanol Ablation of Metastatic Lymph Nodes in Patients With Papillary Thyroid Carcinoma-Predictors of Clinical Outcome
J Clin Endocrinol Metab, 111 (1), e185-e194
DOI 10.1210/clinem/dgaf298, PubMed 40405530
Frøen HM, Brodtkorb M, Holte H, Kolstad A, Myhre AE, Remberger M, Tjønnfjord GE, Gedde-Dahl T (2025)
Allogeneic stem cell transplantation for patients with lymphoma 2011-21
Tidsskr Nor Laegeforen, 145 (3)
DOI 10.4045/tidsskr.24.0443, PubMed 40042014
Fure M, Risum K, Fauske L, Eik H (2025)
"I am trapped in my body": a qualitative exploration of bodily experiences during brace treatment among adolescents with idiopathic scoliosis
Int J Qual Stud Health Well-being, 20 (1), 2569615
DOI 10.1080/17482631.2025.2569615, PubMed 41069108
Furtner J, Berchtold L, Le Rhun E, Silvani A, Rudà R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Sahm F, Wick W, Minniti G, Weller M, König F, Preusser M (2025)
Prognostic value of 1D, 2D, and volumetric tumor size increases in recurrent WHO grade 2 and 3 meningiomas: Radiological post-hoc analysis of the EORTC-BTG-1320 trial
Neurooncol Adv, 7 (1), vdaf152
DOI 10.1093/noajnl/vdaf152, PubMed 40735273
Gabrielsen E, Wilsgaard T, Frydenberg H, Lofterød T, Dalen SM, Mortensen E, Solbu MD, Nalwoga H, Akslen LA, Blix ES, Haugnes HS (2025)
Higher pre-diagnostic serum syndecan-4 levels are associated with increased breast cancer risk: a case-cohort study
Breast Cancer Res Treat, 213 (3), 365-375
DOI 10.1007/s10549-025-07786-4, PubMed 40694191
Garcia-Foncillas J, Bayle A, Arnold D, Avouac B, Awada A, de la Cruz-Merino L, Helland Å, Lassen U, Laurent-Puig P, Normanno N, Rohrberg K, Taieb J, Stenzinger A (2025)
Overcoming barriers to advanced biomolecular technologies that inform treatment of solid tumors: a roadmap to access
Future Oncol, 21 (14), 1745-1752
DOI 10.1080/14796694.2025.2501523, PubMed 40340714
Ghadimi M, Pelzer U, Besselink MG, Siveke J, Telgmann R, Braren R, Wilmink H, Crede M, Koenig A, Koenig U, Liffers ST, Antweiler K, Uijterwijk B, Seppanen H, Nordin A, Puolakkainen P, Dajani OF, Labori KJ, Johansson M, Bratlie SO, Friede T, Jo P (2025)
Study protocol of the METAPANC trial - intensified treatment in patients with local operable but oligometastatic pancreatic cancer - multimodal surgical treatment versus chemotherapy alone: a randomized controlled trial
BMC Cancer, 25 (1), 208
DOI 10.1186/s12885-025-13573-7, PubMed 39915735
Gjelsvik YM, Myklebust TÅ, Fosså SD, Haug ES, Kvåle R, Ursin G, Johannesen TB (2025)
A nationwide, longitudinal collection of patient-reported outcomes from prostate cancer patients and controls
Qual Life Res, 34 (9), 2689-2700
DOI 10.1007/s11136-025-04017-7, PubMed 40603678
Grønberg BH, Killingberg KT, Fløtten Ø, Bjaanæs MM, Brustugun OT, Madebo T, Langer SW, Risumlund SL, Schytte T, Helbekkmo N, Neumann K, Yksnøy Ø, Engleson J, Fluge S, Naustdal T, Giske LE, Nyman J, Tsakonas G, Halvorsen TO (2025)
High-Dose Versus Standard-Dose Twice-Daily Thoracic Radiotherapy in Limited-Stage SCLC: Final Survival Data, Long-Term Toxicity, and Relapse Patterns in a Randomized, Open-Label, Phase II Trial
J Thorac Oncol, 20 (8), 1108-1119
DOI 10.1016/j.jtho.2025.04.007, PubMed 40258573
Gudmundstuen AM, Iversen PO, Pesonen M, Hjermstad MJ, Bye A, Tjønnfjord GE, Skaarud KJ (2025)
Comparing indirect calorimetry and predictive equations for energy expenditure - 1 year follow-up of adult hematopoietic stem cell transplanted recipients
Clin Nutr ESPEN, 70, 218-226
DOI 10.1016/j.clnesp.2025.09.027, PubMed 41038512
Hannestad I, Myklebust TÅ, Fosså SD, Müller S, Aas K (2025)
Real-world implementation and guideline adherence at inclusion of active surveillance for men with prostate cancer: a population-based study from the Cancer Registry of Norway
Scand J Urol, 60, 218-225
DOI 10.2340/sju.v60.45023, PubMed 41369008
Hansen CR, Samsøe E, Smulders B, Sand HMB, Holm AIS, Furre T, Jensen K, Johansen J, Maare C, Kristensen CA, Andersen M, Bratland Å, Grau C, Eriksen JG, Overgaard J (2025)
Radiotherapy quality assurance of patients with squamous cell carcinoma of the head and neck included in the DAHANCA 19 randomised phase III trial
Radiother Oncol, 211, 111096
DOI 10.1016/j.radonc.2025.111096, PubMed 40825443
Harba D, Corell A, Mansouri A, Brandal P, Blomstrand M, Jakola AS (2025)
A scoping review of proton radiation therapy and mutant-isocitrate dehydrogenase-inhibitors in IDH mutated lower-grade gliomas: pushing beyond surrogate end-points
Acta Neurochir (Wien), 167 (1), 196
DOI 10.1007/s00701-025-06612-6, PubMed 40682696
Hartmann S, Banys-Paluchowski M, Berger T, Ditsch N, Stickeler E, de Boniface J, Gentilini OD, Schroth J, Karadeniz Cakmak G, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D, Kadayaprath G, Pinto D, Peintinger F, Schlichting E, Dostalek L, Nina H, Valiyeva H, Vanhoeij M, Perhavec A, Zippel D et al. (2025)
Lost axillary markers after neoadjuvant chemotherapy in breast cancer patients - data from the prospective international AXSANA (EUBREAST 3) cohort study (NCT04373655)
Eur J Surg Oncol, 51 (9), 110253
DOI 10.1016/j.ejso.2025.110253, PubMed 40587927
Heggebø LC, Borgen IMH, Blakstad H, Saxhaug C, Rønning PA, Niehusmann PF, Werlenius K, Blomstrand M, Brandal P (2025)
Case report: Pseudoprogression mimicking neoplastic recurrence three months after completion of proton beam therapy for an IDH-mutant astrocytoma CNS WHO grade 3
Front Oncol, 15, 1397912
DOI 10.3389/fonc.2025.1397912, PubMed 39949738
Heggebø LC, Garrote FLB, Fjæra LF, Hervani M, Ramberg C, Ottestad A, Blakstad H, Martens T, Rueegg CS, Gustavsson M, Henry T, Blomstrand M, Hellebust TP, Brandal P (2025)
Protons or Photons in Pituitary Neuroendocrine Tumors-That Is Not the Question
Int J Part Ther, 17, 101194
DOI 10.1016/j.ijpt.2025.101194, PubMed 40678408
Heinrich MC, Blay JY, Gelderblom H, George S, Schöffski P, von Mehren M, Zalcberg JR, Jones RL, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Boye K, Goldstein D, Sánchez C, Siontis BL, Cox P, Davis E, Sherman ML, Ruiz-Soto R, Bauer S (2025)
Updated Overall Survival and Long-Term Safety With Ripretinib Versus Sunitinib in Patients With GI Stromal Tumor: Final Overall Survival Analysis From INTRIGUE
J Clin Oncol, 43 (20), 2239-2244
DOI 10.1200/JCO-24-02818, PubMed 40408605
Hermansen JU, Athanasiadis P, Yin Y, Rise AF, Arribas AJ, Cascione L, Russnes HG, Helland Å, Mato AR, Bertoni F, Tjønnfjord GE, Aittokallio T, Skånland SS (2025)
Proteasome inhibition overcomes resistance to targeted therapies in B-cell malignancy models and in an index patient
Cell Death Dis, 16 (1), 555
DOI 10.1038/s41419-025-07884-7, PubMed 40701968
Hofheinz RD, Fokas E, Benhaim L, Price TJ, Arnold D, Beets-Tan R, Guren MG, Hospers GAP, Lonardi S, Nagtegaal ID, Perez RO, Cervantes A, Martinelli E, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org (2025)
Localised rectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up
Ann Oncol, 36 (9), 1007-1024
DOI 10.1016/j.annonc.2025.05.528, PubMed 40412553
Hoppe R, Winter S, Lo WY, Michailidou K, Bolla MK, Keeman R, Wang Q, Dennis J, Lush M, Kalari KR, Goetz MP, Wang L, Cairns J, Weinshilboum R, Shepherd L, Chen BE, Häberle L, Ruebner M, Beckmann MW, He W, Larson NL, Armasu SM, Schroth W, Chowbay B, Khor CC et al. (2025)
Lessons learned from a candidate gene study investigating aromatase inhibitor treatment outcome in breast cancer
NPJ Breast Cancer, 11 (1), 18
DOI 10.1038/s41523-025-00733-y, PubMed 39971965
Horndalsveen H, Haakensen VD, Madebo T, Grønberg BH, Halvorsen TO, Koivunen J, Oselin K, Cicenas S, Helbekkmo N, Aanerud M, Ahvonen J, Silvoniemi M, Bjaanæs MM, Farooqi S, Nebdal D, Dalsgaard AM, Danielsen BK, Børve M, Dalen TS, Öjlert ÅK, Helland Å (2025)
Blood-based tumor mutational burden as a biomarker in unresectable non-small cell lung cancer treated with chemoradiotherapy and durvalumab
Front Oncol, 15, 1681420
DOI 10.3389/fonc.2025.1681420, PubMed 41199847
Hustad KS, Koteng LH, Urrizola A, Arends J, Bye A, Dajani O, Deliens L, Fallon M, Hjermstad MJ, Kohlen M, Kurita GP, Lundeby T, Mitrea N, Payne C, Roselló-Keränen S, Warmbrodt N, de Wilde A, Kaasa S, de Vos-Geelen J, Laird BJA, MyPath consortium (2025)
Practical cancer nutrition, from guidelines to clinical practice: a digital solution to patient-centred care
ESMO Open, 10 (4), 104529
DOI 10.1016/j.esmoop.2025.104529, PubMed 40179818
Hustad KS, Kaasa S, Laird BJA (2025)
Integrated nutritional care in cancer; about time?
Curr Opin Support Palliat Care, 19 (3), 198-202
DOI 10.1097/SPC.0000000000000765, PubMed 40689650
Hønnåshagen TK, Skoge LJ, Sæbøe-Larssen S, Håkenstad H, Kvalheim G, Sioud M (2025)
Production of mRNA-Loaded Dendritic Cell Cancer Vaccines
Methods Mol Biol, 2965, 245-258
DOI 10.1007/978-1-0716-4742-4_11, PubMed 40877508
Høyvik AJK, Kvassheim M, Ma LW, Wiig E, Hillestad T, Revheim ME, Liukaityte R, Bruland Ø, Juzeniene A (2025)
Therapeutic evaluation of [²¹²Pb]Pb-AB001 and [¹⁷⁷Lu]Lu-PSMA-617 in a mouse model of disseminated prostate cancer
Eur J Nucl Med Mol Imaging, 52 (13), 4847-4859
DOI 10.1007/s00259-025-07330-y, PubMed 40397137
Inderberg EM, Singh N, Miller R, Arbe-Barnes S, Eriksen HK, Lversen B, Juul HV, Eriksen JA, Handeland KR (2025)
Generation of frameshift-mutated TGFβR2-specific T cells in healthy subjects following administration with cancer vaccine candidate FMPV-1/GM-CSF in a phase 1 study
Cancer Immunol Immunother, 74 (4), 115
DOI 10.1007/s00262-025-03969-6, PubMed 39998682
Jansen F, Eerenstein SE, Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto AA, Hammerlid E, Scricciolo M, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2025)
Unmet supportive care needs among head and neck cancer survivors beyond 5 years after diagnosis: a multinational cohort study
Lancet Reg Health Eur, 59, 101495
DOI 10.1016/j.lanepe.2025.101495, PubMed 41142659
Jansson AK, Cohn-Cedermark G, Negaard HFS, Tandstad T, Ståhl O, Hedlund A, Karlsdottir Å, Hellström M, Langberg CW, Sköld C, Haugnes HS, Glimelius I (2025)
High-dose chemotherapy in male germ cell cancer patients-a study by the SWENOTECA group
Br J Cancer, 134 (5), 746-753
DOI 10.1038/s41416-025-03322-9, PubMed 41423507
Jánváry ZL, Bajcsay A, Stelczer G, Kontra G, Pócza T, Gerdán M, Lövey J, Kocsis ZS, Ladányi K, Pap É, Major T, Polgár C (2025)
Long-term clinical results of early-stage lung cancer patients treated with risk-adapted stereotactic body radiotherapy using LINAC or CyberKnife : A single-institution analysis of more than 400 cases
Strahlenther Onkol, 201 (11), 1208-1218
DOI 10.1007/s00066-025-02455-3, PubMed 40853545
Jenssen HB, Dueland S, Smedman TM, Grut H, Abildgaard A, Line PD, Syversveen T (2025)
Prognostic role of tumour volume and downstaging response on outcome after liver transplantation for colorectal liver metastases: retrospective study
BJS Open, 10 (1)
DOI 10.1093/bjsopen/zraf170, PubMed 41564012
Jiang L, Ladetto M, Hermine O, Kluin-Nelemans JC, Walewski J, Doorduijn J, Vergote V, Giné E, Jerkeman M, Hutchings M, Trneny M, Mey U, Riise J, Shpilberg O, Da Silva MG, Ribrag V, Schmidt C, Klapper W, Unterhalt M, Dreyling M, Hoster E (2025)
Marked survival gains in patients ≤ 65 years with advanced-stage mantle cell lymphoma: a pooled analysis of six randomized phase III trials, 1996-2020
Haematologica, 111 (5), 1694-1704
DOI 10.3324/haematol.2025.288929, PubMed 41163573
Johansen SH, Reinertsen KV, Wisløff T, Sæter M, Sarvari SI, Kiserud CE, Strandos N, Edvardsen E, Grydeland M, Nilsen TS, Thorsen L (2025)
Effects of aerobic exercise on late effects and quality of life in long-term breast cancer survivors: a randomized controlled trial
JNCI Cancer Spectr, 9 (6)
DOI 10.1093/jncics/pkaf102, PubMed 41117797
Johansen SH, Sæter M, Sarvari SI, Reinertsen KV, Edvardsen E, Wisløff T, Scott JM, Grydeland M, Raastad T, Hallén J, Kiserud CE, Lie HC, Solberg PA, Haugaa KH, Jensen JSS, Vatningen LH, Thorsen L, Nilsen TS (2025)
Effects of Aerobic Exercise on Cardiorespiratory Fitness and Cardiovascular Risk Factors in Long-Term Breast Cancer Survivors: A Randomized Controlled Trial
JACC CardioOncol, 7 (4), 414-426
DOI 10.1016/j.jaccao.2025.04.006, PubMed 40537190
Karlsson AT, Hjermstad MJ, Aass N, Skovlund E, Astrup GL, Kaasa S, Yri OE (2025)
Patient-Reported Outcomes Before and After Radiotherapy for Brain Metastases-A Prospective Cohort Study of 239 Non-Small-Cell Lung Cancer Patients
Cancers (Basel), 17 (9)
DOI 10.3390/cancers17091529, PubMed 40361454
Kenkhuis MF, Doorenbos M, Mast IH, Aaronson NK, van Beurden M, Bohus M, Courneya KS, Daley AJ, Galvão DA, Goedendorp MM, van Harten WH, Hayes SC, Hiensch AE, Irwin ML, Kersten MJ, Knoop H, May AM, McConnachie A, van Mechelen W, Mutrie N, Newton RU, Nollet F, Oldenburg HS, Schmidt ME, Schmitz KH et al. (2025)
Exercise effects on symptoms of depression and anxiety vary by patient, clinical, and intervention characteristics in cancer survivors: Results from pooled analyses of individual participant data of 26 RCTs
Support Care Cancer, 33 (7), 647
DOI 10.1007/s00520-025-09646-9, PubMed 40591016
Kimby E, Schär S, Pirosa MC, Vanazzi A, Mey UM, Rauch D, Wahlin BE, Hitz F, Hernberg M, Johansson AS, de Nully Brown P, Hagberg H, Ferreri AJM, Krasniqi F, Voegeli M, Novak U, Zander T, Bersvendsen H, Mamot C, Mingrone W, Stathis A, Dirnhofer S, Hayoz S, Østenstad B, Zucca E (2025)
Six-month rituximab-lenalidomide regimen in advanced untreated follicular lymphoma: SAKK 35/10 trial 10-year update
Blood Adv, 9 (7), 1712-1719
DOI 10.1182/bloodadvances.2024014840, PubMed 39883948
Knoth J, Nout RA, Pötter R, Mahantshetty U, Jürgenliemk-Schulz I, Haie-Meder C, Fortin I, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, Haverkort MAD, van Limbergen E, Pieters BR, Tan LT, Boryshchuk D, Ristl R, Hawaldar R, Kannan S, de Leeuw AAC, Eder-Nesvacil N et al. (2025)
Distant Metastasis After Chemoradiation and Image Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer
Int J Radiat Oncol Biol Phys, 123 (2), 503-512
DOI 10.1016/j.ijrobp.2025.04.037, PubMed 40354949
Kobbeltvedt MR, Lobmaier I, Spreafico M, Callegaro D, Miceli R, Kizilaslan F, Swanson D, Hompland I, Pasquali S, Fiocco M, van de Sande MAJ, Gronchi A, Boye K (2025)
A comparison of the risk prediction models PERSARC and Sarculator in patients with localized soft tissue sarcoma of the extremities and trunk wall
ESMO Open, 10 (8), 105517
DOI 10.1016/j.esmoop.2025.105517, PubMed 40712530
Koffi E, Padilla CS, Drabbe C, Schreuder WH, Zemouri C, den Hollander D, Grünhagen DJ, Sodergren S, Singer S, Jones RL, Desar IME, Fauske L, Pinto M, Nixon I, Salah S, Bruland ØS, Soomers VLMN, van de Sande MAJ, de Haan JJ, Verhoef C, Steggink LC, van Houdt WJ, Bootsma TI, Tesselaar MT, van der Graaf WTA et al. (2025)
Health-Related Quality of Life in Patients With a Head and Neck Sarcoma: A Mixed-Methods Study
Head Neck, 47 (11), 3086-3097
DOI 10.1002/hed.28226, PubMed 40583369
Kokkali S, Dolcan A, Boye K, Kyriazoglou A, Boukovinas I, Kalofonou F, Koumarianou A, Asimakopoulou N, Vorrias E, Tsapakidis K, Georgaki E, Boulouta A, Mavroeidis L, Harneshaug M, Theocharis S, Jones RL, Digklia A (2025)
Real-world data on immune checkpoint inhibitors in advanced sarcomas across multiple European institutions
Acta Oncol, 64, 761-768
DOI 10.2340/1651-226X.2025.43135, PubMed 40495323
Kolstad A, Emanuel G, Hjortland GO, Nilssen Y, Ulvestad M, Areffard A, Aahlin EK (2025)
Long-term trends in the clinical management and outcomes of patients with gastroesophageal cancer in Norway
Acta Oncol, 64, 540-549
DOI 10.2340/1651-226X.2025.43167, PubMed 40235057
Kurch L, Landman-Parker J, Georgi TW, Attarbaschi A, Balwierz W, Beishuizen A, Braun M, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Flerlage JE, Fosså A, Hjalgrim LL, Hraskova A, Karlén J, Klekawka T, Leblanc T, Montravers F, Lopci E, Mascarin M, Pears J, Pelz T et al. (2025)
Quantitative Deauville Scoring to Uncover Prognostic Information from ¹⁸F-FDG PET-Based Response Assessment: Data from the EuroNet-PHL-C1 Trial
J Nucl Med, 66 (9), 1331-1337
DOI 10.2967/jnumed.125.269603, PubMed 40639904
Kvestad E, Aarhus L (2025)
[A U-turn on snus]
Tidsskr Nor Laegeforen, 145 (7)
DOI 10.4045/tidsskr.25.0266, PubMed 40474627
Kvæl LAH, Bye A, Bergland A, Fromholt Olsen C (2025)
Healthcare professionals' experiences of the Four Habits Model communication course: a qualitative and survey approach to evaluate impact in an intermediate care setting
BMJ Open, 15 (3), e091143
DOI 10.1136/bmjopen-2024-091143, PubMed 40132831
Kühn T, Banys-Paluchowski M, Ditsch N, Stickeler E, Hauptmann M, Schroth J, Karadeniz Cakmak G, Hahn M, Thill M, Reimer T, Fröhlich S, Schmidt E, Wihlfahrt K, Berger T, Basali T, Ruf F, Rief A, Lux MP, Kolberg HC, Rubio IT, Gasparri ML, Kontos M, Bonci EA, Niinikoski L, Murawa D et al. (2025)
Axillary dissection for low-volume nodal involvement after neoadjuvant therapy in breast cancer: multicentre AXSANA cohort study
Br J Surg, 112 (9)
DOI 10.1093/bjs/znaf180, PubMed 40966675
Laird BJA, Skipworth R, Bonomi PD, Fallon M, Kaasa S, Giorgino R, McMillan DC, Currow DC (2025)
Anamorelin Efficacy in Non-Small-Cell Lung Cancer Patients With Cachexia: Insights From ROMANA 1 and ROMANA 2
J Cachexia Sarcopenia Muscle, 16 (1), e13732
DOI 10.1002/jcsm.13732, PubMed 39992021
Larsen BH, Gerwing J, Lundeby T, Gulbrandsen P, Førde R (2025)
More than an extra set of ears: A video-based analysis exploring the role of companions in routine oncology visits
J Psychosoc Oncol, 43 (5), 682-703
DOI 10.1080/07347332.2025.2457964, PubMed 39910871
Lee A, Bliksrud YT, Onali M, Neugebauer J, Eyskens F, Haas D, Mossler K, Enekwe A, Kiec-Wilk B, Diep LM, Bellettato CM, Zernikow B, Scarpa M, Rahman S, Tangeraas T, MetabERN collaboration group on palliative care (2025)
Palliative Care for Children and Adults With Inherited Metabolic Disease in Europe: An Underutilised Service for Supportive Treatment and Care
J Inherit Metab Dis, 48 (6), e70095
DOI 10.1002/jimd.70095, PubMed 41137497
Leppä S, Meriranta L, Arffman M, Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Pedersen M, Drott K, Pasanen A, Karihtala K, Mannisto S, Wold B, Brodtkorb M, Fagerli UM, Larsen TS, Munksgaard L, Sunela K, Fluge Ø, Jyrkkiö S, Brown P, Holte H (2025)
Biomarker-adapted treatment in high-risk large B-cell lymphoma
Hemasphere, 9 (5), e70139
DOI 10.1002/hem3.70139, PubMed 40357216
Lewis DJ, Jerkeman M, Sorrell L, Wright D, Glimelius I, Poulsen CB, Pasanen A, Rawstron A, Wader KF, Morley N, Burton C, Davies AJ, Lagerlöf I, Dalal S, De Tute R, McNamara C, Crosbie N, Toldbod HE, Sanders J, Allgar V, Aroori S, Warner M, Scully C, Wainman B, Christensen JH et al. (2025)
Ibrutinib and rituximab versus immunochemotherapy in patients with previously untreated mantle cell lymphoma (ENRICH): a randomised, open-label, phase 2/3 superiority trial
Lancet, 406 (10514), 1953-1968
DOI 10.1016/S0140-6736(25)01432-1, PubMed 41052510
Leysen L, Marticic Giljevic K, Piccinin C, Shkodra M, Pe M, Petersen M, Apolone G, Brunelli C, Lombardo C, Velikova G, Gilbert A, Pravettoni G, Ciliberto G, Groenvold M, Ferrer M, Bos N, Pietrobon R, Couespel N, Caraceni A, Guren M, Sirven A, Vachon H, EUonQOL consortium (2025)
Evaluation of the psychometric properties of patient-reported outcome measures of health-related quality of life across the European cancer continuum: a systematic review protocol using COSMIN methodology
BMJ Open, 15 (3), e088716
DOI 10.1136/bmjopen-2024-088716, PubMed 40157731
Lia K, Jørgensen RRK, Wikman P, Wold BL, Övergaard N, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Molin D, Fosså A (2025)
A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma
Haematologica, 110 (10), 2356-2366
DOI 10.3324/haematol.2025.287509, PubMed 40270216
Lia K, Jørgensen RRK, Wikman P, Wold BL, Övergaard N, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Molin D, Fosså A (2025)
Response to Comment on: "A simplified frailty score predicts outcome in curatively treated older patients with classical Hodgkin lymphoma"
Haematologica, 110 (11), 2866-2867
DOI 10.3324/haematol.2025.288284, PubMed 40501391
Lillekroken D, Bye A, Halvorsrud L, Lundeby T (2025)
Living with brain metastasis - a qualitative study of patients' and family members' coping strategies
Int J Qual Stud Health Well-being, 20 (1), 2555228
DOI 10.1080/17482631.2025.2555228, PubMed 40890980
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Palme JÖ, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Traa T, Hagen RK, Frøland AS, Ramberg C, Kristiansen C et al. (2025)
Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study
Lung Cancer, 203, 108527
DOI 10.1016/j.lungcan.2025.108527, PubMed 40184836
Liu Q, Fuster-Garcia E, Thokle Hovden I, MacIntosh BJ, Grodem EOS, Brandal P, Lopez-Mateu C, Sederevicius D, Skogen K, Schellhorn T, Bjornerud A, Eeg Emblem K (2025)
Treatment-Aware Diffusion Probabilistic Model for Longitudinal MRI Generation and Diffuse Glioma Growth Prediction
IEEE Trans Med Imaging, 44 (6), 2449-2462
DOI 10.1109/TMI.2025.3533038, PubMed 40031286
Lorigan P, Medina TM, Nyakas M, Rutten A, Feun LG, Cowey CL, Payne M, Hussain I, Kuzel T, O'Day S, Sheri A, Friedlander PA, Kumar S, Bergersen VS, Foss Ø, Ellingsen EB, Bjørheim J, Bechter OE (2025)
The telomerase vaccine UV1 combined with ipilimumab and nivolumab versus ipilimumab and nivolumab in advanced melanoma (INITIUM): A randomized open-label phase 2 study
Eur J Cancer, 233, 116162
DOI 10.1016/j.ejca.2025.116162, PubMed 41365069
Ludvigsen LUP, Åsberg A, Spetalen S, Sørensen MD, Hamilton-Dutoit S, Gramkow AM, Christiansen CF, Kro GB, Thomsen MK, Ulrichsen SP, Pedersen RM, Holte H, Thiesson HC, Bjerre A, D'Amore F, Dahle DO, Jespersen B, Jensen-Fangel S, Reisæter AV (2025)
Risk and prognosis of posttransplant lymphoproliferative disease in Epstein-Barr virus-seronegative kidney transplant recipients - an observational cohort study from Norway and western Denmark
Am J Transplant, 25 (7), 1547-1560
DOI 10.1016/j.ajt.2025.01.035, PubMed 39884653
Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB (2025)
Effects of Individualized Follow-Up With an App Postcardiac Rehabilitation: Five-Year Follow-Up of a Randomized Controlled Trial
J Med Internet Res, 27, e60256
DOI 10.2196/60256, PubMed 39946716
Lunde P, Bye A, Grimsmo J, Pripp AH, Ritschel V, Jarstad E, Nilsson BB (2025)
Authors' Reply: The Transtheoretical Model: Is It Still the Best We Have?
J Med Internet Res, 27, e79131
DOI 10.2196/79131, PubMed 40698751
Lunde P, Finbråten HS, Pripp AH, Nilsson BB, Grimsmo J, Bye A (2025)
Effect of a mHealth intervention on health literacy in patients completing cardiac rehabilitation: A randomized controlled trial with one- and five-year follow-up
Int J Cardiol Cardiovasc Risk Prev, 26, 200445
DOI 10.1016/j.ijcrp.2025.200445, PubMed 40534777
Machak GN, Bruland ØS, Kovalev AV, Rodionova SS (2025)
Rethinking the role of bisphosphonates after denosumab treatment in locally advanced or unresectable aneurysmal bone cysts: A meta-analysis
World J Orthop, 16 (8), 107083
DOI 10.5312/wjo.v16.i8.107083, PubMed 40838228
Mair MJ, Lohmann P, Galldiks N, Belting M, Brandal P, Broen MPG, Cicone F, Daisne JF, Ducray F, Ehret F, Furtner J, Jakola AS, Niyazi M, Pellerino A, Rasschaert M, Razis E, Sahm F, Smits M, Tolboom N, Verger A, Le Rhun E, Minniti G, Weller M, Preusser M, Albert NL (2025)
Availability and use of PET in patients with brain tumours - a European Organisation for Research and Treatment of Cancer - Brain Tumour Group (EORTC-BTG) survey
Eur J Nucl Med Mol Imaging, 52 (12), 4627-4638
DOI 10.1007/s00259-025-07366-0, PubMed 40464806
Maravelia P, Yao H, Cai C, Nascimento Silva D, Fransson J, Nilsson OB, Lu YW, Micke P, Botling J, Gatto F, Rovesti G, Carlsten M, Sallberg M, Stål P, Jorns C, Buggert M, Pasetto A (2025)
Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation
Gut, 74 (7), 1125-1136
DOI 10.1136/gutjnl-2024-334148, PubMed 39832892
Marhelava K, Fidyt K, Pepek M, Krawczyk M, Forcados C, Malinowska A, Swiderska B, Fernandez-Fuentes N, Czerwik N, Baranowska I, Krzywdzinska A, Sedek L, Slota L, Perkowski B, Villatoro A, Leray T, Lech-Maranda E, Menendez P, Inderberg EM, Wälchli S, Winiarska M, Firczuk M (2025)
LILRB1-directed CAR-T cells for the treatment of hematological malignancies
Leukemia, 39 (6), 1395-1411
DOI 10.1038/s41375-025-02580-z, PubMed 40186066
Marzorati C, Voskanyan V, Sala D, Grasso R, Borgogni F, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Gilbert A, Brunelli C, Apolone G, Pravettoni G, EUonQoL Consortium (2025)
Psychosocial factors associated with quality of life in cancer patients undergoing treatment: an umbrella review
Health Qual Life Outcomes, 23 (1), 31
DOI 10.1186/s12955-025-02357-z, PubMed 40188134
Matikas A, Naume B, Wildiers H, Sonke G, Dieci MV, Karakatsanis A, Andersson A, Barnekow E, Kessler LE, Einbeigi Z, Killander F, Linderholm B, Schiza A, Valachis A, Nearchou A, Engebraaten O, Porojnicu A, Soland MH, Mannsåker B, Raj SX, Blix ES, Nordstrand CS, Lambertini M, Vernieri C, Punie K et al. (2025)
Randomised trial of trastuzumab deruxtecan and biology-driven selection of neoadjuvant treatment for HER2-positive breast cancer: a study protocol of ARIADNE
BMJ Open, 15 (8), e102626
DOI 10.1136/bmjopen-2025-102626, PubMed 40866060
Maziarz RT, Bishop MR, Tam CS, Borchmann P, Worel N, McGuirk JP, Holte H, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Janakiram M, Hsu J, Izutsu K, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Ma W et al. (2025)
Five-Year Analysis of the JULIET Trial of Tisagenlecleucel in Patients With Relapsed/Refractory Large B-Cell Lymphoma
J Clin Oncol, 44 (2), 86-91
DOI 10.1200/JCO-25-00507, PubMed 41252666
Mazzotti L, Borges de Souza P, Azzali I, Angeli D, Nanni O, Sambri V, Semprini S, Bravaccini S, Cerchione C, Gaimari A, Nicolini F, Ancarani V, Martinelli G, Pasetto A, Calderon H, Juan M, Mazza M (2025)
Exploring the Relationship Between Humoral and Cellular T Cell Responses Against SARS-CoV-2 in Exposed Individuals From Emilia Romagna Region and COVID-19 Severity
HLA, 105 (1), e70011
DOI 10.1111/tan.70011, PubMed 39807702
Medhus A, Schink KO, Longva AS, Engebraaten O, Berg K, Weyergang A (2025)
The mechanisms of HER2 targeted ADCs are dependent on Rab GTPases
Ther Adv Med Oncol, 17, 17588359251332473
DOI 10.1177/17588359251332473, PubMed 40297622
Meriranta L, Rask Kragh Jørgensen R, Pasanen A, Kolstad A, Hutchings M, Niemann CU, El-Galaly TC, Riise J, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I, Leppä S, Jerkeman M (2025)
Circulating tumor DNA determinants of response and outcome in relapsed/refractory mantle cell lymphoma
Blood Adv, 9 (17), 4528-4541
DOI 10.1182/bloodadvances.2025015791, PubMed 40402132
Minnai F, Shkodra M, Noci S, Esposito M, Brunelli C, Pigni A, Zecca E, Skorpen F, Klepstad P, Kaasa S, Corli O, Pallotti MC, Maltoni MC, Caraceni AT, Colombo F (2025)
A genome-wide association study of European advanced cancer patients treated with opioids identifies regulatory variants on chromosome 20 associated with pain intensity
Eur J Pain, 29 (1), e4764
DOI 10.1002/ejp.4764, PubMed 39629963
Neilsen BK, Huang RR, Valle LF, Proudfoot JA, Davicioni E, Zhang L, Ryg U, Schulz-Jaavall M, Weidhaas JB, Santoso M, Parmisano S, Calais J, Reiter RE, Rettig MB, Steinberg ML, Sisk A, Brisbane W, Marks LS, Boutros PC, Lilleby WH, Kishan AU (2025)
Genomic and Transcriptomic Profiling of Radiation-Resistant, Locally Recurrent Prostate Cancer
Int J Radiat Oncol Biol Phys, 124 (3), 647-650
DOI 10.1016/j.ijrobp.2025.09.035, PubMed 41105052
Nilsson M, Storaas AH, Johannesen TB, Gjelsvik YM, Aas K, Fosså SD, Myklebust TÅ (2025)
Adverse health outcomes for prostate cancer patients treated with radiotherapy combined with androgen-deprivation therapy: A population-based, controlled study, from Norway
Acta Oncol, 64, 1109-1116
DOI 10.2340/1651-226X.2025.42825, PubMed 40851495
Njølstad TH, Jensen K, Andersen HK, Berstad AE, Hagen G, Johansen CK, Øye K, Glittum J, Dybwad A, Thingstad E, Guren MG, Dormagen JB, Schulz A (2025)
Deep learning reconstruction for detection of liver lesions at standard-dose and reduced-dose abdominal CT
Eur Radiol, 35 (10), 6140-6149
DOI 10.1007/s00330-025-11596-z, PubMed 40251443
Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH (2025)
Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study
Front Oncol, 15, 1506041
DOI 10.3389/fonc.2025.1506041, PubMed 40052133
Nyen JE, Booth AØ, Husby Ø, Bugge C, Engebretsen I, Oteiza F, Helland Å, Fjellbirkeland L, Brustugun OT, Grønberg BH (2025)
Corrigendum: Targeted treatment and survival in advanced non-squamous non-small cell lung cancer patients - a nationwide and longitudinal study
Front Oncol, 15, 1595028
DOI 10.3389/fonc.2025.1595028, PubMed 40206591
Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Duthoy W, Mach N, Fonteyne V, Moon D, Thon K, Mercier C et al. (2025)
Salvage metastasis-directed therapy versus elective nodal radiotherapy for oligorecurrent nodal prostate cancer metastases (PEACE V-STORM): a phase 2, open-label, randomised controlled trial
Lancet Oncol, 26 (6), 695-706
DOI 10.1016/S1470-2045(25)00197-4, PubMed 40339593
Pagui ECK, Brant SB, Svendsen K, Frigessi A, Helland Å, Thoresen S, Jonasson C (2025)
Comparative Effectiveness of Atezolizumab, Nivolumab and Pembrolizumab in Second-Line Treatment of Advanced Non-Small Cell Lung Cancer
Pharmacoepidemiol Drug Saf, 34 (7), e70181
DOI 10.1002/pds.70181, PubMed 40552731
Parissenti AM, Pritzker LB, Dahle MA, Gythfeldt HVL, Masilamani T, Theriault G, St-Onge R, D'costa L, Lingjaerde OC, Haugen MH, Engebraaten O (2025)
High mid-treatment tumour RNA disruption in patients with HER2-negative breast cancer is associated with improved disease-free survival after neoadjuvant chemotherapy
Breast Cancer Res, 27 (1), 143
DOI 10.1186/s13058-025-02092-9, PubMed 40790765
Pati NB, Jin Y, Kumar S, Kyte JA, Ciosk R (2025)
Thermal potentiation improves IFN-γ production but not cytotoxicity in human CAR-T cells
BMC Res Notes, 18 (1), 192
DOI 10.1186/s13104-025-07249-5, PubMed 40270044
Peccatori FA, Niman SM, Partridge AH, Ruggeri M, Colleoni M, Saura C, Shimizu C, Satersdal AB, Kroep JR, Gelmon K, Amant F, Mailliez A, Moore HCF, Ruiz-Borrego M, Walshe JM, Borges VF, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Saunders C, Bjelic-Radisic V, Susnjar S et al. (2025)
Breastfeeding After Hormone Receptor-Positive Breast Cancer: Results From the POSITIVE Trial
J Clin Oncol, 43 (24), 2712-2719
DOI 10.1200/JCO-24-02697, PubMed 40632989
Pierson SK, Brandstadter JD, Torigian DA, Bagg A, Lechowicz MJ, Alapat D, Casper C, Chadburn A, Chandrakasan S, Dispenzieri A, Fosså A, Hoffmann C, Ide M, Kurzrock R, Mukherjee S, Nasta S, Navarro JT, Noy A, Oksenhendler E, Bustamante MS, Shyamsundar S, Streetly M, Wong RSM, Zhang L, Lim MS et al. (2025)
Characterizing the heterogeneity of Castleman disease and oligocentric subtype: findings from the ACCELERATE registry
Blood Adv, 9 (8), 1952-1965
DOI 10.1182/bloodadvances.2024014391, PubMed 39951615
Qvigstad LF, Aas K, Tulipan A, Hole KH, Storås AH, Hammarström C, Ghiasvand R, Holmedal SH, Berge V (2025)
Clinical Trial Protocol for prePSMA: A Multicenter, Randomized, Noninferiority Trial of Preoperative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography as Triage for Extended Pelvic Lymph Node Dissection in Patients Scheduled for Robot-assisted Laparoscopic Radical Prostatectomy
Eur Urol Focus, 11 (6), 915-920
DOI 10.1016/j.euf.2025.07.010, PubMed 40731245
Razis E, Gorlia T, Preusser M, Daisne JF, Vanopdenbosch L, Roth P, Mair MJ, Gross MW, Espeli V, Kazda T, Bruna J, Di Cristofori A, Lombardi G, Valeinis E, Brandsma D, Malmstrom A, Brandal P, Azevedo A, Keric N, Lohmann P, Vernadou A, Baumert BG, Andratschke N, Weller M, de Vos F et al. (2025)
European neuro-oncology quality assessment (ENOQUA): A European organization for the research and treatment of cancer (EORTC) brain tumor group research project
Neurooncol Pract, 13 (3), 518-527
DOI 10.1093/nop/npaf103, PubMed 42131752
Ryg U, Lilleby W, Nilsen LB, Hellebust TP, Seierstad T, Hole KH (2025)
Image-Based Recurrence Patterns After Reirradiation in Prostate Cancer with Long-Term Follow-Up
Adv Radiat Oncol, 10 (12), 101900
DOI 10.1016/j.adro.2025.101900, PubMed 41216207
Røssevold AH, Tekpli X, Lingjærde OC, Russnes HG, Vallon-Christersson J, Borgen E, Lømo J, Garred Ø, Dorraji E, Kristensen VN, Naume B, Kyte JA (2025)
High tumor expression of CTLA4 identifies lymph node-negative basal-like breast cancer patients with excellent prognosis
Commun Med (Lond), 5 (1), 234
DOI 10.1038/s43856-025-00865-z, PubMed 40523912
Sayed Ahmed AF, Wehrle CJ, Ring T, Wu J, Hong H, Nadeem MA, Byrne MM, Iuppa G, Linganna MW, Esfeh JM, Smedman TM, Kamath S, Khalil M, Fujiki M, Alejandro RH, Sasaki K, Schlegel A, Kwon DC, Miller C, Line PD, Hashimoto K, Aucejo F (2025)
Liver transplantation for colorectal metastasis - selection criteria, outcomes, and management recurrence: a systematic review and meta-analysis
Int J Surg, 112 (2), 5155-5171
DOI 10.1097/JS9.0000000000004018, PubMed 41342603
Schytte T, Knap MM, Kristiansen C, Appelt AL, Khalil A, Peucelle C, Lutz CM, Møller DS, Sande EPS, Sundby F, Persson G, Schmidt H, Land LH, Rogg L, Pøhl M, Lund MD, Nielsen M, Levin N, Hansen O, Thing RS, Borissova S, Halvorsen T, Nielsen TB, Hansen TS, Haakensen VD et al. (2025)
Toxicity Within 6 Months of Heterogeneous Fluorodeoxyglucose-Guided Radiotherapy Dose Escalation for Locally Advanced Non-Small Cell Lung Cancer in the Scandinavian Randomized Phase III NARLAL2 Trial
J Clin Oncol, 43 (17), 1972-1983
DOI 10.1200/JCO-24-01386, PubMed 40249893
Seland M, Rognli S, Skaali T, Blomhoff R, Tjønnfjord GE, Eriksen AMA, Solvang G, Thorsen L (2025)
Distress, problems and unmet rehabilitation needs after haematopoietic stem cell transplantation for haematologic malignancies: A cross-sectional study
Eur J Oncol Nurs, 80, 103083
DOI 10.1016/j.ejon.2025.103083, PubMed 41576829
Serban M, Spampinato S, de Leeuw A, Fortin I, Kirisits C, Ye XY, Schmid M, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Bhavana R, Cooper R, Steen Banasik E V, Limbergen EV, Pieters BR, Tan LT, Chopra S, Nout R, Nesvacil N, Kirchheiner K, Pötter R, Jürgenliemk-Schulz IM, Tanderup K (2025)
Evaluation of brachytherapy applicators and their association with morbidity and local control in cervix cancer: An EMBRACE I analysis
Radiother Oncol, 210, 110954
DOI 10.1016/j.radonc.2025.110954, PubMed 40449684
Shkodra M, Laird B (2025)
Pioneering palliative care in the digital era
Curr Opin Support Palliat Care, 19 (4), 290-291
DOI 10.1097/SPC.0000000000000776, PubMed 40901721
Shkodra M, Urrizola A, Fallon M, Sjøgren P, Beuken-van Everdingen MVD, Hagen K, Decoster L, Mosoiu D, Hjermstad MJ, Lundeby T, Kaasa S, Caraceni A, MyPath consortium (2025)
The MyPath Pain Pathway: Developing a Digital Patient-Centred Care Pathway for Cancer Pain
J Pain Symptom Manage, 70 (6), 592-601
DOI 10.1016/j.jpainsymman.2025.08.012, PubMed 40849029
Singer S, Amdal CD, Bjordal K, Herlofson BB, Astrup GL, Boehm A, Wöhner U, Hammerlid E, Gama RR, Jacinto AA, Jansen F, Verdonck-de Leeuw IM, Dragan T, Duprez F, Kiyota N, Pinto M, Krüger M, Guntinas-Lichius O, Inhestern J, Tramacere F, Bonomo P, Fanetti G, Nuyts S, Plath M, Stempler N et al. (2025)
Late Toxicity and Long-Term Quality of Life in Survivors of Cancer of the Major Salivary Glands More Than 5 Years After Diagnosis: A Multi-National Study
Head Neck, 48 (1), 13-25
DOI 10.1002/hed.28263, PubMed 40747834
Singh HV, Nakken E, Fauske L (2025)
Bridging cultural and linguistic barriers: South Asian minority women's experiences of radiotherapy for cervical cancer in Norway
Tech Innov Patient Support Radiat Oncol, 34, 100315
DOI 10.1016/j.tipsro.2025.100315, PubMed 40496552
Singh R, Kyte JA (2025)
STEAP1: a promising target in prostate cancer therapy
Trends Cancer, 11 (8), 722-725
DOI 10.1016/j.trecan.2025.05.007, PubMed 40527692
Skipar K, Hompland T, Lund KV, Fjeldbo CS, Lindemann K, Hellebust TP, Lyng H, Bruheim K (2025)
Tolerability, safety and feasibility of metformin combined with chemoradiotherapy in patients with locally advanced cervical cancer: A phase II, randomized study
Acta Oncol, 64, 439-447
DOI 10.2340/1651-226X.2025.43045, PubMed 40105683
Skipar K, Ørvik MS, Evers C, Balteskard L, Ekanger C, Giske LE, Ødegaard K, Østrem EH, Nordstrand CS, Tøndel H, Nieder C, Guren MG, Kaasa S, Ragnum HB (2025)
Palliative radiotherapy in symptomatic pelvic soft tissue tumors (PallSoft)- protocol for a national, randomized, non-inferiority study
BMC Cancer, 25 (1), 1051
DOI 10.1186/s12885-025-14424-1, PubMed 40597814
Skourti E, Seip K, Mensali N, Jabeen S, Juell S, Øynebråten I, Pettersen S, Engebraaten O, Corthay A, Inderberg EM, Dolznig H, Mælandsmo GM, Egeland EV, Prasmickaite L (2025)
Chemoresistant tumor cell secretome potentiates immune suppression in triple negative breast cancer
Breast Cancer Res, 27 (1), 131
DOI 10.1186/s13058-025-02082-x, PubMed 40660361
Skøyeneie SCT, Wik HS, Tjønnfjord GE, Fauske L, Gedde-Dahl T, Myhre AEL (2025)
Family Caregivers’ Experiences of Hospital at Home Following Allogeneic Haematopoietic Stem Cell Transplantation: A Qualitative Study
European Journal of Cancer Care, 2025 (1), 7043910
DOI 10.1155/ecc/7043910, PublikaID 544
Skaara TR, Amdal CD, Jespersen H, Namtvedt SK (2025)
[Cholestasis following use of fenbendazole as alternative cancer treatment]
Tidsskr Nor Laegeforen, 145 (12)
DOI 10.4045/tidsskr.25.0229, PubMed 41097960
Skåre TS, Lundeby T, Lund JÅ, Hjermstad MJ, Midtbust MH (2025)
First-time use of electronic patient-reported outcome measures in a cluster randomized trial: a qualitative study
J Patient Rep Outcomes, 9 (1), 9
DOI 10.1186/s41687-025-00840-1, PubMed 39832107
Skåre TS, Lundeby T, Lund JÅ, Lundereng ED, Kaasa S, de Glas N, Øyen KR, Guldhav KV, Midtbust MH (2025)
Exploring Perspectives of Patients With Cancer on Implementing Electronic Patient-Reported Outcome Measures to Enhance Patient-Centered Care: Qualitative Study
JMIR Cancer, 11, e79144
DOI 10.2196/79144, PubMed 41289561
Skaarud KJ, Gudmundstuen AM, Pesonen M, Hjermstad MJ, Iversen PO, Tjønnfjord GE (2025)
The role of fat-soluble vitamins for graft-versus host disease after myeloablative conditioning in allogeneic stem cell transplanted patients
Sci Rep, 15 (1), 1675
DOI 10.1038/s41598-024-84805-2, PubMed 39799129
Slørdahl KS, Skovlund E, Olsen JÅ, Tvedt R, Thomsen M, Kaasa S, Guren MG (2025)
Patient-reported outcomes after chemoradiotherapy for anal cancer
Acta Oncol, 64, 1005-1013
DOI 10.2340/1651-226X.2025.43636, PubMed 40734575
Smedman TM, Line PD, Dueland S (2025)
Assessing the attitudes of next of kin toward living donor liver transplantation for patients with colorectal liver metastases
Scand J Surg, 114 (2), 123-125
DOI 10.1177/14574969251335467, PubMed 40271620
Sodergren SC, Edwards R, Krishnatry R, Guren MG, Dennis K, Franco P, de Felice F, Darlington AS, Vassiliou V (2025)
Improving our understanding of the quality of life of patients with metastatic or recurrent/persistent anal cancer: a systematic review
Support Care Cancer, 33 (6), 475
DOI 10.1007/s00520-025-09520-8, PubMed 40372578
Sodergren SC, Husson O, Janssen S, Rohde GE, Hossain MJ, Abaza H, Alkan A, Al-Omari A, Ben-Aharon I, Bentsen L, Guren MG, Ioannidis G, Ishiki H, Koehler M, Lidington E, Lugowska I, McDonald F, Krishnamurthy MN, Korenblum C, Majorana A, Memos N, Otth M, Pappot H, Pérez-Campdepadrós M, Petranovic D et al. (2025)
Development of a Health-Related Quality of Life Tool for Adolescents and Young Adults With Cancer
JAMA Netw Open, 8 (12), e2549071
DOI 10.1001/jamanetworkopen.2025.49071, PubMed 41632126
Solberg S, Slørdahl KS, Aanerud M, Brustugun OT, Grønberg BH, Helbekkmo N, Helland Å, Nilssen Y (2025)
Too much or too little? The trajectory of systemic anti-cancer treatment throughout the last year of life of lung cancer patients in Norway
BJC Rep, 3 (1), 70
DOI 10.1038/s44276-025-00183-w, PubMed 41068480
Sorbye H, Hjortland GO, Vestermark LW, Ladekarl M, Svensson J, Sundlöv A, Janson ET, Garresori H, Hofsli E, Kersten C, Elvebakken H, Pfeiffer P, Morken S, Assmus J, Lothe IMB, Tabaksblat E, Knigge U, Couvelard A, Perren A, Langer SW (2025)
Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Br J Cancer, 133 (3), 316-324
DOI 10.1038/s41416-025-03054-w, PubMed 40382522
Sorbye H, Hjortland GO, Vestermark LW, Ladekarl M, Svensson J, Sundlöv A, Janson ET, Garresori H, Hofsli E, Kersten C, Elvebakken H, Pfeiffer P, Morken S, Assmus J, Lothe IMB, Tabaksblat E, Knigge U, Couvelard A, Perren A, Langer SW (2025)
Correction: Characteristics and treatment outcome in a prospective cohort of 639 advanced high-grade digestive neuroendocrine neoplasms (NET G3 and NEC). The NORDIC NEC 2 study
Br J Cancer, 133 (3), 420
DOI 10.1038/s41416-025-03095-1, PubMed 40659859
Storås AH, Tsuruda KM, Myklebust TÅ, Haug ES, Fosså SD, Andreassen BK (2025)
Postoperative Treatment and Survival in Locally Advanced Prostate Cancer: Real-World Outcomes
Clin Genitourin Cancer, 24 (1), 102480
DOI 10.1016/j.clgc.2025.102480, PubMed 41519644
Storaas E, Switlyk MD, Dahl S, Amdal CD, Bratland Å, Huynh TM, Eide HA, Vischioni B, Orlandi E, Dale E (2025)
Distinct patterns of osteoradionecrosis after photon-based radiotherapy and carbon ion radiotherapy for unresectable adenoid cystic carcinoma of the head and neck: case series from two institutions
Acta Oncol, 64, 63-68
DOI 10.2340/1651-226X.2025.42209, PubMed 39813173
Stålberg SM, Silwal-Pandit L, Hamfjord J, Nebdal DJH, Lehtiö J, Lingjærde OC, Skålhegg BS, Kure EH (2025)
Elevated KRAS protein level is associated with better survival in pancreatic cancer
BMC Cancer, 25 (1), 1080
DOI 10.1186/s12885-025-14461-w, PubMed 40596921
Svalastoga M, Larsen TL, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2025)
Effect of drug interactions with apixaban on clinical outcomes in cancer patients with venous thromboembolism
Front Oncol, 15, 1520725
DOI 10.3389/fonc.2025.1520725, PubMed 39931081
Svendsen K, Nes LS, Leithe S, Meland A, Gjelsvik YM, Børøsund E, Larsson IM, Myklebust TÅ, Balto A, Rygg CM, Kiserud CE, Antoni MH, Chalder T, Mjaaland I, Carlson LE, Eriksen HR, Ursin G (2025)
Testing two digital stress-management interventions in a randomized controlled trial of breast cancer patients
Sci Rep, 15 (1), 38966
DOI 10.1038/s41598-025-22889-0, PubMed 41198868
Svestad JG, Mikalsen SG, Heydari M, Francke RH, Hervani M, Hellebust TP (2025)
Setup Accuracy and Efficiency of Real-Time Video Assistance for Surface-Guided Positioning in Radiation Therapy of Right-Sided Locoregional Breast Cancer
Adv Radiat Oncol, 10 (9), 101829
DOI 10.1016/j.adro.2025.101829, PubMed 40757180
Sweegers MG, de Jongh E, Bedding C, Nicklin E, Doege D, Alfieri S, Gangeri L, Scacciati B, Caraceni A, Brunelli C, Bredart A, Rojas-Concha L, Pappot H, Apolone G, Bos N, Ciliberto G, Couespel N, Ferrer M, Kaasa S, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Groenvold M et al. (2025)
Development of a unified system for assessing health related quality of life across the cancer care continuum: the EUonQoL Delphi study to identify priorities for quality of life domains
J Patient Rep Outcomes, 9 (1), 70
DOI 10.1186/s41687-025-00907-z, PubMed 40536596
Switlyk MD, Dale E, Tafjord S, Willumsen L, Hole KH, Hompland T (2025)
Reduced field-of-view DWI outperforms conventional DWI in assessing tumor heterogeneity and HPV status in head and neck cancer
Sci Rep, 15 (1), 31889
DOI 10.1038/s41598-025-17284-8, PubMed 40883428
Sæbøe-Larssen S, Sioud M (2025)
Large-Scale Production of Unmodified mRNA for Reprogramming Human Dendritic Cells and T Cells
Methods Mol Biol, 2965, 235-244
DOI 10.1007/978-1-0716-4742-4_10, PubMed 40877507
Sæbøe-Larssen S, Sioud M (2025)
Enhancing Cancer Vaccine Efficacy: siRNA-Based Modulation of Immune Suppressive Factors in Dendritic Cells
Methods Mol Biol, 2965, 259-273
DOI 10.1007/978-1-0716-4742-4_12, PubMed 40877509
Sæter M, Johansen SH, Reinertsen KV, Thorsen L, Haugaa KH, Nilsen TS, Sarvari SI (2025)
Cardiorespiratory fitness, cardiac morphology and function, and cardiovascular risk factors in long-term breast cancer survivors compared with non-cancer controls
Cardiooncology, 11 (1), 1
DOI 10.1186/s40959-024-00296-0, PubMed 39755716
Tahara M, Greil R, Rischin D, Harrington KJ, Burtness B, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Lin J, Gumuscu B, Lerman N, Soulières D (2025)
Pembrolizumab with or without chemotherapy in recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up from the randomized phase III KEYNOTE-048 study
Eur J Cancer, 221, 115395
DOI 10.1016/j.ejca.2025.115395, PubMed 40262400
Tangerud Å, Gudmundsdottir S, Moberg IO (2025)
[Breast gland tissue in the axilla]
Tidsskr Nor Laegeforen, 145 (10)
DOI 10.4045/tidsskr.25.0211, PubMed 40923175
Tanovic N, Kvestad E, Kåsine T, Hansen G, Fevang B (2025)
Necrotising soft tissue infection in the head and neck region, 2017-2023
Tidsskr Nor Laegeforen, 145 (13)
DOI 10.4045/tidsskr.25.0216, PubMed 41196216
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2025)
Reply to 'Comment on "Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis"'
Int J Cancer, 158 (8), 2197-2199
DOI 10.1002/ijc.70292, PubMed 41409034
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2025)
Toxicities in long-term survivors of head and neck cancer-A multi-national cross-sectional analysis
Int J Cancer, 157 (10), 2061-2070
DOI 10.1002/ijc.70033, PubMed 40735927
Thomassen D, Roychoudhury S, Amdal CD, Reynders D, Musoro JZ, Sauerbrei W, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2025)
Handling missing values in patient-reported outcome data in the presence of intercurrent events
BMC Med Res Methodol, 25 (1), 56
DOI 10.1186/s12874-025-02510-8, PubMed 40025441
Thöne P, Egger M, Gruber MS, Gruber G, Kasassov C, Nyiri D, Weis E, Werl H, Trinkl L, Lilleby W, Clodi M, Bräutigam E, Dieplinger B, Aigner A, Geinitz H (2025)
Safety, Immunogenicity, and Efficacy of COVID-19 Vaccines in Radiation-Oncology Patients: A Systematic Review and Meta-Analysis
Vaccines (Basel), 13 (7)
DOI 10.3390/vaccines13070715, PubMed 40733692
Tinglum Skøyeneie SC, Wik HS, Tjønnfjord GE, Fauske L, Gedde-Dahl T, Solvang G, Myhre AE (2025)
Perceptions of safety in hospital at home following allogeneic haematopoietic stem cell transplantation: A qualitative study
Eur J Oncol Nurs, 80, 103044
DOI 10.1016/j.ejon.2025.103044, PubMed 41325692
Trewin-Nybråten CB, Lambert PC, Marienhagen K, Andreassen L, Johannesen TB, Niehusmann P, Oltedal L, Schipmann S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Brandal P, Ingebrigtsen T, Skaga E, advisory board for the Norwegian Brain and Spinal Cord Tumour Registry (2025)
Unveiling regional differences in glioblastoma patient survival with real-world data from the Norwegian brain tumor quality registry
J Neurooncol, 175 (3), 1355-1366
DOI 10.1007/s11060-025-05218-3, PubMed 40932639
Ullern A, Holm K, Andresen NK, Røssevold AH, Bang C, Naume B, Hov JR, Kyte JA (2025)
Gut microbiota diversity is prognostic in metastatic hormone receptor-positive breast cancer patients receiving chemotherapy and immunotherapy
Mol Oncol, 20 (2), 511-523
DOI 10.1002/1878-0261.70117, PubMed 40852937
Ullmann Miller J, Fauske L, Sigurdardottir S, Arfa S, von der Lippe C (2025)
'In the dark': parents' lifelong commitment to supporting children with Bardet-Biedl syndrome
Health Psychol Behav Med, 13 (1), 2467432
DOI 10.1080/21642850.2025.2467432, PubMed 39968158
Urrizola A, Dajani O, Aass N, Bjerkeset E, Hjermstad MJ, Kaasa S, Klepstad P, Pirnat A, Raaness I, Steinsheim H, Bye A (2025)
Nutrition impact symptom monitoring and weight loss outcomes: a longitudinal radiotherapy study
BMJ Support Palliat Care, 15 (4), 522-525
DOI 10.1136/spcare-2024-004939, PubMed 38862183
Vagnildhaug OM, Habberstad RH, Salvesen Ø, Balstad TR, Bye A, Dajani O, Kaasa S, Klepstad P, Solheim TS (2025)
A comparison of inflammatory markers' potential to predict weight loss in advanced cancer: a prospective observational study
J Circ Biomark, 14, 12-20
DOI 10.33393/jcb.2025.3510, PubMed 40727926
Vandraas KF, Hjorth S, Trewin-Nybråten CB, Ursin G, Botteri E, Andreassen BK, Reinertsen KV, Blix ES, Naume B, Støer NC (2025)
Anti-Her2 therapy patterns in metastatic breast cancer-Real-world data suggest undertreatment
Int J Cancer, 158 (3), 633-641
DOI 10.1002/ijc.70120, PubMed 40892038
Wang S, Santacana-Font G, Kedra D, Gilfillan S, Tena-Chaves D, Bergholtz H, Engebraaten O, Lingjaerde OC, Gutiérrez-Fernández J, Norum JH, Sørlie T, López-Aviles S, Hurtado A (2025)
The harmonized activities of HER2-HER3 heterodimer and deacetylated FOXA1 evade hormone response by regulating FOXA1 chromatin binding
Nucleic Acids Res, 53 (20)
DOI 10.1093/nar/gkaf1086, PubMed 41224124
Wang Y, Van Nieuwenhuysen E, Revheim ME, Deroose CM, Eriksson AGZ, Eyjolfsdottir B, Van Gorp T, Baert T, Aksnes AK, Myren K, Vergote I, Bruland ØS (2025)
First experience with intraperitoneal ²²⁴Ra-labeled microparticles after cytoreductive surgery in patients with peritoneal recurrence of platinum-sensitive epithelial ovarian cancer
Gynecol Oncol, 204, 158-164
DOI 10.1016/j.ygyno.2025.11.018, PubMed 41349345
Wedde TB, Hagen MS, M Vatne K, Nilsen LB, Hellebust TP, Lilleby W (2025)
Patient-reported long-term sexual morbidity in prostate cancer survivors treated with external beam radiation therapy alone or combined with high-dose-rate brachytherapy
Scand J Urol, 60, 14-22
DOI 10.2340/sju.v60.42165, PubMed 41396780
Wei Q, Foyn H, Landskron J, Wang S, Rye IH, Skånland SS, Russnes HEG, Klaveness J, Ahmad R, Taskén K (2025)
Identification of a group of 9-amino-acridines that selectively downregulate regulatory T cell functions through FoxP3
iScience, 28 (3), 111931
DOI 10.1016/j.isci.2025.111931, PubMed 40034859
Wens FSPL, Zonca F, van Tinteren H, Timmermann B, Laprie A, Boterberg T, Gaze M, Lim P, Jazmati D, Dieckmann K, Vennarini S, Melchior P, Weber B, Albiac MR, Szulc A, Grigorenko V, Magelssen H, van Beek K, Graf N, Papadakis V, Neggers SJCMM, van den Heuvel-Eibrink MM, Janssens GO, Polak R (2025)
Late toxicity after upper abdominal radiotherapy in pediatric Wilms tumor and neuroblastoma survivors. A systematic review on behalf of SIOPEN and SIOP-RTSG
Radiother Oncol, 209, 110961
DOI 10.1016/j.radonc.2025.110961, PubMed 40441488
Westgaard KL, Amdal CD, Taylor KJ, Falk RS, Bjordal K, Singer S, Hammerlid E, Krüger M, Stromberger C, Guntinas-Lichius O, Duprez F, Stempler N, Yarom N, Papadopoulou E, Herlofson BB (2025)
Oral health-related quality of life among long-term head and neck cancer survivors: a multinational study
Support Care Cancer, 33 (10), 868
DOI 10.1007/s00520-025-09930-8, PubMed 40975748
Westgaard KL, Amdal CD, Taylor KJ, Falk RS, Bjordal K, Singer S, Hammerlid E, Krüger M, Stromberger C, Guntinas-Lichius O, Duprez F, Stempler N, Yarom N, Papadopoulou E, Herlofson BB (2025)
Correction to: Oral health‑related quality of life among long‑term head and neck cancer survivors: a multinational study
Support Care Cancer, 33 (10), 894
DOI 10.1007/s00520-025-09991-9, PubMed 41032125
Winther RR, Hjermstad MJ, Yri OE, Skovlund E, Aass N, Astrup GL, Kaasa S, Saxhaug C, Vik-Mo EO (2025)
Survival, quality of life, and motor function in brain metastases surgery: The role of complete resection
Neurooncol Pract, 12 (4), 644-653
DOI 10.1093/nop/npaf011, PubMed 40814420
Yaqub S, Brudvik KW, Smedman TM, Syversveen T, Line PD, Dueland S (2025)
Liver transplantation for colorectal metastases following hepatic resection
Br J Surg, 112 (9)
DOI 10.1093/bjs/znaf193, PubMed 40971970
Yaqub S, Busund S, Smedman TM, Syversveen T, Khan A, Solheim JM, Folseraas T, Wiencke K, Lassen K, Dueland S, Line PD (2025)
Liver transplantation for locally advanced non-resectable intrahepatic cholangiocarcinoma treated with neoadjuvant therapy: early results from the TESLA trial
Br J Surg, 112 (3)
DOI 10.1093/bjs/znaf054, PubMed 40099404
Yaqub S, Longva A, Angelsen JH, Brudvik KW, Carling U, Edwin B, Fretland ÅA, Grünhagen DJ, Line PD, Røsok BI, Smedman TM, Sparrelid E, Syversveen T, Villanger O, Lassen K (2025)
Multimodal treatment for colorectal liver metastases: A toolbox for clinicians
Scand J Surg, 114 (2), 126-134
DOI 10.1177/14574969251333524, PubMed 40247715
Yip D, Zalcberg J, Blay JY, Eriksson M, Espinoza D, Price T, Marreaud S, Italiano A, Steeghs N, Boye K, Underhill C, Gebski V, Simes J, Gelderblom H, Joensuu H (2025)
Imatinib alternating with regorafenib compared to imatinib alone for the first-line treatment of advanced gastrointestinal stromal tumor: The AGITG ALT-GIST intergroup randomized phase II trial
Br J Cancer, 132 (10), 897-904
DOI 10.1038/s41416-025-02983-w, PubMed 40133509
Yri OE, J A Laird B (2025)
Cancer pain - all change please?
Clin Med (Lond), 25 (4), 100341
DOI 10.1016/j.clinme.2025.100341, PubMed 40588130
Yri OE, Kaasa S (2025)
A balancing ACT: maximizing the benefits of appropriate brain radiation therapy-authors' reply
Lancet Reg Health Eur, 52, 101291
DOI 10.1016/j.lanepe.2025.101291, PubMed 40247950
Zucca E, Ceriani L, Ciccone G, Di Rocco A, Pirosa MC, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A et al. (2025)
Impact of immunochemotherapy regimens on outcomes of patients with primary mediastinal B-cell lymphoma in the IELSG37 trial
Blood, 146 (23), 2758-2764
DOI 10.1182/blood.2025028823, PubMed 40939190
Åsberg E, Giskeødegård GF, Karlsen J, Kiserud CE, Aune G, Nilsen M, Reidunsdatter RJ (2025)
Sexual health in female and male cancer survivors - compared with age-matched cancer-free controls in Norway
Acta Oncol, 64, 380-390
DOI 10.2340/1651-226X.2025.42451, PubMed 40052251

Publications 2024

Alm-Kruse K, Gjerset GM, Tjelmeland IBM, Isern CB, Kramer-Johansen J, Garratt AM (2024)
How do survivors after out-of-hospital cardiac arrest perceive their health compared to the norm population? A nationwide registry study from Norway
Resusc Plus, 17, 100549
DOI 10.1016/j.resplu.2023.100549, PubMed 38292469
Andresen NK, Røssevold AH, Borgen E, Schirmer CB, Gilje B, Garred Ø, Lømo J, Stensland M, Nordgård O, Falk RS, Mathiesen RR, Russnes HG, Kyte JA, Naume B (2024)
Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors - a biomarker analysis of the ALICE and ICON trials
Mol Oncol, 19 (7), 2092-2108
DOI 10.1002/1878-0261.13675, PubMed 38978352
Andresen NK, Røssevold AH, Quaghebeur C, Gilje B, Boge B, Gombos A, Falk RS, Mathiesen RR, Julsrud L, Garred Ø, Russnes HG, Lereim RR, Chauhan SK, Lingjærde OC, Dunn C, Naume B, Kyte JA (2024)
Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial
J Immunother Cancer, 12 (1)
DOI 10.1136/jitc-2023-007990, PubMed 38242720
Apolone G, Costantini M, Caselli L, Bos N, Caraceni A, Ciliberto G, Couespel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Velikova G, Garin O, Gilbert A, Machiavelli A, Marzorati C, Miceli R, Pe M, Petersen MA, Tanzilli A, van Schelven F et al. (2024)
Validation of the European Oncology toolkit for the self-assessment of Quality of Life (EUonQoL-Kit) in cancer patients and survivors: study protocol of a pan European survey
BMC Public Health, 24 (1), 3517
DOI 10.1186/s12889-024-21008-4, PubMed 39696103
Areklett EW, Hagen BI, Stubberud J, Fagereng E, Andersson S, Lindemann K (2024)
Digital goal management training for cognitive impairment in cervical cancer survivors-a randomized comparison study
J Cancer Surviv, 20 (3), 978-989
DOI 10.1007/s11764-024-01701-4, PubMed 39576570
Arffman M, Meriranta L, Autio M, Holte H, Jørgensen J, Brown P, Jyrkkiö S, Jerkeman M, Drott K, Fluge Ø, Björkholm M, Karjalainen-Lindsberg ML, Beiske K, Pedersen MØ, Leivonen SK, Leppä S (2024)
Inflammatory and subtype-dependent serum protein signatures predict survival beyond the ctDNA in aggressive B cell lymphomas
Med, 5 (6), 583-602.e5
DOI 10.1016/j.medj.2024.03.007, PubMed 38579729
Ask EH, Tschan-Plessl A, Hoel HJ, Kolstad A, Holte H, Malmberg KJ (2024)
MetaGate: Interactive analysis of high-dimensional cytometry data with metadata integration
Patterns (N Y), 5 (7), 100989
DOI 10.1016/j.patter.2024.100989, PubMed 39081571
Autio M, Brück O, Pollari M, Karjalainen-Lindsberg ML, Beiske K, Jørgensen JM, Holte H, Pellinen T, Leivonen SK, Leppä S (2024)
Characterization of tumor microenvironment and cell interaction patterns in testicular and diffuse large B-cell lymphomas
Haematologica, 110 (6), 1339-1350
DOI 10.3324/haematol.2024.286267, PubMed 39665214
Azim HA, Niman SM, Partridge AH, Demeestere I, Ruggeri M, Colleoni M, Saura C, Shimizu C, Saetersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V et al. (2024)
Fertility Preservation and Assisted Reproduction in Patients With Breast Cancer Interrupting Adjuvant Endocrine Therapy to Attempt Pregnancy
J Clin Oncol, 42 (23), 2822-2832
DOI 10.1200/JCO.23.02292, PubMed 38810178
Bai B, Wise JF, Vodák D, Nakken S, Sharma A, Blaker YN, Brodtkorb M, Hilden V, Trøen G, Ren W, Lorenz S, Lawrence MS, Myklebost O, Kimby E, Pan-Hammarström Q, Steen CB, Meza-Zepeda LA, Beiske K, Smeland EB, Hovig E, Lingjærde OC, Holte H, Myklebust JH (2024)
Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma
Blood Cancer J, 14 (1), 147
DOI 10.1038/s41408-024-01124-5, PubMed 39191762
Balstad TR, Bråtveit M, Solheim TS, Koteng LH, Bye A, Jakobsen RD, Schødt-Osmo B, Fjeldstad SH, Erichsen M, Vagnildhaug OM, Paur I, Ottestad I (2024)
Validity of dietary intake methods in cancer cachexia
Curr Opin Support Palliat Care, 18 (3), 145-153
DOI 10.1097/SPC.0000000000000709, PubMed 38980805
Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2024)
Corrigendum to "Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study" [Gynecologic Oncology 175 (2023) 72-80]
Gynecol Oncol, 183, 7-8
DOI 10.1016/j.ygyno.2024.02.026, PubMed 38484693
Bjerring AW, Smeland KH, Stokke T, Haugaa KH, Holte E, Rösner A, Kiserud CE, Edvardsen T, Sarvari SI (2024)
Long-term cardiac effects of modern treatment for Hodgkin's lymphoma
Cardiooncology, 10 (1), 19
DOI 10.1186/s40959-024-00222-4, PubMed 38576044
Bjørgo E, Fagereng GL, Russnes HG, Smeland S, Taskén K, Helland Å (2024)
Acta Oncologica Nordic Precision Cancer Medicine Symposium 2023 - merging clinical research and standard healthcare
Acta Oncol, 63, 487-490
DOI 10.2340/1651-226X.2024.24954, PubMed 38910311
Blakstad H, Mendoza Mireles EE, Kierulf-Vieira KS, Singireddy D, Mdala I, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Vik-Mo EO, Brandal P (2024)
The impact of cancer patient pathway on timing of radiotherapy and survival: a cohort study in glioblastoma patients
J Neurooncol, 169 (1), 137-145
DOI 10.1007/s11060-024-04709-z, PubMed 38762830
Bobrowicz M, Kusowska A, Krawczyk M, Zhylko A, Forcados C, Slusarczyk A, Barankiewicz J, Domagala J, Kubacz M, Šmída M, Dostalova L, Marhelava K, Fidyt K, Pepek M, Baranowska I, Szumera-Cieckiewicz A, Inderberg EM, Wälchli S, Granica M, Graczyk-Jarzynka A, Majchrzak M, Poreba M, Gehlert CL, Peipp M, Firczuk M et al. (2024)
CD20 expression regulates CD37 levels in B-cell lymphoma - implications for immunotherapies
Oncoimmunology, 13 (1), 2362454
DOI 10.1080/2162402X.2024.2362454, PubMed 38846084
Borchmann P, Ferdinandus J, Schneider G, Moccia A, Greil R, Hertzberg M, Schaub V, Hüttmann A, Keil F, Dierlamm J, Hänel M, Novak U, Meissner J, Zimmermann A, Mathas S, Zijlstra JM, Fosså A, Viardot A, Hertenstein B, Martin S, Giri P, Scholl S, Topp MS, Jung W, Vucinic V et al. (2024)
Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trial
Lancet, 404 (10450), 341-352
DOI 10.1016/S0140-6736(24)01315-1, PubMed 38971175
Brativnyk A, Ankill J, Helland Å, Fleischer T (2024)
Multi-omics analysis reveals epigenetically regulated processes and patient classification in lung adenocarcinoma
Int J Cancer, 155 (2), 282-297
DOI 10.1002/ijc.34915, PubMed 38489486
Bratteteig M, Rueegg CS, Lie HC, Thorsen L, Larsen EH, Larsen MH, Torsvik IK, Götte M, Järvelä LS, Kriemler S, Larsen HB, Anderssen SA, Ruud E, Grydeland M (2024)
Physical activity behaviors and screen time in young childhood cancer survivors: the Physical Activity in Childhood Cancer Survivors Study
J Cancer Surviv, 20 (2), 554-565
DOI 10.1007/s11764-024-01671-7, PubMed 39287916
Brenne AT, Løhre ET, Knudsen AK, Lund JÅ, Thronæs M, Driller B, Brunelli C, Kaasa S (2024)
Standardizing Integrated Oncology and Palliative Care Across Service Levels: Challenges in Demonstrating Effects in a Prospective Controlled Intervention Trial
Oncol Ther, 12 (2), 345-362
DOI 10.1007/s40487-024-00278-3, PubMed 38744750
Brown LR, Sousa MS, Yule MS, Baracos VE, McMillan DC, Arends J, Balstad TR, Bye A, Dajani O, Dolan RD, Fallon MT, Greil C, Hjermstad MJ, Jakobsen G, Maddocks M, McDonald J, Ottestad IO, Phillips I, Sayers J, Simpson MR, Vagnildhaug OM, Solheim TS, Laird BJA, Skipworth RJE, Cancer Cachexia Endpoints Working Group (2024)
Body weight and composition endpoints in cancer cachexia clinical trials: Systematic Review 4 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 15 (3), 816-852
DOI 10.1002/jcsm.13478, PubMed 38738581
Bührer E, D'Haese D, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A, Hentrich M et al. (2024)
Impact of teratoma on survival probabilities of patients with metastatic non-seminomatous germ cell cancer: Results from the IGCCCG Update Consortium
Eur J Cancer, 202, 114042
DOI 10.1016/j.ejca.2024.114042, PubMed 38564927
Bøhn SKH, Svendsen K, Balto A, Gjelsvik YM, Myklebust TÅ, Børøsund E, Eriksen HR, Meland A, Østby K, Nes LS, Kiserud CE, Reinertsen KV, Ursin G (2024)
Health-related quality of life among women diagnosed with in situ or invasive breast cancer and age-matched controls: a population-based study
J Patient Rep Outcomes, 8 (1), 105
DOI 10.1186/s41687-024-00781-1, PubMed 39298004
Cameron AL, Mandeville H, Coppadoro B, Periasamy M, Davila Fajardo R, Ferrari A, Gaze MN, Helfre S, Magelssen H, Minard-Colin V, Ramos M, Schoot R, Zanetti I, Bisogno G, Chisholm JC, Merks JHM (2024)
The Impact of Radiation Therapy on Metastatic Rhabdomyosarcoma: Results From the EpSSG MTS 2008 Study
Int J Radiat Oncol Biol Phys, 121 (2), 388-402
DOI 10.1016/j.ijrobp.2024.08.039, PubMed 39222824
Casey NP, Kleinmanns K, Forcados C, Gelebart PF, Joaquina S, Lode M, Benard E, Kaveh F, Caulier B, Helgestad Gjerde C, García de Jalón E, Warren DJ, Lindemann K, Rokkones E, Davidson B, Myhre MR, Kvalheim G, Bjørge L, McCormack E, Inderberg EM, Wälchli S (2024)
Efficient CAR T cell targeting of the CA125 extracellular repeat domain of MUC16
J Immunother Cancer, 12 (4)
DOI 10.1136/jitc-2023-008179, PubMed 38604812
Caulier B, Joaquina S, Gelebart P, Dowling TH, Kaveh F, Thomas M, Tandaric L, Wernhoff P, Katyayini NU, Wogsland C, Gjerstad ME, Fløisand Y, Kvalheim G, Marr C, Kobold S, Enserink JM, Gjertsen BT, McCormack E, Inderberg EM, Wälchli S (2024)
CD37 is a safe chimeric antigen receptor target to treat acute myeloid leukemia
Cell Rep Med, 5 (6), 101572
DOI 10.1016/j.xcrm.2024.101572, PubMed 38754420
Chauhan SK, Dunn C, Andresen NK, Røssevold AH, Skorstad G, Sike A, Gilje B, Raj SX, Huse K, Naume B, Kyte JA (2024)
Peripheral immune cells in metastatic breast cancer patients display a systemic immunosuppressed signature consistent with chronic inflammation
NPJ Breast Cancer, 10 (1), 30
DOI 10.1038/s41523-024-00638-2, PubMed 38653982
Chávez-Villa M, Ruffolo LI, Byrne M, Line PD, Dueland S, Tomiyama K, Hernandez-Alejandro R (2024)
Reply to A. Jain et al
J Clin Oncol, 42 (26), 3165-3166
DOI 10.1200/JCO.24.00922, PubMed 38976818
Chen N, McGrath CB, Ericsson CI, Vaselkiv JB, Rencsok EM, Stopsack KH, Guard HE, Autio KA, Rathkopf DE, Enting D, Bitting RL, Mateo J, Githiaka CW, Chi KN, Cheng HH, Davis ID, Anderson SG, Badal SAM, Bjartell A, Russnes KM, Heath EI, Pomerantz MM, Henegan JC, Hyslop T, Esteban E et al. (2024)
Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer
Cancer Epidemiol Biomarkers Prev, 33 (3), 419-425
DOI 10.1158/1055-9965.EPI-23-1207, PubMed 38189661
Chen ZJ, Li XA, Brenner DJ, Hellebust TP, Hoskin P, Joiner MC, Kirisits C, Nath R, Rivard MJ, Thomadsen BR, Zaider M (2024)
AAPM Task Group Report 267: A joint AAPM GEC-ESTRO report on biophysical models and tools for the planning and evaluation of brachytherapy
Med Phys, 51 (6), 3850-3923
DOI 10.1002/mp.17062, PubMed 38721942
Chiavelli C, Prapa M, Rovesti G, Silingardi M, Neri G, Pugliese G, Trudu L, Dall'Ora M, Golinelli G, Grisendi G, Vinet J, Bestagno M, Spano C, Papapietro RV, Depenni R, Di Emidio K, Pasetto A, Nascimento Silva D, Feletti A, Berlucchi S, Iaccarino C, Pavesi G, Dominici M (2024)
Autologous anti-GD2 CAR T cells efficiently target primary human glioblastoma
NPJ Precis Oncol, 8 (1), 26
DOI 10.1038/s41698-024-00506-z, PubMed 38302615
Chopra S, Bosse T, Horeweg N, Deodhar K, Menon S, Rafael T, Pai V, Rijstenberg L, van Kemenade F, Kannan S, Mahantshetty U, Segedin B, Huang F, Bruheim K, Perez M, Rai B, Tan LT, Giannakopoulos N, Schmid M, Tanderup K, Pötter R, Nout RA (2024)
Biomarker Expression and Clinical Outcomes in International Study of Chemoradiation and Magnetic Resonance Imaging-Based Image-Guided Brachytherapy for Locally Advanced Cervical Cancer: BIOEMBRACE
Int J Radiat Oncol Biol Phys, 121 (1), 97-106
DOI 10.1016/j.ijrobp.2024.07.2316, PubMed 39067486
Cilla S, Rossi R, Habberstad R, Klepstad P, Dall'Agata M, Kaasa S, Valenti V, Donati CM, Maltoni M, Morganti AG (2024)
Explainable Machine Learning Model to Predict Overall Survival in Patients Treated With Palliative Radiotherapy for Bone Metastases
JCO Clin Cancer Inform, 8, e2400027
DOI 10.1200/CCI.24.00027, PubMed 38917384
Dahl AA (2024)
[What actually is mental health?]
Tidsskr Nor Laegeforen, 144 (11)
DOI 10.4045/tidsskr.24.0420, PubMed 39319761
Dahl AA, Johannesen TB, Gjelsvik Y, Myklebust TÅ, Fosså SD (2024)
A controlled study of use and effectiveness of phosphodiesterase-5 inhibitors in long-term survivors after curative radiotherapy for prostate cancer (PCa)
Radiother Oncol, 204, 110704
DOI 10.1016/j.radonc.2024.110704, PubMed 39732292
Dahl AA, Smeland KB, Eikeland S, Fagerli UM, Bersvendsen HS, Fosså A, Kiserud CE (2024)
Distressed personality is associated with late adverse effects in long-term survivors of Hodgkin lymphoma
Acta Oncol, 63, 600-606
DOI 10.2340/1651-226X.2024.40312, PubMed 39099321
Damek A, Kurch L, Franke FC, Attarbaschi A, Beishuizen A, Cepelova M, Ceppi F, Daw S, Dieckmann K, Fernández-Teijeiro A, Feuchtinger T, Flerlage JE, Fosså A, Georgi TW, Hasenclever D, Hraskova A, Karlen J, Klekawka T, Kluge R, Körholz D, Landman-Parker J, Leblanc T, Mauz-Körholz C, Metzler M, Pears J et al. (2024)
Hodgkin lymphoma: hypodense lesions in mediastinal masses
Sci Rep, 14 (1), 14591
DOI 10.1038/s41598-024-64253-8, PubMed 38918503
Dávila Fajardo R, Scarzello G, Gaze MN, Boterberg T, Cameron A, Fuchs J, Guérin F, Hoskin P, Krasin MJ, Kroon P, Magelssen H, Mercke C, Merks JHM, Paulsen F, Pommier P, Ramos M, Rees H, Rogers T, Schmid M, Seitz G, Slater O, Smeulders N, Stenman J, Terwisscha S, Chargari C et al. (2024)
Brachytherapy for rhabdomyosarcoma: Survey of international clinical practice and development of guidelines
Radiother Oncol, 195, 110273
DOI 10.1016/j.radonc.2024.110273, PubMed 38588921
Deng WH, Lie HC, Ruud E, Loge JH, Kiserud CE, Rueegg CS (2024)
Profiles of Fatigue and Psychological Symptoms in Long-Term Childhood, Adolescent, and Young Adult Cancer Survivors-The NOR-CAYACS Study
Cancer Med, 13 (22), e70425
DOI 10.1002/cam4.70425, PubMed 39584526
Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB (2024)
Impact of pain and adverse health outcomes on long-term US testicular cancer survivors
J Natl Cancer Inst, 116 (3), 455-467
DOI 10.1093/jnci/djad236, PubMed 37966940
Dreyling M, Doorduijn J, Giné E, Jerkeman M, Walewski J, Hutchings M, Mey U, Riise J, Trneny M, Vergote V, Shpilberg O, Gomes da Silva M, Leppä S, Jiang L, Stilgenbauer S, Kerkhoff A, Jachimowicz RD, Celli M, Hess G, Arcaini L, Visco C, van Meerten T, Wirths S, Zinzani PL, Novak U et al. (2024)
Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network
Lancet, 403 (10441), 2293-2306
DOI 10.1016/S0140-6736(24)00184-3, PubMed 38705160
Dreyling M, Fowler NH, Dickinson M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, María Ferreri AJ, Teshima T, Patten PEM, McGuirk JP, Petzer AL et al. (2024)
Durable response after tisagenlecleucel in adults with relapsed/refractory follicular lymphoma: ELARA trial update
Blood, 143 (17), 1713-1725
DOI 10.1182/blood.2023021567, PubMed 38194692
Egeland EV, Seip K, Skourti E, Øy GF, Pettersen SJ, Pandya AD, Dahle MA, Haugen MH, Kristian A, Nakken S, Engebraaten O, Mælandsmo GM, Prasmickaite L (2024)
The SRC-family serves as a therapeutic target in triple negative breast cancer with acquired resistance to chemotherapy
Br J Cancer, 131 (10), 1656-1667
DOI 10.1038/s41416-024-02875-5, PubMed 39390250
Eide NA, Noer A, Jespersen H, Jebsen P, Geisler J (2024)
Delayed Distant Recurrence of a Uveal Melanoma 4 Decades after Enucleation
Case Rep Oncol, 17 (1), 1131-1139
DOI 10.1159/000541341, PubMed 39474560
Elvebakken H, Venizelos A, Perren A, Couvelard A, Lothe IMB, Hjortland GO, Myklebust TÅ, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Knappskog S, Sorbye H (2024)
Treatment outcome according to genetic tumour alterations and clinical characteristics in digestive high-grade neuroendocrine neoplasms
Br J Cancer, 131 (4), 676-684
DOI 10.1038/s41416-024-02773-w, PubMed 38909137
Engelaar M, Bos N, van Schelven F, Lorenzo I Sunyer N, Couespel N, Apolone G, Brunelli C, Caraceni A, Ferrer M, Groenvold M, Kaasa S, Ciliberto G, Lombardo C, Pietrobon R, Pravettoni G, Sirven A, Vachon H, Gilbert A, Rademakers J (2024)
Collaborating with cancer patients and informal caregivers in a European study on quality of life: protocol to embed patient and public involvement within the EUonQoL project
Res Involv Engagem, 10 (1), 59
DOI 10.1186/s40900-024-00597-9, PubMed 38863075
Fange Gjelstad IM, Lyckander C, Høidalen A, Bratland Å, Blomhoff R, Paur I, Henriksen C (2024)
Impact of radiotherapy on body weight in head and neck cancer patients: A prospective study
Clin Nutr ESPEN, 65, 390-399
DOI 10.1016/j.clnesp.2024.12.019, PubMed 39710169
Farooqi SJ, Zhao Z, Öjlert ÅK, Thunold S, Juul HV, Bjaanæs MM, Horndalsveen H, Nymoen HMG, Helland Å, Haakensen VD (2024)
Serum cytokines as a biomarker for immune checkpoint inhibitor toxicity in patients with pleural mesothelioma
Front Immunol, 15, 1480183
DOI 10.3389/fimmu.2024.1480183, PubMed 39687621
Fazio R, Arnold D, Folprecht G, Guren MG, Koessler T, Wyrwicz L, Sclafani F (2024)
Highlights from the ESMO Annual Meeting 2023 - EORTC GI Tract Group picks from the colorectal and anal cancer track
ESMO Gastrointest Oncol, 3, 100038
DOI 10.1016/j.esmogo.2023.100038, PubMed 41648745
Felip E, Metro G, Soo RA, Wolf J, Solomon BJ, Tan DS, Ardizzoni A, Lee DH, Sequist LV, Barlesi F, Ponce-Aix S, Abreu DR, Campelo MRG, Sprauten M, Djentuh LO, Smith N, Jary A, Belli R, Glaser S, Zou M, Cui X, Giovannini M, Yang JC (2024)
Capmatinib plus nazartinib in patients with EGFR-mutated non-small cell lung cancer
Eur J Cancer, 208, 114182
DOI 10.1016/j.ejca.2024.114182, PubMed 38986421
Festvåg LE, Sverre BL, Paulsen Ø, Eilertsen G (2024)
Advance care planning with older Norwegian adults in their homes: a narrative ethnographic study
BMC Palliat Care, 23 (1), 44
DOI 10.1186/s12904-024-01378-7, PubMed 38369465
Filippi AR, Bar J, Chouaid C, Christoph DC, Field JK, Fietkau R, Garassino MC, Garrido P, Haakensen VD, Kao S, Markman B, McDonald F, Mornex F, Moskovitz M, Peters S, Sibille A, Siva S, van den Heuvel M, Vercauter P, Anand S, Chander P, Licour M, de Lima AR, Qiao Y, Girard N (2024)
Real-world outcomes with durvalumab after chemoradiotherapy in patients with unresectable stage III NSCLC: interim analysis of overall survival from PACIFIC-R
ESMO Open, 9 (6), 103464
DOI 10.1016/j.esmoop.2024.103464, PubMed 38833971
Fischer A, Albert TK, Moreno N, Interlandi M, Mormann J, Glaser S, Patil P, de Faria FW, Richter M, Verma A, Balbach ST, Wagener R, Bens S, Dahlum S, Göbel C, Münter D, Inserte C, Graf M, Kremer E, Melcher V, Di Stefano G, Santi R, Chan A, Dogan A, Bush J et al. (2024)
Lack of SMARCB1 expression characterizes a subset of human and murine peripheral T-cell lymphomas
Nat Commun, 15 (1), 8571
DOI 10.1038/s41467-024-52826-0, PubMed 39362842
Fleischer T, Haugen MH, Ankill J, Silwal-Pandit L, Børresen-Dale AL, Hedenfalk I, Hatschek T, Tost J, Engebraaten O, Kristensen VN (2024)
An integrated omics approach highlights how epigenetic events can explain and predict response to neoadjuvant chemotherapy and bevacizumab in breast cancer
Mol Oncol, 18 (8), 2042-2059
DOI 10.1002/1878-0261.13656, PubMed 38671580
Fosså SD, Holck Storås A, Aas K, Børge Johannesen T, Maria Gjelsvik Y, Myklebust TÅ (2024)
Pretreatment Patient-reported Overall Health: A Prognostic Factor for Early Overall Mortality After Primary Curative Treatment of Prostate Cancer
Eur Urol Open Sci, 63, 62-70
DOI 10.1016/j.euros.2024.03.005, PubMed 38558766
Frich L, Hermann R, Ryder T (2024)
Breast implant-associated anaplastic large cell lymphoma
Tidsskr Nor Laegeforen, 144 (12)
DOI 10.4045/tidsskr.24.0315, PubMed 39404238
Gaimari A, De Lucia A, Nicolini F, Mazzotti L, Maltoni R, Rughi G, Zurlo M, Marchesini M, Juan M, Parras D, Cerchione C, Martinelli G, Bravaccini S, Tettamanti S, Pasetto A, Pasini L, Magnoni C, Gazzola L, Borges de Souza P, Mazza M (2024)
Significant Advancements and Evolutions in Chimeric Antigen Receptor Design
Int J Mol Sci, 25 (22)
DOI 10.3390/ijms252212201, PubMed 39596267
Gelderblom H, Bhadri V, Stacchiotti S, Bauer S, Wagner AJ, van de Sande M, Bernthal NM, López Pousa A, Razak AA, Italiano A, Ahmed M, Le Cesne A, Tinoco G, Boye K, Martín-Broto J, Palmerini E, Tafuto S, Pratap S, Powers BC, Reichardt P, Casado Herráez A, Rutkowski P, Tait C, Zarins F, Harrow B et al. (2024)
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Lancet, 403 (10445), 2709-2719
DOI 10.1016/S0140-6736(24)00885-7, PubMed 38843860
Gerdtsson A, Negaard HFS, Almås B, Bergdahl AG, Cohn-Cedermark G, Glimelius I, Halvorsen D, Haugnes HS, Hedlund A, Hellström M, Holmberg G, Karlsdóttir Á, Kjellman A, Larsen SM, Thor A, Wahlqvist R, Ståhl O, Tandstad T (2024)
Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
BJU Int, 133 (6), 717-724
DOI 10.1111/bju.16289, PubMed 38293778
Green D, van Ewijk R, Tirtei E, Andreou D, Baecklund F, Baumhoer D, Bielack SS, Botchu R, Boye K, Brennan B, Capra M, Cottone L, Dirksen U, Fagioli F, Fernandez N, Flanagan AM, Gambarotti M, Gaspar N, Gelderblom H, Gerrand C, Gomez-Mascard A, Hardes J, Hecker-Nolting S, Kabickova E, Kager L et al. (2024)
Biological Sample Collection to Advance Research and Treatment: A Fight Osteosarcoma Through European Research and Euro Ewing Consortium Statement
Clin Cancer Res, 30 (16), 3395-3406
DOI 10.1158/1078-0432.CCR-24-0101, PubMed 38869831
Grivas P, Garralda E, Meric-Bernstam F, Mellinghoff IK, Goyal L, Harding JJ, Dees EC, Bahleda R, Azad NS, Karippot A, Kurzrock R, Tabernero J, Kononen J, Ng MCH, Mehta R, Uboha NV, Bigot F, Boni V, Bowyer SE, Breder V, Cervantes A, Chan N, Cleary JM, Dhawan M, Eefsen RL et al. (2024)
Evaluating Debio 1347 in Patients with FGFR Fusion-Positive Advanced Solid Tumors from the FUZE Multicenter, Open-Label, Phase II Basket Trial
Clin Cancer Res, 30 (20), 4572-4583
DOI 10.1158/1078-0432.CCR-24-0012, PubMed 38771739
Guldhav KV, Andersen JR, Eldal K, Lundeby T, Hegland PA (2024)
Practices for Reporting Scale Structure and Summarizing Scores in Studies Using FAMCARE Scale to Assess Caregiver Satisfaction with Cancer Care: A Scoping Review
Patient Relat Outcome Meas, 15, 271-286
DOI 10.2147/PROM.S479195, PubMed 39534014
Guldvik IJ, Ramberg H, Kristensen G, Røder A, Mills IG, Lilleby W, Taskén KA (2024)
Systemic interrogation of immune-oncology-related proteins in patients with locally advanced prostate cancer undergoing androgen deprivation and intensity-modulated radiotherapy
World J Urol, 42 (1), 95
DOI 10.1007/s00345-024-04787-8, PubMed 38386171
Gullhaug A, Haakensen VD, De Ruysscher D, Simone CB, Hotca-Cho AE, Chhabra AM, Hellebust TP, Paulsen EE, Dimopoulos MP, Johansen S (2024)
Lung cancer reirradiation: Exploring modifications to utilization, treatment modalities and factors associated with outcomes
J Med Imaging Radiat Sci, 55 (2), 221-231
DOI 10.1016/j.jmir.2024.02.004, PubMed 38429174
Halldorsson S, Nagymihaly RM, Patel A, Brandal P, Panagopoulos I, Leske H, Lund-Iversen M, Sahm F, Vik-Mo EO (2024)
Accurate and comprehensive evaluation of O6-methylguanine-DNA methyltransferase promoter methylation by nanopore sequencing
Neuropathol Appl Neurobiol, 50 (3), e12984
DOI 10.1111/nan.12984, PubMed 38783575
Hamfjord J, Guren TK, Glimelius B, Sorbye H, Pfeiffer P, Dajani O, Lingjærde OC, Tveit KM, Spindler KG, Pallisgaard N, Kure EH (2024)
Exploring Early Kinetic Profiles of CEA, ctDNA and cfDNA in Patients With RAS-/BRAF-Mutated Metastatic Colorectal Cancer
Clin Colorectal Cancer, 24 (2), 153-158
DOI 10.1016/j.clcc.2024.11.004, PubMed 39743478
Hanekamp BA, Virdee PS, Goh V, Jones M, Hvass Hansen R, Hjorth Johannesen H, Schulz A, Serup-Hansen E, Guren MG, Muirhead R (2024)
Diffusion-weighted magnetic resonance imaging as an early prognostic marker of chemoradiotherapy response in squamous cell carcinoma of the anus: An individual patient data meta-analysis
Phys Imaging Radiat Oncol, 31, 100618
DOI 10.1016/j.phro.2024.100618, PubMed 39188809
Heggebø LC, Blakstad H, Eriksson MC, Brandal P (2024)
Lomustine overdose in a patient with diffuse glioma: symptoms, management and outcome
BMJ Case Rep, 17 (7)
DOI 10.1136/bcr-2024-260450, PubMed 39043464
Helland Å (2024)
[Nobel Prize for tiny RNA fragments]
Tidsskr Nor Laegeforen, 144 (15)
DOI 10.4045/tidsskr.24.0603, PubMed 39692664
Helland Å, Steinskog ESS, Blix ES, Flobak Å, Brabrand S, Puco K, Niehusmann P, Meltzer S, Oppedal IA, Haug Å, Torkildsen CF, Randen U, Gilje B, Lønning PE, Gjertsen BT, Hovland R, Russnes HG, Fagereng GL, Smeland S, Tasken K (2024)
[Raising the quality of cancer treatment]
Tidsskr Nor Laegeforen, 144 (1)
DOI 10.4045/tidsskr.23.0740, PubMed 38258713
Heramb-Aamot J, Mala T, Fauske L (2024)
Everyday Life Six to Eight Months After Esophagectomy for Cancer: A Qualitative Study
Anticancer Res, 44 (2), 743-750
DOI 10.21873/anticanres.16865, PubMed 38307550
Hershenfeld SA, Tobin JWD, Shelton V, Calvente L, Lajkosz K, Liu T, Brodtkorb M, d'Amore FA, Ludvigsen M, Baetz T, LeBrun D, Johnson N, Crump M, Hong M, Kuruvilla J, Tremblay-LeMay R, MacManus M, Tsang R, Hodgson DC, Gandhi MK, Kridel R (2024)
Single gene mutations and prognosis in limited-stage follicular lymphoma treated with radiation therapy
Br J Haematol, 205 (5), 1810-1814
DOI 10.1111/bjh.19698, PubMed 39112220
Hjermstad MJ, Jakobsen G, Arends J, Balstad TR, Brown LR, Bye A, Coats AJS, Dajani OF, Dolan RD, Fallon MT, Greil C, Grzyb A, Kaasa S, Koteng LH, May AM, McDonald J, Ottestad I, Philips I, Roeland EJ, Sayers J, Simpson MR, Skipworth RJE, Solheim TS, Sousa MS, Vagnildhaug OM et al. (2024)
Quality of life endpoints in cancer cachexia clinical trials: Systematic review 3 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 15 (3), 794-815
DOI 10.1002/jcsm.13453, PubMed 38553255
Hjermstad MJ, Pirnat A, Aass N, Andersen S, Astrup GL, Dajani O, Garresori H, Guldhav KV, Hamre H, Haukland EC, Jordal F, Lundeby T, Løhre ET, Mjåland S, Paulsen Ø, Semb KA, Staff ES, Wester T, Kaasa S (2024)
PALLiative care in ONcology (PALLiON): A cluster-randomised trial investigating the effect of palliative care on the use of anticancer treatment at the end of life
Palliat Med, 38 (2), 229-239
DOI 10.1177/02692163231222391, PubMed 38193250
Hompland I, Boye K, Wiedswang AM, Papakonstantinou A, Røsok B, Joensuu H, Bruland Ø (2024)
Discontinuation of imatinib in patients with oligometastatic gastrointestinal stromal tumour who are in complete radiological remission: a prospective multicentre phase II study
Acta Oncol, 63, 288-293
DOI 10.2340/1651-226X.2024.39851, PubMed 38712513
Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Dale E, Malinen E, Futsaether CM (2024)
Deep learning with uncertainty estimation for automatic tumor segmentation in PET/CT of head and neck cancers: impact of model complexity, image processing and augmentation
Biomed Phys Eng Express, 10 (5)
DOI 10.1088/2057-1976/ad6dcd, PubMed 39127060
Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2024)
Corrigendum: Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
Front Med (Lausanne), 11, 1421603
DOI 10.3389/fmed.2024.1421603, PubMed 38813378
Huynh TM, Falk RS, Hellebust TP, Dale E, Astrup GL, Hjermstad MJ, Malinen E, Bjordal K, Kiserud CE, Herlofson BB, Nome R, Amdal CD (2024)
Chronic fatigue in long-term survivors of head and neck cancer treated with radiotherapy
Radiother Oncol, 195, 110231
DOI 10.1016/j.radonc.2024.110231, PubMed 38518958
Hyldebrandt HK, Stormorken AT, Vitelli V, Mæhle L, Schlichting E, Grindedal EM (2024)
Risk reducing mastectomy in Norwegian BRCA1/2 carriers
Eur J Surg Oncol, 51 (3), 109571
DOI 10.1016/j.ejso.2024.109571, PubMed 39765192
Haakensen VD, Öjlert ÅK, Thunold S, Farooqi S, Nowak AK, Chin WL, Grundberg O, Szejniuk WM, Cedres S, Sørensen JB, Dalen TS, Lund-Iversen M, Bjaanæs M, Helland Å (2024)
UV1 telomerase vaccine with ipilimumab and nivolumab as second line treatment for pleural mesothelioma - A phase II randomised trial
Eur J Cancer, 202, 113973
DOI 10.1016/j.ejca.2024.113973, PubMed 38447379
Ilmarinen T, Bratland Å, Tøndel H, Guðjónsson A, Gebre-Medhin M, Palmgren B, Mäenpää H, Bjørndal K, Grau Eriksen J (2024)
Current aspects of the quality of head and neck cancer care - survey of the Scandinavian Society for Head and Neck Oncology
Acta Otolaryngol, 144 (5-6), 404-408
DOI 10.1080/00016489.2024.2386097, PubMed 39109489
Jerkeman M, Kolstad A, Hutchings M, Pasanen A, Meriranta L, Niemann CU, Kragh Jørgensen RR, El-Galaly TC, Riise J, Leppä S, Christensen JH, Sonnevi K, Pedersen LB, Wader KF, Glimelius I (2024)
MRD-driven treatment with venetoclax-R2 in mantle cell lymphoma: the Nordic Lymphoma Group MCL7 VALERIA trial
Blood Adv, 8 (2), 407-415
DOI 10.1182/bloodadvances.2023011920, PubMed 38113470
Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA (2024)
Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers
Int J Mol Sci, 25 (1)
DOI 10.3390/ijms25010586, PubMed 38203757
Jin Y, Dunn C, Persiconi I, Sike A, Skorstad G, Beck C, Kyte JA (2024)
Correction: Jin et al. Comparative Evaluation of STEAP1 Targeting Chimeric Antigen Receptors with Different Costimulatory Domains and Spacers. Int. J. Mol. Sci. 2024, 25, 586
Int J Mol Sci, 25 (18)
DOI 10.3390/ijms251810024, PubMed 39337718
Joensuu H, Reichardt A, Eriksson M, Hohenberger P, Boye K, Cameron S, Lindner LH, Jost PJ, Bauer S, Schütte J, Lindskog S, Kallio R, Jaakkola PM, Goplen D, Wardelmann E, Reichardt P (2024)
Survival of patients with ruptured gastrointestinal stromal tumour treated with adjuvant imatinib in a randomised trial
Br J Cancer, 131 (2), 299-304
DOI 10.1038/s41416-024-02738-z, PubMed 38862742
Karlsson AT, Hjermstad MJ, Aass N, Skovlund E, Kaasa S, Yri OE (2024)
Overall Survival after Radiotherapy for Brain Metastases According to ECOG Status-A Prospective Study of 294 NSCLC Patients
Cancers (Basel), 16 (8)
DOI 10.3390/cancers16081486, PubMed 38672568
Kirchheiner K, Zaharie A, Smet S, Spampinato S, Chargari C, Haie-Meder C, Mahantshetty U, Šegedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Pötter R, Sturdza A, Schmid MP, Tanderup K, De Leeuw A, Jürgenliemk-Schulz IM, Nout RA, EMBRACE Collaborative Group (2024)
Association Between the Regular Use of Vaginal Dilators and/or Sexual Activity and Vaginal Morbidity in Locally Advanced Cervical Cancer Survivors: An EMBRACE-I Study Report
Int J Radiat Oncol Biol Phys, 121 (2), 452-464
DOI 10.1016/j.ijrobp.2024.09.011, PubMed 39278418
Kristensen MH, Holm AIS, Hansen CR, Zukauskaite R, Samsøe E, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Overgaard J, Eriksen JG (2024)
High-dose loco-regional pattern of failure after primary radiotherapy in p16 positive and negative head and neck squamous cell carcinoma - A DAHANCA 19 study
Clin Transl Radiat Oncol, 46, 100772
DOI 10.1016/j.ctro.2024.100772, PubMed 38596816
Kristensen MH, Sørensen MK, Tramm T, Alsner J, Sørensen BS, Maare C, Johansen J, Primdahl H, Bratland Å, Kristensen CA, Andersen M, Lilja-Fischer JK, Holm AIS, Samsøe E, Hansen CR, Zukauskaite R, Overgaard J, Eriksen JG (2024)
Tumor volume and cancer stem cell expression as prognostic markers for high-dose loco-regional failure in head and neck squamous cell carcinoma - A DAHANCA 19 study
Radiother Oncol, 193, 110149
DOI 10.1016/j.radonc.2024.110149, PubMed 38341096
Labori KJ, Bratlie SO, Andersson B, Angelsen JH, Biörserud C, Björnsson B, Bringeland EA, Elander N, Garresori H, Grønbech JE, Haux J, Hemmingsson O, Liljefors MG, Myklebust TÅ, Nymo LS, Peltola K, Pfeiffer P, Sallinen V, Sandström P, Sparrelid E, Stenvold H, Søreide K, Tingstedt B, Verbeke C, Öhlund D et al. (2024)
Neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer (NORPACT-1): a multicentre, randomised, phase 2 trial
Lancet Gastroenterol Hepatol, 9 (3), 205-217
DOI 10.1016/S2468-1253(23)00405-3, PubMed 38237621
Labori KJ, Bratlie SO, Dueland S, Lassen K (2024)
NORPACT-1: implications for future trials - Authors' reply
Lancet Gastroenterol Hepatol, 9 (5), 408-409
DOI 10.1016/S2468-1253(24)00079-7, PubMed 38604194
Larsen SG, Graf W, Larsen RH, Revheim ME, Mariathasan AM, Sørensen O, Spasojevic M, Rashid G, Lundstrøm N, Gjertsen TJ, Aksnes AK, Bruland ØS (2024)
Eighteen-Months Safety and Efficacy Following Intraperitoneal Treatment With ²²⁴Radium-Labeled Microparticles After CRS-HIPEC in Patients With Peritoneal Metastasis From Colorectal Cancer
J Surg Oncol, 130 (6), 1395-1402
DOI 10.1002/jso.27897, PubMed 39428687
Lereim RR, Dunn C, Aamdal E, Chauhan SK, Straume O, Guren TK, Kyte JA (2024)
Plasma protein dynamics during ipilimumab treatment in metastatic melanoma: associations with tumor response, adverse events and survival
Oncoimmunology, 14 (1), 2440967
DOI 10.1080/2162402X.2024.2440967, PubMed 39703053
Lia K, Jørgensen RRK, L Wold B, Fluge Ø, Fagerli UM, Bersvendsen H, Bø IB, Bhargava S, Fosså A (2024)
Overall survival and causes of death in elderly patients with Hodgkin lymphoma: a Norwegian population-based case-control study
Haematologica, 109 (5), 1403-1412
DOI 10.3324/haematol.2023.283721, PubMed 37881879
Lilleby W, Kishan A, Geinitz H (2024)
Acute and long-term toxicity in primary hypofractionated external photon radiation therapy in patients with localized prostate cancer
World J Urol, 42 (1), 41
DOI 10.1007/s00345-023-04714-3, PubMed 38244053
Lillekroken D, Bye A, Halvorsrud L, Terragni L, Debesay J (2024)
Food for Soul-Older Immigrants' Food Habits and Meal Preferences After Immigration: A Systematic Literature Review
J Immigr Minor Health, 26 (4), 775-805
DOI 10.1007/s10903-023-01571-5, PubMed 38165601
Long GV, Carlino MS, McNeil C, Ribas A, Gaudy-Marqueste C, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance AM, Daud AI, Hamid O, Larkin J, Yao L, Singh R, Lal R, Robert C (2024)
Pembrolizumab versus ipilimumab for advanced melanoma: 10-year follow-up of the phase III KEYNOTE-006 study
Ann Oncol, 35 (12), 1191-1199
DOI 10.1016/j.annonc.2024.08.2330, PubMed 39306585
Long GV, Hauschild A, Santinami M, Kirkwood JM, Atkinson V, Mandala M, Merelli B, Sileni VC, Nyakas M, Haydon A, Dutriaux C, Robert C, Mortier L, Schachter J, Schadendorf D, Lesimple T, Plummer R, Larkin J, Tan M, Adnaik SB, Burgess P, Jandoo T, Dummer R (2024)
Final Results for Adjuvant Dabrafenib plus Trametinib in Stage III Melanoma
N Engl J Med, 391 (18), 1709-1720
DOI 10.1056/NEJMoa2404139, PubMed 38899716
Lordick F, Mauer ME, Stocker G, Cella CA, Ben-Aharon I, Piessen G, Wyrwicz L, Al-Haidari G, Fleitas-Kanonnikoff T, Boige V, Lordick Obermannová R, Martens UM, Gomez-Martin C, Thuss-Patience P, Arrazubi V, Avallone A, Shiu KK, Artru P, Brenner B, Buges Sanchez C, Chau I, Lorenzen S, Daum S, Sinn M, Merelli B et al. (2024)
Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study
Ann Oncol, 36 (2), 197-207
DOI 10.1016/j.annonc.2024.10.829, PubMed 39542422
Lund JÅ, Lydersen S, Aksnessæther B, Solberg A, Wanderås A, Lervåg C, Kaasa S, Tøndel H (2024)
Image guided radiotherapy in curative treatment for prostate cancer. 5-year results from a randomized controlled trial (RIC-trial)
Radiother Oncol, 196, 110309
DOI 10.1016/j.radonc.2024.110309, PubMed 38670265
Lunde P, Grimsmo J, Nilsson BB, Bye A, Finbråten HS (2024)
Health literacy in patients participating in cardiac rehabilitation: A prospective cohort study with pre-post-test design
Int J Cardiol Cardiovasc Risk Prev, 22, 200314
DOI 10.1016/j.ijcrp.2024.200314, PubMed 39161973
Löffeler S, Bertilsson H, Müller C, Aas K, Haugnes HS, Aksnessæther B, Pesonen M, Thon K, Tandstad T, Murtola T, Poulsen MH, Nordstrøm T, Vigmostad MN, Ottosson F, Holmsten K, Christiansen O, Slaaen M, Haug ES, Storås AH, Asphaug L, Rannikko A, Brasso K, Scandinavian Prostate Cancer Group (SPCG) and the Norwegian Get‐Randomized (GRand) Initiative (2024)
Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
BJU Int, 133 (6), 680-689
DOI 10.1111/bju.16314, PubMed 38469686
Machak GN, Bruland ØS, Romanova TN, Kovalev AV (2024)
Denosumab induction and Zoledronic acid maintenance therapy for recurrent unresectable giant cell tumour of the distal tibia: A case report with sustained tumour control after drug withdrawal
J Bone Oncol, 45, 100596
DOI 10.1016/j.jbo.2024.100596, PubMed 38545297
MacManus MP, Seymour JF, Tsang H, Fisher R, Keane C, Sabdia MB, Law SC, Gunawardana J, Nath K, Kazakoff SH, Marques-Piubelli ML, Duenas DE, Green MR, Roos D, O'Brien P, McCann A, Tsang R, Davis S, Christie D, Cheah C, Amanuel B, Cochrane T, Butler J, Johnston A, Shanavas M et al. (2024)
Adjuvant rituximab and elevated intratumoural CD8 expression are associated with sustained disease control after radiotherapy in a randomised trial of systemic therapy in early-stage follicular lymphoma
EBioMedicine, 110, 105468
DOI 10.1016/j.ebiom.2024.105468, PubMed 39631145
Maggadottir SM, Dueland S, Mensali N, Hamre H, Andresen PA, Myhre MR, Juul HV, Bigalke I, Lundby M, Hønnåshagen TK, Sæbøe-Larssen S, Josefsen D, Hagtvedt T, Wälchli S, Kvalheim G, Inderberg EM (2024)
Transient TCR-based T cell therapy in a patient with advanced treatment-resistant MSI-high colorectal cancer
Mol Ther, 32 (6), 2021-2029
DOI 10.1016/j.ymthe.2024.04.009, PubMed 38582964
Mahon P, Chatzitheofilou I, Dekker A, Fernández X, Hall G, Helland A, Traverso A, Van Marcke C, Vehreschild J, Ciliberto G, Tonon G (2024)
A federated learning system for precision oncology in Europe: DigiONE
Nat Med, 30 (2), 334-337
DOI 10.1038/s41591-023-02715-8, PubMed 38195748
Mala T, Abelseth BK, Al-Haidari G, Dørum LMR, Hatlevoll I, Rekstad LC, Stenvold H, Øvrebø KK, Aahlin EK (2024)
[Significantly improved survival in oesophageal cancer]
Tidsskr Nor Laegeforen, 144 (15)
DOI 10.4045/tidsskr.24.0547, PubMed 39692659
Marsilla J, Weiss J, Ye XY, Welch M, Milosevic M, Lyng H, Hompland T, Bruheim K, Tadic T, Haibe-Kains B, Han K (2024)
A T2-weighted MRI-based radiomic signature for disease-free survival in locally advanced cervical cancer following chemoradiation: An international, multicentre study
Radiother Oncol, 199, 110463
DOI 10.1016/j.radonc.2024.110463, PubMed 39067707
Martelli M, Ceriani L, Ciccone G, Ricardi U, Kriachok I, Botto B, Balzarotti M, Tucci A, Usai SV, Zilioli VR, Pennese E, Arcaini L, Dabrowska-Iwanicka A, Ferreri AJM, Merli F, Zhao W, Rigacci L, Cellini C, Hodgson D, Ionescu C, Minoia C, Lucchini E, Spina M, Fosså A, Janikova A et al. (2024)
Omission of Radiotherapy in Primary Mediastinal B-Cell Lymphoma: IELSG37 Trial Results
J Clin Oncol, 42 (34), 4071-4083
DOI 10.1200/JCO-24-01373, PubMed 39159403
Mediå LM, Fauske L, Sigurdardottir S, Billaud Feragen KJ, Waehre A (2024)
Differences of sex development and surgical decisions: focus group interviews with health care professionals in Norway
Health Psychol Behav Med, 12 (1), 2371134
DOI 10.1080/21642850.2024.2371134, PubMed 38979393
Miceli R, Eriksson H, Lo Russo G, Alfieri S, Moksnes Bjaanæs M, Pietrantonio F, De Cecco L, Prelaj A, Proto C, Franzén J, McDonnell D, Berenguer Pina JJ, Beninato T, Mazzeo L, Giannatempo P, Verzoni E, Crown J, Helland Å, Eustace A (2024)
Gender Difference in sidE eFfects of ImmuNotherapy: a possible clue to optimize cancEr tReatment (G-DEFINER): study protocol of an observational prospective multicenter study
Acta Oncol, 63, 213-219
DOI 10.2340/1651-226X.2024.24179, PubMed 38647024
Minnai F, Shkodra M, Noci S, Brunelli C, Pigni A, Zecca E, Skorpen F, Klepstad P, Kaasa S, Corli O, Pallotti MC, Maltoni MC, Caraceni AT, Colombo F (2024)
Genomic Study in Opioid-Treated Cancer Patients Identifies Variants Associated With Nausea-Vomiting
J Pain Symptom Manage, 69 (2), 175-182.e5
DOI 10.1016/j.jpainsymman.2024.10.033, PubMed 39515597
Nilssen Y, Brustugun OT, Fjellbirkeland L, Grønberg BH, Haram PM, Helbekkmo N, Helland Å, Wahl SGF, Aanerud M, Solberg S (2024)
Small Cell Lung Cancer in Norway: Patterns of Care by Health Region and Survival Trends
Clin Lung Cancer, 25 (5), e221-e228.e3
DOI 10.1016/j.cllc.2024.04.002, PubMed 38692990
Nilssen Y, Brustugun OT, Fjellbirkeland L, Helland Å, Møller B, Wahl SGF, Solberg S (2024)
Distribution and characteristics of malignant tumours by lung lobe
BMC Pulm Med, 24 (1), 106
DOI 10.1186/s12890-024-02918-w, PubMed 38439038
Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Johannesen TB, Fosså SD (2024)
Adverse Health Outcomes 3 Years after Radical Prostatectomy Compared with Men in the General Population: A Study from the Cancer Registry of Norway
Clin Genitourin Cancer, 22 (6), 102219
DOI 10.1016/j.clgc.2024.102219, PubMed 39340952
Nome RV, Flatebø Ø, Bøe SL, Klaasen RA, Aamdal E, Normann M, Bolstad N, Warren DJ (2024)
A simple automated assay format for measuring multiple immune checkpoint inhibitors
J Pharm Biomed Anal, 255, 116657
DOI 10.1016/j.jpba.2024.116657, PubMed 39756153
Nymoen HM, Alver TN, Horndalsveen H, Eide HA, Bjaanæs MM, Brustugun OT, Grønberg BH, Haakensen VD, Helland Å (2024)
Thoracic radiation in combination with erlotinib-results from a phase 2 randomized trial
Front Oncol, 14, 1412716
DOI 10.3389/fonc.2024.1412716, PubMed 39148905
Ohnstad HO, Blix ES, Akslen LA, Gilje B, Raj SX, Skjerven H, Borgen E, Janssen EAM, Mortensen E, Brekke MB, Falk RS, Schlichting E, Boge B, Songe-Møller S, Olsson P, Heie A, Mannsåker B, Vestlid MA, Kursetgjerde T, Gravdehaug B, Suhrke P, Sanchez E, Bublevic J, Røe OD, Geitvik GA et al. (2024)
Impact of Prosigna test on adjuvant treatment decision in lymph node-negative early breast cancer-a prospective national multicentre study (EMIT-1)
ESMO Open, 9 (6), 103475
DOI 10.1016/j.esmoop.2024.103475, PubMed 38838499
Olsen SU, Tazmini K, Aas AM, Ranhoff AH, Pripp AH, Hesseberg K, Sunde S, Bye A (2024)
The incidence and mortality of refeeding syndrome in older hospitalized patients, based on three different diagnostic criteria: A longitudinal study
Clin Nutr ESPEN, 61, 101-107
DOI 10.1016/j.clnesp.2024.03.006, PubMed 38777421
Oort Q, Reijneveld JC, Sikkes SAM, Koekkoek JAF, Boele F, Young T, Brannan C, Chalk T, Talacchi A, Mazzotta A, Narita Y, Sato H, Miyakita Y, Shamieh O, Alrjoob W, Pace A, Petranovic D, Ploh M, Capela A, Silva J, Hjermstad MJ, Purkart TU, Seidel C, Talhi N, Pichler J et al. (2024)
Instrumental activities of daily living in neuro-oncology: International validation of the EORTC IADL-BN32 questionnaire
Eur J Cancer, 212, 114335
DOI 10.1016/j.ejca.2024.114335, PubMed 39332215
Os SS, Skipar K, Skovlund E, Hompland I, Hellebust TP, Guren MG, Lindemann K, Nakken ES (2024)
Survival prediction in patients with gynecological cancer irradiated for brain metastases
Acta Oncol, 63, 206-212
DOI 10.2340/1651-226X.2023.34899, PubMed 38647023
Papadakis V, Astigarraga I, van den Bos C, Donadieu J, Henter JI, Jacobs S, Lehrnbecher T, Munthe-Kaas MC, Naeije L, Nanduri V, Nguyen T, Nysom K, Pears J, Raciborska A, Sieni E, Svojgr K, Tzotzola V, Minkov M, European Consortium for Histiocytosis (ECHO) (2024)
The ECHO recommendations for dealing with vinblastine shortage affecting standard treatment of systemic Langerhans cell histiocytosis
Pediatr Blood Cancer, 71 (3), e30850
DOI 10.1002/pbc.30850, PubMed 38185727
Prysiazhniuk Y, Server A, Leske H, Bech-Aase Ø, Helseth E, Eijgelaar RS, Fuster-García E, Brandal P, Bjørnerud A, Otáhal J, Petr J, Nordhøy W (2024)
Diffuse glioma molecular profiling with arterial spin labeling and dynamic susceptibility contrast perfusion MRI: A comparative study
Neurooncol Adv, 6 (1), vdae113
DOI 10.1093/noajnl/vdae113, PubMed 39036439
Puco K, Fagereng GL, Brabrand S, Niehusmann P, Støre Blix E, Samdal Steinskog ES, Haug Å, Fredvik Torkildsen C, Oppedal IA, Meltzer S, Flobak Å, Johansson KAM, Bjørge L, Hjortland GO, Dalhaug A, Lund JÅ, Gilje B, Grønlie Cameron M, Hovland R, Falk RS, Smeland S, Giercksky Russnes HE, Taskén K, Helland Å, InPreD Consortium et al. (2024)
IMPRESS-Norway: improving public cancer care by implementing precision medicine in Norway; inclusion rates and preliminary results
Acta Oncol, 63, 379-384
DOI 10.2340/1651-226X.2024.28322, PubMed 38779911
Pulczynski EJ, Simonsen MR, Kuittinen O, Fagerli UM, Erlanson M, Fluge Ø, Leppä S, Østenstad B, Fosså A, Eriksson M, El-Galaly T, Kuitunen H, Papworth K, Ljungqvist M, Pedersen MB, Pollari M (2024)
Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up
Haematologica, 109 (7), 2359-2363
DOI 10.3324/haematol.2024.285207, PubMed 38546689
Qvigstad LF, Eri LM, Lien MD, Fosså SD, Aas K, Berge V (2024)
Reduction of lower urinary tract symptoms in prostate cancer patients treated with robot assisted laparoscopic prostatectomy
Scand J Urol, 59, 121-125
DOI 10.2340/sju.v59.40070, PubMed 38888041
Rask Kragh Jørgensen R, Bergström F, Eloranta S, Tang Severinsen M, Bjøro Smeland K, Fosså A, Haaber Christensen J, Hutchings M, Bo Dahl-Sørensen R, Kamper P, Glimelius I, E Smedby K, K Parsons S, Mae Rodday A, J Maurer M, M Evens A, C El-Galaly T, Hjort Jakobsen L (2024)
Machine Learning-Based Survival Prediction Models for Progression-Free and Overall Survival in Advanced-Stage Hodgkin Lymphoma
JCO Clin Cancer Inform, 8, e2300255
DOI 10.1200/CCI.23.00255, PubMed 38608215
Ree AH, Høye E, Esbensen Y, Beitnes AR, Negård A, Bernklev L, Tetlie LK, Fretland ÅA, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Nilsen HL, Flatmark K, Meltzer S (2024)
Complete response of metastatic microsatellite-stable BRAF V600E colorectal cancer to first-line oxaliplatin-based chemotherapy and immune checkpoint blockade
Oncoimmunology, 13 (1), 2372886
DOI 10.1080/2162402X.2024.2372886, PubMed 38952672
Ree AH, Šaltytė Benth J, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Johansen C, Negård A, Bjørnetrø T, Nilsen HL, Berg JP, Flatmark K, Meltzer S (2024)
First-line oxaliplatin-based chemotherapy and nivolumab for metastatic microsatellite-stable colorectal cancer-the randomised METIMMOX trial
Br J Cancer, 130 (12), 1921-1928
DOI 10.1038/s41416-024-02696-6, PubMed 38664577
Reis Costa D, Winge-Main AK, Skog A, Tsuruda KM, Robsahm TE, Kulle Andreassen B (2024)
From trials to practice: Immune checkpoint inhibitor therapy for melanoma patients in Norway
Acta Oncol, 63, 965-973
DOI 10.2340/1651-226X.2024.41266, PubMed 39690735
Rekeland IG, Sørland K, Neteland LL, Fosså A, Alme K, Risa K, Dahl O, Tronstad KJ, Mella O, Fluge Ø (2024)
Six-year follow-up of participants in two clinical trials of rituximab or cyclophosphamide in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome
PLoS One, 19 (7), e0307484
DOI 10.1371/journal.pone.0307484, PubMed 39042627
Riba M, Sala C, Culhane AC, Flobak Å, Patocs A, Boye K, Plevova K, Pospíšilová Š, Gandolfi G, Morelli MJ, Bucci G, Edsjö A, Lassen U, Al-Shahrour F, Lopez-Bigas N, Hovland R, Cuppen E, Valencia A, Poirel HA, Rosenquist R, Scollen S, Arenas Marquez J, Belien J, De Nicolo A, De Maria R et al. (2024)
The 1+Million Genomes Minimal Dataset for Cancer
Nat Genet, 56 (5), 733-736
DOI 10.1038/s41588-024-01721-x, PubMed 38702538
Riis MLH (2024)
The Challenges of Lobular Carcinomas from a Surgeon's Point of View
Clin Breast Cancer, 24 (8), e645-e654
DOI 10.1016/j.clbc.2024.06.007, PubMed 39033066
Ringborg U, von Braun J, Celis J, Baumann M, Berns A, Eggermont A, Heard E, Heitor M, Chandy M, Chen CJ, Costa A, De Lorenzo F, De Robertis EM, Dubee FC, Ernberg I, Gabriel M, Helland Å, Henrique R, Jönsson B, Kallioniemi O, Korbel J, Krause M, Lowy DR, Michielin O, Nagy P et al. (2024)
Strategies to decrease inequalities in cancer therapeutics, care and prevention: Proceedings on a conference organized by the Pontifical Academy of Sciences and the European Academy of Cancer Sciences, Vatican City, February 23-24, 2023
Mol Oncol, 18 (2), 245-279
DOI 10.1002/1878-0261.13575, PubMed 38135904
Rosselle L, Leray T, Joaquina S, Caulier B, McCormack E, Gelebart P, Wälchli S, Inderberg EM (2024)
Protocol for production of tonic CAR T cells with dasatinib
STAR Protoc, 6 (1), 103529
DOI 10.1016/j.xpro.2024.103529, PubMed 39739533
Rossi R, Medici F, Habberstad R, Klepstad P, Cilla S, Dall'Agata M, Kaasa S, Caraceni AT, Morganti AG, Maltoni M (2024)
Development of a predictive model for patients with bone metastases referred to palliative radiotherapy: Secondary analysis of a multicenter study (the PRAIS trial)
Cancer Med, 13 (19), e70050
DOI 10.1002/cam4.70050, PubMed 39390750
Safont MM, Leitch C, Popa M, Gjerstad ME, Caulier B, Inderberg EM, Wälchli S, Gelebart P, McCormack E (2024)
Protocol for the development of a bioluminescent AML-PDX mouse model for the evaluation of CAR T cell therapy
STAR Protoc, 5 (4), 103522
DOI 10.1016/j.xpro.2024.103522, PubMed 39673705
Samuel R, Knight SR, Adams R, Das P, Dorth J, Finch D, Guren MG, Hawkins MA, Moug S, Rajdev L, Sebag-Montefiore D, Renehan AG, Fish R, plus the CORMAC-2 collaborators (2024)
International consensus to define outcomes for trials of chemoradiotherapy for anal cancer (CORMAC-2): defining the outcomes from the CORMAC core outcome set
EClinicalMedicine, 78, 102939
DOI 10.1016/j.eclinm.2024.102939, PubMed 39720423
Scherrens AL, Jacobs A, Beernaert K, Pardon K, Raemdonck E, Fallon M, Cresswell K, Faric N, Williams R, Lundeby T, Hjermstad MJ, Deliens L, Kaasa S (2024)
Integrating patient-centred and tumour-centred cancer care: the EU-MyPath implementation project offers an innovative digital solution with care pathways
Palliat Care Soc Pract, 18, 26323524241296143
DOI 10.1177/26323524241296143, PubMed 39568798
Schlichting E (2024)
[Men can have breast cancer too]
Tidsskr Nor Laegeforen, 144 (5)
DOI 10.4045/tidsskr.24.0144, PubMed 38651719
Schou-Bredal I, Moberg IO, Schou SM, Sætnan EV, Fuglesteg IK, Tønseth KA, Schlichting E (2024)
Preoperative Expectations of Women Undergoing Breast Reconstruction Surgery
Plast Reconstr Surg Glob Open, 12 (6), e5928
DOI 10.1097/GOX.0000000000005928, PubMed 38903141
Sharma A, Debik J, Naume B, Ohnstad HO, Oslo Breast Cancer Consortium (OSBREAC), Bathen TF, Giskeødegård GF (2024)
Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes
Oncogenesis, 13 (1), 22
DOI 10.1038/s41389-024-00521-6, PubMed 38871719
Shelton V, Detroja R, Liu T, Isaev K, Silva A, Passerini V, Bakhtiari M, Calvente L, Hong M, He MY, Modi S, Hershenfeld SA, Ludvigsen M, Madsen C, Hamilton-Dutoit S, d'Amore FA, Brodtkorb M, Johnson NA, Baetz T, LeBrun D, Tobin JWD, Gandhi MK, Mungall AJ, Xu W, Ben-Neriah S et al. (2024)
Identification of genetic subtypes in follicular lymphoma
Blood Cancer J, 14 (1), 128
DOI 10.1038/s41408-024-01111-w, PubMed 39112453
Shkodra M, Mulvey M, Fallon M, Brunelli C, Zecca E, Bracchi P, Caputo M, Massa G, Lo Dico S, Rolke R, Kaasa S, Caraceni A (2024)
Application and accuracy of the EAPC/IASP diagnostic algorithm for neuropathic cancer pain and quantitative sensory testing profile in patients with pain due to cancer
Pain Rep, 9 (2), e1140
DOI 10.1097/PR9.0000000000001140, PubMed 38375093
Singer S, Hammerlid E, Tomaszewska IM, Amdal CD, Herlofson BB, Santos M, Castro Silva J, Mehanna H, Fullerton A, Young T, Fernandez Gonzalez L, Inhestern J, Pinto M, Arraras JI, Yarom N, Bonomo P, Baumann I, Galalae R, Nicolatou-Galitis O, Kiyota N, Raber-Durlacher J, Salem D, Fabian A, Boehm A, Krejovic-Trivic S et al. (2024)
The european organisation for research and treatment of cancer head and neck cancer module (EORTC QLQ-HN43): Estimates for minimal important difference and minimal important change
Eur J Cancer, 212, 115062
DOI 10.1016/j.ejca.2024.115062, PubMed 39405647
Sioud M, Juzeniene A, Sæbøe-Larssen S (2024)
Exploring the Impact of mRNA Modifications on Translation Efficiency and Immune Tolerance to Self-Antigens
Vaccines (Basel), 12 (6)
DOI 10.3390/vaccines12060624, PubMed 38932353
Skaga E, Trewin-Nybråten CB, Niehusmann P, Johannesen TB, Marienhagen K, Oltedal L, Schipman S, Skjulsvik AJ, Solheim O, Solheim TS, Sundstrøm T, Vik-Mo EO, Petter Brandal, Ingebrigtsen T (2024)
Stable glioma incidence and increased patient survival over the past two decades in Norway: a nationwide registry-based cohort study
Acta Oncol, 63, 83-94
DOI 10.2340/1651-226X.2024.24970, PubMed 38501768
Skipar K, Hompland T, Lund KV, Lindemann K, Hellebust TP, Bruheim K, Lyng H (2024)
MRI-guided dynamic risk assessment in cervical cancer based on tumor hypoxia at diagnosis and volume response at brachytherapy
Radiother Oncol, 195, 110263
DOI 10.1016/j.radonc.2024.110263, PubMed 38556173
Slørdahl KS, Balto A, Guren MG, Wibe A, Kørner H, Norderval S, Gjelsvik YM, Myklebust TÅ, Larsen IK (2024)
Patient-reported outcomes after treatment for rectal cancer-A prospective nationwide study
Colorectal Dis, 27 (1) (in press)
DOI 10.1111/codi.17231, PubMed 39515999
Slaaen M, Røyset IM, Saltvedt I, Grønberg BH, Halsteinli V, Døhl Ø, Vossius C, Kirkevold Ø, Bergh S, Rostoft S, Oldervoll L, Bye A, Melby L, Røsstad T, Eriksen GF, Sollid MIV, Rolfson D, Šaltytė Benth J (2024)
Geriatric assessment with management for older patients with cancer receiving radiotherapy: a cluster-randomised controlled pilot study
BMC Med, 22 (1), 232
DOI 10.1186/s12916-024-03446-4, PubMed 38853251
Sodergren SC, Hurley-Wallace A, Vassiliou V, Alkhaffaf B, Batsaikhan B, Darlington AS, Fleitas-Kanonnikof T, Guren MG, Honda M, Kim YW, Kim S, Krishnamurthy MN, Loh SY, Turhal NS, Zhou J, Dennis K, Krishnatry R, Terashima M, Tsironis G, Yoshikawa T, Terada M, EORTC Quality of Life Group (2024)
Revisiting the use of the EORTC QLQ-STO22 to assess health-related quality of life of patients with gastric cancer: incorporating updated treatment options and cross-cultural perspectives
Gastric Cancer, 27 (4), 722-734
DOI 10.1007/s10120-024-01492-8, PubMed 38668819
Sorbye H, Hjortland GO, Vestermark LW, Sundlov A, Assmus J, Couvelard A, Perren A, Langer SW (2024)
NETest in advanced high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 36 (11), e13428
DOI 10.1111/jne.13428, PubMed 38937137
Stoevesandt D, Ludwig C, Mauz-Körholz C, Körholz D, Hasenclever D, McCarten K, Flerlage JE, Kurch L, Wohlgemuth WA, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlén J, Cepelová M, Klekawka T, Attarbaschi A, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T, Daw S, Steglich J (2024)
Pulmonary lesions in early response assessment in pediatric Hodgkin lymphoma: prevalence and possible implications for initial staging
Pediatr Radiol, 54 (5), 725-736
DOI 10.1007/s00247-024-05859-y, PubMed 38296856
Stray K, Wibe T, Debesay J, Bye A (2024)
Older adults' perceptions and experiences of interprofessional communication as part of the delivery of integrated care in the primary healthcare sector: a meta-ethnography of qualitative studies
BMC Geriatr, 24 (1), 146
DOI 10.1186/s12877-024-04745-4, PubMed 38347442
Stub T, Mathisen M, Thorsen L, Kiserud CE, Lie HC (2024)
Experiences Using Nonpharmacological Interventions for Chronic Fatigue: A Focus Group Study of Long-Term Survivors of Young Adult Cancers With Fatigue
Cancer Rep (Hoboken), 7 (9), e2139
DOI 10.1002/cnr2.2139, PubMed 39233646
Støyten M, Knutsen T, Stikbakke E, Agledahl I, Wilsgaard T, Eggen AE, Richardsen E, Giovannucci E, Thune I, Haugnes HS (2024)
Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
Acta Oncol, 63, 154-163
DOI 10.2340/1651-226X.2024.32953, PubMed 38591351
Svendsen K, Leithe S, Trewin-Nybråten CB, Balto A, Nes LS, Meland A, Børøsund E, Kiserud CE, Reinertsen KV, Eriksen HR, Gjelsvik YM, Ursin G (2024)
How Did Breast Cancer Patients Fare during Different Phases of the COVID-19 Pandemic in Norway Compared to Age-Matched Controls?
Cancers (Basel), 16 (3)
DOI 10.3390/cancers16030602, PubMed 38339359
Tabouret E, Furtner J, Graillon T, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepúlveda-Sánchez JM, Brandal P, Bendszus M, Golfinopoulos V, Gorlia T, Weller M, Sahm F, Wick W, Preusser M (2024)
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas
Neuro Oncol, 26 (7), 1302-1309
DOI 10.1093/neuonc/noae037, PubMed 38452246
Taskén K, Haj Mohammad SF, Fagereng GL, Sørum Falk R, Helland Å, Barjesteh van Waalwijk van Doorn-Khosrovani S, Steen Carlsson K, Ryll B, Jalkanen K, Edsjö A, Russnes HG, Lassen U, Hallersjö Hult E, Lugowska I, Blay JY, Verlingue L, Abel E, Lowery MA, Krebs MG, Staal Rohrberg K, Ojamaa K, Oliveira J, Verheul HMW, Voest EE, Gelderblom H et al. (2024)
PCM4EU and PRIME-ROSE: Collaboration for implementation of precision cancer medicine in Europe
Acta Oncol, 63, 385-391
DOI 10.2340/1651-226X.2024.34791, PubMed 38779910
Tauziède-Espariat A, Nicaise Y, Sievers P, Sahm F, von Deimling A, Guillemot D, Pierron G, Duchesne M, Edjlali M, Dangouloff-Ros V, Boddaert N, Roux A, Dezamis E, Hasty L, Lhermitte B, Hirsch E, Hirsch MPV, Ardellier FD, Karnoub MA, Csanyi M, Maurage CA, Mokhtari K, Bielle F, Rigau V, Roujeau T et al. (2024)
CNS tumors with PLAGL1-fusion: beyond ZFTA and YAP1 in the genetic spectrum of supratentorial ependymomas
Acta Neuropathol Commun, 12 (1), 55
DOI 10.1186/s40478-023-01695-7, PubMed 38581034
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2024)
Long-term health-related quality of life in head and neck cancer survivors: A large multinational study
Int J Cancer, 154 (10), 1772-1785
DOI 10.1002/ijc.34861, PubMed 38312044
Thomassen D, Roychoudhury S, Amdal CD, Reynders D, Musoro JZ, Sauerbrei W, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2024)
The role of the estimand framework in the analysis of patient-reported outcomes in single-arm trials: a case study in oncology
BMC Med Res Methodol, 24 (1), 290
DOI 10.1186/s12874-024-02408-x, PubMed 39580440
Thor A, Negaard HFS, Grenabo Bergdahl A, Almås B, Melsen Larsen S, Lundgren PO, Gerdtsson A, Halvorsen D, Johannsdottir B, Jansson AK, Hellström M, Wahlqvist R, Langberg CW, Hedlund A, Akre O, Glimelius I, Ståhl O, Haugnes HS, Cohn-Cedermark G, Kjellman A, Tandstad T (2024)
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
Eur Urol Open Sci, 65, 13-19
DOI 10.1016/j.euros.2024.05.006, PubMed 38966804
Thunold S, Hernes E, Farooqi S, Öjlert ÅK, Francis RJ, Nowak AK, Szejniuk WM, Nielsen SS, Cedres S, Perdigo MS, Sørensen JB, Meltzer C, Mikalsen LTG, Helland Å, Malinen E, Haakensen VD (2024)
Outcome prediction based on [18F]FDG PET/CT in patients with pleural mesothelioma treated with ipilimumab and nivolumab +/- UV1 telomerase vaccine
Eur J Nucl Med Mol Imaging, 52 (2), 693-707
DOI 10.1007/s00259-024-06853-0, PubMed 39133306
Torland LA, Lai X, Kumar S, Riis MH, Geisler J, Lüders T, Tekpli X, Kristensen V, Sahlberg K, Tahiri A (2024)
Benign breast tumors may arise on different immunological backgrounds
Mol Oncol, 18 (10), 2495-2509
DOI 10.1002/1878-0261.13655, PubMed 38757377
Tulipan A, Kratochwil C, Lilleby J, Lilleby W (2024)
A case of severe side effects to androgen receptor inhibitor and consequently switch to radioligand therapy in early castration resistant prostate cancer
Urol Case Rep, 54, 102752
DOI 10.1016/j.eucr.2024.102752, PubMed 38779691
Ullern A, Holm K, Røssevold AH, Andresen NK, Bang C, Lingjærde OC, Naume B, Hov JR, Kyte JA (2024)
Gut microbiota diversity is prognostic and associated with benefit from chemo-immunotherapy in metastatic triple-negative breast cancer
Mol Oncol, 19 (4), 1229-1243
DOI 10.1002/1878-0261.13760, PubMed 39545921
Vagnildhaug OM, Balstad TR, Ottestad I, Bye A, Greil C, Arends J, Baracos V, Brown LR, Dajani OF, Dolan RD, Fallon M, Fraser E, Grzyb A, Hjermstad MJ, Jakobsen G, Kaasa S, McDonald J, Philips I, Sayers J, Simpson MR, Sousa MS, Skipworth RJE, Laird BJA, Solheim TS, Cancer Cachexia Endpoints Working Group (2024)
Appetite and dietary intake endpoints in cancer cachexia clinical trials: Systematic Review 2 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 15 (2), 513-535
DOI 10.1002/jcsm.13434, PubMed 38343065
van der Perk MEM, Broer L, Yasui Y, Laven JSE, Robison LL, Tissing WJE, Versluys B, Bresters D, Kaspers GJL, Lambalk CB, Overbeek A, Loonen JJ, Beerendonk CCM, Byrne J, Berger C, Clemens E, van Dulmen-den Broeder E, Dirksen U, van der Pal HJ, de Vries ACH, Winther JF, Ranft A, Fosså SD, Grabow D, Muraca M et al. (2024)
Interindividual variation in ovarian reserve after gonadotoxic treatment in female childhood cancer survivors - a genome-wide association study: results from PanCareLIFE
Fertil Steril, 122 (3), 514-524
DOI 10.1016/j.fertnstert.2024.05.002, PubMed 38729340
Vandraas K, Reinertsen KV, Gudim HB, Bowen CA, Gjerdalen G, Schlichting E, Naume B, Sætersdal A (2024)
[Breast cancer during pregnancy]
Tidsskr Nor Laegeforen, 144 (12)
DOI 10.4045/tidsskr.24.0182, PubMed 39404245
Voskanyan V, Marzorati C, Sala D, Grasso R, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, Pravettoni G (2024)
Psychosocial factors associated with quality of life in cancer survivors: umbrella review
J Cancer Res Clin Oncol, 150 (5), 249
DOI 10.1007/s00432-024-05749-8, PubMed 38727730
Voskanyan V, Marzorati C, Sala D, Grasso R, Pietrobon R, van der Heide I, Engelaar M, Bos N, Caraceni A, Couspel N, Ferrer M, Groenvold M, Kaasa S, Lombardo C, Sirven A, Vachon H, Velikova G, Brunelli C, Apolone G, Pravettoni G (2024)
Correction to: Psychosocial factors associated with quality of life in cancer survivors: umbrella review
J Cancer Res Clin Oncol, 150 (9), 408
DOI 10.1007/s00432-024-05929-6, PubMed 39222144
Western B, Ivarsson A, Vistad I, Demmelmaier I, Aaronson NK, Radcliffe G, van Beurden M, Bohus M, Courneya KS, Daley AJ, Galvão DA, Garrod R, Goedendorp MM, Griffith KA, van Harten WH, Hayes SC, Herrero-Roman F, Hiensch AE, Irwin ML, James E, Kenkhuis MF, Kersten MJ, Knoop H, Lucia A, May AM et al. (2024)
Dropout from exercise trials among cancer survivors-An individual patient data meta-analysis from the POLARIS study
Scand J Med Sci Sports, 34 (2), e14575
DOI 10.1111/sms.14575, PubMed 38339809
Westgaard A, Pirnat A, Hjermstad MJ, Aass N, Kaasa S, Dajani OF (2024)
Prognostic Value of Performance Status, Albumin, and CRP in Last-Line Chemotherapy for Pancreatic vs. Other Gastrointestinal Cancers-Simple Tools Matter
Curr Oncol, 31 (9), 5462-5471
DOI 10.3390/curroncol31090404, PubMed 39330032
Willemsen M, Bulgarelli J, Chauhan SK, Lereim RR, Angeli D, Grisendi G, Krebbers G, Davidson I, Kyte JA, Guidoboni M, Luiten RM, Bakker WJ (2024)
Changes in AXL and/or MITF melanoma subpopulations in patients receiving immunotherapy
Immunooncol Technol, 24, 101009
DOI 10.1016/j.iotech.2024.101009, PubMed 39697983
Willmann J, Balermpas P, Rimner A, Appelt AL, Vasquez Osorio EM, Rønde HS, Day M, Embring A, Gabryś D, Guren MG, Hoskin P, Massaccesi M, Mayo C, Murray L, Nieder C, Guckenberger M, Andratschke N (2024)
Ongoing prospective studies on reirradiation: A systematic review of a clinical trials database
Radiother Oncol, 202, 110624
DOI 10.1016/j.radonc.2024.110624, PubMed 39532233
Waage A, Khan A, Labori KJ, Birkeland KI, Scholz H, Jensen TG, Tholfsen T, Line PD, Hagness M (2024)
Implementation of a nationwide program for total pancreatectomy and islet autotransplantation in chronic pancreatitis: A Scandinavian single-center observational study
Scand J Surg, 114 (2), 174-182
DOI 10.1177/14574969241298985, PubMed 39558154
Yri OE, Astrup GL, Karlsson AT, van Helvoirt R, Hjermstad MJ, Husby KM, Loge JH, Lund JÅ, Lundeby T, Paulsen Ø, Skovlund E, Taran MI, Winther RR, Aass N, Kaasa S (2024)
Survival and quality of life after first-time diagnosis of brain metastases: a multicenter, prospective, observational study
Lancet Reg Health Eur, 49, 101181
DOI 10.1016/j.lanepe.2024.101181, PubMed 39807153
Ystgaard MF, Myklebust TÅ, Smeby J, Larsen IK, Guren TK, Kure EH, Tveit KM, Glimelius B, Guren MG, Hamfjord J (2024)
Early-onset colorectal cancer incidence in Norway: a national registry-based study (1993-2022) analyzing subsite and morphology trends
ESMO Gastrointest Oncol, 7, 100065
DOI 10.1016/j.esmogo.2024.100065, PubMed 41646485
Yule MS, Thompson J, Leesahatsawat K, Sousa MS, Anker SD, Arends J, Balstad TR, Brown LR, Bye A, Dajani O, Fallon M, Hjermstad MJ, Jakobsen G, McDonald J, McGovern J, Roeland EJ, Sayers J, Skipworth RJE, Ottestad IO, Philips I, Simpson MR, Solheim TS, Vagnildhaug OM, McMillan D, Laird BJA et al. (2024)
Biomarker endpoints in cancer cachexia clinical trials: Systematic Review 5 of the cachexia endpoint series
J Cachexia Sarcopenia Muscle, 15 (3), 853-867
DOI 10.1002/jcsm.13491, PubMed 38783477
Zhou Y, Ray PS, Zhu J, Stein F, Rettel M, Sekaran T, Sahadevan S, Perez-Perri JI, Roth EK, Myklebost O, Meza-Zepeda LA, von Deimling A, Fu C, Brosig AN, Boye K, Nathrath M, Blattmann C, Lehner B, Hentze MW, Kulozik AE (2024)
Systematic analysis of RNA-binding proteins identifies targetable therapeutic vulnerabilities in osteosarcoma
Nat Commun, 15 (1), 2810
DOI 10.1038/s41467-024-47031-y, PubMed 38561347
Østergaard DE, Embring A, Sehested A, Magelssen H, Vogelius IR, Kjærsgaard M, Nysom K, Mathiasen R, Lukacova S, Maraldo MV (2024)
REMIT: Reirradiation of Diffuse Midline Glioma Patients -A Nordic Society of Paediatric Haematology and Oncology Feasibility Study
Clin Oncol (R Coll Radiol), 37, 103682
DOI 10.1016/j.clon.2024.103682, PubMed 39626445

Publications 2023

Abadpour S, Niemi EM, Orrhult LS, Hermanns C, de Vries R, Nogueira LP, Haugen HJ, Josefsen D, Krauss S, Gatenholm P, van Apeldoorn A, Scholz H (2023)
Adipose-Derived Stromal Cells Preserve Pancreatic Islet Function in a Transplantable 3D Bioprinted Scaffold
Adv Healthc Mater, 12 (32), e2300640
DOI 10.1002/adhm.202300640, PubMed 37781993
Acosta Roa AM, Skingen VE, Rekstad BL, Undseth C, Rusten E, Hernes E, Guren MG, Malinen E (2023)
Stability of metabolic tumor volume may enable radiotherapy dose painting in anal cancer
Phys Med, 114, 103151
DOI 10.1016/j.ejmp.2023.103151, PubMed 37813051
Albertsen PC, Bjerner LJ, Pasovic L, Müller S, Fosså S, Carlsson SV, Oldenburg J (2023)
Opportunistic prostate-specific antigen testing in Norwegian men: a public health challenge
BJU Int, 133 (1), 104-111
DOI 10.1111/bju.16211, PubMed 37869764
Alnes SR, Lærum-Onsager E, Bye A, Vistven A, Franzén E, Holst M, Brovold T (2023)
Mobile health technology, exercise adherence and optimal nutrition post rehabilitation among people with Parkinson's Disease (mHEXANUT) - a randomized controlled trial protocol
BMC Neurol, 23 (1), 93
DOI 10.1186/s12883-023-03134-5, PubMed 36864377
Amdal CD, Moan JM, Dale E, Falk RS, Johansen S, Bjordal K (2023)
Impact of hyperfractionated re-irradiation on quality of life in patients with recurrent or second primary head and neck cancer, a prospective single institutional study
Clin Transl Radiat Oncol, 42, 100654
DOI 10.1016/j.ctro.2023.100654, PubMed 37415638
Ascierto PA, Lipson EJ, Dummer R, Larkin J, Long GV, Sanborn RE, Chiarion-Sileni V, Dréno B, Dalle S, Schadendorf D, Callahan MK, Nyakas M, Atkinson V, Gomez-Roca CA, Yamazaki N, Tawbi HA, Sarkis N, Warad D, Dolfi S, Mitra P, Suryawanshi S, Grob JJ (2023)
Nivolumab and Relatlimab in Patients With Advanced Melanoma That Had Progressed on Anti-Programmed Death-1/Programmed Death Ligand 1 Therapy: Results From the Phase I/IIa RELATIVITY-020 Trial
J Clin Oncol, 41 (15), 2724-2735
DOI 10.1200/JCO.22.02072, PubMed 36780608
Baech J, Husby S, Trab T, Kragholm K, Brown P, Gørløv JS, Jørgensen JM, Gudbrandsdottir S, Severinsen MT, Grønbaek K, Larsen TS, Wästerlid T, Eloranta S, Smeland KB, Jakobsen LH, El-Galaly TC (2023)
Cardiovascular diseases after high-dose chemotherapy and autologous stem cell transplant for lymphoma: A Danish population-based study
Br J Haematol, 204 (3), 967-975
DOI 10.1111/bjh.19272, PubMed 38155503
Bartula I, Tran AD, Nowak AK, Ahmed T, Morton RL, Burmeister BH, Dolven-Jacobsen K, Nobes J, Thompson JF, Fogarty GB, Lo SN, Hong AM (2023)
Longitudinal trajectory of quality of life for patients with melanoma brain metastases: A secondary analysis from a whole brain radiotherapy randomized clinical trial
Clin Transl Radiat Oncol, 41, 100597
DOI 10.1016/j.ctro.2023.100597, PubMed 37441544
Beck C, Casey NP, Persiconi I, Moharrami NN, Sike A, Jin Y, Kyte JA (2023)
Development of a TGFβ-IL-2/15 Switch Receptor for Use in Adoptive Cell Therapy
Biomedicines, 11 (2)
DOI 10.3390/biomedicines11020459, PubMed 36830995
Berndsen M, Renberg S, Hølmebakk T, Hancke E, Puls F, Karlsson F, Stoldt S, Bjerkehagen B, Haglund de Flon F, Muth A, Papakonstantinou A, Boye K, Lindskog S (2023)
Long-term outcome after surgical resection of non-high-risk gastrointestinal stromal tumours without adjuvant therapy
Br J Surg, 110 (12), 1857-1862
DOI 10.1093/bjs/znad309, PubMed 37758514
Bjerner J, Bratt O, Aas K, Albertsen PC, Fosså SD, Kvåle R, Lilja H, Müller C, Müller S, Stensvold A, Thomas O, Røe OD, Vickers A, Walz J, Carlsson SV, Oldenburg J (2023)
Baseline Serum Prostate-specific Antigen Value Predicts the Risk of Subsequent Prostate Cancer Death-Results from the Norwegian Prostate Cancer Consortium
Eur Urol, 86 (1), 20-26
DOI 10.1016/j.eururo.2023.04.028, PubMed 37169639
Bjerre Trent PK, Nordskar NJ, Wangen KR, Engeskaug MI, Opheim MLØ, Aune G, Staff AC, Thorsen L, Falk RS, Eriksson AGZ (2023)
Self-reported lower extremity lymphedema and quality of life after surgical staging of endometrial carcinoma: A population based cross-sectional study
Gynecol Oncol, 175, 72-80
DOI 10.1016/j.ygyno.2023.05.070, PubMed 37327542
Blakstad H, Brekke J, Rahman MA, Arnesen VS, Miletic H, Brandal P, Lie SA, Chekenya M, Goplen D (2023)
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
PLoS One, 18 (2), e0281166
DOI 10.1371/journal.pone.0281166, PubMed 36730349
Blakstad H, Mendoza Mireles EE, Heggebø LC, Magelssen H, Sprauten M, Johannesen TB, Vik-Mo EO, Leske H, Niehusmann P, Skogen K, Helseth E, Emblem KE, Brandal P (2023)
Incidence and outcome of pseudoprogression after radiation therapy in glioblastoma patients: A cohort study
Neurooncol Pract, 11 (1), 36-45
DOI 10.1093/nop/npad063, PubMed 38222046
Boye K, Gorunova L, Gunawan B, Hompland I, Sander B, Panagopoulos I, Langer C, Golas M, Heim S, Füzesi L, Hølmebakk T, Micci F (2023)
Genomic Complexity as a Biomarker to De-Escalate Adjuvant Imatinib Treatment in High-Risk Gastrointestinal Stromal Tumor
JCO Precis Oncol, 7, e2200351
DOI 10.1200/PO.22.00351, PubMed 36724411
Bratland Å, Munoz-Couselo E, Mortier L, Roshdy O, González R, Schachter J, Arance AM, Grange F, Meyer N, Joshi AJ, Billan S, Hughes BGM, Grob JJ, Ramakrishnan K, Ge J, Gumuscu B, Swaby RF, Gutzmer R (2023)
Health-Related Quality of Life with Pembrolizumab in Patients with Locally Advanced or Recurrent or Metastatic Cutaneous Squamous Cell Carcinoma: KEYNOTE-629
Dermatol Ther (Heidelb), 13 (12), 3165-3180
DOI 10.1007/s13555-023-01059-y, PubMed 37943491
Bruland ØS, Larsen RH, Baum RP, Juzeniene A (2023)
Editorial: Targeted alpha particle therapy in oncology
Front Med (Lausanne), 10, 1165747
DOI 10.3389/fmed.2023.1165747, PubMed 36960341
Braadland PR, Bergquist A, Kummen M, Bossen L, Engesæter LK, Reims HM, Björk I, Grzyb K, Abildgaard A, Småstuen MC, Folseraas T, Trøseid M, Ulvik A, Ueland PM, Melum E, Line PD, Høivik ML, Grønbæk H, Karlsen TH, Vesterhus M, Hov JR (2023)
Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
J Hepatol, 79 (4), 955-966
DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
Bøhn S, Oldervoll LM, Reinertsen KV, Seland M, Fosså A, Kiserud C, Skaali T, Nilsen TS, Blomhoff R, Henriksen HB, Lie HC, Berge T, Fjerstad E, Wisløff T, Slott M, Zajmovic I, Thorsen L (2023)
The feasibility of a multidimensional intervention in lymphoma survivors with chronic fatigue
Support Care Cancer, 32 (1), 22
DOI 10.1007/s00520-023-08204-5, PubMed 38095797
Børø S, Thoresen S, Boge Brant S, Helland Å (2023)
Initial investigation of using Norwegian health data for the purpose of external comparator arms - an example for non-small cell lung cancer
Acta Oncol, 62 (12), 1642-1648
DOI 10.1080/0284186X.2023.2264484, PubMed 37801361
Casey NP, Klee CH, Fåne A, Caulier B, Graczyk-Jarzynka A, Krawczyk M, Fidyt K, Josefsson SE, Köksal H, Dillard P, Patkowska E, Firczuk M, Smeland EB, Winiarska M, Myklebust JH, Inderberg EM, Wälchli S (2023)
Efficient chimeric antigen receptor targeting of a central epitope of CD22
J Biol Chem, 299 (7), 104883
DOI 10.1016/j.jbc.2023.104883, PubMed 37269947
Dahl AA, Bentzen AG, Fosså SD, Hess SL, Kiserud CE (2023)
A study of modifiable factors associated with health-related quality of life in long-term cervical cancer survivors
Acta Obstet Gynecol Scand, 102 (2), 218-225
DOI 10.1111/aogs.14490, PubMed 36683549
Dahl AA, Smedsland SK, Vandraas KF, Bøhn SK, Falk RS, Kiserud CE, Reinertsen KV (2023)
High neuroticism is associated with common late adverse effects in a nationwide sample of long-term breast cancer survivors
Breast Cancer Res Treat, 202 (1), 97-104
DOI 10.1007/s10549-023-07055-2, PubMed 37528264
Dahl AA, Smeland KB, Eikeland S, Fagerli UM, Bersvendsen HS, Fosså A, Kiserud CE (2023)
Work ability and work status changes in long-term Hodgkin lymphoma survivors with focus on late adverse effects
J Cancer Surviv, 18 (6), 1921-1930
DOI 10.1007/s11764-023-01432-y, PubMed 37526861
de Muinck EJ, Trosvik P, Nguyen N, Fashing PJ, Stigum VM, Robinson N, Hermansen JU, Munthe-Kaas MC, Baumbusch LO (2023)
Reduced abundance of Faecalibacterium prausnitzii in the gut microbiota of children diagnosed with cancer, a pilot study
Front Microbiomes, 2, 1151889
DOI 10.3389/frmbi.2023.1151889, PubMed 41853354
Dingemans AM, van Walree N, Schramel F, Soud MY, Baltruškevičienė E, Lybaert W, Veldhorst M, van den Berg CA, Kaasa S (2023)
High Protein Oral Nutritional Supplements Enable the Majority of Cancer Patients to Meet Protein Intake Recommendations during Systemic Anti-Cancer Treatment: A Randomised Controlled Parallel-Group Study
Nutrients, 15 (24)
DOI 10.3390/nu15245030, PubMed 38140289
Dueland S, Smedman TM, Syversveen T, Grut H, Hagness M, Line PD (2023)
Long-Term Survival, Prognostic Factors, and Selection of Patients With Colorectal Cancer for Liver Transplant: A Nonrandomized Controlled Trial
JAMA Surg, 158 (9), e232932
DOI 10.1001/jamasurg.2023.2932, PubMed 37494056
Eikeland SA, Smeland KB, Simensen VC, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2023)
Chronic fatigue in long-term survivors of Hodgkin's lymphoma after contemporary risk-adapted treatment
Acta Oncol, 62 (1), 80-88
DOI 10.1080/0284186X.2023.2168215, PubMed 36715320
Elvebakken H, Hjortland GO, Garresori H, Andresen PA, Janssen EAM, Vintermyr OK, Lothe IMB, Sorbye H (2023)
Impact of KRAS and BRAF mutations on treatment efficacy and survival in high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 35 (4), e13256
DOI 10.1111/jne.13256, PubMed 37017614
Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Glimelius I, Marklund A, Larsen TS, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S (2023)
Reproduction patterns among non-Hodgkin lymphoma survivors by subtype in Sweden, Denmark and Norway: A population-based matched cohort study
Br J Haematol, 202 (4), 785-795
DOI 10.1111/bjh.18938, PubMed 37325886
Entrop JP, Weibull CE, Smedby KE, Jakobsen LH, Øvlisen AK, Molin D, Glimelius I, Marklund A, Holte H, Fosså A, Smeland KB, El-Galaly TC, Eloranta S (2023)
Reproduction patterns among classical Hodgkin lymphoma survivors treated with BEACOPP and ABVD in Sweden, Denmark and Norway-A population-based matched cohort study
Int J Cancer, 153 (4), 723-731
DOI 10.1002/ijc.34552, PubMed 37119033
Fallon MT, Caraceni A, Laird BJA, Kaasa S (2023)
Reply to the Letter to the Editor "A simple way of doing the complex but utmost important things: cancer pain management" by S. Singhal, M. Verma and D. Kukreja
Ann Oncol, 34 (5), 496-497
DOI 10.1016/j.annonc.2023.02.005, PubMed 37121609
Farnes I, Kleive D, Verbeke CS, Aabakken L, Issa-Epe A, Småstuen MC, Fosby BV, Dueland S, Line PD, Labori KJ (2023)
Resection rates and intention-to-treat outcomes in borderline and locally advanced pancreatic cancer: real-world data from a population-based, prospective cohort study (NORPACT-2)
BJS Open, 7 (6)
DOI 10.1093/bjsopen/zrad137, PubMed 38155512
Fauske L, Jebsen NL, Bondevik H, Bruland ØS (2023)
Exploring the Patient Perspective of Bone Sarcoma Survivors Who Have Undergone Particle Radiotherapy Abroad
Anticancer Res, 43 (5), 2031-2039
DOI 10.21873/anticanres.16364, PubMed 37097689
Figlioli G, Billaud A, Wang Q, Bolla MK, Dennis J, Lush M, Kvist A, Adank MA, Ahearn TU, Antonenkova NN, Auvinen P, Behrens S, Bermisheva M, Bogdanova NV, Bojesen SE, Bonanni B, Brüning T, Camp NJ, Campbell A, Castelao JE, Cessna MH, Nbcs Collaborators, Czene K, Devilee P, Dörk T et al. (2023)
Spectrum and Frequency of Germline FANCM Protein-Truncating Variants in 44,803 European Female Breast Cancer Cases
Cancers (Basel), 15 (13)
DOI 10.3390/cancers15133313, PubMed 37444426
Fløisand Y, Remberger M, Bigalke I, Josefsen D, Vålerhaugen H, Inderberg EM, Olaussen RW, Gjertsen BT, Goedkoop R, Geiger C, Prinz PU, Schnorfeil FM, Pinkernell K, Schendel DJ, Kvalheim G (2023)
WT1 and PRAME RNA-loaded dendritic cell vaccine as maintenance therapy in de novo AML after intensive induction chemotherapy
Leukemia, 37 (9), 1842-1849
DOI 10.1038/s41375-023-01980-3, PubMed 37507426
Flølo TN, Fosså A, Nedkvitne JIP, Waage JER, Rekdal M, Dankel SN, Fernø J, Mellgren G, Nedrebø BG (2023)
Long-term impact of gastropexy on use of acid-reducing medication, second operations for gastroesophageal reflux and subjective reflux symptoms after sleeve gastrectomy
Clin Obes, 13 (5), e12618
DOI 10.1111/cob.12618, PubMed 37583310
Foldvari Z, Knetter C, Yang W, Gjerdingen TJ, Bollineni RC, Tran TT, Lund-Johansen F, Kolstad A, Drousch K, Klopfleisch R, Leisegang M, Olweus J (2023)
A systematic safety pipeline for selection of T-cell receptors to enter clinical use
NPJ Vaccines, 8 (1), 126
DOI 10.1038/s41541-023-00713-y, PubMed 37607971
Fosså SD, Haugnes HS, Dahl AA, Kiserud CE, Fosså A, Skalleberg J, Myklebust TÅ (2023)
Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
Ann Oncol, 34 (12), 1165-1174
DOI 10.1016/j.annonc.2023.09.3101, PubMed 37739265
Franke FC, Damek A, Steglich J, Kurch L, Hasenclever D, Georgi TW, Wohlgemuth WA, Mauz-Körholz C, Körholz D, Kluge R, Landman-Parker J, Wallace WH, Fosså A, Vordermark D, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Attarbaschi A, Ceppi F, Hraskova A, Uyttebroeck A, Beishuizen A, Dieckmann K, Leblanc T et al. (2023)
Differentiation between rebound thymic hyperplasia and thymic relapse after chemotherapy in pediatric Hodgkin lymphoma
Pediatr Blood Cancer, 70 (8), e30421
DOI 10.1002/pbc.30421, PubMed 37243889
Garset-Zamani M, von Buchwald C, Karevold G, Agander TK, Mateu-Regué À, Eide HA, Tvedskov JF (2023)
An HPV-Vaccinated Patient With Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma
JAMA Otolaryngol Head Neck Surg, 149 (1), 92-94
DOI 10.1001/jamaoto.2022.3762, PubMed 36416857
Gelderblom H, Jones RL, Blay JY, George S, von Mehren M, Zalcberg JR, Kang YK, Razak AA, Trent J, Attia S, Le Cesne A, Siontis BL, Goldstein D, Boye K, Sanchez C, Steeghs N, Rutkowski P, Druta M, Serrano C, Somaiah N, Chi P, Harrow B, Becker C, Reichmann W, Sherman ML et al. (2023)
Patient-reported outcomes and tolerability in patients receiving ripretinib versus sunitinib after treatment with imatinib in INTRIGUE, a phase 3, open-label study
Eur J Cancer, 192, 113245
DOI 10.1016/j.ejca.2023.113245, PubMed 37598656
Gerdtsson A, Torisson G, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2023)
Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
BJU Int, 132 (3), 329-336
DOI 10.1111/bju.16040, PubMed 37129962
Gerdtsson AS, Matos Rodrigues J, Eskelund CW, Husby S, Grønbæk K, Räty R, Kolstad A, Geisler C, Porwit A, Jerkeman M, Ek S (2023)
Overexpression of the key metabolic protein CPT1A defines mantle cell lymphoma patients with poor response to standard high-dose chemotherapy independent of MIPI and complement established highrisk factors
Haematologica, 108 (4), 1092-1104
DOI 10.3324/haematol.2022.281420, PubMed 36519324
Gjerset GM, Kiserud CE, Wisløff T, McCarthy JB, Thorsen L (2023)
Perceived burden and need for support among caregivers of cancer patients
Acta Oncol, 62 (7), 794-802
DOI 10.1080/0284186X.2023.2240008, PubMed 37540581
Gombos A, Goncalves A, Curigliano G, Bartsch R, Kyte JA, Ignatiadis M, Awada A (2023)
How I treat endocrine-dependent metastatic breast cancer
ESMO Open, 8 (2), 100882
DOI 10.1016/j.esmoop.2023.100882, PubMed 36806375
Groendahl AR, Huynh BN, Tomic O, Søvik Å, Dale E, Malinen E, Skogmo HK, Futsaether CM (2023)
Automatic gross tumor segmentation of canine head and neck cancer using deep learning and cross-species transfer learning
Front Vet Sci, 10, 1143986
DOI 10.3389/fvets.2023.1143986, PubMed 37026102
Grønningsæter SR, Blakkisrud J, Selboe S, Revheim ME, Bruland ØS, Bønsdorff TB, Larsen SG, Stokke C (2023)
Radiation safety considerations for the use of radium-224-calciumcarbonate-microparticles in patients with peritoneal metastasis
Front Med (Lausanne), 10, 1058914
DOI 10.3389/fmed.2023.1058914, PubMed 36844217
Gudmundstuen AM, Efficace F, Tjønnfjord GE, Skaarud KJ, Cottone F, Hjermstad MJ, Iversen PO (2023)
The prognostic value of patient-reported outcomes in allogeneic hematopoietic stem cell transplantation: exploratory analysis of a randomized nutrition intervention trial
Ann Hematol, 102 (4), 927-935
DOI 10.1007/s00277-023-05149-x, PubMed 36864210
Gulbrandsen MS, Nøding AS, Smeland KB, Eikeland SA, Kiserud CE, Hjermstad MJ, Fosså A (2023)
Health-related quality of life, depressive symptoms, and chronic fatigue in long-term survivors of Hodgkin lymphoma
Leuk Lymphoma, 64 (6), 1139-1150
DOI 10.1080/10428194.2023.2198053, PubMed 37144290
Hanekamp BA, Viktil E, Slørdahl KS, Dormagen JB, Kløw NE, Malinen E, Brunborg C, Guren MG, Schulz A (2023)
Magnetic resonance imaging of anal cancer: tumor characteristics and early prediction of treatment outcome
Strahlenther Onkol, 200 (1), 19-27
DOI 10.1007/s00066-023-02114-5, PubMed 37429949
Harrington KJ, Ferris RL, Gillison M, Tahara M, Argiris A, Fayette J, Schenker M, Bratland Å, Walker JWT, Grell P, Even C, Chung CH, Redman R, Coutte A, Salas S, Grant C, de Azevedo S, Soulières D, Hansen AR, Wei L, Khan TA, Miller-Moslin K, Roberts M, Haddad R (2023)
Efficacy and Safety of Nivolumab Plus Ipilimumab vs Nivolumab Alone for Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: The Phase 2 CheckMate 714 Randomized Clinical Trial
JAMA Oncol, 9 (6), 779-789
DOI 10.1001/jamaoncol.2023.0147, PubMed 37022706
Haugen MH, von der Lippe Gythfeldt H, Egeland EV, Svartdal Normann L, Pandya AD, Vedin LL, Juell S, Tenstad E, Øy GF, Kristian A, Marangoni E, Sørlie T, Steffensen K, Maelandsmo GM, Engebraaten O (2023)
Liver X receptors induce antiproliferative effects in basal-like breast cancer
Mol Oncol, 17 (10), 2041-2055
DOI 10.1002/1878-0261.13476, PubMed 37341140
Heggebø LC, Borgen IMH, Rylander H, Kiserud C, Nordenmark TH, Hellebust TP, Evensen ME, Gustavsson M, Ramberg C, Sprauten M, Magelssen H, Blakstad H, Moorthy J, Andersson K, Raunert I, Henry T, Moe C, Granlund C, Goplen D, Brekke J, Johannessen TA, Solheim TS, Marienhagen K, Humberset Ø, Bergström P et al. (2023)
Investigating survival, quality of life and cognition in PROton versus photon therapy for IDH-mutated diffuse grade 2 and 3 GLIOmas (PRO-GLIO): a randomised controlled trial in Norway and Sweden
BMJ Open, 13 (3), e070071
DOI 10.1136/bmjopen-2022-070071, PubMed 36940951
Helland Å, Myklebust TÅ, Conte S, Frederiksen LE, Aarøe J, Enerly E (2023)
EGFR-mutation testing, treatment patterns and clinical outcomes in patients with stage IB-IIIA non-small cell lung cancer in Norway-a nationwide cohort study
Cancer Treat Res Commun, 38, 100785
DOI 10.1016/j.ctarc.2023.100785, PubMed 38190787
Hiensch AE, Beckhaus J, Witlox L, Monninkhof EM, Schagen SB, van Vulpen JK, Sweegers MG, Newton RU, Aaronson NK, Galvão DA, Steindorf K, Stuiver MM, Mesters I, Knoop H, Goedendorp MM, Bohus M, Thorsen L, Schulz KH, Schmidt ME, Ulrich CM, Sonke GS, van Harten WH, Winters-Stone KM, Velthuis MJ, Taaffe DR et al. (2023)
Moderators of exercise effects on self-reported cognitive functioning in cancer survivors: an individual participant data meta-analysis
J Cancer Surviv, 18 (5), 1492-1503
DOI 10.1007/s11764-023-01392-3, PubMed 37160571
Hindi N, Razak A, Rosenbaum E, Jonczak E, Hamacher R, Rutkowski P, Bhadri VA, Skryd A, Brahmi M, Alshibany A, Jagodzinska-Mucha P, Bauer S, Connolly E, Gelderblom H, Boye K, Henon C, Bae S, Bogefors K, Vincenzi B, Martinez-Trufero J, Lopez-Martin JA, Redondo A, Valverde C, Blay JY, Moura DS et al. (2023)
Efficacy of immune checkpoint inhibitors in alveolar soft-part sarcoma: results from a retrospective worldwide registry
ESMO Open, 8 (6), 102045
DOI 10.1016/j.esmoop.2023.102045, PubMed 38016251
Hjelle LV, Sælen M, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Wilsgaard T, Fosså SD, Haugnes HS (2023)
The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
Eur Urol Open Sci, 53, 6-15
DOI 10.1016/j.euros.2023.04.005, PubMed 37441342
Hjermstad MJ, Aass N, Gravli TH, Smeland S, Kaasa S (2023)
[Patient-centred cancer care]
Tidsskr Nor Laegeforen, 143 (1)
DOI 10.4045/tidsskr.22.0668, PubMed 36655956
Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
A shared mucosal gut microbiota signature in primary sclerosing cholangitis before and after liver transplantation
Hepatology, 77 (3), 715-728
DOI 10.1002/hep.32773, PubMed 36056902
Hole MJ, Jørgensen KK, Holm K, Braadland PR, Meyer-Myklestad MH, Medhus AW, Reikvam DH, Götz A, Grzyb K, Boberg KM, Karlsen TH, Kummen M, Hov JR (2023)
Reply: The mucosal gut signature in primary sclerosing cholangitis before and after liver transplantation. Is the dysbiosis index really predictive for the recurrence of PSC?
Hepatology, 77 (6), E188-E189
DOI 10.1097/HEP.0000000000000340, PubMed 36815351
Holm MO, Bye A, Falkmer U, Tobberup R, Rasmussen HH, Lauridsen C, Yilmaz MK, Søndergaard J, Poulsen LØ (2023)
The effect of nutritional interventions in acute radiation-induced diarrhoea in patients with primary pelvic cancer: A systematic review
Crit Rev Oncol Hematol, 188, 104038
DOI 10.1016/j.critrevonc.2023.104038, PubMed 37236410
Holme IK, Hollund HA, Vandraas K, Kiserud CE, Reinertsen KV, Loge JH, Lie HC (2023)
Sexual Problems as Late Effects: Awareness and Information Needs Among 1870 Long-term Norwegian Childhood, Adolescent, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
J Adolesc Young Adult Oncol, 13 (1), 203-212
DOI 10.1089/jayao.2023.0031, PubMed 37579257
Huuhtanen J, Kasanen H, Peltola K, Lönnberg T, Glumoff V, Brück O, Dufva O, Peltonen K, Vikkula J, Jokinen E, Ilander M, Lee MH, Mäkelä S, Nyakas M, Li B, Hernberg M, Bono P, Lähdesmäki H, Kreutzman A, Mustjoki S (2023)
Single-cell characterization of anti-LAG-3 and anti-PD-1 combination treatment in patients with melanoma
J Clin Invest, 133 (6)
DOI 10.1172/JCI164809, PubMed 36719749
Huynh BN, Groendahl AR, Tomic O, Liland KH, Knudtsen IS, Hoebers F, van Elmpt W, Malinen E, Dale E, Futsaether CM (2023)
Head and neck cancer treatment outcome prediction: a comparison between machine learning with conventional radiomics features and deep learning radiomics
Front Med (Lausanne), 10, 1217037
DOI 10.3389/fmed.2023.1217037, PubMed 37711738
Huynh TM, Dale E, Falk RS, Hellebust TP, Astrup GL, Malinen E, Edin NFJ, Bjordal K, Herlofson BB, Kiserud CE, Helland Å, Amdal CD (2023)
Radiation-induced long-term dysphagia in survivors of head and neck cancer and association with dose-volume parameters
Radiother Oncol, 190, 110044
DOI 10.1016/j.radonc.2023.110044, PubMed 38061420
Høland M, Berg KCG, Eilertsen IA, Bjerkehagen B, Kolberg M, Boye K, Lingjærde OC, Guren TK, Mandahl N, van den Berg E, Palmerini E, Smeland S, Picci P, Mertens F, Sveen A, Lothe RA (2023)
Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets
EBioMedicine, 97, 104829
DOI 10.1016/j.ebiom.2023.104829, PubMed 37837931
Isaksen KT, Galleberg R, Mastroianni MA, Rinde M, Rusten LS, Barzenje D, Ramslien F, Fluge O, Slaaen M, Meyer P, Liestol K, Smeland EB, Lingjarde OC, Holte H, Brodtkorb M (2023)
The Geriatric Prognostic Index: a clinical prediction model for survival of older diffuse large B-cell lymphoma patients treated with standard immunochemotherapy
Haematologica, 108 (9), 2454-2466
DOI 10.3324/haematol.2022.282289, PubMed 36861406
Janik AM, Terlecka A, Spałek MJ, Boye K, Szostakowski B, Chmiel P, Szumera-Ciećkiewicz A, Bobak K, Świtaj T, Rutkowski P, Czarnecka AM (2023)
Diagnostics and Treatment of Extrameningeal Solitary Fibrous Tumors
Cancers (Basel), 15 (24)
DOI 10.3390/cancers15245854, PubMed 38136399
Jenul A, Stokmo HL, Schrunner S, Hjortland GO, Revheim ME, Tomic O (2023)
Novel ensemble feature selection techniques applied to high-grade gastroenteropancreatic neuroendocrine neoplasms for the prediction of survival
Comput Methods Programs Biomed, 244, 107934
DOI 10.1016/j.cmpb.2023.107934, PubMed 38016391
Jesse S, Kuhlmann L, Hildebrand LS, Magelssen H, Schmaus M, Timmermann B, Andres S, Fietkau R, Distel LV (2023)
Increased Radiation Sensitivity in Patients with Phelan-McDermid Syndrome
Cells, 12 (5)
DOI 10.3390/cells12050820, PubMed 36899955
Joaquina S, Forcados C, Caulier B, Inderberg EM, Wälchli S (2023)
Determination of CAR T cell metabolism in an optimized protocol
Front Bioeng Biotechnol, 11, 1207576
DOI 10.3389/fbioe.2023.1207576, PubMed 37409169
Joensuu H, Wardelmann E, Eriksson M, Reichardt A, Hall KS, Schütte J, Cameron S, Hohenberger P, Sihto H, Jost PJ, Lindner LH, Bauer S, Nilsson B, Kallio R, Pesonen T, Reichardt P (2023)
KIT and PDGFRA Mutations and Survival of Gastrointestinal Stromal Tumor Patients Treated with Adjuvant Imatinib in a Randomized Trial
Clin Cancer Res, 29 (17), 3313-3319
DOI 10.1158/1078-0432.CCR-22-3980, PubMed 37014660
Juzeniene A, Stenberg VY, Bruland ØS, Revheim ME, Larsen RH (2023)
Dual targeting with ²²⁴Ra/²¹²Pb-conjugates for targeted alpha therapy of disseminated cancers: A conceptual approach
Front Med (Lausanne), 9, 1051825
DOI 10.3389/fmed.2022.1051825, PubMed 36733936
Kalmbach S, Grau M, Zapukhlyak M, Leich E, Jurinovic V, Hoster E, Staiger AM, Kurz KS, Weigert O, Gaitzsch E, Passerini V, Engelhard M, Herfarth K, Beiske K, Micci F, Möller P, Bernd HW, Feller AC, Klapper W, Stein H, Hansmann ML, Hartmann S, Dreyling M, Holte H, Lenz G et al. (2023)
Novel insights into the pathogenesis of follicular lymphoma by molecular profiling of localized and systemic disease forms
Leukemia, 37 (10), 2058-2065
DOI 10.1038/s41375-023-01995-w, PubMed 37563306
Klee CH, Villatoro A, Casey NP, Inderberg EM, Wälchli S (2023)
In vitro re-challenge of CAR T cells
Methods Cell Biol, 183, 335-353
DOI 10.1016/bs.mcb.2023.06.003, PubMed 38548418
Knappskog S, Grob T, Venizelos A, Amstutz U, Hjortland GO, Lothe IM, Kersten C, Hofsli E, Sundlöv A, Elvebakken H, Garresori H, Couvelard A, Svensson J, Sorbye H, Perren A (2023)
Mutation Spectrum in Liquid Versus Solid Biopsies From Patients With Advanced Gastroenteropancreatic Neuroendocrine Carcinoma
JCO Precis Oncol, 7, e2200336
DOI 10.1200/PO.22.00336, PubMed 36753687
Langberg CW, Horndalsveen H, Helland Å, Haakensen VD (2023)
Factors associated with failure to start consolidation durvalumab after definitive chemoradiation for locally advanced NSCLC
Front Oncol, 13, 1217424
DOI 10.3389/fonc.2023.1217424, PubMed 37476372
Larsen SG, Graf W, Mariathasan AB, Sørensen O, Spasojevic M, Goscinski MA, Selboe S, Lundstrøm N, Holtermann A, Revheim ME, Bruland ØS (2023)
First experience with ²²⁴Radium-labeled microparticles (Radspherin®) after CRS-HIPEC for peritoneal metastasis in colorectal cancer (a phase 1 study)
Front Med (Lausanne), 10, 1070362
DOI 10.3389/fmed.2023.1070362, PubMed 36936230
Larsen TL, Svalastoga M, Brekke J, Enden T, Frøen H, Garresori H, Jacobsen EM, Paulsen PQ, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2023)
Arterial events in cancer patients treated with apixaban for venous thrombosis
Thromb Res, 228, 128-133
DOI 10.1016/j.thromres.2023.05.017, PubMed 37327527
Le Tourneau C, André F, Helland Å, Mileshkin L, Minnaard W, Schiel A, Taskén K, Thomas DM, Veronese ML, Durán-Pacheco G, Leyens L, Rufibach K, Thomas M, Krämer A (2023)
Modified study designs to expand treatment options in personalised oncology: a multistakeholder view
Eur J Cancer, 194, 113278
DOI 10.1016/j.ejca.2023.113278, PubMed 37820553
Leich E, Brodtkorb M, Schmidt T, Altenbuchinger M, Lingjærde OC, Lockmer S, Holte H, Nedeva T, Grieb T, Sander B, Sundström C, Spang R, Kimby E, Rosenwald A (2023)
Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy
Leuk Lymphoma, 64 (12), 1927-1937
DOI 10.1080/10428194.2023.2240462, PubMed 37683053
Leivonen SK, Friman T, Autio M, Vaittinen S, Jensen AW, D'Amore F, Hamilton-Dutoit SJ, Holte H, Beiske K, Kovanen PE, Räty R, Leppä S (2023)
Characterization and clinical impact of the tumor microenvironment in post-transplant aggressive B-cell lymphomas
Haematologica, 108 (11), 3044-3057
DOI 10.3324/haematol.2023.282831, PubMed 37259566
Leske H, Blakstad H, Lund-Iversen M, Skovholt EK, Niehusmann P, Ramm-Pettersen JT, Skogen K, Kongelf G, Sprauten M, Magelssen H, Brandal P (2023)
Astrocytoma (CNS WHO grade 4), IDH-mutant with co-occurrence of BRAF p.V600E mutation, and homozygous loss of CDKN2A
Neuropathology, 43 (5), 385-390
DOI 10.1111/neup.12895, PubMed 36754566
Lilleby W, Seierstad T, Inderberg EM, Hole KH (2023)
Impact of human telomerase reverse transcriptase peptide vaccine combined with androgen deprivation therapy and radiotherapy in de novo metastatic prostate cancer: Long-term clinical monitoring
Int J Cancer, 152 (10), 2166-2173
DOI 10.1002/ijc.34448, PubMed 36715014
Lindberg S, Grozman V, Karlsson K, Onjukka E, Lindbäck E, Jirf KA, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Møller DS, Hoffmann L, Knap MM, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Hagen RK, Frøland AS, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB et al. (2023)
Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors
Int J Radiat Oncol Biol Phys, 117 (5), 1222-1231
DOI 10.1016/j.ijrobp.2023.06.246, PubMed 37423292
Liu L, Choi J, Musoro JZ, Sauerbrei W, Amdal CD, Alanya A, Barbachano Y, Cappelleri JC, Falk RS, Fiero MH, Regnault A, Reijneveld JC, Sandin R, Thomassen D, Roychoudhury S, Goetghebeur E, le Cessie S, SISAQOL-IMI Work Package 3 (2023)
Single-arm studies involving patient-reported outcome data in oncology: a literature review on current practice
Lancet Oncol, 24 (5), e197-e206
DOI 10.1016/S1470-2045(23)00110-9, PubMed 37142381
Lloret I, Hompland I, Lobmaier IV, Sundseth J, Server A (2023)
Ewing sarcoma of the temporal bone with aneurysmal bone cyst-like changes: A rare case report with an unusual radiological presentation
Neuroradiol J, 37 (5), 640-644
DOI 10.1177/19714009231212358, PubMed 37923348
Ludvigsen M, Campbell AJ, Enemark MB, Hybel TE, Karjalainen-Lindsberg ML, Beiske K, Bjerre M, Pedersen LM, Holte H, Leppä S, Jørgensen JM, Honoré B (2023)
Proteomics uncovers molecular features for relapse risk stratification in patients with diffuse large B-cell lymphoma
Blood Cancer J, 13 (1), 161
DOI 10.1038/s41408-023-00931-6, PubMed 37884514
Luminari S, Fossa A, Trotman J, Molin D, d'Amore F, Enblad G, Berkahn L, Barrington SF, Radford J, Federico M, Kirkwood AA, Johnson PWM (2023)
Long-Term Follow-Up of the Response-Adjusted Therapy for Advanced Hodgkin Lymphoma Trial
J Clin Oncol, 42 (1), 13-18
DOI 10.1200/JCO.23.01177, PubMed 37883739
Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Dajani O, Mariussen KL, Steindal SA (2023)
Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-based Palliative Care: Scoping Review
J Med Internet Res, 25, e43429
DOI 10.2196/43429, PubMed 36989024
Mauz-Körholz C, Landman-Parker J, Fernández-Teijeiro A, Attarbaschi A, Balwierz W, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Ceppi F, Claviez A, Daw S, Dieckmann K, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kurch L, Leblanc T, Mann G, Montravers F, Pears J, Pelz T et al. (2023)
Response-adapted omission of radiotherapy in children and adolescents with early-stage classical Hodgkin lymphoma and an adequate response to vincristine, etoposide, prednisone, and doxorubicin (EuroNet-PHL-C1): a titration study
Lancet Oncol, 24 (3), 252-261
DOI 10.1016/S1470-2045(23)00019-0, PubMed 36858722
McDonald J, Sayers J, Anker SD, Arends J, Balstad TR, Baracos V, Brown L, Bye A, Dajani O, Dolan R, Fallon MT, Fraser E, Griel C, Grzyb A, Hjermstad M, Jamal-Hanjani M, Jakobsen G, Kaasa S, McMillan D, Maddocks M, Philips I, Ottestad IO, Reid KF, Sousa MS, Simpson MR et al. (2023)
Physical function endpoints in cancer cachexia clinical trials: Systematic Review 1 of the cachexia endpoints series
J Cachexia Sarcopenia Muscle, 14 (5), 1932-1948
DOI 10.1002/jcsm.13321, PubMed 37671529
Mediå LM, Sigurdardottir S, Fauske L, Waehre A (2023)
Understanding sexual health concerns among adolescents and young adults with differences of sex development: a qualitative study
Int J Qual Stud Health Well-being, 18 (1), 2204635
DOI 10.1080/17482631.2023.2204635, PubMed 37092307
Mendoza Mireles EE, Skaga E, Server A, Leske H, Brandal P, Helseth E, Rønning PA, Vik-Mo EO (2023)
The benefit of complete resection of contrast enhancing tumor in glioblastoma patients: A population-based study
Neurooncol Pract, 10 (6), 555-564
DOI 10.1093/nop/npad037, PubMed 38026582
Mensali N, Köksal H, Joaquina S, Wernhoff P, Casey NP, Romecin P, Panisello C, Rodriguez R, Vimeux L, Juzeniene A, Myhre MR, Fåne A, Ramírez CC, Maggadottir SM, Duru AD, Georgoudaki AM, Grad I, Maturana AD, Gaudernack G, Kvalheim G, Carcaboso AM, de Alava E, Donnadieu E, Bruland ØS, Menendez P et al. (2023)
ALPL-1 is a target for chimeric antigen receptor therapy in osteosarcoma
Nat Commun, 14 (1), 3375
DOI 10.1038/s41467-023-39097-x, PubMed 37291203
Mikalsen SG, Skjøtskift T, Flote VG, Hämäläinen NP, Heydari M, Rydén-Eilertsen K (2023)
Extensive clinical testing of Deep Learning Segmentation models for thorax and breast cancer radiotherapy planning
Acta Oncol, 62 (10), 1184-1193
DOI 10.1080/0284186X.2023.2270152, PubMed 37883678
Miranda R, Raemdonck E, Deliens L, Kaasa S, Zimmermann C, Rodin G, Robijn L, Lundeby T, Houbracken I, Beernaert K (2023)
Do cancer centres and palliative care wards routinely measure patients' quality of life? An international cross-sectional survey study
Support Care Cancer, 31 (8), 499
DOI 10.1007/s00520-023-07964-4, PubMed 37523097
Mo T, Brandal SHB, Geier OM, Engebråten O, Nilsen LB, Kristensen VN, Hole KH, Hompland T, Fleischer T, Seierstad T (2023)
MRI Assessment of Changes in Tumor Vascularization during Neoadjuvant Anti-Angiogenic Treatment in Locally Advanced Breast Cancer Patients
Cancers (Basel), 15 (18)
DOI 10.3390/cancers15184662, PubMed 37760629
Morken S, Langer SW, Sundlöv A, Vestermark LW, Ladekarl M, Hjortland GO, Svensson JB, Tabaksblat EM, Haslerud TM, Assmus J, Detlefsen S, Couvelard A, Perren A, Sorbye H (2023)
Phase II study of everolimus and temozolomide as first-line treatment in metastatic high-grade gastroenteropancreatic neuroendocrine neoplasms
Br J Cancer, 129 (12), 1930-1939
DOI 10.1038/s41416-023-02462-0, PubMed 37872405
Møller CT, Tafjord G, Blindheim A, Berge V, Fosså S, Andreassen BK (2023)
Initial management and survival of patients with primary metastatic bladder cancer before the immunotherapy era: a population-based study from Norway
Scand J Urol, 58, 101-108
DOI 10.2340/sju.v58.5923, PubMed 37953521
Namløs HM, Khelik K, Nakken S, Vodák D, Hovig E, Myklebost O, Boye K, Meza-Zepeda LA (2023)
Chromosomal instability and a deregulated cell cycle are intrinsic features of high-risk gastrointestinal stromal tumours with a metastatic potential
Mol Oncol, 17 (11), 2432-2450
DOI 10.1002/1878-0261.13514, PubMed 37622176
Nilsen TS, Sæter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, Hallén J, Edvardsen E, Grydeland M, Kiserud CE, Lie HC, Solberg PA, Wisløff T, Sharples AP, Raastad T, Haugaa KH, Thorsen L (2023)
Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial
JMIR Res Protoc, 12, e45244
DOI 10.2196/45244, PubMed 36920460
Nilsen TS, Sæter M, Sarvari SI, Reinertsen KV, Johansen SH, Edvardsen ER, Hallén J, Edvardsen E, Grydeland M, Kiserud CE, Lie HC, Solberg PA, Wisløff T, Sharples AP, Raastad T, Haugaa KH, Thorsen L (2023)
Correction: Effects of Aerobic Exercise on Cardiorespiratory Fitness, Cardiovascular Risk Factors, and Patient-Reported Outcomes in Long-Term Breast Cancer Survivors: Protocol for a Randomized Controlled Trial
JMIR Res Protoc, 12, e54462
DOI 10.2196/54462, PubMed 37963373
Nilssen Y, Solberg S, Brustugun OT, Møller B, Sundset A, Wahl SGF, Helland Å (2023)
Tracheal cancer: a rare and deadly but potentially curable disease that also affects younger people
Eur J Cardiothorac Surg, 64 (1)
DOI 10.1093/ejcts/ezad244, PubMed 37348858
Nilsson K, Klevebro F, Sunde B, Rouvelas I, Lindblad M, Szabo E, Halldestam I, Smedh U, Wallner B, Johansson J, Johnsen G, Aahlin EK, Johannessen HO, Alexandersson von Döbeln G, Hjortland GO, Wang N, Shang Y, Borg D, Quaas A, Bartella I, Bruns C, Schröder W, Nilsson M (2023)
Oncological outcomes of standard versus prolonged time to surgery after neoadjuvant chemoradiotherapy for oesophageal cancer in the multicentre, randomised, controlled NeoRes II trial
Ann Oncol, 34 (11), 1015-1024
DOI 10.1016/j.annonc.2023.08.010, PubMed 37657554
Nilsson MP, Undseth C, Albertsson P, Eidem M, Havelund BM, Johannsson J, Johnsson A, Radu C, Serup-Hansen E, Spindler KL, Zakrisson B, Guren MG, Kronborg C (2023)
Nordic anal cancer (NOAC) group consensus guidelines for risk-adapted delineation of the elective clinical target volume in anal cancer
Acta Oncol, 62 (8), 897-906
DOI 10.1080/0284186X.2023.2240490, PubMed 37504978
Niyoteka S, Seban RD, Rouhi R, Scarsbrook A, Genestie C, Classe M, Carré A, Sun R, La Greca Saint-Esteven A, Chargari C, McKenna J, McDermott G, Malinen E, Tanadini-Lang S, Guckenberger M, Guren MG, Lemanski C, Deutsch E, Robert C (2023)
A common [18F]-FDG PET radiomic signature to predict survival in patients with HPV-induced cancers
Eur J Nucl Med Mol Imaging, 50 (13), 4010-4023
DOI 10.1007/s00259-023-06320-2, PubMed 37632562
Normann LS, Haugen MH, Hongisto V, Aure MR, Leivonen SK, Kristensen VN, Tahiri A, Engebraaten O, Sahlberg KK, Mælandsmo GM (2023)
High-throughput screen in vitro identifies dasatinib as a candidate for combinatorial treatment with HER2-targeting drugs in breast cancer
PLoS One, 18 (1), e0280507
DOI 10.1371/journal.pone.0280507, PubMed 36706086
Oh DY, Algazi A, Capdevila J, Longo F, Miller W, Chun Bing JT, Bonilla CE, Chung HC, Guren TK, Lin CC, Motola-Kuba D, Shah M, Hadoux J, Yao L, Jin F, Norwood K, Lebellec L (2023)
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study
Cancer, 129 (8), 1195-1204
DOI 10.1002/cncr.34657, PubMed 36748723
Opheim LØ, Engeskaug I, Bjerre Trent PK, Thorsen L, Staff AC, Nordskar NJ, Utne I, Hagen M, Eriksson AGZ (2023)
Associations between modifiable lifestyle factors and health-related quality of life among endometrial carcinoma survivors - A cross-sectional study
Gynecol Oncol, 179, 52-62
DOI 10.1016/j.ygyno.2023.10.012, PubMed 37924595
Ost P, Siva S, Brabrand S, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Everaerts W, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Scorsetti M, Zapatero A, Villafranca Iturre AE, Eito C, Couñago F, Muto P, Van De Voorde L, Mach N, Bultijnck R, Fonteyne V, Moon D, Thon K et al. (2023)
PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial
Eur Urol Oncol, 7 (3), 462-468
DOI 10.1016/j.euo.2023.09.007, PubMed 37821242
Otrebski Nilsson M, Aas K, Myklebust TÅ, Gjelsvik YM, Haug ES, Fosså SD, Johannesen TB (2023)
Do all prostate cancer patients want, and experience shared decision making prior to curative treatment?
Scand J Urol, 58, 133-140
DOI 10.2340/sju.v58.14730, PubMed 38116675
Ottesen JA, Yi D, Tong E, Iv M, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Bjørnerud A, Zaharchuk G, Grøvik E (2023)
2.5D and 3D segmentation of brain metastases with deep learning on multinational MRI data
Front Neuroinform, 16, 1056068
DOI 10.3389/fninf.2022.1056068, PubMed 36743439
Palmerini E, Reichardt P, Hall KS, Bertulli R, Bielack SS, Comandone A, Egerer G, Hansmeier A, Kevric M, Carretta E, Hansson L, Jebsen N, Eriksson M, Bruland ØS, Donati DM, Ibrahim T, Smeland S, Ferrari S (2023)
Outcome of rare primary malignant bone sarcoma treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.)
Cancer, 129 (22), 3564-3573
DOI 10.1002/cncr.34964, PubMed 37530385
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Ruíz-Borrego M, Moore HCF, Saunders C, Bjelic-Radisic V et al. (2023)
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
N Engl J Med, 388 (18), 1645-1656
DOI 10.1056/NEJMoa2212856, PubMed 37133584
Pasetto A, Lu YC (2023)
Editorial: Personalized immunotherapy for cancer
Front Oncol, 13, 1171907
DOI 10.3389/fonc.2023.1171907, PubMed 36959783
Pe M, Alanya A, Falk RS, Amdal CD, Bjordal K, Chang J, Cislo P, Coens C, Dirven L, Speck RM, Fitzgerald K, Galinsky J, Giesinger JM, Holzner B, Le Cessie S, O'Connor D, Oliver K, Pawar V, Quinten C, Schlichting M, Ren J, Roychoudhury S, Taphoorn MJB, Velikova G, Wintner LM et al. (2023)
Setting International Standards in Analyzing Patient-Reported Outcomes and Quality of Life Endpoints in Cancer Clinical Trials-Innovative Medicines Initiative (SISAQOL-IMI): stakeholder views, objectives, and procedures
Lancet Oncol, 24 (6), e270-e283
DOI 10.1016/S1470-2045(23)00157-2, PubMed 37269858
Pettersen S, Øy GF, Egeland EV, Juell S, Engebråten O, Mælandsmo GM, Prasmickaite L (2023)
Breast cancer patient-derived explant cultures recapitulate in vivo drug responses
Front Oncol, 13, 1040665
DOI 10.3389/fonc.2023.1040665, PubMed 36910663
Piperno-Neumann S, Carlino MS, Boni V, Loirat D, Speetjens FM, Park JJ, Calvo E, Carvajal RD, Nyakas M, Gonzalez-Maffe J, Zhu X, Shirley MD, Ramkumar T, Fessehatsion A, Burks HE, Yerramilli-Rao P, Kapiteijn E (2023)
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
Br J Cancer, 128 (6), 1040-1051
DOI 10.1038/s41416-022-02133-6, PubMed 36624219
Rakaee M, Andersen S, Giannikou K, Paulsen EE, Kilvaer TK, Busund LR, Berg T, Richardsen E, Lombardi AP, Adib E, Pedersen MI, Tafavvoghi M, Wahl SGF, Petersen RH, Bondgaard AL, Yde CW, Baudet C, Licht P, Lund-Iversen M, Grønberg BH, Fjellbirkeland L, Helland Å, Pøhl M, Kwiatkowski DJ, Donnem T (2023)
Machine learning-based immune phenotypes correlate with STK11/KEAP1 co-mutations and prognosis in resectable NSCLC: a sub-study of the TNM-I trial
Ann Oncol, 34 (7), 578-588
DOI 10.1016/j.annonc.2023.04.005, PubMed 37100205
Ramsower CA, Rosenthal A, Robetorye RS, Mwangi R, Maurer M, Villa D, McDonnell T, Feldman A, Cohen JB, Habermann T, Campo E, Clot G, Bühler MM, Kulis M, Martin-Subero JI, Giné E, Cook JR, Hill B, Raess PW, Beiske KH, Reichart A, Hartmann S, Holte H, Scott D, Rimsza L (2023)
Evaluation of clinical parameters and biomarkers in older, untreated mantle cell lymphoma patients receiving bendamustine-rituximab
Br J Haematol, 204 (1), 160-170
DOI 10.1111/bjh.19153, PubMed 37881141
Richartz N, Pietka W, Yadav A, Bostad M, Bhagwat S, Naderi S, Naderi EH, Stokke T, Ruud E, Blomhoff HK (2023)
N-acetyl cysteine turns EPAC activators into potent killers of acute lymphoblastic leukemia cells
J Biol Chem, 300 (1), 105509
DOI 10.1016/j.jbc.2023.105509, PubMed 38042493
Riis ML, Augestad L, Flote VG, Tangerud A, Frich L (2023)
Simultaneous cutaneous melanoma and ipsilateral breast cancer with metastasis to the same axilla. A case report with a focus on a multidisciplinary approach
Int J Surg Case Rep, 114, 109119
DOI 10.1016/j.ijscr.2023.109119, PubMed 38061088
Riis RN, Riis MH, Benth JŠ, Augestad KM (2023)
Beyond the transanal total mesorectal excision moratorium: local and distant recurrence among patients operated for low rectal tumours-5-year follow-up from a Norwegian University Hospital
Br J Surg, 110 (11), 1547-1548
DOI 10.1093/bjs/znad275, PubMed 37672389
Robert C, Carlino MS, McNeil C, Ribas A, Grob JJ, Schachter J, Nyakas M, Kee D, Petrella TM, Blaustein A, Lotem M, Arance A, Daud AI, Hamid O, Larkin J, Anderson J, Krepler C, Grebennik D, Long GV (2023)
Seven-Year Follow-Up of the Phase III KEYNOTE-006 Study: Pembrolizumab Versus Ipilimumab in Advanced Melanoma
J Clin Oncol, 41 (24), 3998-4003
DOI 10.1200/JCO.22.01599, PubMed 37348035
Robsahm TE, Tsuruda KM, Hektoen HH, Storås AH, Cook MB, Hurwitz LM, Langseth H (2023)
Applying recommended definition of aggressive prostate cancer: a validation study using high-quality data from the Cancer Registry of Norway
Acta Oncol, 62 (1), 8-14
DOI 10.1080/0284186X.2023.2175331, PubMed 36762472
Rohde M, Eriksen JG, Pareek M, Bratland Å, Mäkitie A, Hammarstedt-Nordenvall L, Wessel I, Lybeck JS, Mäenpää H, Gebre-Medhin M, Godballe C (2023)
Diagnosis of locally recurrent head and neck squamous cell carcinoma in the Nordic HNC centers and feasibility of the Odense-Birmingham definition
Acta Oncol, 62 (9), 1102-1105
DOI 10.1080/0284186X.2023.2245550, PubMed 37602835
Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M (2023)
Correction to: Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
Gastric Cancer, 26 (1), 167
DOI 10.1007/s10120-022-01346-1, PubMed 36269499
Rugo HS, Van Poznak CH, Neven P, Danielewicz I, Lee SC, Campone M, Chik JYK, Vega Alonso E, Naume B, Brain E, Siegel JM, Li R, Uema D, Wagner VJ, Coleman RE (2023)
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Breast Cancer Res Treat, 204 (2), 249-259
DOI 10.1007/s10549-023-07147-z, PubMed 38123789
Sah VR, Jespersen H, Karlsson J, Nilsson LM, Bergqvist M, Johansson I, Carneiro A, Helgadottir H, Levin M, Ullenhag G, Ståhlberg A, Olofsson Bagge R, Nilsson JA, Ny L (2023)
Chemokine Analysis in Patients with Metastatic Uveal Melanoma Suggests a Role for CCL21 Signaling in Combined Epigenetic Therapy and Checkpoint Immunotherapy
Cancer Res Commun, 3 (5), 884-895
DOI 10.1158/2767-9764.CRC-22-0490, PubMed 37377898
Salim R, Husby S, Winther Eskelund C, Scott DW, Holte H, Kolstad A, Räty R, Ek S, Jerkeman M, Geisler C, Sommer Kristensen L, Dahl M, Grønbæk K (2023)
Exploring new prognostic biomarkers in Mantle Cell Lymphoma: a comparison of the circSCORE and the MCL35 score
Leuk Lymphoma, 64 (8), 1414-1423
DOI 10.1080/10428194.2023.2216819, PubMed 37259807
Sanchez VA, Shuey MM, Dinh PC, Monahan PO, Fosså SD, Sesso HD, Dolan ME, Einhorn LH, Vaughn DJ, Martin NE, Feldman DR, Kroenke K, Fung C, Frisina RD, Travis LB (2023)
Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy
J Clin Oncol, 41 (12), 2211-2226
DOI 10.1200/JCO.22.01456, PubMed 36626694
Sars C, Sackey H, Frisell J, Dickman PW, Karlsson F, Kindts I, Marta GN, Freitas-Junior R, Tvedskov TF, Kassem L, Ali AS, Ihalainen H, Neron M, Kontos M, Kaidar-Person O, Meattini I, Francken AB, van Duijnhoven F, Moberg IO, Marinko T, Kollar A, Ahmed M, Remoundos D, Banks J, Jagsi R et al. (2023)
Current clinical practice in the management of phyllodes tumors of the breast: an international cross-sectional study among surgeons and oncologists
Breast Cancer Res Treat, 199 (2), 293-304
DOI 10.1007/s10549-023-06896-1, PubMed 36879102
Schipmann-Miletic S, Sivakanesan S, Rath DS, Brandal P, Vik-Mo E, Bjørås M, Solheim O, Ingebrigtsen T, Sund F, Bjerkvig R, Miletic H, Johannessen TA, Sundstrøm T (2023)
[Glioblastoma in adults]
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.22.0314, PubMed 36718891
Schmid MP, Lindegaard JC, Mahantshetty U, Tanderup K, Jürgenliemk-Schulz I, Haie-Meder C, Fokdal LU, Sturdza A, Hoskin P, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Petric P, Ramazanova D, Ristl R, Kannan S, Hawaldar R, Ecker S, Kirchheiner K, Tan LT et al. (2023)
Risk Factors for Local Failure Following Chemoradiation and Magnetic Resonance Image-Guided Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
J Clin Oncol, 41 (10), 1933-1942
DOI 10.1200/JCO.22.01096, PubMed 36599120
Schneider KM, Kummen M, Trivedi PJ, Hov JR (2023)
Role of microbiome in autoimmune liver diseases
Hepatology, 80 (4), 965-987
DOI 10.1097/HEP.0000000000000506, PubMed 37369002
Shoushtari AN, Olszanski AJ, Nyakas M, Hornyak TJ, Wolchok JD, Levitsky V, Kuryk L, Hansen TB, Jäderberg M (2023)
Pilot Study of ONCOS-102 and Pembrolizumab: Remodeling of the Tumor Microenvironment and Clinical Outcomes in Anti-PD-1-Resistant Advanced Melanoma
Clin Cancer Res, 29 (1), 100-109
DOI 10.1158/1078-0432.CCR-22-2046, PubMed 36112545
Skjerven HK, Myklebust EM, Korvald C, Stubberud K, Hovda T, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2023)
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study
Eur J Surg Oncol, 50 (2), 107938
DOI 10.1016/j.ejso.2023.107938, PubMed 38199004
Skoie IM, Skogås JG, Langø T, Myhr KM, Myhre PL, Goll R, Fretland SØ, Helland Å (2023)
New centres to carry out more clinical trials in Norway
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.22.0722, PubMed 36718905
Skaali T, Blomhoff R, Lindemann K, Smeland S, Bruheim K, Seland M, Thorsen L (2023)
Self-reported distress and problems after treatment for gynecological cancer - Correlation between a short screening tool and longer measures of anxiety/depression and health-related quality of life
Acta Obstet Gynecol Scand, 103 (2), 387-395
DOI 10.1111/aogs.14709, PubMed 37991142
Sletten OJ, Aalen JM, Smiseth OA, Khan FH, Fossa A, Kiserud CE, Villegas-Martinez M, Hisdal J, Remme EW, Skulstad H (2023)
Mental Stress Reduces Left Ventricular Strain: Can It Lead to Misinterpretation of Cancer Therapy-Related Cardiac Dysfunction?
J Am Soc Echocardiogr, 37 (5), 564-566
DOI 10.1016/j.echo.2023.11.010, PubMed 37981246
Smedsland SK, Falk RS, Reinertsen KV, Kiserud CE, Brekke M, Bøhn SH, Dahl AA, Vandraas KF (2023)
Burden of late effects in a nationwide sample of long-term breast cancer survivors
Cancer, 130 (1), 140-149
DOI 10.1002/cncr.35019, PubMed 37776533
Smedsland SK, Vandraas KF, Falk RS, Horn J, Reidunsdatter RJ, Kiserud CE, Dahl AA, Brekke M, Reinertsen KV (2023)
Sexual health in long-term breast cancer survivors: a comparison with female population controls from the HUNT study
Breast Cancer Res Treat, 201 (3), 479-488
DOI 10.1007/s10549-023-07021-y, PubMed 37490170
Solbakken AM, Sellevold S, Spasojevic M, Julsrud L, Emblemsvåg HL, Reims HM, Sørensen O, Thorgersen EB, Fauske L, Ågren JSM, Brennhovd B, Ryder T, Larsen SG, Flatmark K (2023)
Navigation-Assisted Surgery for Locally Advanced Primary and Recurrent Rectal Cancer
Ann Surg Oncol, 30 (12), 7602-7611
DOI 10.1245/s10434-023-13964-9, PubMed 37481493
Solmunde E, Falstie-Jensen AM, Lorenzen EL, Ewertz M, Reinertsen KV, Dekkers OM, Cronin-Fenton DP (2023)
Breast cancer, breast cancer-directed radiation therapy and risk of hypothyroidism: A systematic review and meta-analysis
Breast, 68, 216-224
DOI 10.1016/j.breast.2023.02.008, PubMed 36868138
Spampinato S, Tanderup K, Lindegaard JC, Schmid MP, Sturdza A, Segedin B, Jürgenliemk-Schulz IM, De Leeuw A, Bruheim K, Mahantshetty U, Chargari C, Rai B, Cooper R, van der Steen-Banasik E, Sundset M, Wiebe E, Villafranca E, Van Limbergen E, Pieters BR, Tee Tan L, Lutgens LCHW, Hoskin P, Smet S, Pötter R, Nout R et al. (2023)
Association of persistent morbidity after radiotherapy with quality of life in locally advanced cervical cancer survivors
Radiother Oncol, 181, 109501
DOI 10.1016/j.radonc.2023.109501, PubMed 36720348
Spasevska I, Sharma A, Steen CB, Josefsson SE, Blaker YN, Kolstad A, Rustad EH, Meyer S, Isaksen K, Chellappa S, Kushekhar K, Beiske K, Førsund MS, Spetalen S, Holte H, Østenstad B, Brodtkorb M, Kimby E, Olweus J, Taskén K, Newman AM, Lorenz S, Smeland EB, Alizadeh AA, Huse K et al. (2023)
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma
Blood Adv, 7 (23), 7216-7230
DOI 10.1182/bloodadvances.2023010158, PubMed 37695745
Storås AH, Tsuruda K, Fosså SD, Andreassen BK (2023)
Time trends in systemic treatment for patients with metastatic prostate cancer: a national cohort study
Acta Oncol, 62 (12), 1716-1722
DOI 10.1080/0284186X.2023.2257876, PubMed 37725527
Svendsen K, Nes LS, Meland A, Larsson IM, Gjelsvik YM, Børøsund E, Rygg CM, Myklebust TÅ, Reinertsen KV, Kiserud CE, Skjerven H, Antoni MH, Chalder T, Mjaaland I, Carlson LE, Eriksen HR, Ursin G (2023)
Coping After Breast Cancer: Protocol for a Randomized Controlled Trial of Stress Management eHealth Interventions
JMIR Res Protoc, 12, e47195
DOI 10.2196/47195, PubMed 37103493
Switlyk MD, Hopland A, Sivanesan S, Brennhovd B, Ottosson F, Berner K, Axcrona U, Hole KH (2023)
Multi-parametric MRI without artificial erection for preoperative assessment of primary penile carcinoma: A pilot study on the correlation between imaging and histopathological findings
Eur J Radiol Open, 10, 100478
DOI 10.1016/j.ejro.2023.100478, PubMed 36793771
Sælen MG, Hjelle LV, Aarsæther E, Knutsen T, Andersen S, Bentzen AG, Richardsen E, Fosså SD, Haugnes HS (2023)
Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
Acta Oncol, 62 (6), 657-665
DOI 10.1080/0284186X.2023.2224051, PubMed 37353983
Taylor KJ, Amdal CD, Bjordal K, Astrup GL, Herlofson BB, Duprez F, Gama RR, Jacinto A, Hammerlid E, Scricciolo M, Jansen F, Verdonck-de Leeuw IM, Fanetti G, Guntinas-Lichius O, Inhestern J, Dragan T, Fabian A, Boehm A, Wöhner U, Kiyota N, Krüger M, Bonomo P, Pinto M, Nuyts S, Silva JC et al. (2023)
Serious Long-Term Effects of Head and Neck Cancer from the Survivors' Point of View
Healthcare (Basel), 11 (6)
DOI 10.3390/healthcare11060906, PubMed 36981562
Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BT et al. (2023)
A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer
Cancer Immunol Immunother, 72 (7), 2357-2373
DOI 10.1007/s00262-023-03421-7, PubMed 36939854
Thorgersen EB, Asvall J, Schjalm C, McAdam KE, Bruland ØS, Larsen SG, Mollnes TE (2023)
Effect of Intraperitoneal ²²⁴Radium-Labelled Microparticles on Compartmentalized Inflammation After Cytoreductive Surgery and Hypertherm Intraperitoneal Chemotherapy
Technol Cancer Res Treat, 22, 15330338231192902
DOI 10.1177/15330338231192902, PubMed 37574949
Thorsen L, Courneya KS, Steene-Johannessen J, Gran JM, Haugnes HS, Negaard HFS, Kiserud CE, Fosså SD (2023)
Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
Int J Cancer, 153 (8), 1512-1519
DOI 10.1002/ijc.34625, PubMed 37334652
Tjelta J, Fjæra LF, Ytre-Hauge KS, Boer CG, Stokkevåg CH (2023)
A systematic approach for calibrating a Monte Carlo code to a treatment planning system for obtaining dose, LET, variable proton RBE and out-of-field dose
Phys Med Biol, 68 (22)
DOI 10.1088/1361-6560/ad0281, PubMed 37820690
Trewin-Nybråten CB, Larsen IK, Møller B, Heikkilä R (2023)
Hospital surgical volume and colorectal cancer survival in Norway: A nationwide cohort study
Cancer Epidemiol, 85, 102404
DOI 10.1016/j.canep.2023.102404, PubMed 37343490
Trøseid M, Arribas JR, Assoumou L, Holten AR, Poissy J, Terzić V, Mazzaferri F, Baño JR, Eustace J, Hites M, Joannidis M, Paiva JA, Reuter J, Püntmann I, Patrick-Brown TDJH, Westerheim E, Nezvalova-Henriksen K, Beniguel L, Dahl TB, Bouscambert M, Halanova M, Péterfi Z, Tsiodras S, Rezek M, Briel M et al. (2023)
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655
Turcas A, Kelly SM, Bernier-Chastagner V, Bolle S, Cameron A, Corning C, Clementel E, Dieckmann K, Davila Fajardo R, Gaze MN, Laprie A, Magelssen H, Meroni S, Pignoli E, Safwat A, Scarzello G, Talbot J, Timmermann B, Boterberg T, Mandeville HC (2023)
Management of the vertebrae as an organ at risk in paediatric radiotherapy clinical trials: Initial QUARTET experience
Radiother Oncol, 187, 109810
DOI 10.1016/j.radonc.2023.109810, PubMed 37468069
Upreti RP, Mmbaga E, Haugnes HS, Kiserud CE, Del Risco Kollerud R (2023)
Most common health problems in general practice among adolescents, and young adults' survivors of lymphoma: a register-based cohort study in Norway
Acta Oncol, 62 (12), 1607-1615
DOI 10.1080/0284186X.2023.2273894, PubMed 37897712
Valstad H, Eyjolfsdottir B, Wang Y, Kristensen GB, Skeie-Jensen T, Lindemann K (2023)
Pelvic exenteration for vulvar cancer: Postoperative morbidity and oncologic outcome - A single center retrospective analysis
Eur J Surg Oncol, 49 (9), 106958
DOI 10.1016/j.ejso.2023.06.010, PubMed 37349160
van de Wal D, Fauske L, Bruland ØS, Jones RL, Kasper B, Wilson R, van der Graaf WTA, Husson O (2023)
Psychological and social challenges of patients with locally advanced and metastatic gastrointestinal stromal tumours (GIST) on long-term treatment with tyrosine kinase inhibitors: a qualitative study with patients and medical oncologists
Support Care Cancer, 31 (6), 352
DOI 10.1007/s00520-023-07810-7, PubMed 37233829
van Ewijk R, Cleirec M, Herold N, le Deley MC, van Eijkelenburg N, Boudou-Rouquette P, Risbourg S, Strauss SJ, Palmerini E, Boye K, Kager L, Hecker-Nolting S, Marchais A, Gaspar N, FOSTER Consortium (Fight OsteoSarcoma Through European Research), work package 3 on recurrent/refractory osteosarcoma trials (2023)
A systematic review of recent phase-II trials in refractory or recurrent osteosarcoma: Can we inform future trial design?
Cancer Treat Rev, 120, 102625
DOI 10.1016/j.ctrv.2023.102625, PubMed 37738712
Vandraas K, Reinertsen KV, Smedsland S, Bøhn S, Kiserud C, Falk RS, Lie HC (2023)
Fear of cancer recurrence eight years after early-stage breast cancer - results from a national survey
Acta Oncol, 62 (6), 635-641
DOI 10.1080/0284186X.2023.2224052, PubMed 37337306
Vandraas KF, Smedsland S, Engan HK, Kiserud C, Naume B, Brekke M, Reinertsen KV (2023)
Late effects after breast cancer treatment
Tidsskr Nor Laegeforen, 143 (11)
DOI 10.4045/tidsskr.23.0017, PubMed 37589367
Venizelos A, Sorbye H, Elvebakken H, Perren A, Lothe IMB, Couvelard A, Hjortland GO, Sundlöv A, Svensson J, Garresori H, Kersten C, Hofsli E, Detlefsen S, Vestermark LW, Ladekarl M, Tabaksblat EM, Knappskog S (2023)
Germline pathogenic variants in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
Endocr Relat Cancer, 30 (10)
DOI 10.1530/ERC-23-0057, PubMed 37410378
Vistnes M, Erusappan PM, Sasi A, Nordén ES, Bergo KK, Romaine A, Lunde IG, Zhang L, Olsen MB, Øgaard J, Carlson CR, Wang CH, Riise J, Dahl CP, Fiane AE, Hauge-Iversen IM, Espe E, Melleby AO, Tønnessen T, Aronsen JM, Sjaastad I, Christensen G (2023)
Inhibition of the extracellular enzyme A disintegrin and metalloprotease with thrombospondin motif 4 prevents cardiac fibrosis and dysfunction
Cardiovasc Res, 119 (10), 1915-1927
DOI 10.1093/cvr/cvad078, PubMed 37216909
Vittrup AS, Kirchheiner K, Pötter R, Fokdal LU, Jensen NBK, Spampinato S, Haie-Meder C, Schmid MP, Sturdza AE, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Wiebe E, van der Steen-Banasik E, Cooper R, Van Limbergen E, Sundset M, Pieters BR, Kirisits C, Lindegaard JC, Jürgenliemk-Schulz IM, Nout R, Tanderup K et al. (2023)
Overall Severe Morbidity After Chemo-Radiation Therapy and Magnetic Resonance Imaging-Guided Adaptive Brachytherapy in Locally Advanced Cervical Cancer: Results From the EMBRACE-I Study
Int J Radiat Oncol Biol Phys, 116 (4), 807-824
DOI 10.1016/j.ijrobp.2023.01.002, PubMed 36641039
Wallander K, Öfverholm I, Boye K, Tsagkozis P, Papakonstantinou A, Lin Y, Haglund de Flon F (2023)
Sarcoma care in the era of precision medicine
J Intern Med, 294 (6), 690-707
DOI 10.1111/joim.13717, PubMed 37643281
Wedde TB, Smaastuen MC, Vatne K, Schulz-Jaavall MB, Fosså SD, Lilleby WL (2023)
External beam radiotherapy of prostate cancer with or without high dose-rate brachytherapy: the Norwegian experience with long-term urinary and bowel adverse effects
Scand J Urol, 58, 68-75
DOI 10.2340/sju.v58.9571, PubMed 37644904
Wehrle CJ, Fujiki M, Schlegel A, Whitsett Linganna M, Pita A, Kim JK, Kwon DCH, Miller C, Hashimoto K, Dueland S, Sasaki K, Sapisochin G, Line PD, Hernandez-Alejandro R, Aucejo F (2023)
Update to 'A Contemporary Systematic Review on Liver Transplantation for Unresectable Liver Metastasis of Colorectal Cancer'
Ann Surg Oncol, 31 (2), 697-700
DOI 10.1245/s10434-023-14611-z, PubMed 37996635
Werlenius K, Kinhult S, Solheim TS, Magelssen H, Löfgren D, Mudaisi M, Hylin S, Bartek J, Strandéus M, Lindskog M, Rashid HB, Carstam L, Gulati S, Solheim O, Bartek J, Salvesen Ø, Jakola AS (2023)
Effect of Disulfiram and Copper Plus Chemotherapy vs Chemotherapy Alone on Survival in Patients With Recurrent Glioblastoma: A Randomized Clinical Trial
JAMA Netw Open, 6 (3), e234149
DOI 10.1001/jamanetworkopen.2023.4149, PubMed 37000452
Winge-Main A, Robsahm TE, Nyakas M, Festervoll G, Torkilseng E, Thybo S, Pati S, Carroll R (2023)
Long-term outcomes of stage IIB-IV melanoma patients: nationwide data from Norway
Future Oncol, 19 (3), 205-215
DOI 10.2217/fon-2022-0969, PubMed 36974621
Winther RR, Skovlund E, Andreassen JS, Arvidsson L, Halvardson J, Solheim O, Bartek J, Kaasa S, Hjermstad MJ, Vik-Mo EO (2023)
Preoperative Prognostic Index for Patients with Brain Metastases-A Population-Based Multi-Centre Study
Cancers (Basel), 15 (12)
DOI 10.3390/cancers15123174, PubMed 37370784
Yi D, Grøvik E, Tong E, Iv M, Emblem KE, Nilsen LB, Saxhaug C, Latysheva A, Jacobsen KD, Helland Å, Zaharchuk G, Rubin D (2023)
Erratum: "MRI pulse sequence integration for deep-learning-based brain metastases segmentation"
Med Phys, 50 (8), 5294
DOI 10.1002/mp.16594, PubMed 37573581
Åsberg RE, Nilsen M, Hjermstad MJ, Reinertsen KV, Karlsen J, Giskeødegård GF, Reidunsdatter RJ (2023)
Norwegian general population normative data for the European Organization for Research and Treatment of Cancer questionnaires: the Quality of Life Questionnaire-Core 30, the Sexual Health Questionnaire QLQ-SHQ22 and the sexual domains of the QLQ-BR23/BR45
Eur J Cancer, 190, 112943
DOI 10.1016/j.ejca.2023.112943, PubMed 37515905

Publications 2022

Abrantes R, Duarte HO, Gomes C, Wälchli S, Reis CA (2022)
CAR-Ts: new perspectives in cancer therapy
FEBS Lett, 596 (4), 403-416
DOI 10.1002/1873-3468.14270, PubMed 34978080
Achard V, Jaccard M, Vanhoutte F, Siva S, Heikkilä R, Dirix P, Liefhooghe N, Otte FX, Gomez-Iturriaga A, Berghen C, Shelan M, Conde-Moreno A, López Campos F, Papachristofilou A, Guckenberger M, Meersschout S, Putora PM, Zwahlen D, Couñago F, Scorsetti M, Eito C, Barrado M, Zapatero A, Muto P, Van De Voorde L et al. (2022)
Oligorecurrent nodal prostate cancer: Radiotherapy quality assurance of the randomized PEACE V-STORM phase II trial
Radiother Oncol, 172, 1-9
DOI 10.1016/j.radonc.2022.04.020, PubMed 35476942
Amdal CD, Falk RS, Singer S, Pe M, Piccinin C, Bottomley A, Appiah LT, Arraras JI, Bayer O, Buanes EA, Darlington AS, Arbanas GD, Hofsø K, Holzner B, Sahlstrand-Johnson P, Kuliś D, Parmar G, Rmeileh NMEA, Schranz M, Sodergren S, Bjordal K (2022)
A multicenter international prospective study of the validity and reliability of a COVID-19-specific health-related quality of life questionnaire
Qual Life Res, 32 (2), 447-459
DOI 10.1007/s11136-022-03272-2, PubMed 36273365
Amdal CD, Taylor K, Kuliś D, Falk RS, Bottomley A, Arraras JI, Barte JH, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Mariano MP, Pe M, Piccinin C, Riccetti N, Schranz M, Wheelwright S, Bjordal K (2022)
Health-related quality of life in patients with COVID-19; international development of a patient-reported outcome measure
J Patient Rep Outcomes, 6 (1), 26
DOI 10.1186/s41687-022-00434-1, PubMed 35348945
Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB (2022)
Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments
Ear Hear, 43 (3), 794-807
DOI 10.1097/AUD.0000000000001172, PubMed 35067571
Bahadoer RR, Bastiaannet E, Peeters KCMJ, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2022)
The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries
J Geriatr Oncol, 13 (6), 803-812
DOI 10.1016/j.jgo.2022.04.011, PubMed 35527207
Bajor M, Graczyk-Jarzynka A, Marhelava K, Burdzinska A, Muchowicz A, Goral A, Zhylko A, Soroczynska K, Retecki K, Krawczyk M, Klopotowska M, Pilch Z, Paczek L, Malmberg KJ, Wälchli S, Winiarska M, Zagozdzon R (2022)
PD-L1 CAR effector cells induce self-amplifying cytotoxic effects against target cells
J Immunother Cancer, 10 (1)
DOI 10.1136/jitc-2021-002500, PubMed 35078921
Barnes DJ, Dutton P, Bruland Ø, Gelderblom H, Faleti A, Bühnemann C, van Maldegem A, Johnson H, Poulton L, Love S, Tiemeier G, van Beelen E, Herbschleb K, Haddon C, Billingham L, Bradley K, Ferrari S, Palmerini E, Picci P, Dirksen U, Strauss SJ, Hogendoorn PCW, Buddingh E, Blay JY, Cleton-Jansen AM et al. (2022)
Outcomes from a mechanistic biomarker multi-arm and randomised study of liposomal MTP-PE (Mifamurtide) in metastatic and/or recurrent osteosarcoma (EuroSarc-Memos trial)
BMC Cancer, 22 (1), 629
DOI 10.1186/s12885-022-09697-9, PubMed 35672690
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
Melanoma - investigation and primary treatment
Tidsskr Nor Laegeforen, 142 (15)
DOI 10.4045/tidsskr.22.0043, PubMed 36286571
Berentzen Å, Brevig T, Hermann R, Ryder T, Winge-Main AK (2022)
Correction: Melanoma - investigation and primary treatment
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0806, PubMed 36655962
Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T (2022)
Circulating T Cell Activation and Exhaustion Markers Are Associated With Radiation Pneumonitis and Poor Survival in Non-Small-Cell Lung Cancer
Front Immunol, 13, 875152
DOI 10.3389/fimmu.2022.875152, PubMed 35911763
Berg J, Halvorsen AR, Bengtson MB, Lindberg M, Halvorsen B, Aukrust P, Helland Å, Ueland T (2022)
Corrigendum: Circulating T cell activation and exhaustion markers are associated with radiation pneumonitis and poor survival in non-small-cell lung cancer
Front Immunol, 13, 1051156
DOI 10.3389/fimmu.2022.1051156, PubMed 36263024
Blakstad H, Wohlleben C, Saxhaug C, Brandal P (2022)
SMART syndrome: two cases highlighting a complex and rare complication of brain irradiation
BMJ Case Rep, 15 (9)
DOI 10.1136/bcr-2022-249599, PubMed 36167430
Boye K, Lobmaier I, Kobbeltvedt MR, Thorkildsen J, Taksdal I, Bjerkehagen B, Bruland ØS, Zaikova O, Sundby Hall K, Hompland I (2022)
Real-world evidence on perioperative chemotherapy in localized soft tissue sarcoma of the extremities and trunk wall; a population-based study
Acta Oncol, 61 (7), 793-800
DOI 10.1080/0284186X.2022.2082259, PubMed 35698755
Brunvoll SH, Flote VG, Halset EH, Bertheussen GF, Skjerven H, Lømo J, Thune I, Hjartåker A (2022)
Normal and unusual days for dietary intake during the 12 months after a breast cancer diagnosis in women
Eur J Nutr, 61 (8), 3873-3885
DOI 10.1007/s00394-022-02925-9, PubMed 35750881
Burtness B, Rischin D, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Ge J, Swaby RF, Gumuscu B, Harrington K (2022)
Pembrolizumab Alone or With Chemotherapy for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma in KEYNOTE-048: Subgroup Analysis by Programmed Death Ligand-1 Combined Positive Score
J Clin Oncol, 40 (21), 2321-2332
DOI 10.1200/JCO.21.02198, PubMed 35333599
Bye A, Bjerkeset E, Stensheim H, Loge JH, Hjermstad MJ, Klepstad P, Habberstad R, Kaasa S, Aass N (2022)
Benefits of Study Participation for Patients with Advanced Cancer Receiving Radiotherapy: A Prospective Observational Study
Palliat Med Rep, 3 (1), 264-271
DOI 10.1089/pmr.2022.0044, PubMed 36876292
Bøhn SH, Vandraas KF, Kiserud CE, Dahl AA, Thorsen L, Ewertz M, Lie HC, Falk R, Reinertsen KV (2022)
Work status changes and associated factors in a nationwide sample of Norwegian long-term breast cancer survivors
J Cancer Surviv, 18 (2), 375-384
DOI 10.1007/s11764-022-01202-2, PubMed 35314959
Børø S, Thoresen S, Helland Å (2022)
Improvements in survival for patients with stage IV adenocarcinoma in the lung, diagnosed between 2010 - 2020 - A population-based registry study from Norway
Front Oncol, 12, 1017902
DOI 10.3389/fonc.2022.1017902, PubMed 36523970
Callesen LB, Hamfjord J, Boysen AK, Pallisgaard N, Guren TK, Kure EH, Spindler KG (2022)
Circulating tumour DNA and its clinical utility in predicting treatment response or survival in patients with metastatic colorectal cancer: a systematic review and meta-analysis
Br J Cancer, 127 (3), 500-513
DOI 10.1038/s41416-022-01816-4, PubMed 35440666
Callesen LB, Takacova T, Hamfjord J, Würschmidt F, Oldhafer KJ, Brüning R, Arnold D, Spindler KG (2022)
Circulating DNA in patients undergoing loco-regional treatment of colorectal cancer metastases: a systematic review and meta-analysis
Ther Adv Med Oncol, 14, 17588359221133171
DOI 10.1177/17588359221133171, PubMed 36339929
Carlsson G, Koumarianou A, Guren TK, Haux J, Katsaounis P, Kentepozidis N, Pfeiffer P, Brændengen M, Mavroudis D, Taflin H, Skintemo L, Tell R, Papadimitriou C (2022)
A phase I/II study of arfolitixorin and 5-fluorouracil in combination with oxaliplatin (plus or minus bevacizumab) or irinotecan in metastatic colorectal cancer
ESMO Open, 7 (5), 100589
DOI 10.1016/j.esmoop.2022.100589, PubMed 36183444
Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, Geisler CH, Kjems J, Kristensen LS, Grønbæk K (2022)
Correction: Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
Leukemia, 36 (4), 1198
DOI 10.1038/s41375-022-01526-z, PubMed 35181760
Dahl AA, Fosså SD (2022)
High Neuroticism Is Related to More Overall Functional Problems and Lower Function Scores in Men Who Had Surgery for Non-Relapsing Prostate Cancer
Curr Oncol, 29 (8), 5823-5832
DOI 10.3390/curroncol29080459, PubMed 36005197
Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2022)
A study of high neuroticism in long-term survivors of childhood, adolescence, and young adult cancers
Sci Rep, 12 (1), 12325
DOI 10.1038/s41598-022-15697-3, PubMed 35853946
Dahle DO, Skauby M, Langberg CW, Brabrand K, Wessel N, Midtvedt K (2022)
Renal Cell Carcinoma and Kidney Transplantation: A Narrative Review
Transplantation, 106 (1), e52-e63
DOI 10.1097/TP.0000000000003762, PubMed 33741842
Dijkstra EA, Hospers GAP, Kranenbarg EM, Fleer J, Roodvoets AGH, Bahadoer RR, Guren MG, Tjalma JJJ, Putter H, Crolla RMPH, Hendriks MP, Capdevila J, Radu C, van de Velde CJH, Nilsson PJ, Glimelius B, van Etten B, Marijnen CAM (2022)
Quality of life and late toxicity after short-course radiotherapy followed by chemotherapy or chemoradiotherapy for locally advanced rectal cancer - The RAPIDO trial
Radiother Oncol, 171, 69-76
DOI 10.1016/j.radonc.2022.04.013, PubMed 35447283
Dorraji E, Borgen E, Segura-Peña D, Rawat P, Smorodina E, Dunn C, Greiff V, Sekulić N, Russnes H, Kyte JA (2022)
Development of a High-Affinity Antibody against the Tumor-Specific and Hyperactive 611-p95HER2 Isoform
Cancers (Basel), 14 (19)
DOI 10.3390/cancers14194859, PubMed 36230782
Dueland S, Smedman TM, Grut H, Syversveen T, Jørgensen LH, Line PD (2022)
PET-Uptake in Liver Metastases as Method to Predict Tumor Biological Behavior in Patients Transplanted for Colorectal Liver Metastases Developing Lung Recurrence
Cancers (Basel), 14 (20)
DOI 10.3390/cancers14205042, PubMed 36291826
Eide IJZ, Stensgaard S, Helland Å, Ekman S, Mellemgaard A, Hansen KH, Cicenas S, Koivunen J, Grønberg BH, Sørensen BS, Brustugun OT (2022)
Osimertinib in non-small cell lung cancer with uncommon EGFR-mutations: a post-hoc subgroup analysis with pooled data from two phase II clinical trials
Transl Lung Cancer Res, 11 (6), 953-963
DOI 10.21037/tlcr-21-995, PubMed 35832438
Eikeland SA, Smeland KB, Brekke M, Kiserud CE, Fosså A (2022)
Late-effect awareness and follow-up of cancer in general practice
Scand J Prim Health Care, 40 (3), 360-369
DOI 10.1080/02813432.2022.2139457, PubMed 36380478
Ellingsen EB, Bounova G, Kerzeli I, Anzar I, Simnica D, Aamdal E, Guren T, Clancy T, Mezheyeuski A, Inderberg EM, Mangsbo SM, Binder M, Hovig E, Gaudernack G (2022)
Characterization of the T cell receptor repertoire and melanoma tumor microenvironment upon combined treatment with ipilimumab and hTERT vaccination
J Transl Med, 20 (1), 419
DOI 10.1186/s12967-022-03624-z, PubMed 36089578
Ellingsen EB, Aamdal E, Guren T, Lilleby W, Brunsvig PF, Mangsbo SM, Aamdal S, Hovig E, Mensali N, Gaudernack G, Inderberg EM (2022)
Durable and dynamic hTERT immune responses following vaccination with the long-peptide cancer vaccine UV1: long-term follow-up of three phase I clinical trials
J Immunother Cancer, 10 (5)
DOI 10.1136/jitc-2021-004345, PubMed 35613827
Eriksen GF, Benth JŠ, Grønberg BH, Rostoft S, Kirkhus L, Kirkevold Ø, Oldervoll LM, Bye A, Hjelstuen A, Slaaen M (2022)
Geriatric impairments are associated with reduced quality of life and physical function in older patients with cancer receiving radiotherapy - A prospective observational study
J Geriatr Oncol, 14 (1), 101379
DOI 10.1016/j.jgo.2022.09.008, PubMed 36180379
Evensen H, Hjermstad MJ, Cvancarova M, Kristensen V, Larssen L, Skattum J, Hauge T, Sandstad O, Medhus AW (2022)
Quality of life in patients with achalasia: Associations with Eckardt score and objective treatment outcomes after peroral endoscopic myotomy
Endosc Int Open, 10 (12), E1570-E1576
DOI 10.1055/a-1968-7682, PubMed 36531682
Evensen ME, Furre T, Malinen E, Løndalen AM, Dale E (2022)
Mucosa-sparing dose painting of head and neck cancer
Acta Oncol, 61 (2), 141-145
DOI 10.1080/0284186X.2021.2022200, PubMed 34991431
Falk P, Severin M, Berglund Å, Guren MG, Hofsli E, Österlund P, Tandberg A, Eberhard J, Sorbye H (2022)
Sex hormones and sperm parameters after adjuvant oxaliplatin-based treatment for colorectal cancer
Cancer Treat Res Commun, 31, 100517
DOI 10.1016/j.ctarc.2022.100517, PubMed 35114500
Fallon M, Dierberger K, Leng M, Hall PS, Allende S, Sabar R, Verastegui E, Gordon D, Grant L, Lee R, McWillams K, Murray GD, Norris L, Reid C, Sande TA, Caraceni A, Kaasa S, Laird BJA (2022)
An international, open-label, randomised trial comparing a two-step approach versus the standard three-step approach of the WHO analgesic ladder in patients with cancer
Ann Oncol, 33 (12), 1296-1303
DOI 10.1016/j.annonc.2022.08.083, PubMed 36055465
Fauske L, Wærstad PH, Hompland I, Bruland ØS (2022)
Hope as a Lifeline: Imatinib Discontinuation in Patients With Oligometastatic Gastrointestinal Stromal Tumours
Anticancer Res, 42 (2), 955-963
DOI 10.21873/anticanres.15555, PubMed 35093895
Forcados C, Joaquina S, Casey NP, Caulier B, Wälchli S (2022)
How CAR T Cells Breathe
Cells, 11 (9)
DOI 10.3390/cells11091454, PubMed 35563759
Fosså SD, Dahl AA, Johannesen TB, Gjelsvik YM, Storås AH, Myklebust TÅ (2022)
Late Adverse Health Outcomes and Quality of Life after curative radiotherapy + long-term ADT in Prostate Cancer Survivors: Comparison with men from the general population
Clin Transl Radiat Oncol, 37, 78-84
DOI 10.1016/j.ctro.2022.08.003, PubMed 36093341
Fosså SD, Dahl AA, Thorsen L, Hellesnes R, Kiserud CE, Tandstad T, Brydøy M, Haugnes HS, Myklebust TÅ (2022)
Mortality and Second Cancer Incidence After Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
J Clin Oncol, 40 (23), 2588-2599
DOI 10.1200/JCO.21.02105, PubMed 35380874
Franco P, Segelov E, Johnsson A, Riechelmann R, Guren MG, Das P, Rao S, Arnold D, Spindler KG, Deutsch E, Krengli M, Tombolini V, Sebag-Montefiore D, De Felice F (2022)
A Machine-Learning-Based Bibliometric Analysis of the Scientific Literature on Anal Cancer
Cancers (Basel), 14 (7)
DOI 10.3390/cancers14071697, PubMed 35406469
Frich PS, Sigstad E, Berstad AE, Fagerlid KH, Paulsen TH, Bjøro T, Flinder LI (2022)
Long-Term Efficacy of Ethanol Ablation as Treatment of Metastatic Lymph Nodes From Papillary Thyroid Carcinoma
J Clin Endocrinol Metab, 107 (5), e2141-e2147
DOI 10.1210/clinem/dgab907, PubMed 34922379
Georgiesh T, Aggerholm-Pedersen N, Schöffski P, Zhang Y, Napolitano A, Bovée JVMG, Hjelle Å, Tang G, Spalek M, Nannini M, Swanson D, Baad-Hansen T, Sciot R, Hesla AC, Huang P, Dorleijn D, Haugland HK, Lacambra M, Skoczylas J, Pantaleo MA, Haas RL, Meza-Zepeda LA, Haller F, Czarnecka AM, Loong H et al. (2022)
Validation of a novel risk score to predict early and late recurrence in solitary fibrous tumour
Br J Cancer, 127 (10), 1793-1798
DOI 10.1038/s41416-022-01959-4, PubMed 36030294
Gianinazzi ME, Kiserud CE, Ruud E, Lie HC (2022)
Who Knows? Information Received, and Knowledge about, Cancer, Treatment and Late Effects in a National Cohort of Long-Term Childhood, Adolescent and Young Adult Cancer Survivors
Cancers (Basel), 14 (6)
DOI 10.3390/cancers14061534, PubMed 35326685
Girard N, Bar J, Garrido P, Garassino MC, McDonald F, Mornex F, Filippi AR, Smit HJM, Peters S, Field JK, Christoph DC, Sibille A, Fietkau R, Haakensen VD, Chouaid C, Markman B, Hiltermann TJN, Taus A, Sawyer W, Allen A, Chander P, Licour M, Solomon B (2022)
Treatment Characteristics and Real-World Progression-Free Survival in Patients With Unresectable Stage III NSCLC Who Received Durvalumab After Chemoradiotherapy: Findings From the PACIFIC-R Study
J Thorac Oncol, 18 (2), 181-193
DOI 10.1016/j.jtho.2022.10.003, PubMed 36307040
Gjerset GM, Skaali T, Seland M, Thorsen L (2022)
Health-Related Quality of Life, Fatigue, Level of Physical Activity, and Physical Capacity Before and After an Outpatient Rehabilitation Program for Women Within Working Age Treated for Breast Cancer
J Cancer Educ, 38 (3), 948-956
DOI 10.1007/s13187-022-02211-6, PubMed 35974293
Glatzer M, Tanderup K, Rovirosa A, Fokdal L, Ordeanu C, Tagliaferri L, Chargari C, Strnad V, Dimopoulos JA, Šegedin B, Cooper R, Nakken ES, Petric P, van der Steen-Banasik E, Lössl K, Jürgenliemk-Schulz IM, Niehoff P, Hermansson RS, Nout RA, Putora PM, Plasswilm L, Tselis N (2022)
Role of Brachytherapy in the Postoperative Management of Endometrial Cancer: Decision-Making Analysis among Experienced European Radiation Oncologists
Cancers (Basel), 14 (4)
DOI 10.3390/cancers14040906, PubMed 35205653
Gongora M, Stranne J, Johansson E, Bottai M, Thellenberg Karlsson C, Brasso K, Hansen S, Jakobsen H, Jäderling F, Lindberg H, Lilleby W, Meidahl Petersen P, Mirtti T, Olsson M, Rannikko A, Røder MA, Henrik Vincent P, Akre O (2022)
Characteristics of Patients in SPCG-15-A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer
Eur Urol Open Sci, 41, 63-73
DOI 10.1016/j.euros.2022.04.013, PubMed 35813256
Gorunova L, Boye K, Panagopoulos I, Berner JM, Bjerkehagen B, Hompland I, Lobmaier I, Hølmebakk T, Hveem TS, Heim S, Micci F (2022)
Cytogenetic and molecular analyses of 291 gastrointestinal stromal tumors: site-specific cytogenetic evolution as evidence of pathogenetic heterogeneity
Oncotarget, 13, 508-517
DOI 10.18632/oncotarget.28209, PubMed 35284037
Gulati G, Tjessem KH, Horndalsveen H, Halvorsen S, Haakensen VD (2022)
[Checkpoint inhibitor-induced myocarditis]
Tidsskr Nor Laegeforen, 142 (18)
DOI 10.4045/tidsskr.21.0817, PubMed 36511752
Guldvik IJ, Braadland PR, Sivanesan S, Ramberg H, Kristensen G, Tennstedt P, Røder A, Schlomm T, Berge V, Eri LM, Lilleby W, Mills IG, Taskén KA (2022)
Low Blood Levels of LRG1 Before Radical Prostatectomy Identify Patients with High Risk of Progression to Castration-resistant Prostate Cancer
Eur Urol Open Sci, 45, 68-75
DOI 10.1016/j.euros.2022.09.002, PubMed 36353660
Habberstad R, Aass N, Mollnes TE, Damås JK, Brunelli C, Rossi R, Garcia-Alonso E, Kaasa S, Klepstad P (2022)
Inflammatory Markers and Radiotherapy Response in Patients With Painful Bone Metastases
J Pain Symptom Manage, 64 (4), 330-339
DOI 10.1016/j.jpainsymman.2022.06.018, PubMed 35803553
Harrington KJ, Burtness B, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Brana I, Basté N, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesia R, Ngamphaiboon N, Rordorf T, Wan Ishak WZ, Lin J, Gumuscu B, Swaby RF, Rischin D (2022)
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study
J Clin Oncol, 41 (4), 790-802
DOI 10.1200/JCO.21.02508, PubMed 36219809
Hauger SL, Borgen IMH, Løvstad M, Lu J, Forslund MV, Kleffelgård I, Andelic N, Røe C (2022)
Community-Based Interventions After Acquired Brain Injury-A Systematic Review of Intervention Types and Their Effectiveness
J Head Trauma Rehabil, 37 (5), E355-E369
DOI 10.1097/HTR.0000000000000765, PubMed 35125426
Helland Å, Andersen KK, Myklebust TÅ, Johannesen TB, Aarøe J, Enerly E (2022)
EGFR-mutation testing and TKI treatment patterns in locally advanced and metastatic NSCLC in Norway - A nationwide retrospective cohort study
Cancer Treat Res Commun, 33, 100636
DOI 10.1016/j.ctarc.2022.100636, PubMed 36155129
Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
J Transl Med, 20 (1), 225
DOI 10.1186/s12967-022-03432-5, PubMed 35568909
Helland Å, Russnes HG, Fagereng GL, Al-Shibli K, Andersson Y, Berg T, Bjørge L, Blix E, Bjerkehagen B, Brabrand S, Cameron MG, Dalhaug A, Dietzel D, Dønnem T, Enerly E, Flobak Å, Fluge S, Gilje B, Gjertsen BT, Grønberg BH, Grønås K, Guren T, Hamre H, Haug Å, Heinrich D et al. (2022)
Correction to: Improving public cancer care by implementing precision medicine in Norway: IMPRESS-Norway
J Transl Med, 20 (1), 317
DOI 10.1186/s12967-022-03518-0, PubMed 35841045
Helliesen JS, Kristiansen I, Brekke HK, Støkket RS, Bye A (2022)
Nutrition impact symptoms and the risk of malnutrition in people with Parkinson's disease: A cross-sectional study
J Hum Nutr Diet, 36 (1), 40-50
DOI 10.1111/jhn.13070, PubMed 35897145
Horndalsveen H, Alver TN, Dalsgaard AM, Rogg LV, Helbekkmo N, Grønberg BH, Halvorsen TO, Ramberg C, Haakensen VD, Öjlert ÅK, Bjaanaes MM, Helland Å (2022)
Atezolizumab and stereotactic body radiotherapy in patients with advanced non-small cell lung cancer: safety, clinical activity and ctDNA responses-the ComIT-1 trial
Mol Oncol, 17 (3), 487-498
DOI 10.1002/1878-0261.13330, PubMed 36330681
Huse K, Bai B, Hilden VI, Bollum LK, Våtsveen TK, Munthe LA, Smeland EB, Irish JM, Wälchli S, Myklebust JH (2022)
Mechanism of CD79A and CD79B Support for IgM+ B Cell Fitness through B Cell Receptor Surface Expression
J Immunol, 209 (10), 2042-2053
DOI 10.4049/jimmunol.2200144, PubMed 36426942
Hustad KS, Rundblad A, Ottestad I, Christensen JJ, Holven KB, Ulven SM (2022)
Comprehensive lipid and metabolite profiling in healthy adults with low and high consumption of fatty fish: a cross-sectional study - CORRIGENDUM
Br J Nutr, 128 (2), 367-368
DOI 10.1017/S0007114522001519, PubMed 35579033
Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2022)
Idiopathic Duro-Optic Calcification
J Neuroophthalmol, 44 (1), e204
DOI 10.1097/WNO.0000000000001722, PubMed 36255093
Huynh TTM, Aass HCD, Falk RS, Astrup GL, Helland Å, Bjøro T, Bjordal K, Dale E, Hellebust TP, Herlofson BB, Malinen E, Kiserud CE, Osnes T, Amdal CD (2022)
Associations between patient-reported late effects and systemic cytokines in long-term survivors of head and neck cancer treated with radiotherapy
J Cancer Surviv, 17 (4), 1082-1093
DOI 10.1007/s11764-022-01273-1, PubMed 36350483
Hynne H, Aqrawi LA, Jensen JL, Thiede B, Palm Ø, Amdal CD, Westgaard KL, Herlofson BB, Utheim TP, Galtung HK (2022)
Proteomic Profiling of Saliva and Tears in Radiated Head and Neck Cancer Patients as Compared to Primary Sjögren's Syndrome Patients
Int J Mol Sci, 23 (7)
DOI 10.3390/ijms23073714, PubMed 35409074
Høye E, Dagenborg VJ, Torgunrud A, Lund-Andersen C, Fretland ÅA, Lorenz S, Edwin B, Hovig E, Fromm B, Inderberg EM, Greiff V, Ree AH, Flatmark K (2022)
T cell receptor repertoire sequencing reveals chemotherapy-driven clonal expansion in colorectal liver metastases
Gigascience, 12
DOI 10.1093/gigascience/giad032, PubMed 37161965
Ivanova A, Rodríguez-Cano R, Kvalem IL, Harcourt D, Kiserud CE, Amdal CD (2022)
Body image concerns in long-term head and neck cancer survivors: prevalence and role of clinical factors and patient-reported late effects
J Cancer Surviv, 17 (2), 526-534
DOI 10.1007/s11764-022-01311-y, PubMed 36509859
Jaeger U, Tam CS, Borchmann P, McGuirk JP, Johansen M, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Salles G, Schuster SJ, He F, Maziarz RT, Mayer S, Makita S, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P et al. (2022)
Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma
Blood Adv, 6 (16), 4816-4820
DOI 10.1182/bloodadvances.2021006193, PubMed 35687492
Jakobsen G, Gjeilo KH, Hjermstad MJ, Klepstad P (2022)
An Update on Prevalence, Assessment, and Risk Factors for Sleep Disturbances in Patients with Advanced Cancer-Implications for Health Care Providers and Clinical Research
Cancers (Basel), 14 (16)
DOI 10.3390/cancers14163933, PubMed 36010925
Jakobsen G, Sjue K, Paulsen Ø, Kaasa S, Hjermstad MJ, Klepstad P (2022)
Zopiclone versus placebo for short-term treatment of insomnia in patients with advanced cancer-a double-blind, randomized placebo-controlled clinical multicenter phase IV trial
Support Care Cancer, 31 (1), 60
DOI 10.1007/s00520-022-07537-x, PubMed 36534165
Jespersen H (2022)
Moles and melanoma
Tidsskr Nor Laegeforen, 142 (15)
DOI 10.4045/tidsskr.22.0626, PubMed 36286558
Jin Y, Lorvik KB, Jin Y, Beck C, Sike A, Persiconi I, Kvaløy E, Saatcioglu F, Dunn C, Kyte JA (2022)
Development of STEAP1 targeting chimeric antigen receptor for adoptive cell therapy against cancer
Mol Ther Oncolytics, 26, 189-206
DOI 10.1016/j.omto.2022.06.007, PubMed 35860008
Khadse A, Haakensen VD, Silwal-Pandit L, Hamfjord J, Micke P, Botling J, Brustugun OT, Lingjærde OC, Helland Å, Kure EH (2022)
Prognostic Significance of the Loss of Heterozygosity of KRAS in Early-Stage Lung Adenocarcinoma
Front Oncol, 12, 873532
DOI 10.3389/fonc.2022.873532, PubMed 35574381
Killingberg KT, Halvorsen TO, Fløtten Ø, Brustugun OT, Langer SW, Nyman J, Hornslien K, Madebo T, Schytte T, Risum S, Tsakonas G, Engleson J, Grønberg BH (2022)
Patient-reported health-related quality of life from a randomized phase II trial comparing standard-dose with high-dose twice daily thoracic radiotherapy in limited stage small-cell lung cancer
Lung Cancer, 166, 49-57
DOI 10.1016/j.lungcan.2022.02.002, PubMed 35183991
Kiserud CE, Lockmer S, Baerug I, Dahl AA, Kimby E, Østenstad B (2022)
Health-related quality of life and chronic fatigue in long-term survivors of indolent lymphoma - a comparison with normative data
Leuk Lymphoma, 64 (2), 349-355
DOI 10.1080/10428194.2022.2142050, PubMed 36342349
Kishan AU, Marco N, Schulz-Jaavall MB, Steinberg ML, Tran PT, Juarez JE, Dang A, Telesca D, Lilleby WA, Weidhaas JB (2022)
Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation
Radiother Oncol, 167, 226-232
DOI 10.1016/j.radonc.2021.12.040, PubMed 34990726
Kishan AU, Steigler A, Denham JW, Zapatero A, Guerrero A, Joseph D, Maldonado X, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Pisansky TM et al. (2022)
Interplay Between Duration of Androgen Deprivation Therapy and External Beam Radiotherapy With or Without a Brachytherapy Boost for Optimal Treatment of High-risk Prostate Cancer: A Patient-Level Data Analysis of 3 Cohorts
JAMA Oncol, 8 (3), e216871
DOI 10.1001/jamaoncol.2021.6871, PubMed 35050303
Kopetz S, Grothey A, Van Cutsem E, Yaeger R, Wasan H, Yoshino T, Desai J, Ciardiello F, Loupakis F, Hong YS, Steeghs N, Guren TK, Arkenau HT, Garcia-Alfonso P, Belani A, Zhang X, Tabernero J (2022)
Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC
ESMO Open, 7 (3), 100477
DOI 10.1016/j.esmoop.2022.100477, PubMed 35653981
Kosgallana S, Jayasekara P, Abeysinghe P, Hjermstad M, Lalloo R (2022)
Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka
BMC Oral Health, 22 (1), 359
DOI 10.1186/s12903-022-02392-y, PubMed 35986341
Kreye G, Lundeby T, Latino N, Galotti M, Kaasa S (2022)
ESMO Designated Centres of Integrated Oncology and Palliative Care (ESMO DCs): education, research and programme development survey
ESMO Open, 7 (6), 100622
DOI 10.1016/j.esmoop.2022.100622, PubMed 36356414
Kristensen A, Grønberg BH, Fløtten Ø, Kaasa S, Solheim TS (2022)
Trajectory of health-related quality of life during the last year of life in patients with advanced non-small-cell lung cancer
Support Care Cancer, 30 (11), 9351-9358
DOI 10.1007/s00520-022-07359-x, PubMed 36109393
Kryeziu K, Bergsland CH, Guren TK, Sveen A, Lothe RA (2022)
Multiplex immunohistochemistry of metastatic colorectal cancer and ex vivo tumor avatars
Biochim Biophys Acta Rev Cancer, 1877 (1), 188682
DOI 10.1016/j.bbcan.2022.188682, PubMed 35065193
Kvammen JA, Stensvold E, Godang K, Bollerslev J, Myklebust TÅ, Brandal P, Henriksen C, Bechensteen AG (2022)
Bone mineral density and nutrition in long-term survivors of childhood brain tumors
Clin Nutr ESPEN, 50, 162-169
DOI 10.1016/j.clnesp.2022.05.025, PubMed 35871919
Kyte JA (2022)
Strategies for Improving the Efficacy of CAR T Cells in Solid Cancers
Cancers (Basel), 14 (3)
DOI 10.3390/cancers14030571, PubMed 35158839
Kørner H, Guren MG, Larsen IK, Haugen DF, Søreide K, Kørner LR, Søreide JA (2022)
Characteristics and fate of patients with rectal cancer not entering a curative-intent treatment pathway: A complete nationwide registry cohort of 3,304 patients
Eur J Surg Oncol, 48 (8), 1831-1839
DOI 10.1016/j.ejso.2022.04.013, PubMed 35527055
Langen Stokmo H, Aly M, Bowitz Lothe IM, Borja AJ, Mehdizadeh Seraj S, Ghorpade R, Miao X, Hjortland GO, Malinen E, Sorbye H, Werner TJ, Alavi A, Revheim ME (2022)
Volumetric parameters from [¹⁸ F]FDG PET/CT predicts survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms
J Neuroendocrinol, 34 (7), e13170
DOI 10.1111/jne.13170, PubMed 35729738
Larsen BH, Lundeby T, Gulbrandsen P, Førde R, Gerwing J (2022)
Physicians' responses to advanced cancer patients' existential concerns: A video-based analysis
Patient Educ Couns, 105 (10), 3062-3070
DOI 10.1016/j.pec.2022.06.007, PubMed 35738963
Larsen EH, Mellblom AV, Larsen MH, Ruud E, Thorsen L, Petersen NN, Larsen HB, Fridh MK, Lie HC (2022)
Perceived barriers and facilitators to physical activity in childhood cancer survivors and their parents: A large-scale interview study from the International PACCS Study
Pediatr Blood Cancer, 70 (1), e30056
DOI 10.1002/pbc.30056, PubMed 36251019
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Osvik Velle E, Skuterud Wik H, Ghanima W, Sandset PM, Dahm AEA (2022)
Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up
J Thromb Haemost, 20 (5), 1166-1181
DOI 10.1111/jth.15666, PubMed 35114046
Larsen TL, Garresori H, Brekke J, Enden T, Frøen H, Jacobsen EM, Quist-Paulsen P, Porojnicu AC, Ree AH, Torfoss D, Velle EO, Wik HS, Ghanima W, Sandset PM, Dahm AEA (2022)
"Low dose apixaban as secondary prophylaxis of venous thromboembolism in cancer patients - 30 months follow-up": Reply
J Thromb Haemost, 20 (8), 1937-1939
DOI 10.1111/jth.15774, PubMed 35859282
Larsen TL, Ghanima W, Sandset PM, Frøen H, Jacobsen EM, Torfoss D, Dahm AEA (2022)
[Factor Xa inhibitors in the prevention and treatment of venous thromboembolism in cancer patients]
Tidsskr Nor Laegeforen, 142 (1)
DOI 10.4045/tidsskr.22.0228, PubMed 36655971
Lee CJ, Modave E, Boeckx B, Kasper B, Aamdal S, Leahy MG, Rutkowski P, Bauer S, Debiec-Rychter M, Sciot R, Lambrechts D, Wozniak A, Schöffski P (2022)
Correlation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial
Int J Mol Sci, 23 (10)
DOI 10.3390/ijms23105689, PubMed 35628499
Lie HC, Anderssen S, Rueegg CS, Raastad T, Grydeland M, Thorsen L, Stensrud T, Edvardsen E, Larsen MH, Torsvik IK, Bovim LP, Götte M, Lähteenmäki PM, Kriemler S, Larsen HB, Fridh MK, Ørstavik K, Brun H, Matthews I, Hornset E, Ruud E (2022)
The Physical Activity and Fitness in Childhood Cancer Survivors (PACCS) Study: Protocol for an International Mixed Methods Study
JMIR Res Protoc, 11 (3), e35838
DOI 10.2196/35838, PubMed 35258456
Lindegaard JC, Petric P, Schmid MP, Nesvacil N, Haie-Meder C, Fokdal LU, Sturdza AE, Hoskin P, Mahantshetty U, Segedin B, Bruheim K, Huang F, Rai B, Cooper R, van der Steen-Banasik E, Van Limbergen E, Pieters BR, Tan LT, Nout RA, De Leeuw AAC, Kirchheiner K, Spampinato S, Jürgenliemk-Schulz I, Tanderup K, Kirisits C et al. (2022)
Prognostic Implications of Uterine Cervical Cancer Regression During Chemoradiation Evaluated by the T-Score in the Multicenter EMBRACE I Study
Int J Radiat Oncol Biol Phys, 113 (2), 379-389
DOI 10.1016/j.ijrobp.2022.02.005, PubMed 35157992
Lofterød T, Frydenberg H, Veierød MB, Jenum AK, Reitan JB, Wist EA, Thune I (2022)
The influence of metabolic factors and ethnicity on breast cancer risk, treatment and survival: The Oslo ethnic breast cancer study
Acta Oncol, 61 (5), 649-657
DOI 10.1080/0284186X.2022.2053573, PubMed 35348396
Lunde P, Bye A, Bruusgaard KA, Hellem E, Nilsson BB (2022)
Patients' Experiences of Using a Smartphone App After Cardiac Rehabilitation: Qualitative Study
JMIR Hum Factors, 9 (1), e34294
DOI 10.2196/34294, PubMed 35319476
Lundeby T, Finset A, Kaasa S, Wester TE, Hjermstad MJ, Dajani O, Wist E, Aass N (2022)
A complex communication skills training program for physicians providing advanced cancer care - content development and barriers and solutions for implementation
J Commun Healthc, 16 (1), 46-57
DOI 10.1080/17538068.2022.2039468, PubMed 36919800
Lundeby T, Hjermstad MJ, Aass N, Kaasa S (2022)
Integration of palliative care in oncology-the intersection of cultures and perspectives of oncology and palliative care
Ecancermedicalscience, 16, 1376
DOI 10.3332/ecancer.2022.1376, PubMed 35702405
Lyng H, Skipar K, Hompland T (2022)
Targeted Therapy on the Screen: Do We Hit the Target?
Clin Cancer Res, 28 (24), 5233-5234
DOI 10.1158/1078-0432.CCR-22-2707, PubMed 36240006
Løndalen A, Blakkisrud J, Revheim ME, Dahle J, Kolstad A, Stokke C (2022)
FDG PET/CT and Dosimetric Studies of ¹⁷⁷Lu-Lilotomab Satetraxetan in a First-in-Human Trial for Relapsed Indolent non-Hodgkin Lymphoma-Are We Hitting the Target?
Mol Imaging Biol, 24 (5), 807-817
DOI 10.1007/s11307-022-01731-3, PubMed 35486292
Maggadóttir SM, Kvalheim G, Wernhoff P, Sæbøe-Larssen S, Revheim ME, Josefsen D, Wälchli S, Helland Å, Inderberg EM (2022)
A phase I/II escalation trial design T-RAD: Treatment of metastatic lung cancer with mRNA-engineered T cells expressing a T cell receptor targeting human telomerase reverse transcriptase (hTERT)
Front Oncol, 12, 1031232
DOI 10.3389/fonc.2022.1031232, PubMed 36439452
Marabelle A, Cassier PA, Fakih M, Kao S, Nielsen D, Italiano A, Guren TK, van Dongen MGJ, Spencer K, Bariani GM, Ascierto PA, Santoro A, Shah M, Asselah J, Iqbal S, Takahashi S, Piha-Paul SA, Ott PA, Chatterjee A, Jin F, Norwood K, Delord JP (2022)
Pembrolizumab for previously treated advanced anal squamous cell carcinoma: results from the non-randomised, multicohort, multicentre, phase 2 KEYNOTE-158 study
Lancet Gastroenterol Hepatol, 7 (5), 446-454
DOI 10.1016/S2468-1253(21)00382-4, PubMed 35114169
Mediå LM, Fauske L, Sigurdardottir S, Feragen KJB, Heggeli C, Wæhre A (2022)
'It was Supposed to be a Secret': a study of disclosure and stigma as experienced by adults with differences of sex development
Health Psychol Behav Med, 10 (1), 579-595
DOI 10.1080/21642850.2022.2102018, PubMed 35898596
Meltzer S, Negård A, Bakke KM, Hamre HM, Kersten C, Hofsli E, Guren MG, Sorbye H, Flatmark K, Ree AH (2022)
Early radiologic signal of responsiveness to immune checkpoint blockade in microsatellite-stable/mismatch repair-proficient metastatic colorectal cancer
Br J Cancer, 127 (12), 2227-2233
DOI 10.1038/s41416-022-02004-0, PubMed 36229579
Mensali N, Inderberg EM (2022)
Emerging Biomarkers for Immunotherapy in Glioblastoma
Cancers (Basel), 14 (8)
DOI 10.3390/cancers14081940, PubMed 35454848
Meriranta L, Alkodsi A, Pasanen A, Lepistö M, Mapar P, Blaker YN, Jørgensen J, Karjalainen-Lindsberg ML, Fiskvik I, Mikalsen LTG, Autio M, Björkholm M, Jerkeman M, Fluge Ø, Brown P, Jyrkkiö S, Holte H, Pitkänen E, Ellonen P, Leppä S (2022)
Molecular features encoded in the ctDNA reveal heterogeneity and predict outcome in high-risk aggressive B-cell lymphoma
Blood, 139 (12), 1863-1877
DOI 10.1182/blood.2021012852, PubMed 34932792
Merklinger-Gruchala A, Jasienska G, Thune I, Kapiszewska M (2022)
Joint effect of particulate matter and cigarette smoke on women's sex hormones
BMC Womens Health, 22 (1), 3
DOI 10.1186/s12905-021-01586-w, PubMed 34996432
Meyer-Myklestad MH, Medhus AW, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Stiksrud B, Trøseid M, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Reikvam DH (2022)
Human Immunodeficiency Virus-Infected Immunological Nonresponders Have Colon-Restricted Gut Mucosal Immune Dysfunction
J Infect Dis, 225 (4), 661-674
DOI 10.1093/infdis/jiaa714, PubMed 33216130
Meyer-Myklestad MH, Medhus AW, Stiksrud B, Lorvik KB, Seljeflot I, Hansen SH, Holm K, Hov JR, Kvale D, Dyrhol-Riise AM, Kummen M, Trøseid M, Reikvam DH (2022)
Probiotics to HIV-Infected Immunological Nonresponders: Altered Mucosal Immunity and Microbial Diversity Restricted to Ileum
J Acquir Immune Defic Syndr, 89 (1), 77-86
DOI 10.1097/QAI.0000000000002817, PubMed 34878437
Mo T, Brandal SHB, Köhn-Luque A, Engebraaten O, Kristensen VN, Fleischer T, Hompland T, Seierstad T (2022)
Quantification of Tumor Hypoxia through Unsupervised Modelling of Consumption and Supply Hypoxia MR Imaging in Breast Cancer
Cancers (Basel), 14 (5)
DOI 10.3390/cancers14051326, PubMed 35267636
Monsen KV, Fosså SD, Myklebust TÅ, Smeland S, Dahl AA, Stensvold A (2022)
Long-term satisfaction with curative treatment and follow-up in prostate cancer survivors
Acta Oncol, 61 (3), 357-362
DOI 10.1080/0284186X.2021.2006775, PubMed 35103559
Mucci LA, Vinson J, Gold T, Gerke T, Filipenko J, Green RM, Anderson SG, Badal S, Bjartell A, Chi KN, Davis ID, Enting D, Fay AP, Lazarus J, Mateo J, McDermott R, Odedina FT, Olmos D, Omlin A, Popoola AA, Ragin C, Roberts R, Russnes KM, Waihenya C, Stopsack KH et al. (2022)
IRONMAN: A Novel International Registry of Men With Advanced Prostate Cancer
JCO Glob Oncol, 8, e2200154
DOI 10.1200/GO.22.00154, PubMed 36332173
Møller CT, Fosså SD, Tafjord G, Babigumira R, Berge V, Andreassen BK (2022)
Primary versus secondary muscle-invasive bladder cancer: survival after curative treatment
Scand J Urol, 56 (3), 214-220
DOI 10.1080/21681805.2022.2056633, PubMed 35506475
Møller CT, Støer NC, Blindheim A, Berge V, Tafjord G, Fosså SD, Andreassen BK (2022)
Downstaging and survival after Neoadjuvant chemotherapy for bladder cancer in Norway; a population-based study
BMC Cancer, 22 (1), 1301
DOI 10.1186/s12885-022-10394-w, PubMed 36510166
Niehusmann P, Stensvold E, Leske H, Pietsch T, Goschzik T, Gielen GH, Due-Tønnessen B, Frič R, Nilssen Y, Brandal P (2022)
Molecular pathological insights reveal a high number of unfavorable risk patients among children treated for medulloblastoma and CNS-PNET in Oslo 2005-2017
Pediatr Blood Cancer, 69 (9), e29736
DOI 10.1002/pbc.29736, PubMed 35570402
Nielsen HJ, Nedrebø BG, Fosså A, Andersen JR, Assmus J, Dagsland VH, Dankel SN, Gudbrandsen OA, Fernø J, Hjellestad I, Hjermstad MJ, Kolotkin RL, Thorsen HL, Mellgren G, Flølo TN (2022)
Seven-year trajectories of body weight, quality of life and comorbidities following Roux-en-Y gastric bypass and sleeve gastrectomy
Int J Obes (Lond), 46 (4), 739-749
DOI 10.1038/s41366-021-01028-5, PubMed 34974544
Nilsen TS, Johansen SH, Thorsen L, Fairman CM, Wisløff T, Raastad T (2022)
Does Androgen Deprivation for Prostate Cancer Affect Normal Adaptation to Resistance Exercise?
Int J Environ Res Public Health, 19 (7)
DOI 10.3390/ijerph19073820, PubMed 35409505
Nilssen Y, Brustugun OT, Eriksen MT, Guren MG, Haug ES, Naume B, Schlichting E, Møller B (2022)
Compliance with recommended cancer patient pathway timeframes and choice of treatment differed by cancer type and place of residence among cancer patients in Norway in 2015-2016
BMC Cancer, 22 (1), 220
DOI 10.1186/s12885-022-09306-9, PubMed 35227226
Nilsson M, Olafsdottir H, Alexandersson von Döbeln G, Villegas F, Gagliardi G, Hellström M, Wang QL, Johansson H, Gebski V, Hedberg J, Klevebro F, Markar S, Smyth E, Lagergren P, Al-Haidari G, Rekstad LC, Aahlin EK, Wallner B, Edholm D, Johansson J, Szabo E, Reynolds JV, Pramesh CS, Mummudi N, Joshi A et al. (2022)
Neoadjuvant Chemoradiotherapy and Surgery for Esophageal Squamous Cell Carcinoma Versus Definitive Chemoradiotherapy With Salvage Surgery as Needed: The Study Protocol for the Randomized Controlled NEEDS Trial
Front Oncol, 12, 917961
DOI 10.3389/fonc.2022.917961, PubMed 35912196
Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2022)
Re: Thyroid hypofunction in aging testicular cancer survivors by Nome et al
Acta Oncol, 61 (3), 385
DOI 10.1080/0284186X.2021.2023214, PubMed 35037554
Nyakas M, Fleten KG, Haugen MH, Engedal N, Sveen C, Farstad IN, Flørenes VA, Prasmickaite L, Mælandsmo GM, Seip K (2022)
AXL inhibition improves BRAF-targeted treatment in melanoma
Sci Rep, 12 (1), 5076
DOI 10.1038/s41598-022-09078-z, PubMed 35332208
Nyrud MK, Bratland Å, Landrø L, Brevig T, Ryder T, Hermann R, Frich L (2022)
Merkel cell carcinoma
Tidsskr Nor Laegeforen, 142 (9)
DOI 10.4045/tidsskr.21.0693, PubMed 35699540
Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2022)
Correction to: A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
Eur Geriatr Med, 13 (5), 1231-1232
DOI 10.1007/s41999-022-00653-1, PubMed 35524006
Osong B, Masciocchi C, Damiani A, Bermejo I, Meldolesi E, Chiloiro G, Berbee M, Lee SH, Dekker A, Valentini V, Gerard JP, Rödel C, Bujko K, van de Velde C, Folkesson J, Sainato A, Glynne-Jones R, Ngan S, Brændengen M, Sebag-Montefiore D, van Soest J (2022)
Bayesian network structure for predicting local tumor recurrence in rectal cancer patients treated with neoadjuvant chemoradiation followed by surgery
Phys Imaging Radiat Oncol, 22, 1-7
DOI 10.1016/j.phro.2022.03.002, PubMed 35372704
Patel SA, Ma TM, Wong JK, Stish BJ, Dess RT, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Tran PT, Krauss DJ, Abu-Isa EI, Pisansky TM, Choo CR, Song DY, Greco S, Deville C, DeWeese TL, Tilki D, Ciezki JP et al. (2022)
External Beam Radiation Therapy With or Without Brachytherapy Boost in Men With Very-High-Risk Prostate Cancer: A Large Multicenter International Consortium Analysis
Int J Radiat Oncol Biol Phys, 115 (3), 645-653
DOI 10.1016/j.ijrobp.2022.09.075, PubMed 36179990
Paur I, Smedshaug GB, Haugum B, Bye A, Eliassen E, Flottorp TL, Juul HJ, Mowe M, Nakken T, Ore S, Sirevåg GK, Sygnestveit K, Thoresen L, Aasen EB, Totland TH, Krogh HW (2022)
The Norwegian Directorate of Health recommends malnutrition screening tool (MST) for all adults
Clin Nutr ESPEN, 52, 28-31
DOI 10.1016/j.clnesp.2022.09.029, PubMed 36513467
Pierson SK, Katz L, Williams R, Mumau M, Gonzalez M, Guzman S, Rubenstein A, Oromendia AB, Beineke P, Fosså A, van Rhee F, Fajgenbaum DC (2022)
CXCL13 is a predictive biomarker in idiopathic multicentric Castleman disease
Nat Commun, 13 (1), 7236
DOI 10.1038/s41467-022-34873-7, PubMed 36433996
Preusser M, Silvani A, Le Rhun E, Soffietti R, Lombardi G, Sepulveda JM, Brandal P, Brazil L, Bonneville-Levard A, Lorgis V, Vauleon E, Bromberg J, Erridge S, Cameron A, Lefranc F, Clement PM, Dumont S, Sanson M, Bronnimann C, Balaná C, Thon N, Lewis J, Mair MJ, Sievers P, Furtner J et al. (2022)
Trabectedin for recurrent WHO grade 2 or 3 meningioma: A randomized phase II study of the EORTC Brain Tumor Group (EORTC-1320-BTG)
Neuro Oncol, 24 (5), 755-767
DOI 10.1093/neuonc/noab243, PubMed 34672349
Pulkka OP, Viisanen L, Tynninen O, Laaksonen M, Reichardt P, Reichardt A, Eriksson M, Hall KS, Wardelmann E, Nilsson B, Sihto H, Joensuu H (2022)
Fibrinogen-like protein 2 in gastrointestinal stromal tumour
J Cell Mol Med, 26 (4), 1083-1094
DOI 10.1111/jcmm.17163, PubMed 35029030
Rao S, Anandappa G, Capdevila J, Dahan L, Evesque L, Kim S, Saunders MP, Gilbert DC, Jensen LH, Samalin E, Spindler KL, Tamberi S, Demols A, Guren MG, Arnold D, Fakih M, Kayyal T, Cornfeld M, Tian C, Catlett M, Smith M, Spano JP (2022)
A phase II study of retifanlimab (INCMGA00012) in patients with squamous carcinoma of the anal canal who have progressed following platinum-based chemotherapy (POD1UM-202)
ESMO Open, 7 (4), 100529
DOI 10.1016/j.esmoop.2022.100529, PubMed 35816951
Richartz N, Pietka W, Gilljam KM, Skah S, Skålhegg BS, Bhagwat S, Naderi EH, Ruud E, Blomhoff HK (2022)
cAMP-Mediated Autophagy Promotes Cell Survival via ROS-Induced Activation of PARP1: Implications for Treatment of Acute Lymphoblastic Leukemia
Mol Cancer Res, 20 (3), 400-411
DOI 10.1158/1541-7786.MCR-21-0652, PubMed 34880123
Riis M, Csanaky G, Lehne G, Tangerud A (2022)
Anaplastic large cell lymphoma, ALK-negative of the breast diagnosed a short time after removal of breast implant in a patient with breast carcinoma: diagnostic and therapeutic considerations
BMJ Case Rep, 15 (3)
DOI 10.1136/bcr-2021-248232, PubMed 35236698
Riise J, Meyer S, Blaas I, Chopra A, Tran TT, Delic-Sarac M, Hestdalen ML, Brodin E, Rustad EH, Dai KZ, Vaage JT, Nissen-Meyer LSH, Sund F, Wader KF, Bjornevik AT, Meyer PA, Nygaard GO, König M, Smeland S, Lund-Johansen F, Olweus J, Kolstad A (2022)
Rituximab-treated patients with lymphoma develop strong CD8 T-cell responses following COVID-19 vaccination
Br J Haematol, 197 (6), 697-708
DOI 10.1111/bjh.18149, PubMed 35254660
Rimstad R, Løkkevik E, Juul-Hansen KE, Holtan A (2022)
Patient needs in evacuation of a tertiary oncology center
J Emerg Manag, 20 (3), 267-272
DOI 10.5055/jem.0626, PubMed 35792815
Rischin D, Harrington KJ, Greil R, Soulières D, Tahara M, de Castro G, Psyrri A, Braña I, Neupane P, Bratland Å, Fuereder T, Hughes BGM, Mesía R, Ngamphaiboon N, Rordorf T, Ishak WZW, Hong RL, Mendoza RG, Jia L, Chirovsky D, Norquist J, Jin F, Burtness B (2022)
Pembrolizumab alone or with chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: Health-related quality-of-life results from KEYNOTE-048
Oral Oncol, 128, 105815
DOI 10.1016/j.oraloncology.2022.105815, PubMed 35381576
Rowsell A, Sodergren SC, Vassiliou V, Darlington AS, Guren MG, Alkhaffaf B, Moorbey C, Dennis K, Terada M (2022)
Systematic review of health-related quality of life (HRQoL) issues associated with gastric cancer: capturing cross-cultural differences
Gastric Cancer, 25 (4), 665-677
DOI 10.1007/s10120-022-01309-6, PubMed 35689705
Ryg U, Seierstad T, Nilsen LB, Hellebust TP, Djupvik LH, Gustafson H, Hydal J, Kishan AU, Hole KH, Lilleby W (2022)
A Prospective Study of High Dose-Rate Brachytherapy or Stereotactic Body Radiotherapy of Intra-Prostatic Recurrence: Toxicity and Long Term Clinical Outcome
Front Oncol, 12, 861127
DOI 10.3389/fonc.2022.861127, PubMed 35463376
Røssevold AH, Andresen NK, Bjerre CA, Gilje B, Jakobsen EH, Raj SX, Falk RS, Russnes HG, Jahr T, Mathiesen RR, Lømo J, Garred Ø, Chauhan SK, Lereim RR, Dunn C, Naume B, Kyte JA (2022)
Atezolizumab plus anthracycline-based chemotherapy in metastatic triple-negative breast cancer: the randomized, double-blind phase 2b ALICE trial
Nat Med, 28 (12), 2573-2583
DOI 10.1038/s41591-022-02126-1, PubMed 36482103
Schei S, Solheim O, Salvesen Ø, Hjermstad MJ, Bouget D, Sagberg LM (2022)
Pretreatment patient-reported cognitive function in patients with diffuse glioma
Acta Neurochir (Wien), 164 (3), 703-711
DOI 10.1007/s00701-022-05126-9, PubMed 35142918
Schmid MP, Harrabi S, Herfarth K, Bruland ØS, Welzel T, Haberer T, Ellerbrock M, Debus J, Uhl M, Seidensaal K (2022)
Particle Therapy in Adult Patients with Pelvic Ewing Sarcoma-Tumor and Treatment Characteristics and Early Clinical Outcomes
Cancers (Basel), 14 (24)
DOI 10.3390/cancers14246045, PubMed 36551530
Schou-Bredal I, Sørensen EM, Kraglund KH, Jensen VS, Drageset S (2022)
Development of the Breast Cancer Survivors Symptom Checklist for Use in Follow-Up Multidisciplinary Appointments
Patient Relat Outcome Meas, 13, 199-208
DOI 10.2147/PROM.S364625, PubMed 36238534
Segelov E, Guren MG, Sebag-Montefiore D, Rao S, Johnsson A, Franco P, Deutsch E, Arnold D, Spindler KG (2022)
"Global Multidisciplinary Team Meetings": Challenging Cases Virtual Forums from the International Multidisciplinary Anal Cancer Conference (IMACC)
Clin Colorectal Cancer, 21 (3), 175-187
DOI 10.1016/j.clcc.2022.02.006, PubMed 35346604
Seidensaal K, Dostal M, Liermann J, Adeberg S, Weykamp F, Schmid MP, Freudlsperger C, Hoffmann J, Hompland I, Herfarth K, Debus J, Harrabi SB (2022)
Inoperable or incompletely resected craniofacial osteosarcoma treated by particle radiotherapy
Front Oncol, 12, 927399
DOI 10.3389/fonc.2022.927399, PubMed 36212490
Shkodra M, Brunelli C, Zecca E, Infante G, Miceli R, Caputo M, Bracchi P, Lo Dico S, Kaasa S, Caraceni A (2022)
Cancer pain: Results of a prospective study on prognostic indicators of pain intensity including pain syndromes assessment
Palliat Med, 36 (9), 1396-1407
DOI 10.1177/02692163221122354, PubMed 36113091
Silva DN, Chrobok M, Ahlén G, Blomberg P, Sällberg M, Pasetto A (2022)
ATMP development and pre-GMP environment in academia: a safety net for early cell and gene therapy development and manufacturing
Immunooncol Technol, 16, 100099
DOI 10.1016/j.iotech.2022.100099, PubMed 36389443
Skipar K, Hompland T, Lund KV, Løndalen A, Malinen E, Kristensen GB, Lindemann K, Nakken ES, Bruheim K, Lyng H (2022)
Risk of recurrence after chemoradiotherapy identified by multimodal MRI and 18F-FDG-PET/CT in locally advanced cervical cancer
Radiother Oncol, 176, 17-24
DOI 10.1016/j.radonc.2022.09.002, PubMed 36113778
Skjerven HK, Danielsen AS, Schlichting E, Sahlberg KK, Hofvind S (2022)
Treatment of Ductal Carcinoma in situ: A Register-Based Study of Norwegian Women Diagnosed between 1995 and 2018
Breast Care (Basel), 17 (5), 486-494
DOI 10.1159/000524564, PubMed 36684407
Skjerven HK, Myklebust EM, Korvald C, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2022)
Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women
Eur J Surg Oncol, 49 (3), 575-582
DOI 10.1016/j.ejso.2022.11.594, PubMed 36509629
Skåre TS, Midtbust MH, Lund JÅ, Kaasa S, Dreyer A (2022)
Barriers and Facilitators When Implementing Electronic Patient-Reported Outcome Measures at a Municipal Cancer Care Unit: A Qualitative Study
Cancer Nurs, 46 (4), E268-E275
DOI 10.1097/NCC.0000000000001120, PubMed 35439218
Smedman TM, Guren TK, Tveit KM, Thomsen M, Andersen MH, Line PD, Dueland S (2022)
Health-Related Quality of Life in Colorectal Cancer Patients Treated With Liver Transplantation Compared to Chemotherapy
Transpl Int, 35, 10404
DOI 10.3389/ti.2022.10404, PubMed 35707633
Smedsland SK, Vandraas KF, Bøhn SK, Dahl AA, Kiserud CE, Brekke M, Falk RS, Reinertsen KV (2022)
Sexual activity and functioning in long-term breast cancer survivors; exploring associated factors in a nationwide survey
Breast Cancer Res Treat, 193 (1), 139-149
DOI 10.1007/s10549-022-06544-0, PubMed 35226237
Smeland K, Holte H, Fagerli UM, Bersvendsen H, Hjermstad MJ, Loge JH, Murbrach K, Linnsund MD, Fluge O, Stenehjem JS, Lund MB, Kvaloy S, Kiserud CE (2022)
Total late effect burden in long-term lymphoma survivors after high-dose therapy with autologous stem-cell transplant and its effect on health-related quality of life
Haematologica, 107 (11), 2698-2707
DOI 10.3324/haematol.2021.280413, PubMed 35484681
Sodergren SC, Johnson CD, Gilbert A, Darlington AS, Cocks K, Guren MG, Rivin Del Campo E, Brannan C, Christensen P, Chu W, Chung H, Dennis K, Desideri I, Gilbert DC, Glynne-Jones R, Jefford M, Johansson M, Johnsson A, Juul T, Kardamakis D, Lai-Kwon J, McFarlane V, Miguel IMC, Nugent K, Peters F et al. (2022)
International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire
Int J Radiat Oncol Biol Phys, 115 (5), 1155-1164
DOI 10.1016/j.ijrobp.2022.11.002, PubMed 36402360
Solberg S, Nilssen Y, Terje Brustugun O, Magnus Haram P, Helland Å, Møller B, Strand TE, Gyrid Freim Wahl S, Fjellbirkeland L (2022)
Concordance between clinical and pathology TNM-staging in lung cancer
Lung Cancer, 171, 65-69
DOI 10.1016/j.lungcan.2022.07.014, PubMed 35926242
Solheim JM, Dueland S, Line PD, Hagness M (2022)
Transplantation for Nonresectable Colorectal Liver Metastases: Long-Term Follow-Up of the First Prospective Pilot Study
Ann Surg, 278 (2), 239-245
DOI 10.1097/SLA.0000000000005703, PubMed 36082986
Stacchiotti S, Dürr HR, Schaefer IM, Woertler K, Haas R, Trama A, Caraceni A, Bajpai J, Baldi GG, Bernthal N, Blay JY, Boye K, Broto JM, Chen WT, Dei Tos PA, Desai J, Emhofer S, Eriksson M, Gronchi A, Gelderblom H, Hardes J, Hartmann W, Healey J, Italiano A, Jones RL et al. (2022)
Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts
Cancer Treat Rev, 112, 102491
DOI 10.1016/j.ctrv.2022.102491, PubMed 36502615
Stalsberg R, Bertheussen GF, Børset H, Thomsen SN, Husøy A, Flote VG, Thune I, Lundgren S (2022)
Do Breast Cancer Patients Manage to Participate in an Outdoor, Tailored, Physical Activity Program during Adjuvant Breast Cancer Treatment, Independent of Health and Socio-Demographic Characteristics?
J Clin Med, 11 (3)
DOI 10.3390/jcm11030843, PubMed 35160292
Steinberg MF, Olsen JA, Persse D, Souders CM, Wik L (2022)
Efficacy of defibrillator pads placement during ventricular arrhythmias, a before and after analysis
Resuscitation, 174, 16-19
DOI 10.1016/j.resuscitation.2022.03.004, PubMed 35276312
Stenberg VY, Tornes AJK, Nilsen HR, Revheim ME, Bruland ØS, Larsen RH, Juzeniene A (2022)
Factors Influencing the Therapeutic Efficacy of the PSMA Targeting Radioligand ²¹²Pb-NG001
Cancers (Basel), 14 (11)
DOI 10.3390/cancers14112784, PubMed 35681766
Stikbakke E, Wilsgaard T, Haugnes HS, Pedersen MI, Knutsen T, Støyten M, Giovannucci E, Eggen AE, Thune I, Richardsen E (2022)
Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
Cancers (Basel), 14 (5)
DOI 10.3390/cancers14051142, PubMed 35267449
Storm-Larsen C, Hande LN, Kummen M, Thunhaug H, Vestad B, Hansen SH, Hovland A, Trøseid M, Lappegård KT, Hov JR (2022)
Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention - a pilot trial
Scand J Clin Lab Invest, 82 (5), 363-370
DOI 10.1080/00365513.2022.2102540, PubMed 35913798
Storås AH, Andreassen BK, Fosså SD (2022)
Characterization of long-term survivors of primary metastatic prostate cancer patients in Norway
Acta Oncol, 61 (5), 615-618
DOI 10.1080/0284186X.2022.2051204, PubMed 35300560
Strømsvik N, Olsson P, Gravdehaug B, Lurås H, Schlichting E, Jørgensen K, Wangensteen T, Vamre T, Heramb C, Mæhle L, Grindedal EM (2022)
"It was an important part of my treatment": a qualitative study of Norwegian breast Cancer patients' experiences with mainstreamed genetic testing
Hered Cancer Clin Pract, 20 (1), 6
DOI 10.1186/s13053-022-00212-6, PubMed 35123550
Staaf J, Häkkinen J, Hegardt C, Saal LH, Kimbung S, Hedenfalk I, Lien T, Sørlie T, Naume B, Russnes H, Marcone R, Ayyanan A, Brisken C, Malterling RR, Asking B, Olofsson H, Lindman H, Bendahl PO, Ehinger A, Larsson C, Loman N, Rydén L, Malmberg M, Borg Å, Vallon-Christersson J (2022)
RNA sequencing-based single sample predictors of molecular subtype and risk of recurrence for clinical assessment of early-stage breast cancer
NPJ Breast Cancer, 8 (1), 94
DOI 10.1038/s41523-022-00465-3, PubMed 35974007
Svestad JG, Heydari M, Mikalsen SG, Flote VG, Nordby F, Hellebust TP (2022)
Surface-guided positioning eliminates the need for skin markers in radiotherapy of right sided breast cancer: A single center randomized crossover trial
Radiother Oncol, 177, 46-52
DOI 10.1016/j.radonc.2022.10.017, PubMed 36309152
Tanem KE, Stensvold E, Wilberg P, Skaare AB, Brandal P, Herlofson BB (2022)
Oral and dental late effects in long-term survivors of childhood embryonal brain tumors
Support Care Cancer, 30 (12), 10233-10241
DOI 10.1007/s00520-022-07405-8, PubMed 36307656
Tanem KE, Stensvold E, Wilberg P, Skaare AB, Singh PB, Brandal P, Herlofson BB (2022)
Taste and smell function in long-term survivors after childhood medulloblastoma/CNS-PNET
Support Care Cancer, 30 (7), 6155-6162
DOI 10.1007/s00520-022-07048-9, PubMed 35426047
Taskén K, Russnes HEG, Aas E, Bjørge L, Blix ES, CONNECT Public–Private Partnership Consortium, Enerly E, Fagereng GL, Flobak Å, Gilje B, Gjertsen BT, Guren TK, Heix J, Hovig E, Hovland R, InPreD-Norway and National Molecular Tumor Board Consortium, IMPRESS-Norway Consortium, Lønning PE, Meza-Zepeda LA, Mæhle PM, Nilsen HL, Thoresen SØ, Widerberg K, Smeland S, Helland Å (2022)
A national precision cancer medicine implementation initiative for Norway
Nat Med, 28 (5), 885-887
DOI 10.1038/s41591-022-01777-4, PubMed 35513529
Theophanous S, Lønne PI, Choudhury A, Berbee M, Dekker A, Dennis K, Dewdney A, Gambacorta MA, Gilbert A, Guren MG, Holloway L, Jadon R, Kochhar R, Mohamed AA, Muirhead R, Parés O, Raszewski L, Roy R, Scarsbrook A, Sebag-Montefiore D, Spezi E, Spindler KG, van Triest B, Vassiliou V, Malinen E et al. (2022)
Development and validation of prognostic models for anal cancer outcomes using distributed learning: protocol for the international multi-centre atomCAT2 study
Diagn Progn Res, 6 (1), 14
DOI 10.1186/s41512-022-00128-8, PubMed 35922837
Tonkopi E, Wikan EJ, Hovland TO, Høgset S, Kofod TA, Sefenu SK, Hughes-Ryan E, D Entremont-O Connell D, Gunn C, Holter T, Johansen S (2022)
A survey of local diagnostic reference levels for the head, thorax, abdomen and pelvis computed tomography in Norway and Canada
Acta Radiol Open, 11 (10), 20584601221131477
DOI 10.1177/20584601221131477, PubMed 36225897
Tornes AJK, Stenberg VY, Larsen RH, Bruland ØS, Revheim ME, Juzeniene A (2022)
Targeted alpha therapy with the ²²⁴Ra/²¹²Pb-TCMC-TP-3 dual alpha solution in a multicellular tumor spheroid model of osteosarcoma
Front Med (Lausanne), 9, 1058863
DOI 10.3389/fmed.2022.1058863, PubMed 36507500
Totland TH, Krogh HW, Smedshaug GB, Tornes RA, Bye A, Paur I (2022)
Harmonization and standardization of malnutrition screening for all adults - A systematic review initiated by the Norwegian Directorate of Health
Clin Nutr ESPEN, 52, 32-49
DOI 10.1016/j.clnesp.2022.09.028, PubMed 36513471
Umu SU, Langseth H, Zuber V, Helland Å, Lyle R, Rounge TB (2022)
Serum RNAs can predict lung cancer up to 10 years prior to diagnosis
Elife, 11
DOI 10.7554/eLife.71035, PubMed 35147498
Vajavaara H, Leivonen SK, Jørgensen J, Holte H, Leppä S (2022)
Low lymphocyte-to-monocyte ratio predicts poor outcome in high-risk aggressive large B-cell lymphoma
EJHaem, 3 (3), 681-687
DOI 10.1002/jha2.409, PubMed 36051040
van Iersel L, Mulder RL, Denzer C, Cohen LE, Spoudeas HA, Meacham LR, Sugden E, Schouten-van Meeteren AYN, Hoving EW, Packer RJ, Armstrong GT, Mostoufi-Moab S, Stades AM, van Vuurden D, Janssens GO, Thomas-Teinturier C, Murray RD, Di Iorgi N, Neggers SJCMM, Thompson J, Toogood AA, Gleeson H, Follin C, Bardi E, Torno L et al. (2022)
Hypothalamic-Pituitary and Other Endocrine Surveillance Among Childhood Cancer Survivors
Endocr Rev, 43 (5), 794-823
DOI 10.1210/endrev/bnab040, PubMed 34962573
Vandraas K, Falk RS, Bøhn SKH, Kiserud C, Lie HC, Smedsland SK, Ewertz M, Dahl S, Brekke M, Reinertsen KV (2022)
Work ability 8 years after breast cancer: exploring the role of social support in a nation-wide survey
Breast Cancer Res Treat, 193 (3), 685-694
DOI 10.1007/s10549-022-06599-z, PubMed 35445949
Vandraas KF, Reinertsen KV, Kiserud CE, Bøhn SK, Lie HC (2022)
Health literacy among long-term survivors of breast cancer; exploring associated factors in a nationwide sample
Support Care Cancer, 30 (9), 7587-7596
DOI 10.1007/s00520-022-07183-3, PubMed 35674792
Weider T, Genoni A, Broccolo F, Paulsen TH, Dahl-Jørgensen K, Toniolo A, Hammerstad SS (2022)
High Prevalence of Common Human Viruses in Thyroid Tissue
Front Endocrinol (Lausanne), 13, 938633
DOI 10.3389/fendo.2022.938633, PubMed 35909527
Westerveld H, Kirchheiner K, Nout RA, Tanderup K, Lindegaard JC, Spampinato S, Sturdza A, Nesvacil N, Bruheim K, Hellebust TP, Pieters BR, Kirisits C, Jürgenliemk-Schulz IM, Pötter R, de Leeuw AAC (2022)
Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study
Radiother Oncol, 168, 8-15
DOI 10.1016/j.radonc.2021.12.034, PubMed 35063582
Winther RR, Hjermstad MJ, Skovlund E, Aass N, Helseth E, Kaasa S, Yri OE, Vik-Mo EO (2022)
Surgery for brain metastases-impact of the extent of resection
Acta Neurochir (Wien), 164 (10), 2773-2780
DOI 10.1007/s00701-021-05104-7, PubMed 35080651
Wolf J, Helland Å, Oh IJ, Migliorino MR, Dziadziuszko R, Wrona A, de Castro J, Mazieres J, Griesinger F, Chlistalla M, Cardona A, Ruf T, Trunzer K, Smoljanovic V, Novello S (2022)
Final efficacy and safety data, and exploratory molecular profiling from the phase III ALUR study of alectinib versus chemotherapy in crizotinib-pretreated ALK-positive non-small-cell lung cancer
ESMO Open, 7 (1), 100333
DOI 10.1016/j.esmoop.2021.100333, PubMed 35042152
Yri OE, Aass N, Kaasa S (2022)
[Whole brain radiotherapy should be restricted]
Tidsskr Nor Laegeforen, 142 (17)
DOI 10.4045/tidsskr.22.0696, PubMed 36416654
Aamdal E, Skovlund E, Jacobsen KD, Straume O, Kersten C, Herlofsen O, Karlsen J, Hussain I, Amundsen A, Dalhaug A, Nyakas M, Hagene KT, Holmsen K, Aamdal S, Kaasa S, Guren TK, Kyte JA (2022)
Health-related quality of life in patients with advanced melanoma treated with ipilimumab: prognostic implications and changes during treatment
ESMO Open, 7 (5), 100588
DOI 10.1016/j.esmoop.2022.100588, PubMed 36116420
Aass N, Kaasa S (2022)
Patient-centred care - is it possible?
Tidsskr Nor Laegeforen, 142 (3)
DOI 10.4045/tidsskr.22.0072, PubMed 35170916

Publications 2021

Abrahamsen CS, Lang-Ree HM, Halvorsen K, Stenbakken CM (2021)
Patients with COPD: Exploring patients' coping ability during an interdisciplinary pulmonary rehabilitation programme: A qualitative focus group study
J Clin Nurs, 30 (9-10), 1479-1488
DOI 10.1111/jocn.15700, PubMed 33555629
Ali M, Giannakopoulou E, Li Y, Lehander M, Virding Culleton S, Yang W, Knetter C, Odabasi MC, Bollineni RC, Yang X, Foldvari Z, Böschen ML, Taraldsrud E, Strønen E, Toebes M, Hillen A, Mazzi S, de Ru AH, Janssen GMC, Kolstad A, Tjønnfjord GE, Lie BA, Griffioen M, Lehmann S, Osnes LT et al. (2021)
T cells targeted to TdT kill leukemic lymphoblasts while sparing normal lymphocytes
Nat Biotechnol, 40 (4), 488-498
DOI 10.1038/s41587-021-01089-x, PubMed 34873326
Aljabri B, Lilleby W, Switlyk MD, Tafjord G (2021)
Restart of androgen deprivation therapy after goserelin induced pituitary apoplexy in a patient with disseminated prostate cancer a case report and five-years follow-up
Urol Case Rep, 37, 101648
DOI 10.1016/j.eucr.2021.101648, PubMed 33868933
Alonso-Álvarez S, Manni M, Montoto S, Sarkozy C, Morschhauser F, Wondergem MJ, Guarini A, Magnano L, Alcoceba M, Chamuleau M, Galimberti S, Gomes da Silva M, Holte H, Zucca E, Lockmer S, Aurer I, Marcheselli L, Stepanishyna Y, Caballero Barrigón MD, Salles G, Federico M (2021)
Primary refractory follicular lymphoma: a poor outcome entity with high risk of transformation to aggressive B cell lymphoma
Eur J Cancer, 157, 132-139
DOI 10.1016/j.ejca.2021.08.005, PubMed 34508995
Amdal CD, Pe M, Falk RS, Piccinin C, Bottomley A, Arraras JI, Darlington AS, Hofsø K, Holzner B, Jørgensen NMH, Kulis D, Rimehaug SA, Singer S, Taylor K, Wheelwright S, Bjordal K (2021)
Health-related quality of life issues, including symptoms, in patients with active COVID-19 or post COVID-19; a systematic literature review
Qual Life Res, 30 (12), 3367-3381
DOI 10.1007/s11136-021-02908-z, PubMed 34146226
ArdeshirRouhaniFard S, Dinh PC, Monahan PO, Fossa SD, Huddart R, Fung C, Song Y, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Kollmannsberger C, Einhorn L, Kroenke K, Travis LB (2021)
Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study
Cancer Epidemiol Biomarkers Prev, 30 (6), 1129-1138
DOI 10.1158/1055-9965.EPI-20-1762, PubMed 33849970
Areklett EW, Fagereng E, Bruheim K, Andersson S, Lindemann K (2021)
Self-reported cognitive impairment in cervical cancer survivors: A cross-sectional study
Psychooncology, 31 (2), 298-305
DOI 10.1002/pon.5818, PubMed 34516040
Autio M, Leivonen SK, Brück O, Mustjoki S, Mészáros Jørgensen J, Karjalainen-Lindsberg ML, Beiske K, Holte H, Pellinen T, Leppä S (2021)
Immune cell constitution in the tumor microenvironment predicts the outcome in diffuse large B-cell lymphoma
Haematologica, 106 (3), 718-729
DOI 10.3324/haematol.2019.243626, PubMed 32079690
Bahadoer RR, Bastiaannet E, Claassen YHM, van der Mark M, van Eycken E, Verbeeck J, Guren MG, Kørner H, Martling A, Johansson R, van de Velde CJH, Dekker JWT (2021)
One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison
Eur J Surg Oncol, 47 (7), 1651-1660
DOI 10.1016/j.ejso.2021.01.011, PubMed 33518367
Balstad TR, Brunelli C, Pettersen CH, Schønberg SA, Skorpen F, Fallon M, Kaasa S, Bye A, Laird BJA, Stene GB, Solheim TS (2021)
Power Comparisons and Clinical Meaning of Outcome Measures in Assessing Treatment Effect in Cancer Cachexia: Secondary Analysis From a Randomized Pilot Multimodal Intervention Trial
Front Nutr, 7, 602775
DOI 10.3389/fnut.2020.602775, PubMed 33585533
Banys-Paluchowski M, Gasparri ML, de Boniface J, Gentilini O, Stickeler E, Hartmann S, Thill M, Rubio IT, Di Micco R, Bonci EA, Niinikoski L, Kontos M, Karadeniz Cakmak G, Hauptmann M, Peintinger F, Pinto D, Matrai Z, Murawa D, Kadayaprath G, Dostalek L, Nina H, Krivorotko P, Classe JM, Schlichting E, Appelgren M et al. (2021)
Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study
Cancers (Basel), 13 (7)
DOI 10.3390/cancers13071565, PubMed 33805367
Barkovskaya A, Goodwin CM, Seip K, Hilmarsdottir B, Pettersen S, Stalnecker C, Engebraaten O, Briem E, Der CJ, Moestue SA, Gudjonsson T, Maelandsmo GM, Prasmickaite L (2021)
Detection of phenotype-specific therapeutic vulnerabilities in breast cells using a CRISPR loss-of-function screen
Mol Oncol, 15 (8), 2026-2045
DOI 10.1002/1878-0261.12951, PubMed 33759347
Baxter JS, Johnson N, Tomczyk K, Gillespie A, Maguire S, Brough R, Fachal L, Michailidou K, Bolla MK, Wang Q, Dennis J, Ahearn TU, Andrulis IL, Anton-Culver H, Antonenkova NN, Arndt V, Aronson KJ, Augustinsson A, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE et al. (2021)
Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element
Am J Hum Genet, 108 (7), 1190-1203
DOI 10.1016/j.ajhg.2021.05.013, PubMed 34146516
Berg J, Ramberg C, Haugstvedt JOS, Bengtson MB, Gabrielsen AM, Brustugun OT, Halvorsen AR, Helland Å (2021)
Lung Function After Stereotactic Body Radiation Therapy for Early-Stage Non-Small Cell Lung Cancer, Changes and Predictive Markers
Front Oncol, 11, 674731
DOI 10.3389/fonc.2021.674731, PubMed 34109123
Beyer J, Collette L, Sauvé N, Daugaard G, Feldman DR, Tandstad T, Tryakin A, Stahl O, Gonzalez-Billalabeitia E, De Giorgi U, Culine S, de Wit R, Hansen AR, Bebek M, Terbuch A, Albany C, Hentrich M, Gietema JA, Negaard H, Huddart RA, Lorch A, Cafferty FH, Heng DYC, Sweeney CJ, Winquist E et al. (2021)
Survival and New Prognosticators in Metastatic Seminoma: Results From the IGCCCG-Update Consortium
J Clin Oncol, 39 (14), 1553-1562
DOI 10.1200/JCO.20.03292, PubMed 33729863
Bishop MR, Dickinson M, Purtill D, Barba P, Santoro A, Hamad N, Kato K, Sureda A, Greil R, Thieblemont C, Morschhauser F, Janz M, Flinn I, Rabitsch W, Kwong YL, Kersten MJ, Minnema MC, Holte H, Chan EHL, Martinez-Lopez J, Müller AMS, Maziarz RT, McGuirk JP, Bachy E, Le Gouill S et al. (2021)
Second-Line Tisagenlecleucel or Standard Care in Aggressive B-Cell Lymphoma
N Engl J Med, 386 (7), 629-639
DOI 10.1056/NEJMoa2116596, PubMed 34904798
Bjerring AW, Fosså SD, Haugnes HS, Nome R, Stokke TM, Haugaa KH, Kiserud CE, Edvardsen T, Sarvari SI (2021)
The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: a 30-year follow-up
Eur Heart J Cardiovasc Imaging, 22 (4), 443-450
DOI 10.1093/ehjci/jeaa289, PubMed 33152065
Bjaanæs MM, Nilsen G, Halvorsen AR, Russnes HG, Solberg S, Jørgensen L, Brustugun OT, Lingjærde OC, Helland Å (2021)
Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
BMC Cancer, 21 (1), 1089
DOI 10.1186/s12885-021-08811-7, PubMed 34625038
Bjaanæs MM, Sande EPS, Loe Ø, Ramberg C, Næss TM, Ottestad A, Rogg LV, Svestad JG, Haakensen VD (2021)
Improved adaptive radiotherapy to adjust for anatomical alterations during curative treatment for locally advanced lung cancer
Phys Imaging Radiat Oncol, 18, 51-54
DOI 10.1016/j.phro.2021.04.003, PubMed 34258408
Blakkisrud J, Løndalen A, Dahle J, Martinsen AC, Kolstad A, Stokke C (2021)
Myelosuppression in patients treated with ¹⁷⁷Lutetium-lilotomab satetraxetan can be predicted with absorbed dose to the red marrow as the only variable
Acta Oncol, 60 (11), 1481-1488
DOI 10.1080/0284186X.2021.1959635, PubMed 34425735
Blindheim AJ, Fosså SD, Babigumira R, Andreassen BK (2021)
The use of reTURB in T1 bladder cancer: a Norwegian population-based study
Scand J Urol, 55 (4), 268-274
DOI 10.1080/21681805.2021.1917652, PubMed 33998957
Bong WK, Gaustadnes LM, Bergland A, Chen W, Bye A (2021)
Community-living older people's interpretation of the Norwegian version of older people's quality of life (OPQOL) questionnaire
Health Soc Care Community, 29 (6), 1695-1705
DOI 10.1111/hsc.13273, PubMed 33440057
Bonsaksen T, Ekeberg Ø, Schou-Bredal I, Skogstad L, Heir T, Grimholt TK (2021)
Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems
Front Public Health, 9, 667729
DOI 10.3389/fpubh.2021.667729, PubMed 34195169
Bonsaksen T, Skogstad L, Grimholt TK, Heir T, Ekeberg O, Lerdal A, Schou-Bredal I (2021)
Substance use in the Norwegian general population: prevalence and associations with disease
J. Subst. Use, 26 (2), 144-150
DOI 10.1080/14659891.2020.1784303
Borchgrevink PC, Glette M, Woodhouse A, Butler S, Landmark T, Romundstad P, Dale O, Stiles TC, Bonaa KH, Thorsvik D, Thünte S, Kaasa S (2021)
A Clinical Description of Chronic Pain in a General Population Using ICD-10 and ICD-11 (The HUNT Pain Examination Study)
J Pain, 23 (2), 337-348
DOI 10.1016/j.jpain.2021.08.007, PubMed 34551343
Borgen IMH, Kleffelgård I, Hauger SL, Forslund MV, Søberg HL, Andelic N, Sveen U, Winter L, Løvstad M, Røe C (2021)
Patient-Reported Problem Areas in Chronic Traumatic Brain Injury
J Head Trauma Rehabil, 37 (5), E336-E345
DOI 10.1097/HTR.0000000000000744, PubMed 34743086
Borza T, Harneshaug M, Kirkhus L, Šaltytė Benth J, Selbæk G, Bergh S, Slaaen M (2021)
The course of depressive symptoms and mortality in older patients with cancer
Aging Ment Health, 26 (6), 1153-1160
DOI 10.1080/13607863.2021.1932739, PubMed 34139140
Bousquet PA, Meltzer S, Fuglestad AJ, Lüders T, Esbensen Y, Juul HV, Johansen C, Lyckander LG, Bjørnetrø T, Inderberg EM, Kersten C, Redalen KR, Ree AH (2021)
The mitochondrial DNA constitution shaping T-cell immunity in patients with rectal cancer at high risk of metastatic progression
Clin Transl Oncol, 24 (6), 1157-1167
DOI 10.1007/s12094-021-02756-w, PubMed 34961902
Boye K, Longhi A, Guren T, Lorenz S, Næss S, Pierini M, Taksdal I, Lobmaier I, Cesari M, Paioli A, Løndalen AM, Setola E, Hompland I, Meza-Zepeda LA, Sundby Hall K, Palmerini E (2021)
Pembrolizumab in advanced osteosarcoma: results of a single-arm, open-label, phase 2 trial
Cancer Immunol Immunother, 70 (9), 2617-2624
DOI 10.1007/s00262-021-02876-w, PubMed 33580363
Brenne AT, Løhre ET, Knudsen AK, Thronæs M, Lund JÅ, Kongshaug N, Neverdal MN, Rystad K, Johansen MH, Braseth TI, Kaasa S (2021)
Implementing a Standardized Care Pathway Integrating Oncology, Palliative Care and Community Care in a Rural Region of Mid-Norway
Oncol Ther, 9 (2), 671-693
DOI 10.1007/s40487-021-00176-y, PubMed 34731447
Brustugun OT (2021)
Cancer and coronavirus risk
Tidsskr Nor Laegeforen, 141 (2)
DOI 10.4045/tidsskr.20.1044, PubMed 33528129
Brustugun OT, Heggelund L (2021)
[COVID-19 vaccination of cancer patients]
Tidsskr Nor Laegeforen, 141 (3)
DOI 10.4045/tidsskr.21.0026, PubMed 33624982
Bruun J, Eide PW, Bergsland CH, Bruck O, Svindland A, Arjama M, Välimäki K, Bjørnslett M, Guren MG, Kallioniemi O, Nesbakken A, Lothe RA, Pellinen T (2021)
E-cadherin is a robust prognostic biomarker in colorectal cancer and low expression is associated with sensitivity to inhibitors of topoisomerase, aurora, and HSP90 in preclinical models
Mol Oncol, 16 (12), 2312-2329
DOI 10.1002/1878-0261.13159, PubMed 34890102
Bugge C, Kaasa S, Sæther EM, Melberg HO, Sonbo Kristiansen I (2021)
What are determinants of utilisation of pharmaceutical anticancer treatment during the last year of life in Norway? A retrospective registry study
BMJ Open, 11 (9), e050564
DOI 10.1136/bmjopen-2021-050564, PubMed 34580099
Bøhn SK, Thune I, Flote VG, Frydenberg H, Bertheussen GF, Husøy A, Fjeldheim F, Brunvoll SH, Hjartåker A, Mowinckel MC, Sandset PM, Iversen PO (2021)
Effects of a 1-Year Physical Activity Intervention on Markers of Hemostasis among Breast Cancer Survivors: A Randomized Controlled Trial
TH Open, 5 (1), e14-e23
DOI 10.1055/s-0040-1721782, PubMed 33564742
Casali PG, Blay JY, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brodowicz T, Buonadonna A, De Álava E, Dei Tos AP, Del Muro XG, Dufresne A, Eriksson M, Fedenko A, Ferraresi V, Ferrari A, Frezza AM, Gasperoni S, Gelderblom H, Gouin F et al. (2021)
Gastrointestinal stromal tumours: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up
Ann Oncol, 33 (1), 20-33
DOI 10.1016/j.annonc.2021.09.005, PubMed 34560242
Caulier B, Enserink JM, Wälchli S (2021)
Pharmacologic Control of CAR T Cells
Int J Mol Sci, 22 (9)
DOI 10.3390/ijms22094320, PubMed 33919245
Chen X, Badian RA, Hynne H, Amdal CD, Herlofson BB, Utheim ØA, Westgaard KL, Fineide F, Jensen JL, Utheim TP (2021)
Alterations in meibomian glands in patients treated with intensity-modulated radiotherapy for head and neck cancer
Sci Rep, 11 (1), 22419
DOI 10.1038/s41598-021-01844-9, PubMed 34789830
Choudhury A, Theophanous S, Lønne PI, Samuel R, Guren MG, Berbee M, Brown P, Lilley J, van Soest J, Dekker A, Gilbert A, Malinen E, Wee L, Appelt AL (2021)
Predicting outcomes in anal cancer patients using multi-centre data and distributed learning - A proof-of-concept study
Radiother Oncol, 159, 183-189
DOI 10.1016/j.radonc.2021.03.013, PubMed 33753156
Dahl M, Husby S, Eskelund CW, Besenbacher S, Fjelstrup S, Côme C, Ek S, Kolstad A, Räty R, Jerkeman M, Geisler CH, Kjems J, Kristensen LS, Grønbæk K (2021)
Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials
Leukemia, 36 (1), 177-188
DOI 10.1038/s41375-021-01311-4, PubMed 34244612
Dahl AA, Kiserud CE, Fosså SD, Loge JH, Reinertsen KV, Ruud E, Lie HC (2021)
A Controlled Study of Major Depressive Episodes in Long-Term Childhood, Adolescence, and Young Adult Cancer Survivors (The NOR-CAYACS Study)
Cancers (Basel), 13 (22)
DOI 10.3390/cancers13225800, PubMed 34830953
Damhuis RAM, Senan S, Khakwani A, Harden S, Helland Ȧ, Strand TE (2021)
Age-related treatment patterns for stage I NSCLC in three European countries
J Geriatr Oncol, 12 (8), 1214-1219
DOI 10.1016/j.jgo.2021.05.005, PubMed 33994330
Dillard P, Casey N, Pollmann S, Vernhoff P, Gaudernack G, Kvalheim G, Wälchli S, Inderberg EM (2021)
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors
Oncoimmunology, 10 (1), 1936757
DOI 10.1080/2162402X.2021.1936757, PubMed 34235003
Dueland S, Smedman TM, Røsok B, Grut H, Syversveen T, Jørgensen LH, Line PD (2021)
Treatment of relapse and survival outcomes after liver transplantation in patients with colorectal liver metastases
Transpl Int, 34 (11), 2205-2213
DOI 10.1111/tri.13995, PubMed 34792825
Eide IJZ, Brustugun OT (2021)
[Lung cancer treated abroad with receptor tyrosine kinase inhibitor]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0147, PubMed 34505490
Eide IJZ, Grut H, Helland Å, Ekman S, Sørensen JB, Hansen KH, Grønberg BH, Cicenas S, Koivunen JP, Mellemgaard A, Brustugun OT (2021)
Intracranial effect of osimertinib in relapsed EGFR-mutated T790M-positive and -negative non-small cell lung cancer patients: results from a phase II study
Acta Oncol, 60 (12), 1565-1571
DOI 10.1080/0284186X.2021.1973092, PubMed 34486915
Eikeland SA, Smeland KB, Mols F, Fagerli UM, Bersvendsen HS, Kiserud CE, Fosså A (2021)
Chemotherapy-induced peripheral neuropathy after modern treatment of Hodgkin's lymphoma; symptom burden and quality of life
Acta Oncol, 60 (7), 911-920
DOI 10.1080/0284186X.2021.1917776, PubMed 33905285
Engebraaten O, Yau C, Berg K, Borgen E, Garred Ø, Berstad MEB, Fremstedal ASV, DeMichele A, Veer LV', Esserman L, Weyergang A (2021)
RAB5A expression is a predictive biomarker for trastuzumab emtansine in breast cancer
Nat Commun, 12 (1), 6427
DOI 10.1038/s41467-021-26018-z, PubMed 34741021
Eriksen GF, Šaltytė Benth J, Grønberg BH, Rostoft S, Kirkhus L, Kirkevold Ø, Hjelstuen A, Slaaen M (2021)
Geriatric impairments are prevalent and predictive of survival in older patients with cancer receiving radiotherapy: a prospective observational study
Acta Oncol, 61 (4), 393-402
DOI 10.1080/0284186X.2021.2009561, PubMed 34874228
Eriksson M, Reichardt P, Joensuu H, Krarup-Hansen A, Hagberg O, Hohenberger P, Hagberg H, Hansson L, Foukakis T, Pulkkanen K, Bauer S, Goplen D, Blach Rossen P, Sundby Hall K (2021)
Benefit of pazopanib in advanced gastrointestinal stromal tumours: results from a phase II trial (SSG XXI, PAGIST)
ESMO Open, 6 (4), 100217
DOI 10.1016/j.esmoop.2021.100217, PubMed 34271307
Fankhauser CD, Oldenburg J, Albers P, Algaba F, Bokemeyer C, Boormans JL, Fischer S, Fizazi K, Gremmels H, Mayor de Castro J, Janisch F, Muilwijk T, Leão R, Nicol D, Nicolai N, Tandstad T, Pilar Laguna M (2021)
Recommendations to Balance Benefits and Risks Of Thromboprophylaxis and to Avoid Central Venous-access Devices During First-line Chemotherapy in Men with Metastatic Germ Cell Tumors: The European Association Of Urology Testicular Cancer Panel Position in 2021
Eur Urol, 80 (1), 4-6
DOI 10.1016/j.eururo.2021.02.032, PubMed 33722419
Farooqi SJ, Bjaanæs MM, Helland Å, Haakensen VD (2021)
[Immunotherapy for malignant pleural mesothelioma]
Tidsskr Nor Laegeforen, 141
DOI 10.4045/tidsskr.21.0503, PubMed 34505475
Farooqi SJ, Helland A, Haakensen VD, Bjaanaes MM (2021)
Immunotherapy in malignant pleural mesothelioma
Tidsskr. Nor. Laegeforen., 141 (12), 1167-1169
Fauske L, Bruland ØS, Dahl AA, Myklebostad A, Reme SE (2021)
Does the Lightning Process Training Programme Reduce Chronic Fatigue in Adolescent and Young Adult Cancer Survivors? A Mixed-Methods Pilot Study
Cancers (Basel), 13 (16)
DOI 10.3390/cancers13164076, PubMed 34439229
Flatmark K, Torgunrud A, Fleten KG, Davidson B, Juul HV, Mensali N, Lund-Andersen C, Inderberg EM (2021)
Peptide vaccine targeting mutated GNAS: a potential novel treatment for pseudomyxoma peritonei
J Immunother Cancer, 9 (10)
DOI 10.1136/jitc-2021-003109, PubMed 34711663
Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL et al. (2021)
Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial
Nat Med, 28 (2), 325-332
DOI 10.1038/s41591-021-01622-0, PubMed 34921238
Frafjord A, Buer L, Hammarström C, Aamodt H, Woldbæk PR, Brustugun OT, Helland Å, Øynebråten I, Corthay A (2021)
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
Front Immunol, 12, 764596
DOI 10.3389/fimmu.2021.764596, PubMed 34868011
Fåne A, Myhre MR, Inderberg EM, Wälchli S (2021)
In vivo experimental mouse model to test CD19CAR T cells generated with different methods
Methods Cell Biol, 167, 149-161
DOI 10.1016/bs.mcb.2021.11.001, PubMed 35152992
Georgiesh T, Namløs HM, Sharma N, Lorenz S, Myklebost O, Bjerkehagen B, Meza-Zepeda LA, Boye K (2021)
Clinical and molecular implications of NAB2-STAT6 fusion variants in solitary fibrous tumour
Pathology, 53 (6), 713-719
DOI 10.1016/j.pathol.2020.11.010, PubMed 33745702
Gerdtsson A, Thor A, Grenabo Bergdahl A, Almås B, Håkansson U, Törnblom M, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Sagstuen Haugnes H, Engen Andreassen K, Melsen Larsen S, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A (2021)
Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
Eur Urol Oncol, 5 (2), 235-243
DOI 10.1016/j.euo.2021.02.002, PubMed 33750683
Gillessen S, Sauvé N, Collette L, Daugaard G, de Wit R, Albany C, Tryakin A, Fizazi K, Stahl O, Gietema JA, De Giorgi U, Cafferty FH, Hansen AR, Tandstad T, Huddart RA, Necchi A, Sweeney CJ, Garcia-Del-Muro X, Heng DYC, Lorch A, Chovanec M, Winquist E, Grimison P, Feldman DR, Terbuch A et al. (2021)
Predicting Outcomes in Men With Metastatic Nonseminomatous Germ Cell Tumors (NSGCT): Results From the IGCCCG Update Consortium
J Clin Oncol, 39 (14), 1563-1574
DOI 10.1200/JCO.20.03296, PubMed 33822655
Gjersvik P, Heikkila R, Johansen TEB (2021)
Rescue treatment for cancer
Tidsskr. Nor. Laegeforen., 141 (5), 487
Groendahl AR, Moe YM, Kaushal CK, Huynh BN, Rusten E, Tomic O, Hernes E, Hanekamp B, Undseth C, Guren MG, Malinen E, Futsaether CM (2021)
Deep learning-based automatic delineation of anal cancer gross tumour volume: a multimodality comparison of CT, PET and MRI
Acta Oncol, 61 (1), 89-96
DOI 10.1080/0284186X.2021.1994645, PubMed 34783610
Groendahl AR, Skjei Knudtsen I, Huynh BN, Mulstad M, Moe YM, Knuth F, Tomic O, Indahl UG, Torheim T, Dale E, Malinen E, Futsaether CM (2021)
A comparison of methods for fully automatic segmentation of tumors and involved nodes in PET/CT of head and neck cancers
Phys Med Biol, 66 (6), 065012
DOI 10.1088/1361-6560/abe553, PubMed 33666176
Gronchi A, Miah AB, Dei Tos AP, Abecassis N, Bajpai J, Bauer S, Biagini R, Bielack S, Blay JY, Bolle S, Bonvalot S, Boukovinas I, Bovee JVMG, Boye K, Brennan B, Brodowicz T, Buonadonna A, De Álava E, Del Muro XG, Dufresne A, Eriksson M, Fagioli F, Fedenko A, Ferraresi V, Ferrari A et al. (2021)
Soft tissue and visceral sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment and follow-up^☆
Ann Oncol, 32 (11), 1348-1365
DOI 10.1016/j.annonc.2021.07.006, PubMed 34303806
Grønberg BH, Killingberg KT, Fløtten Ø, Brustugun OT, Hornslien K, Madebo T, Langer SW, Schytte T, Nyman J, Risum S, Tsakonas G, Engleson J, Halvorsen TO (2021)
High-dose versus standard-dose twice-daily thoracic radiotherapy for patients with limited stage small-cell lung cancer: an open-label, randomised, phase 2 trial
Lancet Oncol, 22 (3), 321-331
DOI 10.1016/S1470-2045(20)30742-7, PubMed 33662285
Grøvik E, Yi D, Iv M, Tong E, Nilsen LB, Latysheva A, Saxhaug C, Jacobsen KD, Helland Å, Emblem KE, Rubin DL, Zaharchuk G (2021)
Handling missing MRI sequences in deep learning segmentation of brain metastases: a multicenter study
NPJ Digit Med, 4 (1), 33
DOI 10.1038/s41746-021-00398-4, PubMed 33619361
Guldvik IJ, Ekseth L, Kishan AU, Stensvold A, Inderberg EM, Lilleby W (2021)
Circulating Tumor Cell Persistence Associates with Long-Term Clinical Outcome to a Therapeutic Cancer Vaccine in Prostate Cancer
J Pers Med, 11 (7)
DOI 10.3390/jpm11070605, PubMed 34206815
Gullhaug A, Hjermstad MJ, Yri O, Svestad JG, Aass N, Johansen S (2021)
Use of radiotherapy in breast cancer patients with brain metastases: a retrospective 11-year single center study
J Med Imaging Radiat Sci, 52 (2), 214-222
DOI 10.1016/j.jmir.2021.01.002, PubMed 33549504
Guren MG, Sebag-Montefiore D, Franco P, Johnsson A, Segelov E, Deutsch E, Rao S, Spindler KG, Arnold D (2021)
Treatment of Squamous Cell Carcinoma of the Anus, Unresolved Areas and Future Perspectives for Research: Perspectives of Research Needs in Anal Cancer
Clin Colorectal Cancer, 20 (4), 279-287
DOI 10.1016/j.clcc.2021.09.006, PubMed 34645589
Habberstad R, Frøseth TCS, Aass N, Bjerkeset E, Abramova T, Garcia-Alonso E, Caputo M, Rossi R, Boland JW, Brunelli C, Lund JÅ, Kaasa S, Klepstad P (2021)
Clinical Predictors for Analgesic Response to Radiotherapy in Patients with Painful Bone Metastases
J Pain Symptom Manage, 62 (4), 681-690
DOI 10.1016/j.jpainsymman.2021.03.022, PubMed 33794301
Hamfjord J, Guren TK, Glimelius B, Sorbye H, Pfeiffer P, Dajani O, Lingjaerde OC, Tveit KM, Pallisgaard N, Spindler KG, Kure EH (2021)
Clinicopathological factors associated with tumour-specific mutation detection in plasma of patients with RAS-mutated or BRAF-mutated metastatic colorectal cancer
Int J Cancer, 149 (6), 1385-1397
DOI 10.1002/ijc.33672, PubMed 33961700
Hamfjord J, Myklebust TÅ, Larsen IK, Kure EH, Glimelius B, Guren TK, Tveit KM, Guren MG (2021)
Survival Trends of Right- and Left-Sided Colon Cancer across Four Decades: A Norwegian Population-Based Study
Cancer Epidemiol Biomarkers Prev, 31 (2), 342-351
DOI 10.1158/1055-9965.EPI-21-0555, PubMed 34853022
Hartkopf AD, Brucker SY, Taran FA, Harbeck N, von Au A, Naume B, Pierga JY, Hoffmann O, Beckmann MW, Rydén L, Fehm T, Aft R, Solà M, Walter V, Rack B, Schuetz F, Borgen E, Ta MH, Bittner AK, Fasching PA, Fernö M, Krawczyk N, Weilbaecher K, Margelí M, Hahn M et al. (2021)
Disseminated tumour cells from the bone marrow of early breast cancer patients: Results from an international pooled analysis
Eur J Cancer, 154, 128-137
DOI 10.1016/j.ejca.2021.06.028, PubMed 34265505
Haugen MH, Lingjærde OC, Hedenfalk I, Garred Ø, Borgen E, Loman N, Hatschek T, Børresen-Dale AL, Naume B, Mills GB, Mælandsmo GM, Engebraaten O (2021)
Protein Signature Predicts Response to Neoadjuvant Treatment With Chemotherapy and Bevacizumab in HER2-Negative Breast Cancers
JCO Precis Oncol, 5
DOI 10.1200/PO.20.00086, PubMed 34036235
Haugnes HS, Negaard HF, Jensvoll H, Wilsgaard T, Tandstad T, Solberg A (2021)
Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study
Eur Urol Open Sci, 32, 19-27
DOI 10.1016/j.euros.2021.07.007, PubMed 34667955
Heck A, Winge-Main AK (2021)
Silent, isolated ACTH deficiency in malignant melanoma patients treated with immune checkpoint inhibitors
BMJ Case Rep, 14 (5)
DOI 10.1136/bcr-2021-241981, PubMed 34045201
Heikkilä R, Myklebust TÅ, Møller B (2021)
Regional variation in cancer survival in Norway
Cancer Epidemiol, 75, 102038
DOI 10.1016/j.canep.2021.102038, PubMed 34571393
Hellesnes R, Myklebust TÅ, Fosså SD, Bremnes RM, Karlsdottir Á, Kvammen Ø, Tandstad T, Wilsgaard T, Negaard HFS, Haugnes HS (2021)
Testicular Cancer in the Cisplatin Era: Causes of Death and Mortality Rates in a Population-Based Cohort
J Clin Oncol, 39 (32), 3561-3573
DOI 10.1200/JCO.21.00637, PubMed 34388002
Hermansen JU, Wojcik DM, Robinson N, Pahnke J, Haugland HK, Jamtøy AH, Flaegstad T, Halvorsen H, Lund B, Baumbusch LO, Munthe-Kaas MC (2021)
The Norwegian childhood cancer biobank
Cancer Rep (Hoboken), 5 (8), e1555
DOI 10.1002/cnr2.1555, PubMed 34541832
Hernes E, Revheim ME, Hole KH, Tulipan AJ, Strømme H, Lilleby W, Seierstad T (2021)
Prostate-Specific Membrane Antigen PET for Assessment of Primary and Recurrent Prostate Cancer with Histopathology as Reference Standard: A Systematic Review and Meta-Analysis
PET Clin, 16 (2), 147-165
DOI 10.1016/j.cpet.2020.12.001, PubMed 33648661
Hernæs KH, Smeland KB, Fagerli UM, Kiserud CE (2021)
Post-treatment work patterns amongst survivors of lymphoma treated with high-dose chemotherapy with autologous stem-cell transplantation
BMC Cancer, 21 (1), 143
DOI 10.1186/s12885-021-07836-2, PubMed 33557789
Hjermstad MJ, Hamfjord J, Aass N, Dajani O, Lundeby T, Wester T, Kaasa S (2021)
Using Process Indicators to Monitor Documentation of Patient-Centred Variables in an Integrated Oncology and Palliative Care Pathway-Results from a Cluster Randomized Trial
Cancers (Basel), 13 (9)
DOI 10.3390/cancers13092194, PubMed 34063594
Hoel F, Hoel A, Pettersen IK, Rekeland IG, Risa K, Alme K, Sørland K, Fosså A, Lien K, Herder I, Thürmer HL, Gotaas ME, Schäfer C, Berge RK, Sommerfelt K, Marti HP, Dahl O, Mella O, Fluge Ø, Tronstad KJ (2021)
A map of metabolic phenotypes in patients with myalgic encephalomyelitis/chronic fatigue syndrome
JCI Insight, 6 (16)
DOI 10.1172/jci.insight.149217, PubMed 34423789
Hompland I, Ferrari S, Bielack S, Palmerini E, Hall KS, Picci P, Hecker-Nolting S, Donati DM, Blattmann C, Bjerkehagen B, Staals E, Kager L, Gambarotti M, Kühne T, Eriksson M, Ferraresi V, Kevric M, Biagini R, Baumhoer D, Brosjø O, Comandone A, Schwarz R, Bertulli R, Kessler T, Hansson L et al. (2021)
Outcome in dedifferentiated chondrosarcoma for patients treated with multimodal therapy: Results from the EUROpean Bone Over 40 Sarcoma Study
Eur J Cancer, 151, 150-158
DOI 10.1016/j.ejca.2021.04.017, PubMed 33990016
Hopland OA, Fosså SD, Ottosson F, Brennhovd B, Svindland A, Hole KH, Hernes E, Eri LM, Diep LM, Berge V (2021)
Robotic salvage pelvic lymph node dissection for locoregional recurrence after radical prostatectomy: a single institution experience
Scand J Urol, 55 (4), 287-292
DOI 10.1080/21681805.2021.1946135, PubMed 34196594
Hugenschmidt H, Labori KJ, Borgen E, Brunborg C, Schirmer CB, Seeberg LT, Naume B, Wiedswang G (2021)
Preoperative CTC-Detection by CellSearch^® Is Associated with Early Distant Metastasis and Impaired Survival in Resected Pancreatic Cancer
Cancers (Basel), 13 (3)
DOI 10.3390/cancers13030485, PubMed 33513877
Husum YS, Skogen K, Brandal P, Rønning PA, Wigers AR, Evang JA, Jørstad ØK (2021)
Bilateral calcification of the optic nerve sheath: A diagnostic dilemma
Am J Ophthalmol Case Rep, 22, 101106
DOI 10.1016/j.ajoc.2021.101106, PubMed 33997471
Høghaug G, Skår R, Tran TN, Diep LM, Bredal IS (2021)
Three-month follow-up effects of a medication management program on nurses' knowledge
Nurse Educ Pract, 51, 102979
DOI 10.1016/j.nepr.2021.102979, PubMed 33588183
Hølmebakk T, Boye K (2021)
ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol, 28 (11), 6846-6847
DOI 10.1245/s10434-021-09608-5, PubMed 33687615
Hølmebakk T, Boye K (2021)
Correction to: ASO Author Reflections: How to Identify Patients at Genuinely High Risk of Recurrence from Localized Gastrointestinal Stromal Tumor of the Stomach?
Ann Surg Oncol, 28 (Suppl 3), 873
DOI 10.1245/s10434-021-09939-3, PubMed 33829360
Hølmebakk T, Wiedswang AM, Meza-Zepeda LA, Hompland I, Lobmaier IVK, Berner JM, Stoldt S, Boye K (2021)
Integrating Anatomical, Molecular and Clinical Risk Factors in Gastrointestinal Stromal Tumor of the Stomach
Ann Surg Oncol, 28 (11), 6837-6845
DOI 10.1245/s10434-021-09605-8, PubMed 33651216
Haakensen VD, Nowak AK, Ellingsen EB, Farooqi SJ, Bjaanæs MM, Horndalsveen H, Mcculloch T, Grundberg O, Cedres SM, Helland Å (2021)
NIPU: a randomised, open-label, phase II study evaluating nivolumab and ipilimumab combined with UV1 vaccination as second line treatment in patients with malignant mesothelioma
J Transl Med, 19 (1), 232
DOI 10.1186/s12967-021-02905-3, PubMed 34059094
Isaksen KT, Mastroianni MA, Rinde M, Rusten LS, Barzenje DA, Ramslien LF, Slaaen M, Jerm MB, Smeland EB, Rostoft S, Liestøl K, Brodtkorb M, Holte H (2021)
A simplified frailty score predicts survival and can aid treatment-intensity decisions in older patients with DLBCL
Blood Adv, 5 (22), 4771-4782
DOI 10.1182/bloodadvances.2021004777, PubMed 34543384
Ito J, Minemura T, Wälchli S, Niimi T, Fujihara Y, Kuroda S, Takimoto K, Maturana AD (2021)
Id2 Represses Aldosterone-Stimulated Cardiac T-Type Calcium Channels Expression
Int J Mol Sci, 22 (7)
DOI 10.3390/ijms22073561, PubMed 33808082
Jakobsen J, Veierød MB, Grimsrud TK, Fosså SD, Hammarström B, Kjærheim K (2021)
Early detection of prostate cancer in firefighters: a register-based study of prognostic factors and survival
Occup Environ Med, 79 (3), 200-206
DOI 10.1136/oemed-2021-107622, PubMed 34510005
Johannesen TB, Smeland S, Aaserud S, Buanes EA, Skog A, Ursin G, Helland Å (2021)
COVID-19 in Cancer Patients, Risk Factors for Disease and Adverse Outcome, a Population-Based Study From Norway
Front Oncol, 11, 652535
DOI 10.3389/fonc.2021.652535, PubMed 33842366
Johansson ALV, Trewin CB, Fredriksson I, Reinertsen KV, Russnes H, Ursin G (2021)
In modern times, how important are breast cancer stage, grade and receptor subtype for survival: a population-based cohort study
Breast Cancer Res, 23 (1), 17
DOI 10.1186/s13058-021-01393-z, PubMed 33526044
Johnson ML, Zvirbule Z, Laktionov K, Helland A, Cho BC, Gutierrez V, Colinet B, Lena H, Wolf M, Gottfried M, Okamoto I, van der Leest C, Rich P, Hung JY, Appenzeller C, Sun Z, Maag D, Luo Y, Nickner C, Vajikova A, Komarnitsky P, Bar J (2021)
Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage-SCLC: Results From the Phase 3 MERU Study
J Thorac Oncol, 16 (9), 1570-1581
DOI 10.1016/j.jtho.2021.03.012, PubMed 33823285
Juzeniene A, Stenberg VY, Bruland ØS, Larsen RH (2021)
Preclinical and Clinical Status of PSMA-Targeted Alpha Therapy for Metastatic Castration-Resistant Prostate Cancer
Cancers (Basel), 13 (4)
DOI 10.3390/cancers13040779, PubMed 33668474
Karlsson AT, Hjermstad MJ, Omdahl T, Aass N, Skovlund E, Hellebust TP, Johansen S, Kaasa S, Yri OE (2021)
Overall survival after initial radiotherapy for brain metastases; a population based study of 2140 patients with non-small cell lung cancer
Acta Oncol, 60 (8), 1054-1060
DOI 10.1080/0284186X.2021.1924399, PubMed 34032536
Kasius JC, Pijnenborg JMA, Lindemann K, Forsse D, van Zwol J, Kristensen GB, Krakstad C, Werner HMJ, Amant F (2021)
Risk Stratification of Endometrial Cancer Patients: FIGO Stage, Biomarkers and Molecular Classification
Cancers (Basel), 13 (22)
DOI 10.3390/cancers13225848, PubMed 34831000
Kerboeuf M, Koppang EO, Haaland AH, Lingaas F, Bruland ØS, Teige J, Moe L (2021)
Early immunohistochemical detection of pulmonary micrometastases in dogs with osteosarcoma
Acta Vet Scand, 63 (1), 41
DOI 10.1186/s13028-021-00608-9, PubMed 34732227
Kirchheiner K, Smet S, Jürgenliemk-Schulz IM, Haie-Meder C, Chargari C, Lindegaard JC, Fokdal LU, Spampinato S, Schmid MP, Sturdza A, Mahantshetty U, Segedin B, Bruheim K, Rai B, Cooper R, Van der Steen-Banasik E, Wiebe E, Sundset M, van Limbergen E, Villafranca E, Westerveld H, Tan LT, Pötter R, Tanderup K, Nout RA et al. (2021)
Impact of Vaginal Symptoms and Hormonal Replacement Therapy on Sexual Outcomes After Definitive Chemoradiotherapy in Patients With Locally Advanced Cervical Cancer: Results from the EMBRACE-I Study
Int J Radiat Oncol Biol Phys, 112 (2), 400-413
DOI 10.1016/j.ijrobp.2021.08.036, PubMed 34478833
Kishan AU, Karnes RJ, Romero T, Wong JK, Motterle G, Tosoian JJ, Trock BJ, Klein EA, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Levin-Epstein R, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Huland H, Tran PT, Martin S et al. (2021)
Comparison of Multimodal Therapies and Outcomes Among Patients With High-Risk Prostate Cancer With Adverse Clinicopathologic Features
JAMA Netw Open, 4 (7), e2115312
DOI 10.1001/jamanetworkopen.2021.15312, PubMed 34196715
Knuth F, Adde IA, Huynh BN, Groendahl AR, Winter RM, Negård A, Holmedal SH, Meltzer S, Ree AH, Flatmark K, Dueland S, Hole KH, Seierstad T, Redalen KR, Futsaether CM (2021)
MRI-based automatic segmentation of rectal cancer using 2D U-Net on two independent cohorts
Acta Oncol, 61 (2), 255-263
DOI 10.1080/0284186X.2021.2013530, PubMed 34918621
Korwisi B, Hay G, Attal N, Aziz Q, Bennett MI, Benoliel R, Cohen M, Evers S, Giamberardino MA, Kaasa S, Kosek E, Lavand'homme P, Nicholas M, Perrot S, Schug S, Smith BH, Svensson P, Vlaeyen JWS, Wang SJ, Treede RD, Rief W, Barke A (2021)
Classification algorithm for the International Classification of Diseases-11 chronic pain classification: development and results from a preliminary pilot evaluation
Pain, 162 (7), 2087-2096
DOI 10.1097/j.pain.0000000000002208, PubMed 33492033
Kryeziu K, Moosavi SH, Bergsland CH, Guren MG, Eide PW, Totland MZ, Lassen K, Abildgaard A, Nesbakken A, Sveen A, Lothe RA (2021)
Increased sensitivity to SMAC mimetic LCL161 identified by longitudinal ex vivo pharmacogenomics of recurrent, KRAS mutated rectal cancer liver metastases
J Transl Med, 19 (1), 384
DOI 10.1186/s12967-021-03062-3, PubMed 34496878
Krüger K, Silwal-Pandit L, Wik E, Straume O, Stefansson IM, Borgen E, Garred Ø, Naume B, Engebraaten O, Akslen LA (2021)
Baseline microvessel density predicts response to neoadjuvant bevacizumab treatment of locally advanced breast cancer
Sci Rep, 11 (1), 3388
DOI 10.1038/s41598-021-81914-0, PubMed 33564016
Kurch L, Mauz-Körholz C, Fosså A, Georgi TW, Kluge R, Bartelt JM, Kunze C, Wohlgemuth WA, Pelz T, Vordermark D, Plößl S, Hasenclever D, Sabri O, Landman-Parker J, Wallace WH, Karlen J, Fernández-Teijeiro A, Cepelova M, Klekawka T, Løndalen AM, Steiner D, Krombach G, Attarbaschi A, Hoffmann M, Ceppi F et al. (2021)
Assessment of Waldeyer's ring in pediatric and adolescent Hodgkin lymphoma patients-Importance of multimodality imaging: Results from the EuroNet-PHL-C1 trial
Pediatr Blood Cancer, 68 (4), e28903
DOI 10.1002/pbc.28903, PubMed 33538093
Lanari J, Hagness M, Sartori A, Rosso E, Gringeri E, Dueland S, Cillo U, Line PD (2021)
Liver transplantation versus liver resection for colorectal liver metastasis: a survival benefit analysis in patients stratified according to tumor burden score
Transpl Int, 34 (9), 1722-1732
DOI 10.1111/tri.13981, PubMed 34448271
Lansu J, Bovée JVMG, Braam P, van Boven H, Flucke U, Bonenkamp JJ, Miah AB, Zaidi SH, Thway K, Bruland ØS, Baldini EH, Jebsen NL, Scholten AN, van den Ende PLA, Krol ADG, Ubbels JF, van der Hage JA, van Werkhoven E, Klomp HM, van der Graaf WTA, van Coevorden F, Schrage Y, van Houdt WJ, Haas RL (2021)
Dose Reduction of Preoperative Radiotherapy in Myxoid Liposarcoma: A Nonrandomized Controlled Trial
JAMA Oncol, 7 (1), e205865
DOI 10.1001/jamaoncol.2020.5865, PubMed 33180100
Larsen BH, Lundeby T, Gerwing J, Gulbrandsen P, Førde R (2021)
"Eh - What type of cells are these - flourishing in the liver?" Cancer patients' disclosure of existential concerns in routine hospital consultations
Patient Educ Couns, 105 (7), 2019-2026
DOI 10.1016/j.pec.2021.11.010, PubMed 34839995
Larsen SG, Goscinski MA, Dueland S, Steigen SE, Hofsli E, Torgunrud A, Lund-Iversen M, Dagenborg VJ, Flatmark K, Sorbye H (2021)
Impact of KRAS, BRAF and microsatellite instability status after cytoreductive surgery and HIPEC in a national cohort of colorectal peritoneal metastasis patients
Br J Cancer, 126 (5), 726-735
DOI 10.1038/s41416-021-01620-6, PubMed 34887523
Lehtiö J, Arslan T, Siavelis I, Pan Y, Socciarelli F, Berkovska O, Umer HM, Mermelekas G, Pirmoradian M, Jönsson M, Brunnström H, Brustugun OT, Purohit KP, Cunningham R, Foroughi Asl H, Isaksson S, Arbajian E, Aine M, Karlsson A, Kotevska M, Gram Hansen C, Drageset Haakensen V, Helland Å, Tamborero D, Johansson HJ et al. (2021)
Proteogenomics of non-small cell lung cancer reveals molecular subtypes associated with specific therapeutic targets and immune evasion mechanisms
Nat Cancer, 2 (11), 1224-1242
DOI 10.1038/s43018-021-00259-9, PubMed 34870237
Li RG, Napoli E, Jorstad IS, Bønsdorff TB, Juzeniene A, Bruland ØS, Larsen RH, Westrøm S (2021)
Calcium Carbonate Microparticles as Carriers of ²²⁴Ra: Impact of Specific Activity in Mice with Intraperitoneal Ovarian Cancer
Curr Radiopharm, 14 (2), 145-153
DOI 10.2174/1874471013666201201102056, PubMed 33261548
Lien TG, Ohnstad HO, Lingjærde OC, Vallon-Christersson J, Aaserud M, Sveli MAT, Borg Å, Osbreac OBO, Garred Ø, Borgen E, Naume B, Russnes H, Sørlie T (2021)
Sample Preparation Approach Influences PAM50 Risk of Recurrence Score in Early Breast Cancer
Cancers (Basel), 13 (23)
DOI 10.3390/cancers13236118, PubMed 34885228
Lilleheie I, Debesay J, Bye A, Bergland A (2021)
The tension between carrying a burden and feeling like a burden: a qualitative study of informal caregivers' and care recipients' experiences after patient discharge from hospital
Int J Qual Stud Health Well-being, 16 (1), 1855751
DOI 10.1080/17482631.2020.1855751, PubMed 33345749
Lindberg K, Grozman V, Karlsson K, Lindberg S, Lax I, Wersäll P, Persson GF, Josipovic M, Khalil AA, Moeller DS, Nyman J, Drugge N, Bergström P, Olofsson J, Rogg LV, Ramberg C, Kristiansen C, Jeppesen SS, Nielsen TB, Lödén B, Rosenbrand HO, Engelholm S, Haraldsson A, Billiet C, Lewensohn R (2021)
The HILUS-Trial-a Prospective Nordic Multicenter Phase 2 Study of Ultracentral Lung Tumors Treated With Stereotactic Body Radiotherapy
J Thorac Oncol, 16 (7), 1200-1210
DOI 10.1016/j.jtho.2021.03.019, PubMed 33823286
Lindberg Å, Eskelund CW, Albertsson-Lindblad A, Kolstad A, Laurell A, Räty R, Grønbaek K, Geisler CH, Jerkeman M (2021)
Pre-treatment health-related quality of life parameters have prognostic impact in patients >65 years with newly diagnosed mantle cell lymphoma: The Nordic Lymphoma Group MCL4 (LENA-BERIT) experience
Hematol Oncol, 40 (1), 22-30
DOI 10.1002/hon.2940, PubMed 34713465
Lindemann K, Smogeli E, Småstuen MC, Bruheim K, Trovik J, Nordberg T, Kristensen GB, Werner HMJ, Nakken E (2021)
Salvage Radiation for Pelvic Relapse after Surgically Treated Endometrial Cancer
Cancers (Basel), 13 (6)
DOI 10.3390/cancers13061367, PubMed 33803531
Liposits G, Orrevall Y, Kaasa S, Osterlund P, Cederholm T (2021)
Nutrition in Cancer Care: A Brief, Practical Guide With a Focus on Clinical Practice
JCO Oncol. Pract., 17 (7), 442-+
DOI 10.1200/OP.20.00704
Lokhande L, Kuci Emruli V, Eskelund CW, Kolstad A, Hutchings M, Räty R, Niemann CU, Grønbaek K, Jerkeman M, Ek S (2021)
Serum proteome modulations upon treatment provides biological insight on response to treatment in relapsed mantle cell lymphoma
Cancer Rep (Hoboken), 5 (7), e1524
DOI 10.1002/cnr2.1524, PubMed 34319003
Lundar T, Due-Tønnessen BJ, Frič R, Brandal P, Due-Tønnessen P (2021)
Choroid Plexus Tumors in Children: Long-Term Follow-Up of Consecutive Single-Institutional Series of 59 Patients Treated over a Period of 8 Decades (1939-2020)
World Neurosurg, 158, e810-e819
DOI 10.1016/j.wneu.2021.11.070, PubMed 34823041
Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
Outcome After Treatment of Spinal Ependymoma in Children and Adolescents: Long-Term Follow-up of a Single Consecutive Institutional Series of 33 Patients Treated Over Eight Decades
World Neurosurg, 150, e228-e235
DOI 10.1016/j.wneu.2021.02.131, PubMed 33684583
Lundar T, Due-Tønnessen BJ, Frič R, Sundseth J, Brandal P, Due-Tønnessen P (2021)
Outcome after treatment of pediatric supratentorial ependymoma: long-term follow-up of a single consecutive institutional series of 26 patients
Br J Neurosurg, 38 (2), 514-522
DOI 10.1080/02688697.2021.1914821, PubMed 34096810
Lundereng ED, Nes AAG, Holmen H, Winger A, Thygesen H, Jøranson N, Borge CR, Chen W, Dajani O, Mariussen KL, Steindal SA (2021)
Health Care Professionals' Experiences and Perspectives on Using Telehealth for Home-Based Palliative Care: Protocol for a Scoping Review
JMIR Res Protoc, 10 (10), e33305
DOI 10.2196/33305, PubMed 34714254
Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
Int J Behav Nutr Phys Act, 18 (1), 62
DOI 10.1186/s12966-021-01123-w, PubMed 33971901
Lærum-Onsager E, Molin M, Olsen CF, Bye A, Debesay J, Hestevik CH, Bjerk M, Pripp AH (2021)
Correction to: Effect of nutritional and physical exercise intervention on hospital readmission for patients aged 65 or older: a systematic review and meta-analysis of randomized controlled trials
Int J Behav Nutr Phys Act, 18 (1), 80
DOI 10.1186/s12966-021-01152-5, PubMed 34172048
Mariathasan AB, Boye K, Dueland S, Flatmark K, Larsen SG (2021)
Metastases in locally advanced rectal cancer undergoing curatively intended treatment
Eur J Surg Oncol, 47 (9), 2377-2383
DOI 10.1016/j.ejso.2021.04.023, PubMed 34049768
Mauz-Körholz C, Landman-Parker J, Balwierz W, Ammann RA, Anderson RA, Attarbaschi A, Bartelt JM, Beishuizen A, Boudjemaa S, Cepelova M, Claviez A, Daw S, Dieckmann K, Fernández-Teijeiro A, Fosså A, Gattenlöhner S, Georgi T, Hjalgrim LL, Hraskova A, Karlén J, Kluge R, Kurch L, Leblanc T, Mann G, Montravers F et al. (2021)
Response-adapted omission of radiotherapy and comparison of consolidation chemotherapy in children and adolescents with intermediate-stage and advanced-stage classical Hodgkin lymphoma (EuroNet-PHL-C1): a titration study with an open-label, embedded, multinational, non-inferiority, randomised controlled trial
Lancet Oncol, 23 (1), 125-137
DOI 10.1016/S1470-2045(21)00470-8, PubMed 34895479
Meltzer S, Torgunrud A, Abrahamsson H, Solbakken AM, Flatmark K, Dueland S, Bakke KM, Bousquet PA, Negård A, Johansen C, Lyckander LG, Larsen FO, Schou JV, Redalen KR, Ree AH (2021)
The circulating soluble form of the CD40 costimulatory immune checkpoint receptor and liver metastasis risk in rectal cancer
Br J Cancer, 125 (2), 240-246
DOI 10.1038/s41416-021-01377-y, PubMed 33837301
Mensali N, Dillard P, Fayzullin A, Köksal H, Gaudernack G, Kvalheim G, Inderberg EM, Wälchli S (2021)
"Built-in" PD-1 blocker to rescue NK-92 activity from PD-L1-mediated tumor escape mechanisms
FASEB J, 35 (9), e21750
DOI 10.1096/fj.202100025R, PubMed 34424568
Merrien M, Wasik AM, Ljung E, Morsy MHA, de Matos Rodrigues J, Carlsten M, Rassidakis GZ, Christensson B, Kolstad A, Jerkeman M, Ek S, Herold N, Wahlin BE, Sander B (2021)
Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma
Virchows Arch, 480 (3), 655-666
DOI 10.1007/s00428-021-03228-w, PubMed 34738194
Moe YM, Groendahl AR, Tomic O, Dale E, Malinen E, Futsaether CM (2021)
Deep learning-based auto-delineation of gross tumour volumes and involved nodes in PET/CT images of head and neck cancer patients
Eur J Nucl Med Mol Imaging, 48 (9), 2782-2792
DOI 10.1007/s00259-020-05125-x, PubMed 33559711
Moosavi SH, Eide PW, Eilertsen IA, Brunsell TH, Berg KCG, Røsok BI, Brudvik KW, Bjørnbeth BA, Guren MG, Nesbakken A, Lothe RA, Sveen A (2021)
De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity
Genome Med, 13 (1), 143
DOI 10.1186/s13073-021-00956-1, PubMed 34470666
Morra A, Escala-Garcia M, Beesley J, Keeman R, Canisius S, Ahearn TU, Andrulis IL, Anton-Culver H, Arndt V, Auer PL, Augustinsson A, Beane Freeman LE, Becher H, Beckmann MW, Behrens S, Bojesen SE, Bolla MK, Brenner H, Brüning T, Buys SS, Caan B, Campa D, Canzian F, Castelao JE, Chang-Claude J et al. (2021)
Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment
Breast Cancer Res, 23 (1), 86
DOI 10.1186/s13058-021-01450-7, PubMed 34407845
Mul J, Melchior P, Seravalli E, Saunders D, Bolle S, Cameron AL, Gurtner K, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Mandeville H, Boterberg T, Kroon PS, Kotte ANTJ, Hoeben BAW, van Rossum PSN, van Grotel M, Graf N, van den Heuvel-Eibrink MM, Rübe C, Janssens GO (2021)
Inter-clinician delineation variation for a new highly-conformal flank target volume in children with renal tumors: A SIOP-Renal Tumor Study Group international multicenter exercise
Clin Transl Radiat Oncol, 28, 39-47
DOI 10.1016/j.ctro.2021.03.001, PubMed 33796796
Murray C, von Possel N, Lie HC, Breivik J (2021)
The Nine Cancer Frames: A Tool to Facilitate Critical Reading of Cancer-Related Information
J Cancer Educ, 37 (6), 1918-1927
DOI 10.1007/s13187-021-02062-7, PubMed 34279845
Myklebust MP, Thor A, Rosenlund B, Gjengstø P, Karlsdottir Á, Brydøy M, Bercea BS, Olsen C, Johnson I, Berg MI, Langberg CW, Andreassen KE, Kjellman A, Haugnes HS, Dahl O (2021)
Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
Sci Rep, 11 (1), 15582
DOI 10.1038/s41598-021-94812-2, PubMed 34341387
Nakken S, Lilleby W, Switlyk MD, Knudsen KE, Lilleby O, Zhao S, Kaveh F, Ekstrøm PO, Urbanucci A, Hovig E (2021)
The Quandary of DNA-Based Treatment Assessment in De Novo Metastatic Prostate Cancer in the Era of Precision Oncology
J Pers Med, 11 (5)
DOI 10.3390/jpm11050330, PubMed 33922147
Napoli E, Bønsdorff TB, Jorstad IS, Bruland ØS, Larsen RH, Westrøm S (2021)
Radon-220 diffusion from 224Ra-labeled calcium carbonate microparticles: Some implications for radiotherapeutic use
PLoS One, 16 (3), e0248133
DOI 10.1371/journal.pone.0248133, PubMed 33662039
Nilssen Y, Eriksen MT, Guren MG, Møller B (2021)
Factors associated with emergency-onset diagnosis, time to treatment and type of treatment in colorectal cancer patients in Norway
BMC Cancer, 21 (1), 757
DOI 10.1186/s12885-021-08415-1, PubMed 34187404
Nobre AR, Risson E, Singh DK, Di Martino JS, Cheung JF, Wang J, Johnson J, Russnes HG, Bravo-Cordero JJ, Birbrair A, Naume B, Azhar M, Frenette PS, Aguirre-Ghiso JA (2021)
Bone marrow NG2⁺/Nestin⁺ mesenchymal stem cells drive DTC dormancy via TGFβ2
Nat Cancer, 2 (3), 327-339
DOI 10.1038/s43018-021-00179-8, PubMed 34993493
Nome RV, Småstuen MC, Fosså SD, Kiserud CE, Åsvold BO, Bjøro T (2021)
Thyroid hypofunction in aging testicular cancer survivors
Acta Oncol, 60 (11), 1452-1458
DOI 10.1080/0284186X.2021.1958004, PubMed 34351829
Olsen CF, Bergland A, Bye A, Debesay J, Langaas AG (2021)
Crossing knowledge boundaries: health care providers' perceptions and experiences of what is important to achieve more person-centered patient pathways for older people
BMC Health Serv Res, 21 (1), 310
DOI 10.1186/s12913-021-06312-8, PubMed 33827714
Olsen CF, Bergland A, Debesay J, Bye A, Langaas AG (2021)
Patient Flow or the Patient's Journey? Exploring Health Care Providers' Experiences and Understandings of Implementing a Care Pathway to Improve the Quality of Transitional Care for Older People
Qual Health Res, 31 (9), 1710-1723
DOI 10.1177/10497323211003861, PubMed 34010082
Olsen SU, Hesseberg K, Aas AM, Pripp AH, Ranhoff AH, Bye A (2021)
A comparison of two different refeeding protocols and its effect on hand grip strength and refeeding syndrome: a randomized controlled clinical trial
Eur Geriatr Med, 12 (6), 1201-1212
DOI 10.1007/s41999-021-00520-5, PubMed 34086194
Olsen SU, Hesseberg K, Aas AM, Ranhoff AH, Bye A (2021)
Refeeding syndrome occurs among older adults regardless of refeeding rates: A systematic review
Nutr Res, 91, 1-12
DOI 10.1016/j.nutres.2021.05.004, PubMed 34130206
Olszewski AJ, Jakobsen LH, Collins GP, Cwynarski K, Bachanova V, Blum KA, Boughan KM, Bower M, Dalla Pria A, Danilov A, David KA, Diefenbach C, Ellin F, Epperla N, Farooq U, Feldman TA, Gerrie AS, Jagadeesh D, Kamdar M, Karmali R, Kassam S, Kenkre VP, Khan N, Kim SH, Klein AK et al. (2021)
Burkitt Lymphoma International Prognostic Index
J Clin Oncol, 39 (10), 1129-1138
DOI 10.1200/JCO.20.03288, PubMed 33502927
Osterman E, Ekström J, Sjöblom T, Kørner H, Myklebust TÅ, Guren MG, Glimelius B (2021)
Accurate population-based model for individual prediction of colon cancer recurrence
Acta Oncol, 60 (10), 1241-1249
DOI 10.1080/0284186X.2021.1953138, PubMed 34279175
Pandya AD, Iversen TG, Moestue S, Grinde MT, Mørch Ý, Snipstad S, Åslund AKO, Øy GF, Kildal W, Engebråten O, Sandvig K, Skotland T, Mælandsmo GM (2021)
Biodistribution of Poly(alkyl cyanoacrylate) Nanoparticles in Mice and Effect on Tumor Infiltration of Macrophages into a Patient-Derived Breast Cancer Xenograft
Nanomaterials (Basel), 11 (5)
DOI 10.3390/nano11051140, PubMed 33924869
Paria BC, Levin N, Lowery FJ, Pasetto A, Deniger DC, Parkhurst MR, Yossef R, Kim SP, Florentin M, Ngo LT, Ray S, Krishna S, Robbins PF, Rosenberg SA (2021)
Rapid Identification and Evaluation of Neoantigen-reactive T-Cell Receptors From Single Cells
J Immunother, 44 (1), 1-8
DOI 10.1097/CJI.0000000000000342, PubMed 33086340
Park J, Choi JY, Choi J, Chung S, Song N, Park SK, Han W, Noh DY, Ahn SH, Lee JW, Kim MK, Jee SH, Wen W, Bolla MK, Wang Q, Dennis J, Michailidou K, Shah M, Conroy DM, Harrington PA, Mayes R, Czene K, Hall P, Teras LR, Patel AV et al. (2021)
Gene-Environment Interactions Relevant to Estrogen and Risk of Breast Cancer: Can Gene-Environment Interactions Be Detected Only among Candidate SNPs from Genome-Wide Association Studies?
Cancers (Basel), 13 (10)
DOI 10.3390/cancers13102370, PubMed 34069208
Partridge AH, Niman SM, Ruggeri M, Peccatori FA, Azim HA, Colleoni M, Saura C, Shimizu C, Sætersdal AB, Kroep JR, Mailliez A, Warner E, Borges VF, Amant F, Gombos A, Kataoka A, Rousset-Jablonski C, Borstnar S, Takei J, Lee JE, Walshe JM, Borrego MR, Moore HC, Saunders C, Cardoso F et al. (2021)
Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy
Breast, 59, 327-338
DOI 10.1016/j.breast.2021.07.021, PubMed 34390999
Peneder P, Stütz AM, Surdez D, Krumbholz M, Semper S, Chicard M, Sheffield NC, Pierron G, Lapouble E, Tötzl M, Ergüner B, Barreca D, Rendeiro AF, Agaimy A, Boztug H, Engstler G, Dworzak M, Bernkopf M, Taschner-Mandl S, Ambros IM, Myklebost O, Marec-Bérard P, Burchill SA, Brennan B, Strauss SJ et al. (2021)
Multimodal analysis of cell-free DNA whole-genome sequencing for pediatric cancers with low mutational burden
Nat Commun, 12 (1), 3230
DOI 10.1038/s41467-021-23445-w, PubMed 34050156
Peters M, de Leeuw AAC, Nomden CN, Tanderup K, Kirchheiner K, Lindegaard JC, Kirisits C, Haie-Meder C, Sturdza A, Fokdal L, Mahantshetty U, Hoskin P, Segedin B, Bruheim K, Rai B, Huang F, Cooper R, van der Steen-Banasik E, van Limbergen E, Pieters BR, Tan LT, van Rossum PSN, Nesvacil N, Nout R, Schmid MP et al. (2021)
Risk factors for nodal failure after radiochemotherapy and image guided brachytherapy in locally advanced cervical cancer: An EMBRACE analysis
Radiother Oncol, 163, 150-158
DOI 10.1016/j.radonc.2021.08.020, PubMed 34480958
Philipson RG, Romero T, Wong JK, Stish BJ, Dess RT, Spratt DE, Pilar A, Reddy C, Wedde TB, Lilleby WA, Fiano R, Merrick GS, Stock RG, Demanes DJ, Moran BJ, Braccioforte M, Tran PT, Martin S, Martinez-Monge R, Krauss DJ, Abu-Isa EI, Valle L, Chong N, Pisansky TM, Choo CR et al. (2021)
Patterns of Clinical Progression in Radiorecurrent High-risk Prostate Cancer
Eur Urol, 80 (2), 142-146
DOI 10.1016/j.eururo.2021.04.035, PubMed 33985797
Pierson SK, Shenoy S, Oromendia AB, Gorzewski AM, Langan Pai RA, Nabel CS, Ruth JR, Parente SAT, Arenas DJ, Guilfoyle M, Reddy M, Weinblatt M, Shadick N, Bower M, Pria AD, Masaki Y, Katz L, Mezey J, Beineke P, Lee D, Tendler C, Kambayashi T, Fosså A, van Rhee F, Fajgenbaum DC (2021)
Discovery and validation of a novel subgroup and therapeutic target in idiopathic multicentric Castleman disease
Blood Adv, 5 (17), 3445-3456
DOI 10.1182/bloodadvances.2020004016, PubMed 34438448
Pilleron S, Charvat H, Araghi M, Arnold M, Fidler-Benaoudia MM, Bardot A, Guren MG, Tervonen H, Little A, O'Connell DL, Gavin A, De P, Thomsen LA, Moller B, Jackson C, Bucher O, Walsh PM, Vernon S, Bray F, Soerjomataram I (2021)
Age disparities in stage-specific colon cancer survival across seven countries: An International Cancer Benchmarking Partnership SURVMARK-2 population-based study. (vol 148, 1575, 2021)
Int. J. Cancer, 149 (6), E9
DOI 10.1002/ijc.33717